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Abstract. 
A review of the published work on pumps designed to assist a failing biological heart 
has been made and discusses the different types of pump presently on the market with the 
characteristics of each. The materials used to make these pumps are also discussed, 
together with some of the methods of output control. The application to the patient is 
described together with the advantages and disadvantages. 
A Tesla type pump appeared to offer an alternative solution to those problems listed 
above. This is not a new design but appeared to offer advantages if applied to the 
application of pumping blood from outside the body. One of these was that at a constant 
speed, the pump supplied constant fluid pressure irrespective of the delivery. It also 
appears that the pump can give fluid shear stress levels that are less than the amount that 
will seriously damage blood components. 
A prototype pump has been built and tested. The pump achieved the performance 
target delivery of 10 I/min at a differential pressure of 200 mm Hg. This was considered to 
be greater than the average performance produced by existing blood pumps but the 
maximum performance that could be produced by the human heart under extreme 
conditions. The pump reached a maximum speed of about 4000 rev/min with a maximum 
power consumption of about 120 Watts. 
The results indicate that this type of pump is a potential blood pump in terms of the 
delivery and pressures achieved. 
The characteristic performance figures are within the envelope of published 
theoretical results. 
The pump tested here needs further development to improve the hydraulic 
performance. Recommendations are made for the direction of future work to improve the 
pump efficiency and flow patterns, biocompatibility and methods of production. Controls and 
power supply also need improvement. 
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Glossary 
Aggregate. A dense cluster of cells wherein macromolecules such as fibrinogen physically 
link adjacent cell membranes. 
Aggregation. A crowded mass of independent but similar units, a cluster. 
Albumin. A water soluble protein coagulated by heat. Serum albumin is found in blood 
plasma and is important for the maintenance of the blood plasma. Albumin is synthesized in 
the liver and the inability to do this is a feature of chronic liver disease, i.e. cirrhosis. 
The type of albumin depends on the source, muscle, milk, blood, serum, egg, vegetable etc. 
Some albumins, (egg), injected directly into the blood are highly poisonous. 
Allograft. A transplant between individuals of the same species, i.e., kidney transplant 
between two unrelated humans. 
Angina. A sense of suffocation or suffocating pain with difficulty in breathing or choking. 
This term is often used to describe Angina Pectoris. It is a usually a pain in the centre of the 
chest induced by exercise and is relieved by rest. In this condition the heart is demanding 
more blood than can be supplied through the coronary arteries, probably due to artery 
disease. The condition can be relieved by drug treatments or by invasive surgery. 
Anomalous. Any deviation from normal. Something that is irregular or deviating from rule. 
Antibody. A special type of blood protein synthesized in lymphoid tissue in response to the 
presence of a particular antigen, which it attacks and renders harmless. The antigen can be 
contained in pollen grains, invading bacteria, foreign blood cells, infectious diseases and 
can be responsible for organ rejection. 
Anticoagulants. Drugs which prevent the coagulation of blood. The main ones in use: -
heparin, phenindione, and warfarin. 
Antigen. Any substance that the body regards as foreign or potentially dangerous and 
against which it produces an antibody. Antigens can trigger the immune response following 
organ transplantation. 
Apical. The apex or tip or summit of an organ. 
Apparent viscosity. The viscosity calculated from Poiseuille's law at any particular flow and 
tube diameter; it is used for suspensions such as blood, that exhibit anomalous viscosity, 
the ratio of shear stress to shear rate at any point in a viscometric flow of an 
inhomogeneous fluid. 
Arrhythmia. Any variation from the normal regular rhythm of the heart beat. Can be a 
symptom of heart disease but can also occur without apparent cause. 
Artery. A blood vessel carrying blood from the heart to an organ(s). The walls of an artery 
consist of four layers, a smooth inner lining, a thin elastic layer, a thick muscular, elastic, 
layer and a tough fibrous outer layer. The structure of arteries enables them to withstand 
the high blood pressure peaks caused by pulsatile action of the heart. See also veins. 
XVII 
Glossary, (continued). 
Aspirin. (Acetylsalicyclic acid.) Widely used drug used for relief of pain, inflammation and 
fever. Taken by mouth, alone or in combination either other analgesics for the relief of the 
less severe types of pain. 
Daily doses used to help prevent coronary thromboses / strokes in those at risk and have a 
protective effect against other conditions 
Atheroma. Degeneration of artery walls due to the formation of fatty plaques and scar tissue. 
Atherosclerosis. Disease of the arteries where fatty plaques develop on the walls of arteries 
and can cause blockage to blood flow. See atheroma. 
Autograft. A transplant within one individual, from one part of the body to another. A skin 
graft would come into this category. 
Autologous - vein. Denoting a graft that is derived from the recipient of the graft. Can also 
indicate a natural 'by-pass' of a blocked artery/vein. (i.e., Multiple capillaries by-passing a 
blockage.) 
Azotaemia. The presence of urea and other nitrogenous bodies in greater concentrations 
than normal in the blood. Usually associated with advanced types of kidney disease. 
(Former name for uraemia, occurs in kidney failure). 
Bilirubin. The chief pigment in human bile, derived from haemoglobin. 
Bioactive material. A material designed to promote a specific response such as bone in-
growth. . 
Biocompatible. A material able to perform with a host in a specific situation. 
Bioinert material. A material which causes little response from the body reactions. 
Biomaterial. Any substance, other than a drug, or combination of substances, synthetic or 
natural in origin, which can be used for a period of time, as whole or part of a system, which 
treats, augments, or replaces any tissue, organ, or function of the body. (Boretos, J.W. and 
Eden, M, Eds., Contemporary Biomaterials, Park Ridge, New Jersey. Noyes Publications, 
p651 - 665. (1984) 
Blood pressure. This is the pressure of the blood produced by the heart. Blood pressure 
varies with each patient and is related to age and physical condition. Accepted figures for a 
healthy adult are a systoliC pressure in the order of 140 mm Hg. and a diastolic pressure of 
80 mm Hg. 
Cannula. A hollow tube designed for insertion into a body cavity, (bladder / blood vessel). 
Carbon dioxide - can poison haemoglobin. The blood of cigarette smokers contains more 
carbon dioxide than normal and babies born to smoking mothers are usually smaller due to 
less oxygen received during fetal development. 
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Glossary, (continued) 
Cardiomyopathy. Diseases of the heart muscle, origin unknown, any chronic disorder 
affecting the heart muscle, can be inherited but can also be caused by other conditions, 
viral infections, alcoholism, vitamin B deficiency, (beri-beri), and amylidosis, cause often 
unknown. May result in enlargement of the heart, heart failure, arrhythmias and embolism. 
Often no specific treatment but patient often improves following control of heart failure and 
arrhythmias. 
CFD. Computational Fluid Dynamics, a mathematical calculation used to determine the flow 
patterns in fluids. 
Cholesterol. 
Chemically a lipid, cholesterol is an important constituent of body cells. It is involved in the 
formation of hormones and bile salts and in the transport of fats in the bloodstream to 
tissues throughout the body. There is evidence that a high blood cholesterol level increases 
the risk of atherosclerosis, (accumulation of fatty deposits on the lining of arteries), and the 
risk of coronary artery disease or stroke. 
Clotting factors. A group of substances present in blood plasma that under certain 
circumstances undergo chemical reactions leading to the blood clotting process. Although 
they have specific names most are referred to by an agreed set of Roman numerals. 
Lack of any of these factors results in the inability of the blood to clot. 
Collagen. A protein, principal constituent of white fibrous connective tissue, occurs in 
tendons. Also found in skin, bone, cartilage and ligaments. Relatively inelastic but has high 
tensile strength. An important constituent of heart and blood vessels and with calcium salts 
provides the rigid structure of bone. 
Covalent bond. A chemical bond in which electrons are shared between two atoms, giving 
each atom a share in each other's electrons. 
Dipyridamole. A drug that dilates the blood vessels of the heart, reduces platelet 
aggregation. Given by mouth or injection to prevent thrombosis. 
Embolus. Any material that lodges in a vein or artery. 
Embolism. The blocking of a blood vessel by an embolus. 
Endothelial cells. Endo - prefix meaning located inside. 
Endothelium - membrane lining various vessels and cavities of the body - fibrous 
layer covered with thin, flat cells, renders the surface perfectly smooth, secretes the fluid for 
lubrication 
Erythrocyte. Another name for the red blood corpuscle. A blood cell containing the red 
pigment, haemoglobin, the principle function of which is to transport oxygen around the 
body. 
Extracorporeal. Outside or unrelated to the body. 
XIX 
Glossary. (Continued) 
Factor. A sUbstance that is essential to a physiological process - often a substance the 
nature of which is unknown. 
Factor XI. A coagulation factor normally present in blood. Deficiency of the factor is 
inherited but rarely causes spontaneous bleeding. However bleeding does occur after 
surgery or trauma to the blood vessels. 
Factor VII. A single chain glycoprotein that is essential for the process of coagulation / 
formation of blood clots. 
Fibrillation. A rapid and chaotic beating of the many individual muscle fibres of the heart, 
the consequence of this is that the heart is unable to maintain effective synchronous 
contractions. 
Atrial fibrillation, a common type of arrhythmia, a rapid and irregular heart rate. 
Ventricular fibrillation, occurs when the heart stops beating, a cardiac arrest, and is 
the cessation of effective pumping of the heart where the muscle fibres are beating rapidly 
without pumping blood. 
Fibrin. Substance formed in the blood as it clots. Produced as threads forming a close 
meshwork through the blood, formed not only from shed blood but also from lymph via. 
lymph vessels. Precursor is fibrogen, soluble protein in blood. 
Giant cells. Any large cell such as a megakaryocyte - may have 1 or many nuclei. 
Mega - prefix denoting largeness 
Megokaryocyte - a cell in the bone marrow, (35 - 160~m in dia.), that produces 
platelets. 
Glutaraldehyde. A chemical used as a disinfectant in health care and other industries. It can 
cause irritation to human skin in concentrations above 2%. Extended exposure has caused 
skin dermatitis and may cause asthma. 
Haemocompatibility. The capability of a substance or material of mixing with and existing 
with blood with no adverse effects on the function of each other. 
Haemodialysis. The technique of removing waste products and poisons from the blood by 
what is basically a filtering process. 
Haemoglobin. The material that produces the red colour of blood. It is a dynamic molecule 
that changes its shape and characteristics and helps regulate oxygen delivery and blood pr 
levels. Main function is to carry oxygen around the body. It binds to oxygen when exposed 
to air, transports oxygen to capillaries, releases oxygen, binds to carbon dioxide, and then 
transports the carbon dioxide to the lungs 
Haemolysis. The breaking up of the blood corpuscles by the action of poisonous 
substances, usually of a protein nature, circulating in the blood or by certain chemicals. It 
can occur gradually in some forms of anaemia and rapidly in poisoning for example via 
snake venom. The destruction of red blood cells. 
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Haemostasis. The arrest of bleeding involving the coagulation of blood / contraction of 
damaged blood vessels. Can include the application of ligatures or diathermy. 
Haemotocrit. The proportion of red blood cells in a column of centrifuged blood + plasma 
mixture. Normal figures are plasma = 55%, red blood cells = 45%. 
Heart output. At rest, output is approx. 6 litres/minute @ 60/80 beats/minute. Active output 
can be as high as 50 litres/minute @ 200 beats/minute. 
Heparin. An anti-coagulant produced by the liver, some white cells and other sites such as 
muscle and lung. It inhibits the action of the enzyme thrombin in the final stages of blood 
coagulation. An extracted, purified form is used for the prevention of blood coagulation in 
patients with thrombosis and similar conditions. It is also used in blood collected for 
examination. 
Complicated in chemical structure, has been prepared in crystalline form. Carbohydrate in 
nature, contains amino and sulphuric acid groups. 
Usually given by injection, not effective when given by mouth. The most important side 
effect is bleeding. 
See also 'low molecular weight heparin' and 'anticoagulants'. 
Heterograft. A transplant between members of a different species, i.e., heart valves taken 
from a pig and transplanted into a human. 
Homograft. See Allograft. 
Hydrophilic. A surface having affinity for water, 'wettable' by water. 
Hydrophobic. A surface not readily 'wettable' by water. 
Hyperplasia. Abnormal multiplication or increase in the number of normal cells in a normal 
arrangement of tissue. 
Hypertrophy. This is the increase in the size of a tissue or organ by the enlargement of its 
cells rather than by its multiplication of cells as in normal growth. Examples are the 
enlargement of the breast during pregnancy, enlargement of remaining kidney following 
failure of the first. 
In vitro. Latin, meaning 'in glass', referring to a laboratory test. 
Intima. Innermost coat, lining the arteries and veins. 
InotropiC. A substance affecting the contraction of heart muscle. Digitalis, dobutamine, 
enoximone have a positive action stimulating contractions and the heart rate to increase. 
Betablockers such as propranolol have a negative reaction reducing contractions and the 
heart rate to decrease. 
In vivo. Latin meaning 'in life', referring to tests in living systems. 
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Ischaemia. Bloodlessness of a part of the body due to contraction, spasm or blocking, (by 
embolus / thrombus). 
Isograft. A transplant between two genetically identical individuals, i.e., identical twins. 
Isomer. The same kind and number of atoms united in different structural forms giving 
different compounds with different characteristics. Similar to allotropism or polymorphism in 
crystalline materials where the same material can exist in more than one crystal structure. 
Laminar flow. The relative motion of elements of a fluid along smooth, parallel paths, this 
occurs at lower values of Reynolds numbers. 
Leucocyte. A white blood cell. Any blood cell that contains a nucleus. 
In health there are 3 major subdivisions, granulocytes, lymphocytes and monocytes that are 
involved in protecting the body against foreign substances and in antibody production. In 
disease a variety of other types may appear in the blood most notably immature forms of 
the normal red or white blood cells. 
Leucocytes constitute one of the most important of the defence mechanisms against 
infection, particularly neutrophil leucocytes. 
Ligature. A cord or thread tied around an artery to stop the blood flow or to prevent the 
escape of blood from a cut end. The cord is usually cat gut or silk and tied with a reef knot. 
Lipid. 
A general term for fats and oils. Lipids, or lipins, as they are sometimes called include 
triglycerides, (simple fats), phospholipids, (important constituents of cell membranes and 
nerve tissue), and sterols such as cholesterol. 
Low molecular weight heparin. A type of heparin more readily absorbed and requires less 
frequent administration than standard heparin. Used as anticoagulant to prevent deep vein 
thrombosis after surgery/kidney dialysis. Less risk of bleeding. Also known as 'enoxaparin'. 
Lysis. The gradual ending of a fever, also used to describe the process of dissolution of a 
blood clot / loosening of adhesions. Denotes dissolution. 
Macrophage. A large scavenger cell, (phagocyte), present in connective tissue. 
Fixed cell. Stationary within connective tissue / major organs / bone marrow / 
nervous system. 
Free cells wander between cells and aggregate at focal sites of infection removing 
bacteria / foreign bodies from blood and tissue. 
Mediastinum. The space in the chest between the lungs that contains the heart, great 
vessels, gullet, lower part of windpipe, thoracic duct, phrenic nerves and other structures. 
Regions are anterior, middle, posterior and superior. 
Morphology. This is the study of forms of things, especially of animals, and their structures. 
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Myocarditis. Chronic or acute inflammation of the heart muscle. May be seen alone or as 
part of pancarditis when the pericardium is involved. 
Newtonian fluid. A fluid in which flow and shear rate are always proportional to the applied 
stress; a fluid in which the ratio of shear stress to shear rate in a visco metric flow, defined 
as the dynamic viscosity, is independent of shear rate and is at most a function of 
temperature. 
Non - newtonian fluid. A fluid in which flow and rate of shear are not proportional to the 
applied stress; a fluid in which the ratio of shear stress to shear rate in a viscometric flow is 
a function of shear rate as well as temperature. 
Oedema. An abnormal accumulation of fluid in the body tissues. Local - from injury giving 
local swelling, or general - causes heart failure, kidney or liver problems. 
Orthotopic. Orthotics - science and practice of fitting surgical appliances to assist 
weakened joints. 
Pacemaker. A device used to produce and maintain a normal heartbeat in patients who 
have heart block, (sinoatrial node). It consists of a battery and electronics that stimulate the 
heart via. a wire attached to the surface of a ventricle, (epicardical pacemaker), or lying in 
contact with the lining of the heart, (endocardical pacemaker). Some pacemakers are 
temporary, others are permanent, some stimulate at a fixed rate, others sense when the 
heart rate falls below a pre-determined rate which then triggers the device, (demand 
pacemaker). 
Pannus. General name given to additional, unwanted tissue growth. 
Perfusion. 1) The passage of a fluid through a tissue, especially the passage of blood 
through lung tissue to pick up oxygen from the air in the alveoli, which is brought there by 
ventilation and release carbon dioxide. If ventilation is impaired, deoxygenated venous 
blood is returned to the general circulation. If perfUSion is impaired, insufficient gas 
exchange takes place. 
2) This is the deliberate introduction of a fluid into a tissue, usually by injection into 
the blood vessels supplying the tissue. 
Pericardium. Sac or membrane lining the heart. 
Phagocyte. A defensive cell that is able to release powerful chemicals to kill invading cells, 
will engulf and digest bacteria, protozoa, cells and cell debris and other small particles. 
Includes White blood cells, (Leucocyte), and Macrophages. Phagocytes take up oxidised 
low-density lipoprotein, (the major cholesterol carrier in the blood), become 'foam' cells 
which congregate on arterial walls. These events are believed to participate in the build up 
of lipid deposits leading to clogged arteries. 
Phagocytosis. Process by which the attacks of bacteria apon the living body are repelled 
and the bacteria destroyed via. the action of the white corpuscles of the blood. 
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Poly. Meaning 'many'. 
Polymer. Chemical compound with large molecules made of many smaller molecules of the 
same kind, i.e. a molecule comprising of 'many mers'. 
Polymorph. Anyone of several forms in which the same thing may occur. An organism 
occurring in several forms, / a substance crystallising in several systems. 
Pulmonary capillary wedge pressure. (PCWP) The pressure of blood in the left atrium, 
indicating the adequacy of the pulmonary circulation. 
Pyrolytic carbon. Pyro - prefix meaning anything connected with fire or produced by heating. 
A biocompatible material, can be used as a coating. 
Rejection. Process where the body rejects a 'foreign' body. This can be a valuable part of 
the body defence mechanism but can act adversely if such organs as heart and kidneys are 
the implanted body as the rejection can lead to the death of the patient. See Tissue Typing. 
Reynolds number. A dimensionless number that is used to describe the flow conditions of a 
fluid in terms of density, viscosity and velocity in a tube or other flow passage. 
Rheology. The science of the deformation and flow of matter. 
Rouleaux. An aggregate of erythrocytes stacked like a pile of coins. 
Shear rate. The change in velocity of a flowing liquid separated by unit distance; its units 
are expressed in inverse seconds, (S-1). The velocity gradient of fluid layers in a given 
vessel; when flow velocity is high, shear rate is high, and vice versa. 
Shear stress. Is a measure of the force required to produce a given rate of flow and is 
expressed in N/m2. 
Sinoatrial node. The pacemaker of the heart, a microscopic area of specialised cardiac 
muscle located in the upper wall of the right atrium near the entry of the vena cava. Fibres 
of the sinoatrial node self excite and contract rhythmically around 70 times/min. Following 
each contraction, the impulse spreads through the atrial muscle and into fibres connecting 
the sinoatrial node with the atrioventricular node. Fibres of the autonomic nervous system 
supply the sinoatrial node and the impulses arriving at the node either accelerate or 
decelerate the heart rate. 
Stenosis. The abnormal narrowing of a passage or opening such as a blood vessel or heart 
valve. 
Sternotomy. Surgical division of the breast bone, (sternum), to allow access to the heart 
and major vessels. 
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Systole. The ~eriod of the cardi~c cycle during which the heart contracts. The term usually 
refers to ventncular systole, which lasts about about 0.3 seconds. Atrial systole lasts about 
0.1 secs. 
Tachycardia. An increase in the heart rate above normal. Can be caused by exercise _ 
excitement - illness. 
Tampon. A pack of gauze, cotton wool or other absorbent material used to plug a cavity or 
canal in order to absorb blood or secretions. 
Tamponade. Abnormal pressure on a part of the body, for example, pressure caused by the 
presence of excessive fluid between the pericardium, (sac surrounding the heart), and the 
heart. 
Tetralogy of Fallot. Cyanotic congenital heart disease. (The child is blue, i.e., a 'blue baby'.) 
This can be a) Stenosis of the pulmonary valve, b) Septal defect, (ventricular defect), 
c) Aorta over rides both ventricles, d) Marked hypertrophy of the right ventricle. 
TETS. Transmission of Energy Through the Skin. A process where electrical power is 
transmitted through the skin of the patient and is used to charge an implanted battery. The 
impl,anted battery is then used to power an implanted control system and blood pump. 
Thrombus. Blood clot or the formation of blood clots. 
Thrombogenic. An agent which promotes the development of a thrombus. 
t-PA. (Tissue plasminogen activator.) A natural protein in the body that can break up a 
thrombosis. It can now be produced by genetic engineering. It requires the presence of 
fibrin as a co-factor and is able to activate plasminogen on the fibrin surface which 
distinguishes it from the other plasminogen activators, strepokinase and urokinase. 
Tissue Typing. This process compares the compatibility of different tissues to the 
immunological responses and is known collectively as histocompatibility. Equality, or near 
equality, of tissue types is essential to ensure acceptance of grafts, transfusions and 
transplants. 
Tribology. The science and technology embracing all subjects involved when surfaces in 
contact move in relation to one another. 
Vein. A blood vessel carrying blood away from an organ(s). A vein consists of three layers, 
an inner coating, a muscular middle layer, and a tough outer layer. The walls of veins are 
thinner than the walls of arteries and most contain valves to ensure that blood flow is in one 
direction only. Veins do not have the pulsatile blood flow associated with arteries. See also 
arteries. 
Viscosity. In general, the resistance to flow or alteration of shape by any substance as a 
result of molecular cohesion; most frequently applied to liquids as the resistance of a fluid to 
flow because of a shearing force. 
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Warfarin. Anticoagulant used in treatment of coronary and venous thrombosis to reduce the 
risk of embolism. Usually given by mouth, maximum effect in 36 hours, action passes off 
within 48 hours of cessation of treatment. Principal toxic effect is bleeding usually from 
gums and other mucous membranes. 
White blood cell. Any cell that contains a nucleus. Three major sub divisions, granulocytes, 
lymphocytes, monocytes - all involved in protecting the body against foreign substances 
and in anti body production. See leukocyte. 
Xenograft. See Hetrograft. 
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CHAPTER 1, INTRODUCTION. 
1.0 Aims 
The purpose of the present work is to investigate the design and 
parameter measurements of a Tesla type pump, (Tesla N., 1856-1943), to 
assess its suitability to pump blood in vivo. 
In order to understand the constraints involved in pumping blood a review 
of the biological and physiological problems involved including effects on the 
heart and other organs is made. 
1.1. The Heart. 
The left ventricle of the heart pumps blood through arteries to all the 
organs in the body where it returns through veins to the right atrium to be 
pumped around again. The failure to pump sufficient blood is linked to 
cardiovascular problems. Signs of heart failure include fatigue, breathlessness 
after exertion and the accumulation of fluid in the lungs, ankles and abdomen. 
The inability of the heart to pump enough blood can cause damage to organs 
such as the kidneys, liver, which can result in death from organ failure in 
addition to any heart problem. 
Initial treatments include drug therapy and lifestyle changes. If treatment, such 
as angioplasty, is not satisfactory, the final solution is a heart transplant. This 
procedure carries risks in terms of rejection. Sufficient donor hearts are 
difficult to obtain and the supply in the USA in the years from 1992 to 2002 
has remained at about 2500 per year with a waiting list of up to 8000 potential 
recipients. Zaroff J. et ai, (Circulation 2002). Many patients die before 
receiving a transplant. 
Alternative treatments include the use of mechanical aids to pump the 
blood around the body. These devices assist or replace the heart and each 
one carries its own set of problems and risks. (New and Emerging Techniques 
- Surgical, 2002) 
Table 1.1 shows the range of possible therapeutic options using 
mechanical pumps to pump blood. 
1 
Therapeutic Description 
options 
Bridge to transplant To support the heart until a transplant can 
be performed. 
Bridge to recovery To be used temporarily while the heart 
recovers from heart failure. 
Post-cardiotomy To provide circulatory support to a patient 
recovery after open-heart surgery. 
Destination therapy To provide permanent support to the heart, 
replacing the need for a transplant. 
Emerging Growth capital Pty Ltd., 2004 
Table 1.1, Therapeutic options for LVAS, (Left Ventricular Assist Systems) 
1.1.1 Description of the human heart. 
The adult human heart is a hollow muscular organ of a conical form, 
placed between the lungs, and enclosed in the pericardium. The average 
heart measures 120 mm in length, 85 mm in the broadest part and 60 mm in 
thickness. The male heart weighs between 280 -340 g, and the female heart 
230-280 g. (Grays Anatomy 1995). Figure 1.1 shows the position of the heart 
in the chest and the construction of the heart. 
The heart is just left of centre in the chest and beats approximately 72 
times a minute at rest, pumping around 5.5 litres/minute of blood for a man 
weighing 70 kg. The heart can increase output to over 11 litres per minute if 
required. 
2 
Figure 1.1. Position of the heart in the 
chest and the 
construction of the heart. 
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1.2 Heart problems and treatments. 
Heart problems appear as cardiovascular events such as angina or 
heart attack. 
Where the coronary arteries have a reduced flow, the heart muscle is 
not supplied with enough blood and the patient may experience pain known 
as angina during normal activities. Some relief can be given with rest or 
drugs, but surgical intervention is sometimes necessary along with control of 
lifestyle. 
Heart attacks occur when any of the coronary arteries supplying blood 
to the heart muscle become blocked and the heart muscle is starved of 
oxygen and nutrients causing permanent damage to the muscle. Immediate 
medical treatment is necessary to relieve the condition. A serious attack may 
require the replacement of the heart depending on the amount of muscle 
damage. 
With the heart functioning properly, the atria and ventricles beat in a 
synchronised sequence. If this does not happen, the ventricles will not pump 
blood effectively. A small electric shock, applied using a pacemaker, can keep 
the ventricle( s) running in phase. 
1.3 Blood. 
Blood can be considered as a suspension of deformable particles 
circulating within a system of flexible vessels. The deformable particles are 
the cells and Appendix 1 shows the characteristics of these. Each cell has its 
own function, for example, red cells transport O2 and CO2 and platelets are 
responsible for blood clotting. The flexible vessels are the arteries, veins and 
capillaries of the blood circulation system. Appendix 2 gives the dimensions of 
the vessels and the physiological flow parameters of the blood circulating 
through the system. 
The blood has nutrients dissolved in it which are used to supply the 
muscles and organs with the 'fuel' they need to operate and it is the only part 
of the body that contacts every other part. 
1.3.1 Blood as a fluid. 
From Massey, (1995), where the relationship of shear stress and rate 
of shear is linear, the fluid is a 'perfect', or Newtonian fluid. The viscosity does 
not change with shear rate. With blood the relationship of shear stress and 
rate of shear is not linear and it is therefore a non - Newtonian fluid. The 
apparent viscosity changes with the shear rate. 
If blood is made to flow through a tube, the rate of blood flow is not 
proportional to the pressure gradient and the apparent viscosity of blood falls 
as the pressure and flow rates rise. There is also an effect on apparent 
viscosity depending on the size of tube used. (Bayliss, 1952). 
Under normal conditions, flow through a blood vessel does not result in 
adverse effects on the blood or blood vessel walls. 
Cells that line the blood vessel walls are constantly exposed to 
mechanical forces generated by blood flow but changes to the fluid stress can 
modify the structure and function of these walls. This can lead to platelet 
growth and changes to the structure of the cells. (Chien, et ai, 1998 and 
Resnick, Gimbrone, 1995.) 
1.3.2 Red blood cells. 
The primary function of red blood cells is to transport oxygen through 
the body. A red blood cell is a biconcave disc. It has a diameter of about 8 
microns with maximum and minimum thickness of 2.4 and 1.0 microns 
respectively. The mean cell volume is about 87 cubic microns. There are 
about 4.5 to 5 million red blood cells per cubic millimetre of blood. 
The membrane surrounding the cell allows water and ions to pass into 
the interior of the cell. It is possible for the cell to enlarge or shrink. and, within 
limits, these actions are reversible but if the limit is exceeded the cell will 
rupture and the contents will escape. The cell then dies, a process known as 
haemolysis. 
A red blood cell does not renew or repair itself and under normal 
conditions it is worn out and will disintegrate after about 120 days. This 
releases the haemoglobin, which is broken down and reused where possible. 
The iron part of the haemoglobin can be returned to the bone marrow or can 
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be stored for future use. The rest of the cell is broken down and consumed by 
phagocytes. The normal destruction rate is around 3 million / second but 
adverse conditions can increase this rate. The body can increase output but 
reaches a maximum at 6 - 8 times normal but if requirements exceed this 
level the patient tends toward anaemia. (Harris, J.W., 1963). 
1.3.3 Flow damage in blood. 
Red blood cells can be destroyed by mechanical means. Abkarian and 
Viallat, (2005), report that when a shear is applied, the cells begin to rotate. 
The shape of the cell will be deformed from the normal bi-concave shape to 
more like an ellipsoid and the membrane is repeatedly stretched in a 'tank 
treading' motion as the cell rotates. The membrane eventually fails due to 
fatigue and the contents, (haemoglobin), are released into the plasma. 
Damage to red blood cells is not necessarily instantaneous. Tests on 
dogs by Berstein et aI., (1967), indicated that immediate damage is a small 
proportion of the damage to blood during the shearing process. Their results 
indicated that there is an increasing lack of red blood cells as time 
progressed, implying the rate of cell destruction was greater than the rate of 
regeneration. 
Rand, (1964), proposed that red cell damage occurred when the strain 
on the cell membrane exceeded a critical value whereafter the cell pores 
opened or the membrane ruptured releasing haemoglobin. 
Work by Sallam and Hwang (1984) and Pinotti, (2000), indicate that 
eddies contained in turbulent flow could destroy red blood cells and that the 
destruction was related to the size of the eddy. They explained that if the 
smallest eddies in a blood sample are larger than the blood cell, any cells will 
be carried along within the eddy and will only experience stresses due to 
relative motion within the turbulent fluid itself. This condition indicates that any 
cell damage is dependant on time as the stresses are likely to be 'low'. 
If the smallest eddies are the same size, or smaller, than the blood cell, 
the energy in those eddies will be transferred to the cell membrane. This may 
rupture, allowing the escape of haemoglobin if the eddies are powerful 
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enough. This condition indicates that cell damage is not only dependant on 
time but also on the energy contained in the fluid eddies. 
Pinotti, (2000), developed the formula below to calculate the size of the 
smallest eddies. 
where:-
Ls = the calculated dimension of the smallest eddy. 
V = the fluid kinetic viscosity 
LE = the characteristic length of the flow, for example, the diameter of a 
tube, (m) 
Uo = the local RMS velocity (m/s) 
Assuming in a radial flow blood pump application that LE is the gap 
between the rotating disc and the volute wall of a rotary blood pump and that 
values of Uo range from 1 to 10 m.s-1, using the formula, Figure 1.2 can be 
generated. The result indicates for gaps between 1 and 3 mm, any eddy 
velocity above about 3 mls gives an eddy smaller than the cell and is likely to 
cause stress damage. Any velocity less than 3 mis, the eddy length is greater 
than the red cell, maximum diameter 8 microns, which will then be carried 
along with the eddy and may not experience significant stresses. In all cases, 
the larger the gap, the greater the eddy length for a given velocity. 
Eddy velocity Vs Eddy length. 
(Blood kinematic viscosity 0.0000047955) 
30 
.,25 
c:: ~ 0 .~ 20 \\ ---Gap 1mm .§. ---Gap 2mm ;; 15 \ -.-Gap 3mm en ~ c:: -<>- Diameter of red blood cell .. ;. 10 
-<>- .- -~ ~ -<>- - --<>- .-"C "C W 5 
0 
0 2 4 6 8 10 12 
Eddy velocity (m/s) 
Calculated from Pinotti M., (2000) 
Figure 1.2 Eddy velocity Vs Eddy length for gaps 1 to 3mm 
7 
It is important that fluid shear stress levels must be kept within 
acceptable levels. Nygaard and Paulsen et aI., (1992), found the stress level 
just after a normal aortic valve was around 4 N/m2. With a partially blocked 
normal valve, a stress of 38 N/m2 was recorded. With an artificial valve, 
stresses of up to 120 N/m2 were found and they considered that this stress 
level was liable to damage blood. 
Prec and Katz et ai, (1949), calculated Reynolds numbers for the 
arterial system and suggested that there may be turbulence at the root of the 
aorta and in the neighbourhood of arterial branches. 
Stein and Sabbah, (1976), measured the Reynolds number in the 
ascending aorta above the aortic valve in 6 normal subjects. They discovered 
Reynolds numbers of 5,700 to 8,900 and, during ejection, blood flow was 
'highly disturbed'. Flow through diseased valves and artificial valves produced 
turbulent flow with Reynolds numbers up to 10,000. 
Goldsmith and Turitto, (1986), produced results showing high Reynolds 
numbers close to the aorta that could be interpreted as turbulent flow. The 
results, on Appendix 2, also showed low Reynolds numbers in the capillaries 
which would indicate laminar flow. 
As turbulent flow is associated with high stresses, it is preferable that 
any blood pump produces laminar or non turbulent flow. 
Blood damage. 
There is little published information on exactly how much damage 
blood can withstand. If red blood cells are ruptured, the haemoglobin can 
escape into the plasma along with the cell fragments. Haemoglobin in the 
plasma can cause kidney damage. (Haemoglobin - Wikipedia. May 2006) 
Leverett and Hellums et aI., (1972), evaluating blood damage using a 
rotational centrifuge, suggested six factors liable to cause damage to red 
blood cells. 
a) Solid - surface interactions. 
Following observations by Blackshear, (1971), interactions with solid 
surfaces can damage red blood cells. The interaction will not necessarily 
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cause mechanical damage but could be cell - surface reactions leading to the 
formation of blood clots. 
b) Centrifugal forces. 
The centrifugal forces generated in a cylindrical viscometer tend to 
push the blood cells to the outer surfaces of the cylinder. Leverett, Hellums, et 
aI., (1972), indicated this could result in cell damage independent of the effect 
of shear stresses. The blood will contact the internal walls of both radial and 
axial flow pumps as it passes through and damage to the blood may occur. 
The design of a blood pump will have to minimise this effect by reducing the 
centrifugal forces by using low rotational speeds and small internal diameters. 
c) Haemolysis at an air - blood interface. 
When blood is exposed to air, it coagulates and forms clots. There 
must be no blood - air interface inside the pump and this effect must not 
occur. Air bubbles in the circulating blood are dangerous as they could cause 
blockage to blood vessels with subsequent damage to the patient. 
d) Cell - cell interaction. 
Leverett and Hellums, (1972), estimated the haemolysis of red blood 
cells at fixed shear rates but at various hematocrit levels, (hematocrit is 
defined as the proportion of red blood cells in a sample of blood), to determine 
if the shear stress acted on individual cells or caused cell - cell interactions. 
They found that varying the hematocrit did not change the percentage of red 
cells haemolysed and concluded that cell - cell interaction was not an 
important mechanism in the destruction of red blood cells in the concentric 
cylinder viscometer. It is assumed that similar conditions apply inside a blood 
pump under the similar kinematic conditions. 
e) Viscous heating. 
During the operation of a blood pump, haemolysis may be caused by a 
rise in blood temperature. Tests by Leverett and Hellums, (1972), using a 
concentric cylinder viscometer and a shear rate of about of 300 N/m2 for a 2 
minute period indicated that a blood temperature rise of 10°C was possible. It 
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was concluded that if the blood temperature reached approximately 49°C. 'it 
will cause significant haemolysis and fragmentation '. 
Similarly Rosenburg, (1995), indicates that any device in contact with 
blood or tissue should not have a temperature rise of 5°C above the core 
temperature on a long term basis. For a normal human core temperature of 
approximately 37°C., this indicates a device maximum permissible 
temperature of 42°C. 
f) Exposure time. 
The effect of the exposure time of blood to surfaces and stress levels 
are important parameters governing blood haemolysis. It is not possible to 
give a 'limiting' figure for either time or stress as separate entities, as damage 
tends to be a cumulative effect. Leverett and Hellums, (1972), reviewed the 
results of prior work and indicated that there are two distinct regions affecting 
the threshold damage relative to time, one is shear stress and the other is 
surface effects. This relationship is shown in Table 1.4. It should be noted that 
not all the results reviewed are obtained with human blood and so may not be 
strictly applicable to human conditions but the data should be good enough for 
comparative purposes. 
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1.3.4 Stress in blood cells. 
The amount of stress that a red blood cell can withstand before 
damage is difficult to determine. Table 1.2 shows some of the results obtained 
from various researchers. 
Stress Comments on cell condition. Reference 
N/m2 
4000 Stress level before damage Bernstein et ai, 
(1967) 
150/400 Red cell destruction Nevaril et aI., 
(1969), 
100/200 Bulk, medium stress, long exposure Blackshear, (1972) 
4000 Bulk, high stress, instant rupture Blackshear, (1972) 
70 Stress level before damage Williams, (1973) 
1/10 Stress level before damage, adjacent to Mohandas et aI., 
foreign surfaces (1974) 
50 Cell damage, turbulent shear stress Sutera and 
conditions. Mehrjardi, (1975) 
250 Test time 4 minutes. Release of haemoglobin Sutera and 
indicating cell damage. Mehrjardi, (1975) 
400/350 Threshold stress limit before damage Sallam and Hwang, 
(1984) 
600 Recalculated results of Sallam and Hwang, Grigioni, Daniele et 
(1984) of threshold limit before damage. aI., (1999) 
Table 1.2, Estimates of the stress levels to damage red blood cells. 
There may not be an exact figure for the start of red cell haemolysis 
and it is possible that haemolysis occurs at almost any stress but is either 
undetectable or is accommodated in the general metabolism of the body. 
Figure 1.3 indicates a stress of 250 N/m2 gives haemolysis of around 
120/0 at an exposure time of 4 minutes. This is a short time as a blood pump 
may run for days, weeks or even years. The design of a pump to run for an 
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appropriate length of time will need shear stress levels lower than the figures 
quoted here. 
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Figure 1.3 Shear stress against percentage haemolysis. 
From the above results it is difficult to determine a precise figure for the 
limiting stress for red blood cells and 250 N/m2 will be used until a more 
accurate figure can be found. Results from Sutera and Mehrjardi, (1975), 
Figure 1.4, using a concentric cylinder viscometer and fixing the stressed red 
blood cells with a 1 % glutaraldehyde solution, tend to confirm this as the rate 
of cell elongation against shear stress appears to approach a maximum 
around 250 - 300 N/m2 . 
Length of red blood cell with shear stress 
16 
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0 ~ blood cell, results by ... .~ 10 / Sutera and Mehrjardi. E 8 
.....- Length of unstressed .t: 6 
- red blood cell C) 
c: 4 Q) 
...J 2 
0 
0 100 200 300 400 
Stress N/m2 
MSXl. - Blood col""""" 
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Figure 1.4, Red blood cell length Vs shear stress. 
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Sutera and Mehrjardi, (1975), conducted tests to determine the effect 
of stress on red blood cells. 
The results, summarised in Table 1.3, indicate that when stressed up 
to 200N/m2 for 4 minutes, the cells will regain their original shape when the 
stress is removed. Stress over this figure damages the cells with no shape 
recovery. 
The length of time for each test is very short considering the time that a 
blood pump will need to run. 
There is little or no agreement between the two results at 350 N/m 2 for 
4 minutes. The comments indicate the cell condition is different for the same 
stress for the same time. 
Stress Time Condition of red Comments 
N/m2 (mins) blood cells 
10 4 No signs of damage Cells appear normal. 
200 4 No signs of damage Cells appear 
undamaged 
200 4 Elongated whole Cells are stretched, 
cells no apparent damage 
350 4 Elongated with some As above but with 
fragments greater stretching. 
350 4 Fragments and All cells showing 
crenulated cells severe damage. 
450 4 Very elongated, Cells damaged, many 
many fragments fragments 
450 2 Elongated with some Cells damaged, with 
fragments fragments and 'dumb 
bell' shaped cells 
Table 1.3. Summary of cell stress tests, Sutera and Mehrjardi, (1975). 
Leverett, Hellums et aI., (1972), produced the results shown in Table 
1.4. They indicate that the threshold level of damage differs depending on the 
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method chosen and it can range from {relatively little' to 4,000 N/m2 . (There is 
no precise definition here of what is meant by (relatively little). The results 
indicate that for a 'long' time, (1000 seconds), and 'low' stress, (60-25 N/m2 ), 
'relatively little' haemolysis results per unit time. Increasing the level of stress 
to 150 N/m2, the threshold level of damage exposure time reduces to 100 
seconds. 
In terms of running a blood pump, the exposure times are extremely 
short, 1000 seconds is less than 17 minutes. The results with exposure times 
of 10-2 to 10-5 seconds are not considered applicable to a practical blood 
pump application. 
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Type of Order of Threshold Comments References 
exposure magnitude level of 
of dama~e, 
exposure N/m 
time, sec 
Turbulent jet 10-0 4000 Forstrom 
(1969), 
Blackshear 
(1971) 
Oscillating 10-4 560 Human and Williams et al 
wire canine (1970) 
Oscillating 10-j 450 Human and Rooney 
bubble canine (1970) 
Capillary flow 10-2 500 Bovine blood Bacher and 
Williams 
(1970) 
Capillary flow 10-L 450 - 700 Canine blood Kashaviah 
(1970), 
Blackshear 
(1971) 
Concentric 10L 150 Leverett and 
cylinder Hellums 
( 1972) 
Concentric 10L - 10j Relatively Surface Shapiro and 
cylinder max. little effects Williams 
stress 60 haemolysis dominate (1970) 
N/m2 per unit 
time 
Concentric 103 Relatively Surface Knapp and 
cylinder max. little effects Yarborough 
stress 25 haemolysis dominate (1969) 
N/m2 per unit 
time 
Concentric 103 Relatively Surface Steinbach 
cylinder max little effects (1970) and 
stress 60 haemolysis dominate Blackshear 
N/m2 per unit (1971 ) 
time 
Red blood damage by shear stress, Leverett, Hellums et aI., Biophysical Journal, Volume 12, (1972), p 257 - 273 
Table 1.4, A summary of shear stress and time on red blood cells. 
Figure 1.5 shows a pictorial interpretation of the results of Leverett, 
Hellums, et aI., (1972) from Table 1.4. The following observations are made 
from those results. 
15 
10000 
1000 
100 
~ 10 
Q) 1 1/1 
cD 0.1 E K 
i= 0.01 
0.001 
0.0001 
0.00001 
Shear Stress Vs Time 
\ v4 minutes 
-- -- ----14- -- .L --
---
.;\ 
Area where ~ ......- --.. 1\ Area where 
surface effects/ \ l( dominate stress effects 
- \ dominate r---. 
---
\. 
, 
\/ 
~ 
10 100 1000 10000 
Shear stress N/m2 
~ Results of Leverett, Hellums, 
Stress N/m"2 
-+- Stress of 25 N/m"2 
....... Stress of 200 N/m"2 
-+- Stress of 450 N/m"2 
After Leverett, Hellums, et aI., (1972). 
Figure 1.5, The relationship of exposure time and the threshold shear stress. 
The results of Leverett, Hellums, et aI., (1972), Figure 1.5, can be 
divided into two parts. One part indicates that with 'low' shear stresses, 
surface effects are significant in determining the damage threshold. In this 
region, if surface effects can be minimised enough to be ineffective, the low 
blood stresses will enable a pump to run for an extended time period. The 
materials used in pump construction are therefore important. 
In the other part of Figure 1.5 where the stress is 'high', stress effects 
are more important than surface effects in the potential for blood damage. 
Under these conditions a blood pump will not be safe to run for long time 
periods. Assuming a blood pump needs to run for years, stress levels and 
surface effects both need to be low to obtain a satisfactory pump 
performance. 
From Figure 1.5, the limiting stress is time dependant. The stress limit 
will be 'low' or 'high' depending on how long the stress is sustained. Examples 
are shown where the stress lines for 200 N/m2 and 450 N/m2 run through both 
the 'stress dominant' and 'surface effects dominant' regions. 
With a stress of 10 N/m2 for 4 minutes, there is no apparent damage to 
the cells. This result is inside the 'surface effects dominate' region shown on 
Figure 1.5. This condition agrees with comments on Table 1.3. 
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With a stress of 25 N/m2, an apparent exposure time of greater than 
10,000 seconds, (2.78 hours), is possible without stress effects being 
dominant. 
If the trend line of Figure 1.5 continues asymptotically, the trend line 
may not cross the 100 N/m2 stress line. Therefore a stress limit of 100 N/m2 
may be acceptable for 10 8.5 seconds, (10 years). This tends to confirm the 
result on Figure 1.3 where there is no appreciable haemolysis at this stress 
level. 
From Table 1.3, at a stress level of 200 N/m2 for 4 minutes the cells are 
stretched. This result, shown on Figure 1.5, falls inside the 'stress effects 
dominant' region. For a stress of 450 N/m2 for 4 minutes, cell damage is 
noted. This is not surprising, as from Figure 1.5, the stress effects are 
dominant down about 0.01 second. 
From these results there may be a maximum blood stress of less than 
100 N/m2 for a satisfactory pump. However this figure is greater than the 
maximum blood shear stress shown in Appendix 2, 'Physiological Flow 
Parameters in the Human Circulation', which quotes a maximum stress of less 
than 6 N/m2 in the arterioles. 
The results from Figure 1.5 show that blood damage can be split into 
two parts, stress effects and surface effects. There will always be a stress 
effect in the surface effects region and there will always be surface effects in 
the stress region. The results of Leverett, Hellums, et aI., (1972) should be 
interpreted as a limit for these characteristics but with low stress levels and 
suitable surfaces, significant blood damage should not occur. 
The time that blood stays inside a particular pump type varies. Reul 
and Akdis, (2000), indicate residence times of 1 second and 1 ms for a 
centrifugal pump and axial flow pump respectively. Even at these times, these 
are not ideal pumps as they run at different stress levels, a centrifugal pump is 
quoted at 20 - 100 N/m2 and a small axial pump is around 400 N/m2. It is 
assumed that pulsating pumps can have longer 'residence' times than this as 
with a 'beat' rate of 60 per minute, the shortest time will be 1 second and 
depending on the internal flow patterns, could be much greater. With a slower 
'beat' rate, the residence times will be even longer. 
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1.3.5 White blood cells, (leukocytes). 
White cells occupy less than 1 % of the total blood volume and number 
about 5-9 thousand white cells per cubic millimetre of blood. The number of 
white cells is variable, increaSing when infection is present and can reach high 
levels with severe conditions. A white blood cell has a life of about 13 days, 
about 100/0 of that of a red blood cell. 
Under the microscope white blood cells appear as flat, circular cells but 
in practice can change shape constantly and have some intrinsic mobility. The 
shape changing ability allows them to pass from the bloodstream into organs 
and back again easily. 
Leukocytes are important cells in that they protect against infection and 
proteins that are 'foreign' to the system. This protection can range from 
combating the infection due to a simple cold up to the rejection of a new 
organ. This protection process must be suppressed for a successful organ 
transplant to take place. 
1.3.6 Platelets. 
Platelets are smaller than a red blood cell and number about 250 to 
300 thousand per cubic millimetre of blood. The lifespan of a platelet is about 
10 to 12 days. 
Platelets seal wounds by forming a plug at a wound site. They can be a 
problem if arterial blood flow is reduced when they build up on the inside of a 
damaged artery. (Berger, Hartwell et aI., 1998). 
Blood flowing through small or narrowed flow passages can influence 
the development of blockages. Normally this is a problem relative to age and 
lifestyle but with an artificial device implanted this can be a problem 
irrespective of age. 
Bluestein, Niu et ai, (1997), reported on the effects of blood flowing 
through a stenosis which is considered to be a narrowed, or partially blocked, 
section of artery. The stenosis produced turbulent flow at the throat with a 
recirculation region afterwards. Platelet deposition at the throat was low as the 
platelets were apparently swept away by the flow, which was up to five times 
greater than at the entrance to the throat. In the recirculation region, platelet 
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deposition was up to twice normal rate. In this area the shear stresses were 
low but with a high blood residence time creating favourable conditions for 
platelet deposition. Figure 1.6 below shows the general pattern of flow and 
platelet deposition. 
Ramstack et aI., (1979), indicated that platelet activation is a non-linear 
function where a large stress for a short time can produce significant platelet 
stimulation where the same stress for an additional length of time produces 
relatively little additional stimulation. 
Fluid flow. 
Centre line t 
of fluid flow. 
a) Platelet deposition region. 
b) Fluid circulation region. 
Figure 1.6 Half section through stenosis showing: -
a) Platelet deposition region and 
b) Fluid circulation region. 
Ramstack et aI., (1979) and Wurzinger et aI., (1983), indicate that 
platelets can be damaged by shear stresses of 10 to 50 N/m 2 . For stresses 
above about 15 N/m2, platelet death appears to start almost immediately but 
then decreases with time, indicating that some platelets are more prone to 
stress damage than others. Brown et aI., (1975), suggested shear stress as 
low as 5 N/m2 stimulated the platelet release reaction and platelet 
aggregation. Shear stress at 10 N/m2 was reported to produce cell lysis which 
appeared to be linearly related to the duration of stress. 
Brown and Leverett et ai, (1975), indicated similar figures for platelet 
damage and lysis and demonstrated that platelets are sensitive to shear 
stress. 
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Analysis by Sutera et aI., (1988), showed that pulsed exposure resulted 
in more platelet aggregation than continuous exposure for the same total 
exposure time to stress. This indicated that both shear and velocity gradients 
might be responsible for enhancing platelet activation. 
Hodges and Jensen, (2002), assumed that molecular forces attract a 
cell to a surface. With the cell drifting in the blood flow, the cell moves towards 
to the surface. As the cell approaches the wall, the attraction forces increase 
and the cell contacts the wall. Depending on the force of the fluid flowing past 
the cell, the cell either stays fixed to and spreads along the wall, or moves 
along the wall by a rolling, or tank treading, motion or is peeled off by fluid 
flow past it. 
Poiseuille, (1799 -1869), noted that during blood flow, cells moved 
towards the centre of a round tube if the flow was high enough. This may be 
why cells build up on a surface where there is little or no fluid flow and there is 
no cell adhesion in regions of fast fluid flow. 
Hung et ai, (1976), indicated that at stress levels of 5 and 10 N/m2, 
there is no measurable cell death for the first 60 to 75 minutes. After this time 
a rising linear characteristic is shown for a time of up to 4 hours. Figure 1.7 
shows these results. Higher levels of stress produced almost immediate 
results. These results may indicate that platelets become weaker during their 
life cycle and that the 'older' cells die first followed by the 'younger' cells later. 
There were no results shown beyond 4 hours which is short compared 
to the time that a blood pump may be needed. 
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Figure 1.7. Platelet death relative to time and stress level. 
1.3.7 Significance of the above results. 
The results shown in Table 1.3 are taken over a period of 4 minutes, or 
less, and during this time damage to red blood cells can be noted. A blood 
pump will operate for long periods of time. Any damage to blood cells caused 
by the pump will have to be at a level the patient can withstand. 
The pump design must not produce fluid stress levels that are high 
enough to cause blood damage. From the above results the maximum fluid 
stress level to cause damage is approximately 200 - 250 N/m2 for red cells 
and 10 N/m 2 for the platelets. Damaged cells will still be able to pass through 
the system and may block vital organs. 
The results from Goldsmith and Turitto, (1986), (shown in Appendix 2), 
indicate that the maximum mean wall shear stress in vivo is less than 6 N/m2. 
This is less than the stresses quoted above. 
Mechanics of fluids theory shows turbulent flow produces stress in 
fluids. Assuming turbulent flow is indicated by a Reynolds number of 2000 or 
above, Goldsmith and Turitto, (1986), show turbulent flow in the ascending 
aorta at a Reynolds number of 3200 to 6000. The Reynolds number in the 
rest of arterial system indicates laminar flow 
Changes in flow direction inside the pump must not produce flow 
patterns where blood is stagnant or in a continuous loop as reactions with 
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construction materials will be increased. The time that blood stays inside the 
pump must also be as short as possible. 
1.4 Summary 
The problem of pumping blood with mechanical pumps has been 
described indicating that shear stress can damage red and white blood cells. 
The length of time needed for change to occur can be as short as 4 minutes. 
If over stressed, the cells do not recover and the clotting and aggregation of 
blood cells is automatic once it is initiated. 
The maximum stress in vivo, of about 6 N/m2, is very low compared to 
the stresses that can be produced by pumping blood. Red cells may survive a 
stress of 100 N/m2 for up to 10 years but further work needs to confirm this 
figure. White cells appear to have a lower damage threshold at 5 to 10 N/m2 
before aggregating. A blood pump will have to produce stress levels less than 
10 N/m2 for a satisfactory life following these results. 
A blood pump should ideally produce laminar fluid flow to reduce blood 
stress levels and cell damage. There should be no recirculation flow or flow 
stagnation of the blood inside the pump. One of the design criteria must be to 
ensure that the time the blood stays inside the pump must be as short as 
possible to reduce surface reactions with the blood. 
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Chapter 2. Review of heart pumps. 
2.1 Introduction. 
To repair or replace a faulty human heart has long been the dream of 
the medical profession. As the body must have a blood supply for survival, 
stopping or removing the heart for repair has not been an option if the supply 
of blood to the body is stopped. Pumps have now been made which take over 
all, or part, of the pumping function of the heart enabling repairs to be carried 
out on the heart without the patient dying. These pumps range from pulsating 
pressure pumps, that imitate the heart, to constant pressure pumps. Not all 
pumps have been successful, fluid dynamics problems have damaged blood 
by excessive shear stresses and unsuitable flow patterns have allowed 
thrombi to form. The basic pump types are described in Appendix 3. 
Most blood pumps are intended for adults but the low flow rates 
required for a child pose an increased thrombus risk when using adult size 
devices due to the reduced blood flow. 
The Table 2.1 shows a brief history of ventricular assist devices. 
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1812 Legallois - first concept 
1849 Loebell - isolated kidney model 
1854 Claude and Bernard - foie lave experiment 
1848 - 1858 Brown and Sequard - demonstrated the need to oxygenate blood 
1868 Ludwig and Schmidt - achieved extracorporal oxygenation 
1882 Von Schroeder - first steady bubble oxygenator 
1885 Frey and Gruber - first film oxygenator 
1916 McLean discovered heparin 
1928 Dale and Schuster - first diaphragm pump 
1934 DeBakey - introduced a simple roller pump 
1937 Gibbon - described a heart lung machine 
1954 Gibbon - first human open heart operation 
1957 Akutsu and kolff - implanted two pumps in a dog 
1961 Dennis - performed left heart bypass 
1962 Kolff and Moulopoulos - introduced the intra aortic balloon pump 
1963 Spencer - supported a girl after a septal defect 
1964 Loitta - first implantation of a pulsatile L VAD 
1966 Kantrowitz - first clinical application 
1968 Raffert - reported on a centrifugal blood pump 
1969 Cooley - implanted the first artificial heart 
1973 Soeter - described the use of extracorporal life support 
1974 Bartlett - use of extracorporal membrane oxygenator 
1980 Pollock - first use of intra aortic balloon pump in children 
1980 Thoratec vebtricular devices 
1982 DeVries - implantation of first Jarvik 7 artificial heart 
1983 Veasy - use of small balloon catheters 
1984 Novocor L VAD used as a bridge to transplant 
1987 First use of a centrifugal Biomedicus pump 
1988 Berlin heart bcomes available 
1989 Extracorporeal Life Support Organisation founded 
1992 First Heartmate pumps implanted 
1992 Berlin heart offered for the first time 
1993 First wearable control system 
1994 Medos VAD in clinical use 
1994 Abiomed BVS 5000 VAD becomes available 
1994 Medos VAD first implantation 
Table 2.1. Brief history of ventricular assist devices 
http://l/IfINW.health.gov.mtlimpaedcard/issue9/2 454/2 454. htm 
Fuchs A, Netz Z., (2002) 
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2.1.1 The generations of heart pumps. 
The first implantable ventricular assist devices were produced in the 
1960's and it has taken 15 - 20 years to reach true clinical applications. 
These pumps were pulsatile devices imitating the action of the human heart. 
They were the first generation of artificial hearts or blood pumps and many 
were total heart replacement pumps where the native heart had been 
removed. These pumps had often had problems with size, patient 
acceptability, power sources, and blood clot generating properties. 
The second generation pumps include constant flow pumps. These run 
in parallel with the heart which is still operating and were intended to solve 
some of the problems of the first generation as they were smaller, lasted 
longer and gave fewer problems. Power and control systems are starting to 
become more acceptable with the possibility that the patient could be 
'unfettered' from the confines of the hospital and the wall power socket. Some 
power packs allow the patient to return home and resume light work, 
producing a general improvement in patient condition. 
The third generation pumps, described by Bourqu and Gernes et ai, 
(2002), have yet to come into general use and are intended to use fully 
implanted pumps and control systems. Some have non contact bearings 
using a magnetic or fluid levitation system and the service life is expected to 
be at least ten years as outlined by Takatani S., (2002). 
There have been many types of blood pumps proposed, or made, and 
some of these are shown in Appendix 3. 
Table 2.2 shows the generations of left ventricular assist systems, 
(LV AS), and general characteristics. Reul and Akdis, (2000) discuss a range 
of blood pumps with advantages and disadvantages, quality of life, reliability 
and cost effectiveness. 
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Advantages Disadvantages 
LVAS 
First Pulsatile pumps. Capable of Poor durability. 
Generation Pumps are air or generating flows Limited mechanical life. 
electrically driven that are close to Risk of thrombotic 
Bulky internal unit. the natural flow events. 
Cumbersome external characteristics of Large implanted size 
equipment. blood. means only a 
proportion of patients is 
suitable. 
May require a 
substantial amount of 
anti-coagulant drugs. 
Second Non-pulsatile pumps. Smaller than first Bearings generate heat, 
Generation Use of contact generation increasing the risk of 
bearings and the devices, hence a thrombotic events. 
rotational force of an wider range of Higher risk of red blood 
impeller to maintain patients can be cell destruction. 
blood flow. treated. Limited mechanical life. 
Two major types: Lower risk of May require amounts of 
centrifugal or axial infection than anti-coagulant drugs. 
flow pumps. first generation 
devices. 
Third Non-pulsatile pumps Lack of contact Magnetically 
generation No contact bearings bearings suspended systems 
Two major types: reduces the risk may be more 
magnetic 1 and of thrombotic complicated and 
hydrodynamic2 events. therefore more prone to 
levitation. Lack of wear failure. 
enhances 
durability 
Less red blood 
cell damage. 
Emerging Growth Capital Pty Ltd., (2004) 
1 Magnetic levitation involves the suspension of the impeller by magnetic forces. 
2 Hydrodynamic levitation involves the suspension of the impeller by fluid forces. 
Table 2.2 The classification of blood pumps. 
The pumping principles of first generation pumps are listed in Table 2.3 
together with the power source. This shows a connection between some 
pumps and power source and that many types of power source have been 
attempted. Many do not appear to have reached application testing. 
31 
PumQing QrinciQle. Energy conversion. 
Displacement pumps Electro - mechanical. 
Hydrodynamic pumps. Electro - magnetic. 
Combinations. Electro - hydraulic. 
- indirect. 
- direct. 
Thermo - mechanical 
Radio - isotope 
Biological - mechanical. 
Hetzer, R., Hennig, E., Loebe, M. (editors), (1997) 
Table 2.3 Types of ventricular assist devices. 
2.1.2 Explanation of pump types. 
Displacement pump. 
This pump gives a pulsating blood flow similar to the biological heart. A 
moving diaphragm, with valves controlling the direction of blood flow, 
achieves the pumping action. 
Hydrodynamic pump. 
This gives a constant pressure blood flow. The flow is produced by a 
rotating impeller and there are no valves to control blood flow direction. 
Electro - hydraulic pump 
This is a pulsating pump with the diaphragm driven by hydrauliC 
means. The non blood side of the diaphragm is acted upon by hydraulic 
pressure generated external to the blood pump. 
Radio- isotope pumps 
Public concern and cost for a radio - isotope pump have eliminated this 
as an implantable power source at present. 
Biological - mechanical pumps 
This uses skeletal muscle to drive a plunger arrangement to drive a 
diaphragm, which then pumps the blood. The muscle is activated by an 
electronic device similar to a cardiac pacemaker. Skeletal muscle is not the 
same as cardiac muscle but Salmons and Jarvis, (1990), et aI., found that 
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skeletal muscle could be transformed into something approaching cardiac 
muscle by applying a low frequency electrical stimulation. 
Figure 2.1 shows a typical arrangement of a muscle powered pump. 
Skeletal 
muscle. 
Muscle 
stimulator. 
... . 
Muscle and plunger 
movement. 
Hydraulic 
actuator 
Blood I 
ejection 
Figure 2.1. Arrangement of a muscle powered blood pump. 
Pumps available or in development are shown in Appendix 3. The 
characteristic differences between the two main pump types are listed in 
Table 2.4. 
Blood pump Pulsatile Non-pulsatile 
Size Large Smaller 
Mechanism Complex Simpler 
Control Complex Simpler 
Valves Two None 
Compliance chamber One None 
Implantability Complex Simpler 
Overall system Same Same 
Cost Higher Lower 
Physiological acceptance OK NA 
Takatani S. (2002) 
Table 2.4. Comparative features of pulsatile and non-pulsatile blood pumps. 
33 
Technical problems of these devices, listed in Table 2.5, are covered in 
detail elsewhere. 
Durability Characteristic 
Membrane Flex life, degradation. 
Gearing Wear, corrosion. 
Bearing Wear, seizure. 
Sealing Wear, seizure. 
Encapsulation Fluid permeation. 
Biocom[2atibility 
Blood contact Thrombus formation, cellular trauma, trauma. 
Tissue contact Cell ingrowth, infection. 
Body fluids Chemical degradation. 
Power sU[2[2ly. 
Batteries / TETS Heat dissipation, efficiency, cycle life. 
Control 
Electronics Reliability 
Sensors Long term stability 
Size and weight 
Compactness of design. Device volume / pump output. 
Anatomical fit Location of components 
Fail safe features 
No fail safe features noted 
Hetzer, R., Hennig, E., Loebe, M. (editors), (1997). 
Table 2.5. Technical problems with ventricular assist devices. 
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2.1.3 Physiological adaptation 
The human heart is a pulsatile device and the arteries leading from it 
are elastic. Each heart beat causes the arteries to expand and then contract 
as the pressure pulse passes. 
Muria and Ichikawa, et aI., (2003) report that the Baylor College of 
Medicine, Houston, Texas conducted tests on 5 calves to determine if the 
change from pulsatile to non-pulsatile blood flow had any serious effects. 
Haemodynamic data was established before each calf was implanted 
with a non-pulsatile biventricular assist system and the analysis was repeated 
at intervals. Initially the results did not correlate but the final results indicated 
that the calves had adapted to the new conditions. If this procedure gives the 
same results in humans, there should be no adaptation problems with 
continuous flow pumps compared to pulsatile flow pumps. 
2.2 Pulsatile flow pumps (displacement) types. 
This section describes the type of pump that delivers fluid in a series of 
pulses, similar to the human heart. The amount of fluid delivered will depend 
on the size of the pump and the pulses / min. 
2.2.1 Peristaltic or roller pumps. 
Method of operation. 
This pump has multiple rollers pressing against flexible wall tubing. 
Figure 2.2 shows the arrangement of the rollers and tubing. The rollers move 
relative to the tubing which is arranged in a near circular arrangement to 
enable maximum roller contact. These are similar to the pumps manufactured 
by Watson-Marlow Bredel Pumps. The rollers separate the fluid into 'packets' 
that are delivered to the user. This type of pump is used in heart-lung 
machines and kidney dialysis procedures. 
The 'finger' pump is similar where a series of fingers press down 
sequentially on to a straight length of tubing creating the 'packet' of blood 
delivery arrangement. 
The output of this pump will vary depending on the rotational speed of 
the roller assembly and the tubing diameter. 
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Rollers rotating 
against wall of pipe Flexible wall pipe 
~rc:-.;~----' --... ~ Fluid out 
Direction of 
rotation 
.-....,------' 
<. Fluid in 
Peristaltic pump 
'Fingers' reciprocate I t j 1 ! 
alternately pumping 
'parcels' of fluid along 
length of pipe. ____ 
Fluid in 
Finger pump 
Flexible wall pipe 
/ 
"-11"~ Fluid out 
Figure 2.2. Peristaltic and finger pumps. 
Advantages and disadvantages of peristaltic or roller pumps 
Advantages. 
Low cost of tubing and reliability. They are simple to use, cheap, easy 
to set up and replace. The amount of blood delivered by the pump can be 
changed by changing the rotation speed of the rollers for a given size of 
tubing. 
Disadvantages. 
Some blood damage and particulate spallation, (small particles 
breaking away from inside the tubing). 
'Old' pumps may suffer from reduced output, as delivery is dependent 
on the tubing expanding fully after each roller has passed. The pump must be 
replaced before the tubing cracks otherwise blood could leak out or air could 
be drawn into the system. Both these will be detrimental to the patient. 
Pump use is limited to about 4 hours due to blood damage and the 
need for high doses of anticoagulant. 
The blood is passed to and from the patient using needles inserted into 
veins or arteries which has the risk of infection. 
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This method is confined to hospital use as staff and specialised 
equipment are needed for satisfactory operation. 
2.2.2 Intra-Aortic Balloon Pump. 
This is not a heart replacement device but it is used as a short-term 
assist device. It is removed as soon as possible. 
Method of operation. 
A balloon placed inside the aorta, downstream of the coronary arteries, 
is inflated at the end of left ventricle contraction. The blood flow through the 
aorta is blocked and a pulse of 'high' pressure blood flows through the 
coronary arteries. The balloon then deflates allowing normal blood flow to the 
body. Hetzer, R., Hennig, E. et aI., (1997) explain the concepts behind this 
method of blood pumping 
This is a gas powered, (helium), temporary device. Careful control of 
the timing of inflation and deflation is necessary and it is for hospital use only. 
The pump is used for a short a time, (hours), and is removed as soon as the 
patient has recovered sufficiently. 
2.2.3 Bi-ventricular blood pump, (Abiomed 5000 blood pump.) 
This is a heart assisting device following surgery and it is not an 
implantable device. 
Method of operation. 
The pump consists of a chamber containing a bladder, made from 
smooth surfaced polyurethane, which passively fills with blood from the 
patient. The pneumatic system externally pressurises the bladder and pumps 
the blood to the patient with valves controlling blood flow direction. The 
bladder volume is 100 ml. and the pump maximum flow rate is about 6 I/min. 
The pump stroke volume is maintained at about 80 ml and computer 
control allows full automation of the system. There is usually no need for staff 
intervention during normal operations. Flow through the pump can be reduced 
to a minimum of 0.5 Ilmin as the patient improves. (Wassenburg, 2000). 
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This pump is intended for short-term use, about 14 days, to allow 
recovery from surgery and can be used singularly on either left or right sides 
of the heart, or two pumps to assist both sides of the heart simultaneously .. 
Figure 2.3 illustrates the operation of this pump. 
Pump 'diastole' 
Blood inflow from patient 
Vent Inflow 
---. bladder 
empties 
Inlet valve opens 
Air 
.. exhausts, 
outflow 
bladder 
valve fills 
closes 
Arterial pressure 
Pump 'systole' 
Blood inflow from patient 
Vent 
-
Inflow 
bladder fills 
Inlet valve closes 
Air 
.. pressure 
applied, 
outflow 
valve bladder 
opens empties 
Blood outflow to patient 
Abiomed Inc., Danvers, MA, USA. 
Figure 2.3. Abiomed BVS 5000 blood pump. 
The pump cannot be used outside the hospital environment and there 
is a risk of infection ariSing from the pipes passing through the patient's skin. 
(Wassenburg, 2000). 
2.2.4 Other pulsatile pump types, general description. 
These are diaphragm pumps driven by air, hydraulic, mechanical or 
electrical methods. Valves are used to control the blood flow direction but 
these can be a problem as they can promote blood clots endangering the 
patient. 
Mussivand T. et aI., (1996), indicate that careful design and assembly 
of the diaphragm is necessary and improvements in prediction techniques 
need to be used to avoid problems 
38 
With all pulsating pumps, sufficient 'wash out' at the junction between 
the diaphragm and the pump housing is necessary as with the increased 
length of time that blood stays inside the pump, the greater chance of surface 
reactions. Figure 2.4 shows this problem. 
Movement 
of pusher 
plate. 
Blood 
Pusher plate and 
diaphragm. 
Pump housing. 
Area where 
blood can 
stagnate. 
Figure 2.4 Showing the possibility of blood trapped 
in a poor 'wash out' region of a pulsating type pump. 
Fuchs and Netz, (2002), describe the particular problems related to 
heart assistance with children. Many of the existing pulsatile pumps have 
pumping chambers that are too large for a child. Correct size is important as a 
pump that is too large can result in a poor wash out at the pumping surfaces 
leading to the development of thrombi with consequent problems. 
2.2.5 Heartmate pump. 
One of the original positive displacement pumps was the Heartmate 
described by Gagnon et ai, (2000). Two versions were produced, a vented 
electric, VE-LVAD, and pneumatic, IP-LVAD. 
Both used a two part titanium housing with entry and exit ports. The 
internal surfaces of the housing were textured by sintering titanium spheres to 
the surface to present a compatible surface to the rest of the blood as it 
flowed through. Each port contains a porcine valve controlling the direction of 
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blood flow. The pump uses a textured surface polyurethane diaphragm to 
attract blood cells. Using these methods a uniform tissue lining is formed 
through the entire internal surface of the pump. 
The pump can operate in a fixed-rate or automatic mode. In addition, 
the IP-LVAD version can be operated in a synchronous mode triggered by the 
patients own electrocardiographic signal. 
In the automatic mode, power is required only to pump the blood out of 
the pump. The pump fills passively, where blood flows into the pump from the 
patient. A position sensor detects when the pump is 90% full and power is 
applied to push the blood out. 
Each pump has a maximum stroke of 83 mm with a maximum pumping 
rate of 140 beats I minute for the IP-LVAD and 120 beats I minute for the VE-
LV AD. This gives flow rates of 11.6 and 9.96 L/min respectively. The pump 
weighs about 680 grams which is about twice the weight of the human heart. 
There is only one size of the Heartmate pump and due to this, it is not 
possible to implant into infants I children or adults who are of small stature. 
2.2.6 Power supplies. 
The HeartMate pump requires careful installation in terms of power as 
the patient is effectively 'fixed' to a power supply, with power cables or 
pneumatic pipes passing through the skin with the chance of infection at the 
entry site. 
Developments have allowed some HeartMate patients to leave hospital 
after careful training in the use of portable systems. Of those patients allowed 
to leave hospital with implanted pumps running, Korfer et ai, (1997), report 
that some were strong enough to return to light work. With the VE-LVAD, the 
power supply consists of batteries carried on the belt and a control system in 
a shoulder holster. With this application there are two percutaneous leads 
coming out of the patient, one is the electrical power cable and the other is the 
vent pipe to equalise the air pressure under the diaphragm as it moves inside 
the pump. 
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With the IP-LVAD, the patient is connected to an external drive 
console, weighing around 33 kg, installed in a portable cart which limits 
patient mobility. This pump has only one pipe for the pneumatic supply. 
(Myers, Macris, 1995). 
One of the later portable power systems, the TETS system, 
(Transmission of Energy Through the Skin), is described later in Chapter 
2.4.2. 
2.2.7 Volume compensation methods. 
Pusher plate pumps always have a varying volume under the pusher 
plate as the pump operates as a volume is created and destroyed on the non-
blood side of the diaphragm 
With electrically driven pumps, as the diaphragm moves, the pump will 
not operate properly if the volume under the diaphragm is not vented, as the 
pump will be trying to compress / expand the air / gas trapped underneath. 
This will affect the efficiency of the pump and cause increased loading on the 
operating system. Pneumatically driven pumps do not have this problem as 
the volume under the plate is pressurised to pump the blood, and evacuated 
to allow blood to enter the pump 
With diaphragm pumps, the problem of venting the volume under the 
diaphragm plate can be solved by:-
a) Allow a vent pipe to exhaust to the atmosphere. This means a pipe 
passing through the skin of the patient with the additional risks of infection. 
b) Fit the pump with a variable volume compliance chamber or balloon. 
These are fitted internally to the patient and are filled with an inert gas. If they 
leak, they have to be refilled which can mean a surgical operation. There is 
the problem of where does the gas go to after it has leaked out? This method 
of volume compensation is rarely used today. 
Figure 2.5a shows the operation of a pneumatically operated blood 
pump and Figure 2.5b shows a volume compensation vent with an electrically 
driven pump. 
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Figure 2.5. HeartMate pump. 
Mode of operation of a positive displacement 
pump giving pulsating blood flow. 
Blood 
volume. 
I Pumo eiection. 
Pump filling. Air 
out. 
~-----------------------
Figure 2.5a. 
Pneumatic version. 
Alternate air pressure application, 
and release, drives diaphragm up 
and down to pump blood 
2.2.8. Installation of a blood pump. 
#- d, 
'-~ "'-- Roller. 
!~,l 
~ 4~· '-~ ~Cam. 
EW :l Volume 
I ~ ;{' ~~~pensation 
Figure 2.5b. 
Electric motor version. 
Roller contact with 
circular face cam allows 
diaphragm to rise and 
fall and to pump blood. 
The original approach to help patients with heart problems was to 
remove the biological heart completely and replace it with an artificial heart if 
a transplant was not available. An alternative approach is to retain the 
biological heart and to fit a blood pump to act as an assist or bypass device. 
This can be used in the short term to allow the patient to recover from surgery 
or to allow a weakened biological heart to recover or to keep the patient alive 
long enough to receive a heart transplant. Many of the pumps produced today 
use this method. Figure 2.6 shows this method of installation using the 
Heartmate pump. This pump, like many others, operates in parallel with the 
biological heart by having the pump implanted between the apex of the left 
ventricle and the descending thoracic abdominal aorta. The pump receives 
low-pressure blood from the left ventricle and ejects it into the high-pressure 
42 
systemic circulation. Frazier, (1 995) , reports that the longest support period by 
one person on of these pumps was 503 days. 
There are no published details of how the pump is installed inside the 
patient and held in place. The body has a tight fitting skin and the internal 
organs fit into place around each other. The installation of a grapefruit sized 
piece of machinery with the pipes or cables must cause problems with 
displacement. There must also be methods of fixing the pump securely in 
place to ensure that there is no strain on the pipes, ventricle and aorta and 
movement relative to other organs that could cause problems. 
Descending thoracic 
abdominal aorta . 
Diaphragm. 
Direction of 
blood flow. 
Pump blood 
delivery tube . 
Heart, left 
ventricle. 
Apex of left 
ventricle . 
Pump blood 
intake tube. 
Heartmate pump. 
Skin entry point. 
Air or power 
supply or volume 
compensation 
vent. 
Loebe et ai , (2000). 
Figure 2.6. HeartMate pump. Installation inside the chest. 
Table 2.6 shows the results of a multi-centre evaluation of the vented 
HeartMate pump. These show that one patient lived for nearly 700 days with 
the pump implanted and that 84% of patients were still alive 1 year after 
implantation. Some adverse events are shown , infection at 40% is the highest 
cause of problems. Problems that may be traced directly to the pump are low 
at 50/0 , neurologic dysfunction , (which is interpreted as a stroke), and 6%, 
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thromboembolism, (which is interpreted as blood clots blocking a blood 
vessel). 
L VAS supported Control, (not 
patients. supported 
With LVAS) 
No. of patients (M, F) 280 (232, 48) 48 (40, 8) 
Age (median) 11-72(55) 21-67 (50) 
Pump duration, days (mean) 1-691 (112),54/280 (19%) 
>180. 
Survived 198/280 (71 %) 
Transplanted 188/280 (67%) 16/48 (33%) 
Post-transplanted 1 year 158/188 (84%) 10/16 (63%) 
survival 
Device removed 10/280 (4%) 
Adverse events 
Bleeding 31 (11%) 
Neurologic dysfunction 14 (5%) 
Infection 113 (40%) 
Thromboembolism 17 (6%) 
Takatani S, (2002) 
Table 2.6, Multi centre clinical evaluation of the vented electric 
HeartMate Thoratec pump as a bridge to transplantation. 
2.2.9 Berlin Heart Pump. 
This is a pneumatically powered diaphragm pump with valves. The 
bloodlines run through skin entry sites and the pump can be supplied in a 
range of sizes suitable for a small child up to an adult. It is intended for short-
term use only as a bridge to recovery or for a patient awaiting transplant. 
For a child to require heart assistance, the device has to be sized 
accordingly. This was emphasised with the cases of a boy in 1998 and a girl 
in 2000 when both were fitted with small pumping systems provided by Berlin 
heart models. Both were kept alive until transplants could be found. 
The Berlin heart pump, first offered in 1992, is a pump for children. It 
consists of a polyurethane housing with integrated diaphragms forming a 
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continuous blood-contacting interior. The three layer drive diaphragm is 
connected to a circular plate to form the air chamber. The multi-layer 
construction of the diaphragm membrane gives a diaphragm that is relatively 
thin but with high flexibility at the diaphragm-housing junction. Figure 2. 7 
shows the general configuration of the pump. 
Inlet and outlet pipes. 
Blood flow direction is 
controlled by valves. 
Casing. 
\ 
Inlet and outlet 
valves 
Air supply. 
Diaphragm, 
inside casing . 
Fuchs A .. Netz H .. (2002) 
Figure 2.7. The general arrangement of the Berlin heart pump. 
The internal blood contacting surfaces are smooth with inner surfaces 
coated with heparin. The blood chambers and outlet ports are transparent so 
that blood flow and any thrombus build up inside the pump can be noted. Two 
basic models are produced with various pumping capacities. They are listed in 
Table 2.7. 
Pump Stroke volume Valve diameter, Valve type. 
size. ml. mm. 
- -
Adult 50 and 60. 12 Bjork Shiley tilting type. 
Child 12, 15, 25 12 Polyurethane tri-Ieaflet 
and 30 
Table 2.7. Details of Berlin heart types. 
Figure 2.8 shows the installation of two Berlin heart pumps. Blood exits and 
enters the pump through pipes passing through the skin . 
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This pump can be used outside the hospital environment after su itable 
training and portable drive units have been developed to enable the patients 
to live relatively normal lives outside the hospital. The units all feature 
rechargeable batteries, together with computer controls and multiple 
redundant systems to ensure patient safety. 
If the patient is outside hospital, frequent checks must be made where 
the pipes enter the body as any infection must be dealt with immediately. The 
infection risk is a problem with all systems that use pipes or cables passing 
through the skin. 
Air supply pipes. 
Blood pipe 
entry sites 
through skin . 
Patient 
head. 
Patient 
feet. 
Perfusion 2000; 15: pp 387-396. 
Drews.T, Loebe. Met ai , (2000) 
Figure 2.8. Installation of two Berlin Heart pumps. 
It should be noted that the power requirements for children are higher 
than those for adults as, due to the small size of the pipes used for children , 
the resistance to fluid flow is high during the operation of the pump and 
positive pressures of up to 350 mmHg and negative pressures of 100 mmHg 
at pumping rates of 140 beats/min are used. The drive unit has to be capable 
of giving this performance satisfactorily. (Drews and Loebe, et ai , 2000 ). 
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2.2.10 AbioCor Heart pump. 
This is an implanted electric pump and is designed to replace the 
biological heart and give patients a new, limited, lease of life. Figure 2.9 
shows the external view of the pump. 
Figure 2.9. AbioCor pump - external view. 
Abiomed , (2002) 
The pump is a total artificial heart, (TAH), where the patient's ventricles 
have been removed and the artificial heart is attached to the remains of the 
atria. The patient is completely dependant on the pump for his/her life. 
The pump is a self contained replacement TAH and is an electrically 
powered hydraulic pump powered by an internal battery which in turn is 
charged through the skin by an external battery pack. An internal electrical 
coil implanted just under the skin collects power from an external coil 
positioned above the internal coil. There are no holes through the skin 
therefore no chance of infection with this method. This is the TETS method 
that will be described later. 
The pump operates by hydraulic pressure generated by a constant 
speed electric motor driving a rotary impellor and the hydraulic fluid is 
switched from left to right ventricle and back again by a rotary valve driven by 
a separate electric motor. Each ventricle is externally compressed by the 
hydraulic fluid to pump blood around the body as required . This is different to 
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the human heart where both ventricles contract at the same time. An 
implanted controller monitors and controls the speed of the artificial h rt ea . 
Figure 2.10 shows the internal hydraulic circu its of the pump. 
(http://www.chfpatients.com/implants/artificialhearts.htm) 
Rotary valve and 
valve motor. 
Flexible double 
membrane 
Front cross 
section. 
Right blood 
pump. 
Impeller 
pump and 
motor. 
Hydraulic flow 
Left blood 
pump. 
Figure 2.10. AbioCor pump hydraulic circuits and rotary valve. 
Abiomed , (2002) 
The pump has a mass of about 0.9 Kg , pumps 10 litres I minute and as 
it is self contained, the patient can be mobile. 
(http:/www .surgeons.org/asernip-s/net -s). 
Surgeons in the USA have implanted seven of these pumps. Only one 
patient was still alive after 12 months following implantation but later died due 
to strokes and other similar complications. After the pumps were removed , the 
atrial valve cage struts showed signs of thrombus and as result of these 
findings a change has been made to the design of the valve . This change is 
expected to improve the life expectancy of the patients. 
48 
Over this test, the average life span of 164 days was considered to be 
a good result considering that each patient was only expected to double his or 
her expected lifespan to around 60 days. (Abiomed, 2002 and Abio Cor 
lawsuit, 2002). 
Table 2.8 is a summary of the clinical evaluation of the AbioCor pump 
up to the end of 2002. 
Patient Sex Age Where Survival, Cause of death. 
no. days 
1 M 59 Jewish hospital 151 Strokes, bleeding. 
2 M 69 Jewish hospital 391 Discharged, 
27/3/02 
3 M - Texas heart 144 Complications due 
institute to strokes. 
4 M 74 University of 56 Multi-organ failure 
California 
5 M 51 Hahnemann 331 Discharged 
University 22/1/02. 
6 M - Texas Heart 0 Bleeding 
Institute 
7 - - Jewish hospital 0 Unknown. 
Takatani S., (2002) 
Table 2.8. Summary of the clinical evaluation of the AbioCor totally 
implantable artificial heart. (TAH). 
The exercise conducted with this TAH seems to be a very expensive 
way of finding that there are faults in the pump. From the figures presented, 5 
out of 7 patients died from known causes and only 1 patient survived for about 
a year. 
The failure of this exercise emphasises the danger of TAH application 
in that the patient is totally dependant on a man made device for his/her life. 
This is reinforced by Fox R. C., (1997), who indicated that the trials of the 
Jarvik-7 TAH were premature. If this pump type fails in any way, the life of the 
patient is at great risk as there no biological heart to fall back on. 
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2.2.11 Baylor pump. 
This is a pulsating pump as a total heart replacement pump or total 
artificial heart, (T AH) . The diameter and thickness of the pump are 97 and 82 
mm respectively giving a volume of 510 ml. The pump has a mass of 0.62 kg 
and has two pumping chambers either side of an electromechanical actuator 
that consists of a DC electric motor and a roller screw mechanism. The rotary 
motion of the motor is converted into a linear motion by the roller screw, giving 
a pumping volume of 63 ml. During blood pumping, the roller screw pushes 
the pusher plate for blood ejection but it is not connected to the pusher plate 
during the blood filling phase. It is assumed the pump fills with blood 
passively. Sensors detect the position of the left pump to control the motor 
speed. Polyurethane or polyolefin rubber is used as the diaphragm material. 
The TAH can give an output of 3-8 litres/min against an afterload of 
100 mm Hg with a filling pressure of 1 - 10 mm Hg. (The term 'afterload ' is 
the pressure that the TAH is pushing against when pumping blood out of the 
TAH). The power consumption ranged from 7 -12 W with an efficiency of 14% 
to 18%. (Takatani S., Shiono M., et ai, 1992). The pump can be built as 
double assembly, as shown in Figure 2.11 , as a TAH, or can be a single 
assembly as a Ventricle Assist Device, (VAD). 
Left eject, right fill . Right eject, left fill . 
Figure 2.11. The Baylor total artificial heart . (TAH) 
Hetzer, R., Hennig , E., Loebe. M. (editors ), (1997) 
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2.2.12 The Novacor pump. 
The Novacor pump is intended to be a fully implanted blood pump to 
assist patients with advanced heart failure. Work on the pump development 
started in the 1970's and progressed until in 1999 when it was claimed that 
1000 patients had received this pump in one of the intended applications. It 
was also stated that one patient had been supported for 4 years on this pump. 
The pump is a ventricle assist device, (VAD), and it is not intended to 
be a total artificial heart, (TAH). The pump is used in anyone of three 
applications, 
a) A bridge to transplantation. The pump is installed and is retained 
until a suitable donor heart is found for the patient. The pump is then replaced 
by the donor heart. 
b) A bridge to recovery. The pump is implanted and assists the heart 
until the heart has recovered enough to be capable of operating unassisted. 
The pump is then removed. 
c) An alternative to transplantation. The pump is implanted and left in 
position as a permanent fixture. 
Figure 2.12 shows the general configuration and cross section of the 
pump which has a stroke volume of 70 ml and will pump 8.5 I/min at a preload 
pressure of 20 mm Hg. 
The pump is implanted in a pocket made just below the ribs on the left 
side of the body. The pumped blood circuit is the normal arrangement for this 
application where the pump inlet is taken from the left ventricle and output is 
pumped back into the aorta. A full description is supplied by Wheeldon, D.R. 
et aI., (2000). Figure 2.13 shows the assembly of the Novacor pump. 
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Outlet and inlet pipes. 
Epoxy outer 
casing. 
Power and control 
cables and air vent 
pipe. 
Electronics 
Valve housing. 
Blood sacs. 
Wheeldon, (2000), Periusion 2000; 15: 355-361 
Figure 2.12 The Novacor pump, part section . 
A . PUMP FILLED 
FRAME 
EOUALIZING L INK 
SOLENOID 
CORE 
SOLENOID COil 
Pump Components 
PUMP HOUSING RING 
Wheeldon, (2000) , Periusion 2000; 15: 355-361 
Figure 2.13. Assembly of Novacor pump. 
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2.2.13 Novacor pump operation. 
The pump consists of two solenoids operating in a scissor action . 
When the solenoids are energised, they compress the pumping sac, with the 
spring system producing a relatively constant load on the sac. At the end of 
the pumping, the solenoids de-energise and the blood sac fills passively from 
the patient. The sequence of operations is shown in the Figures 2.14a) to c) 
below. The direction of blood flow is controlled by valves built into the pump. 
Pump full at end of filling phase 
Wheeldon , (2000), Perfusion 2000; 15: 355-361 
Figure 2.14a. The pump at the end of the filling stroke. The pump sac is full, 
the solenoids have not been activated and the springs are not flexed . 
Solenoids closed, springs flexed , start 
of ejection. 
Wheeldon , (2000), Perfusion 2000; 15: 355-361 
Figure 2.14b. The pump at the start of the pumping stroke. 
The solenoids are closed, the springs are flexed but the 
blood sac has not started to empty. 
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Pump effectively empty at the end of the 
eject phase. 
Wheeldon, (2000), Perfusion 2000; 15: 355-361 
Figure 2.14c The pump at the end of the pumping stroke. 
The solenoids are closed and pressure from the springs has effectively 
emptied the blood pumping sac. 
During pumping, the position of the moving parts is monitored by 
proximity sensors built into the pump. 
The pump is electrically powered and an air vent pipe relieves the 
volume created by the pump operation with both cable and pipe passing 
through the patient abdomen. The pump can run in four moqes, a) fixed rate, 
b) ECG triggered, c) fill rate triggered and d) fill-to-empty. All modes are 
automatically responsive to demand except for fixed rate. 
There are no details of how the pumping sacs are connected to the 
valves. There could be problems if both sets of springs are not perfectly 
matched as there is likely to be axial movement of the sac as the stronger 
spring moves the sac towards the weaker spring. This may tear or rupture the 
flexible connections to the blood pipes. The blood sac may not fully empty 
under these conditions with all the associated problems with blood 
coagulation. 
A failure point may be at the junction of the two solenoids. This is a 
mechanical junction and will be subject to loading every time the pump 
operates. Suitable bearing materials and design are necessary to ensure 
satisfactory operation for the time required for this application. It is assumed 
that operating parts of the pump are sealed from body fluids. 
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2.2.14 Spiral vortex pump. 
The Spiral Vortex pump employs a 'wandering vortex' to give a wash 
out effect inside the pumping chamber. This pump developed by the 
Australian Artificial Heart Program is described by Umezu, M. (1994) as a 
pulsatile pump where blood enters tangentially and follows the downward 
motion of the diaphragm in a spiral motion. When the diaphragm rises, this 
spiral motion continues to circulate, moving upwards, blood washing the 
internal surfaces, until it is ejected from the pump. 
This pump is claimed to have a lower index of haemolysis, at 32 -
35%, than a roller pump and a conventional pulsatile pump running under the 
same conditions. At an output of 3 I/min., the pump is not sufficient to fully 
support an adult but may be enough for a child. No details of applications 
were available. It was not stated what type of valves were fitted or how the 
pump was driven. 
By design, pulsating pumps use valves to control the direction of the 
blood flow. Valves have been the cause of problems with the build up of 
calcified areas, pannus, clot formation and mechanical failure. Tilting disc, 
ball-in-cage types, animal tissue and artificial materials have been used, and 
are a topic of research by themselves. 
The problems with valves will not be discussed here. 
2.2.15 Other pulsatile pump types. 
This section shows proposed mechanical circulatory support systems 
under investigation and demonstrates the variety of designs proposed. 
Following the time taken to develop previous pumps, if these pumps are 
successful, they are not expected to reach general use until well into the 21 st 
century. 
2.2.16 Radioisotope powered pump. 
One Russian system proposed the use of plutonium 238 as fuel for a 
radioisotope powered, closed circuit, steam engine driving two ventricles. 
Steam at a temperature of 1400 C and a pressure of approx. 3.5 kg/cm2 is the 
working fluid for the steam engine. The use of tritium is proposed to eliminate 
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the hazard of radiation injury to the organs but produces other problems. 
There was no published information on how the pump output would be 
controlled. Figure 2.15 shows a general assembly of the pump. (Shumakov, 
Griaznov, 1983). It is likely that the use of implanted capsules containing 
plutonium 238 would not be accepted by the public. 
Ventricle 
Driving 
System 
Heat 
Container 
Diaphragm 
Pump 
Steam 
Engine 
~
Pericardiai 
Cavity 
Figure 2.15. Radioisotope powered heart pump 
Shumakov, Griaznov et aI., Artificial Organs, 7( 1): pp 101-106, (1983) 
2.2.17 The pendulum pump. 
In this Korean design, Figure 2.16, the motor moves back and forth, 
similar to a pendulum, using an epicyclic gear mechanism. This motion 
alternately compresses two bladders, one for each ventricle, with valves 
controlling the direction of blood flow. It is not necessary to use a compliance 
chamber as moving the motor instead of pusher plates saves the dead space 
taken up by the motor. 
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BRV 
Center sensor 
Figure 2.16. Korean pendulum pump. 
Hetzer, R., Hennig, E., Loebe, M. (editors), (1997) 
There is no information on the performance of this pump in terms of 
flows and pressures generated. 
It is a major problem to ensure that there is a suitable 'washout' of the 
bladder after each stroke as any blood left may react with the bladder material 
and cause blood clots. If these clots become detached they could pass to the 
patient. Another problem is movement of the pendulum against the bladder 
may cause wear / puncture of the bladder material. 
2.2.18 Aachen total artificial heart. 
A pump by the Helmholtz Institute at Aachen, used a similar action to 
the Korean pendulum pump to drive two pusher plates, compressing and 
releasing two diaphragms with leaflet valves controlling blood flow. The pump, 
Figure 2.17, shows the pusher plates, 4, pivoted at X, driven by the crank 
mechanism, 10, to alternately compress and release the two bladders or 
diaphragms, 6, that pump the blood through the valves, 1. The crank is driven 
by an electric motor, 8, through reduction gears, 9. The vent, 11, allows the 
power and control cables to enter the pump. 
This pump does not operate the same as the human heart as each 
ventricle will pump alternately. This effect on the body is unknown at present. 
Both the pumping chambers must not have regions where blood can 
pool or stagnate leading to thrombus problems. 
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Hetzer, R., Hennig, E., Loebe, M. (editors), (1997) 
Figure 2.17, General arrangement of the Aachen total artificial heart. 
The pusher plates are pivoted at point X. As the plates move, is there 
may be relative movement between the plate and the non blood surface of the 
blood sac. This may cause mechanical wear which could lead to premature 
failure of the sac and is similar to the Korean pendulum pump previously 
described. 
2.2.19 Vibrating flow pump (1). 
This pump, designed at Tohoku University, Japan, is a left ventricle 
assist system. It is described by Kobayashi S., Nitta S., et al. (1998), as an 
elastic tube, with magnets attached to the outside of the tube. Figure 2.18 
details the assembly. The tube vibrates in an electromagnetic field at 10 - 50 
Hz and blood enters at one end of the pump and is ejected at the other, the 
blood direction being controlled by a jelly fish valve at the outlet end. 
At 25 Hz the pump delivery is 2 I/min. This is not enough to maintain 
life as a heart replacement pump but may be satisfactory as a child pump or 
adult assisting pump. It was stated that 'there was no fatal arrhythmia 
observed during this study'. Comments by Kawano S., Isoyama T., et ai, 
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(2003), indicate that 'the magnets made the pump heavy and the vibration 
system generated an amount of heat'. 
Magnets. 
I 
I 
102 
Bellows. 
Hetzer, R., Hennig, E., Loebe, M. (editors), (1997) 
Figure 2.18. Exploded assembly of the vibrating flow pump. 
Sizes are in millimetres. 
2.2.20 Vibrating flow pump. (2) 
Similar to previous work, another vibrating flow pump has been 
developed at Tohoku University, Japan, by Kawano S., Isoyama T., et ai, 
(2003). This pump uses a cross slider mechanism, (a Scotch Yoke), which 
converts rotary motion into reciprocating, simple harmonic, linear motion. The 
smoothness and life of this mechanism depends on material quality and pump 
speed. Higher speeds will give greater wear and consequent deterioration in 
the quality of the movement. 
The vibrating tube has an inner diameter 4 mm and a vibration 
amplitude of 1.5 mm. The total weight of motor and pump is 50 grams. 
Bellows allow the vibrating part to move and to connect to the rest of the 
pump with a jellyfish valve controlling the direction of blood flow. The motor is 
some distance from the vibrating tube and there is no heat transfer to the 
blood. 
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With a tube frequency of 50 Hz, the maximum pressure achieved is 
about 60 mm Hg with a flow rate of 0.06 I/min. Figure 2.19 shows the general 
assembly of the pump. 
The output of this pump is not enough as a left ventricle assist device 
but could be suitable as an external shunt pump to provide additional blood to 
coronary arteries. 
Motor 
Motor frame 
Bellows Vibrating tube 
Jelly fish 
valve inside 
tube 
Rotating 
disc with 
driving pin. 
Blood flow 
direction. 
Figure 2.19 General assembly of the vibrating flow blood pump. 
2.2.21 Muscle activated pumps. 
Attempts have been made to develop blood pumps powered by 
skeletal muscle. This is different from heart muscle, it fatigues quickly and is 
not suited to long term operation as required for a blood pump. 
Salmons S., Vrbova G, et aI., (1969) and Salmons S., Sreter F., et aI., 
(1976), found that a conditioning process can change skeletal muscle to 
muscle more suited to long term function. Acker M., Hammond R., et aI., 
(1987), indicate that it can be made to be so fatigue resistant that it can be 
used for cardiac assistance. 
A schematic layout of a muscle powered blood pump has been shown 
previously, Figure 2.1. This shows a stimulator causes muscle to contract. 
The muscle contraction moves a plunger which pumps fluid into a hydraulic 
actuator. The actuator moves a diaphragm, which pumps the blood. 
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For an enlarged heart condition, (dilated cardiomyopathy), skeletal 
muscle is wrapped around the heart and, using a pacemaker, squeezes the 
enlarged heart to enable improved pumping. (Pierce W., 2000). Another 
proposal wraps the muscle around the aorta, after the coronary arteries, and 
with timed muscle contractions, improves the blood flow to the coronary 
arteries. Tests on dogs by Thomas and Isoda, et ai, (1996), and Thomas and 
Hammond, et ai, (1999), have shown this procedure to be possible for up to 4 
years. This assistance appears to be similar to the intra aortic balloon pump 
method, where extra blood is forced into the coronary arteries by blocking the 
aorta at correctly timed intervals. 
Other work with this type of power source are given by Farrar, 
Reichenbach et ai, (1995), Takatani, Takami et ai, (1995) and Mizuhara, 
Koshiji et aI., (1995). 
These systems are not as advanced and have not had the success as 
the alternative pumping systems. Work is continuing to evaluate alternative 
power sources. These will not be discussed here. 
2.2.22 Summary of pulsating pumps. 
Pulsating pumps are the first generation of blood pumps. Some have 
reached the production stage; some are still in development while others are 
unlikely to proceed any further. 
With pulsating pumps, the length of time the blood is inside the pump is 
important. The greater the surface contact time, the greater the chance of 
interactions between the blood and the materials. Reul H. and Akdis M., 
(2000), indicate that the blood 'dwell' time for a pulsating pump can be greater 
than 1 second. 
The pumping action of a pulsating pump has to be carefully managed 
as it is possible to create 'dead' areas inside the pumping chamber where the 
blood is stationary or in a stationary vortex. This may lead to blood clots. 
Unsatisfactory pumping actions can create shear stresses causing 
adverse reactions in the blood. Tissue growth into valves or pump outlets can 
cause problems in terms of reduced flow or regurgitation. 
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A compliance chamber or other means of venting the volume created 
and destroyed under the pumping diaphragm must be made. The pneumatic 
HeartMate pump uses this volume to operate the pump but both the electric 
and pneumatic versions use a pipe, or cable, passing through the skin to 
operate or ventilate the pump. Comments regarding the penetration of the 
skin are made later in this summary. Other systems use a small bladder 
installed inside the patient. The bladder connects to the volume on the non 
blood side of the diaphragm and acts as a compliance chamber. If the bladder 
is faulty, a surgical operation may be necessary with the associated 
discomfort to the patient. 
The diaphragm of a pulsating pump is the major component. Extreme 
care is necessary to ensure that it has a satisfactory fatigue life and that 
installation does not cause folding or crumpling that could lead to diaphragm 
failure or thrombus creation. 
With an internally fitted pulsating pump, the patient may experience 
vibration. The vibration, or noise, may not be acceptable to the patient. 
The pump must be attached to a 'structural' part of the patient as 
leaving the pump hanging from the pipes or cables, arteries or veins must be 
very risky. The pump must be securely 'installed' to the patient, otherwise it 
may move as the patient moves. Installing the pump in a 'pocket' constructed 
by the surgeon appears to be the present method but leaves the pump liable 
to start tissue reactions. 
The power supply to the pump has received some attention. Pipes and 
cables passing through the skin are not satisfactory as it leaves the patient 
open to infections. A system to transfer power through the skin is the best that 
can be achieved at present and is described later. 
The problem of battery life needs to be addressed. A life of 8 hours is 
just about long enough for overnight but must restrict the life of the patient in 
terms of daily living, work and social activities. A battery with a greater power 
density would be of great benefit enabling the patient to live a near normal life. 
The problem of producing a completely satisfactory artificial heart has 
not been solved. Even with some of the latest designs, patients are still dying 
prematurely. 
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The next part of this chapter covers the pumps that are non pulsating 
types. These are rotary pumps that do not use valves and provide a constant, 
non-pulsating, blood flow. 
2.3 Continuous flow pumps. 
2.3.1 Introduction 
A continuous flow pump can run at a fixed or variable speed and has 
the advantages over a pulsating type pump of full implantability, a significant 
reduction in physical size, no valves, no diaphragms and the potential for 
higher reliability and longer durability. A continuous flow pump will not have a 
limited fill capacity or require a compliance chamber. 
There is no long term experience of the effect of non pulsatile blood 
supply to the organs of the body although, the pulse effect is less further away 
from the heart, due to the combination of the elasticity and reduction in size of 
the arteries and the viscosity of the blood. 
Reul, Hand Akdis, M, (2000) indicate that blood can stay inside a 
pulsating pump for greater than 1 s but with a constant flow pump it can be 
less, (1 s - 1 ms). Therefore the chance of creating blood clots due to surface 
interactions with a constant flow pump is reduced compared to a pulsating 
pump. 
A disadvantage of this type of pump is with bearings and seals, if these 
are blood immersed, they have the potential to cause problems. Possible 
solutions will be discussed later in this chapter and will include mechanical 
type bearings and magnetic suspension systems. 
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2.3.2 Radial flow pumps. 
With a radial flow pump, the fluid enters in line with the rotating drive 
shaft of the pump. The fluid is collected by a rotating disc(s) and leaves the 
pump tangentially through a delivery outlet. A magnetic drive or electric motor 
drives the pump. 
Many continuous flow blood pumps imitated existing hydraulic pumps 
with bladed discs but were found to cause problems with blood clots, 
cavitation and resulted in patient problems. Sealing the driving shaft against 
blood leakage without blood damage has been a problem. Rotary shaft seals 
are suitable in the short term, (hours), but are prone to leak or fail with blood 
leakage. Industrial sealing methods are not suitable for blood pumps. One 
option appears to be blood lubricated bearings. These have problems which 
will be described later. 
Radial flow pumps can run with a greater clearance between the blade, 
or rotor tip, and the pump casing than axial flow pumps without serious effects 
on pump efficiency. Jarvik R., (1995), indicated that a radial clearance of 
0.102 mm was practical for an axial flow pump but did not offer any figures for 
a radial flow pump. 
The possibility of increased rotor clearance makes magnetic 
suspension bearing systems more suitable for a blood pump as there is less 
danger of the rotor colliding with the pump casing and these would seem to be 
the ideal at present. 
The clearance of blade tips relative to the inside of the pump casing is 
a concern in terms of the shear stress to the blood. This will probably be the 
governing consideration as it may be better to sacrifice an amount of 
efficiency but have a 'safer' pump in terms of haemolysis. 
Examples of radial flow pumps follow. 
2.3.3 Baylor rotary pump. 
Figure 2.20 outlines the general arrangement of the Baylor rotary radial 
flow pump. The part shown is the blood pumping part and does not show the 
pump driving arrangements. 
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This pump is intended to be suitable for extracorporeal and long term 
intracorporeal ventricular assistance. 
A brief description of this pump is taken from Ohara, Makinouchi, et 
aI., (1994) and is summarised below. 
Outlet 
T 
Inlet female 
pivot bearing 
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Impeller 
magnet Impeller 
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Hetzer, R., Hennig, E., Loebe, M. (editors), (1997) and 
Ohara Y, Makinouchi K., et al. (1994) 
Figure 2.20, The Baylor rota~ pump. 
Previous pumps using a drive shaft and seal arrangement suffered 
from blood leakage and the pump needed to be changed eve~ 24 hrs for 
trouble free running. The pump was unsuitable for implantation and a different 
method of mounting the rotor was required. 
With a later design the blood enters through an eccentric inlet port and 
is 'collected' by vanes on the rotor. The blood leaves the pump through the 
tangential outlet port. It is assumed that the small seconda~ vanes on the 
back of the rotor give a 'wash out' effect as this is a possible location for blood 
clots. As the inlet port is eccentric, the top bearing of the rotor is out of the 
blood flow as experience had shown that bearing support bar( s) across the 
pump ent~ may cause thrombus formation. 
The rotor is mounted on two small pivot bearings. Careful design of the 
bearings is necessa~ in order to minimise blood damage and this design 
indicates that the bearings are similar to a mechanical clock where a small 
tapered shaft fits into a cup. This arrangement gives both axial and radial 
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location with a small contact area. The bearings used in this pump were made 
from carbon steel and brass which are not good choices for blood contacting 
materials. After 120 hours of in-vitro tests, wear of 'less than 0.2 mm' was 
reported. This is high for an implanted pump and more work needs to be done 
to solve this problem for a target life of 3 months. 
Yamane T., et aI., (2004), estimated that the minimum shear rate 
around the bottom pivot was 650/s 'which is higher than the threshold for 
thrombus formation'. 
The rotor is driven by internal magnets that follow the rotating magnetic 
field provided by electronics external to the pump. (The electronics are not 
shown). 
The pump can deliver 8 I/min at a pressure of 250 mm Hg at a speed of 
2400 rev/min. At the same speed, and a delivery of 1 I/min, the pressure rise 
is greater than 300 mm Hg. 
2.3.4 Vienna pump. 
The description of this pump is taken from Hetzer, R. et aI., (editors), 
(1997). This is a rotary pump with inbuilt electronics producing a flow of 10 
I/min at a pressure head of 100 mm Hg. with an overall efficiency of 11 % at 
2,500 rev/min. 
Figure 2.21 shows the general layout. The pump has a diameter of 
0.065 m, a volume of 101 ml and a mass of 0.240 kg. and is built with a blood 
pumping section and a section containing the electronics and magnets that 
drive the pump. 
The pumping rotor appears to be supported on three ball bearings, 
running on a convex shaped carbon disc, that are immersed in blood. This 
arrangement is likely to cause damage to the blood cells. Although blood 
contact with the carbon disc itself is unlikely to cause haemolysis, it is 
expected that the action of the balls running over the surface of the disc will 
mechanically damage blood cells. During evaluation tests it was noted 'some 
blood trauma was caused' with a 'haemolysis index as low as 0.0046 g 1100 
L'. 
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Figure 2.21 The Vienna centrifugal pump. 
During testing, depending on the strength of the magnets used, the 
rotation of the rotor on the three ball bearings was stable up to a delivery of 10 
I/min at a pressure of 200 mmHg. Beyond this point the rotor tended to lift 
from the carbon disc and run 'off centre' touching the inside of the housing. 
Stronger magnets could be used but would mean greater contact forces at 
lower speeds. 
It is advantageous to run the pump at a speed and load so that the 
rotor is just on the point of lifting off the surface of the carbon disc in order to 
minimise haemolysis and prolong the pump life. There is nothing to show if 
this was attempted. Schima H. , et aI. , (1995) reported small amounts of 
thrombi were found around the area where the distance balls were located but 
this was considered to be a manufacturing fault. 
Figure 2.22 indicates that if the rotor runs 'off centre ', the resultant 
forces will pull the rotor back to its correct position . 
The vector shown as 'magnetic force ' is understood in terms of 
direction and magnitude. The direction of the vectors shown as 'bearing force ' 
and 'centering force' are not understood . As shown the ball has two 
downward forces with no equal and opposite reaction forces. Any reaction 
force will be 'normal' to the disc surface and will resolve into a vertical force 
opposing the magnetic attraction, and a horizontal force tend ing to make the 
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ball move down the slope of the disc. The horizontal force vector will be in the 
opposite direction to the 'resulting centring force' as shown as on Figure 2.22, 
i.e., the vector will be pulling outwards and will not be a centralising force. 
Magnetic force Bearing 
force 
Resulting centring force 
Schima H., Schmallegger H. et aI., (1995) 
Figure 2.22 Diagram showing the published forces. 
With the three balls running on the carbon disc, equally spaced around 
the circumference and assuming all are experiencing identical forces, the 
rotor will be in unstable equilibrium. If the rotor moves 'off centre' by a small 
amount, one horizontal force will increase while the others will decrease as 
the 'off centre' bearing ball moves down the slope of the carbon disc. As the 
rotor moves 'off centre', the magnetic attraction between the magnets in the 
rotor and one, or more, of the permanent magnets in the base of the pump will 
become greater as one the rotor magnets becomes closer to the base 
magnets. This will result in the so called 'centralising' force on the 'off centre' 
side of the rotor becoming larger while the other will become smaller. The 
rotor will then run eccentrically. This condition is not self correcting and the 
rotor will possibly collide with the pump casing. 
The pumping rotor appears to have a hole in the centre. This may be 
an attempt to prevent thrombus formation under the disc as there will be a 
'wash out' effect under the disc as blood passing through the hole to the 
underside of the disc will be drawn around with it and move outwards with the 
centrifugal forces created by disc rotation. 
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2.3.5 Blood damage with rolling bearings. 
Following the description of the Vienna pump, a literature search was 
made concerning blood damage with rolling bearings. 
Fok and Schubothe, (1960), used a flask, containing quartz beads and 
blood, rotating on a horizontal axis. The results from this work indicated 
haemolysis was present and was related to the length of time of rotation and 
the number of beads in the flask. The paper suggested that haemolysis might 
be produced by high fluid stresses damaging the blood cells as the beads 
moved through the blood and not by direct physical crushing of the cells 
between the quartz bead and the wall of the flask. 
Freitas R., (2003), indicates 'impact' haemolysis is not unknown in 
marathon runners and other physical sports where 'although non mechanical 
factors may contribute, it is generally believed that most of the damage is 
caused by mechanical tearing'. An example is given of where 'a human 
runner, of weight -103 N whose footfall force is spread over an area of 
-100cm2 , can exert a momentary tissue pressure of -105 Nlm2 which is well 
in excess of the red cell fragmentation stress limit of 150-250 Nlm2 '. 
2.3.6 Development of the Vienna pump. 
Yoshino and Uemura et aI., (2001) proposed a development of the 
Vienna pump. It had the same dimensions as before, outer diameter 60 mm, 
height 50 mm, mass 760 g, but the three ball bearing support system was 
replaced by a single ceramic ball mounted under the impeller. A polyethylene 
female pivot was built into the pump casing. No other means of supporting the 
mass of the rotor was used. A magnet at the top of the rotor was used to 
stabilise, or centralise, the rotor. Figure 2.23 shows the general arrangement. 
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Figure 2.23. Vienna single pivot centrifugal blood pump. 
At 1,200 rev/min the rotor tended to wobble but at 1,400 rev/min, the 
rotor was stable. At 1,800 rev/min the rotor started to lift from the bearing. 
Output was 5 I/min at 2,200 rev/min against back pressure of 100 mm Hg. 
Reducing back pressure to 52 mm Hg. gave 9 I/min. There was no information 
to indicate what would happen if the rotor lifted enough to lose contact with 
the ball pivot at the base of the rotor. 
2.3.7 AB 180 pump. 
Westaby S., (2000), describes the AB180 as a radial flow centrifugal 
pump constructed in two parts. The upper housing contains a 6 bladed 25mm 
diameter impeller, running at 2500 - 4500 rev/min. , attached to a stainless 
steel rotor inside a lower housing which contains a stator system. The base of 
the rotor sits within a magnetic field . A three phase, 12V system uses two 
phases for power, the third phase is used for speed sensing. 
Sterile water pumped into the lower housing provides a fluid bearing to 
the rotating surfaces and a heparin delivery system is used for blood 
anticoagulation . 
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A balloon mechanism is fitted to prevent any blood backflow in case 
the pump fails. 
The microelectronic system contains a transformer, a battery to supply 
power when transporting the patient, water and heparin infusion pumps, an air 
pump for the balloon system, alarms and associated electronics. The only 
external control is a speed control knob. This implies a manual control 
system. The pump inflow is inserted into the left atrium with the pump outflow 
connected to the ascending aorta. This implies that the left ventricle is 
'unloaded' and is rested. 
'In vivo' tests using sheep were done by Clark. et ai, (1998). Blood flow 
rates of 1 to 5 I/min were achieved over a cumulative time of 106 days. The 
pump ran at 4,162 rev/min and maintained 73.5% of the blood flow 
requirements of the animal(s) with normal indications for blood parameters. 
The size and weight of the implanted pump reduced the chances of infection. 
'In vivo' tests by Tevaearai et aI., (2001), using calves of a weight 
similar to a human, (71 kg), indicated a delivery of 5.6 IImin at 4500 rev/min 
with acceptable blood pressures. 
2.3.8 VentrAssist radial flow pump. 
Peterson and Woods, (July 2004), report that this pump, made by the 
Australian company Ventracor, is designed as a left ventricular assist device. 
It only has one moving part, the impeller, that is suspended on the blood as it 
rotates. Coils in the pump casing generate the magnetic fields that are picked 
up by the magnets in the impeller. Suitable electronics enable the impeller to 
rotate without any other bearing support. The life of this pump is unknown as 
there are no contacting moving parts to wear. 
The clearance between the rotor and casing and the 'stiffness' of the 
bearing system will be critical. Unless the pump is securely anchored inside 
the patient, are there gyroscopic effects likely to affect the patient? 
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The fully implantable titanium pump, shown in Figure 2.24, is 60 mm in 
diameter, weighs 0.298 kg with a volume of 122 ml. It is designed to be 
suitable for both children and adults with a maximum flow rate of 10 IImin . 
Power 
cable 
Blood outlet 
Blood inlet. 
Fig 2.24, VentrAssist blood pump. 
2.3.9 HeartMate III pump. 
Peterson I. . Woods D., (July 2004). 
Schab R., Loree H.M. , (Date accessed 2005), describe this is a radial 
flow pump with a full magnetic suspension and drive system. Where the 
original diaphragm type pumps had an anticipated life of 2 - 3 years this 
system is intended to make progress towards an L VAD with a life of 10 - 15 
years. The pump is in two parts, a blood pumping chamber, and a suspension 
and driving section. This enables the blood pumping section to be separate 
from the electronics and to be fully disposable. The blood pumping chamber is 
made from titanium and the internal surface is textured to promote the growth 
of the pseudoneointimal layer, similar to the HeartMate I pump. 
The rotor weighs 0.349 kg and the magnetic suspension system can 
handle forces of 31 .5 times this radially and 23.1 times this force axially. This 
gives a very robust suspension system. 
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In vitro tests gave a flow rate of 7 Ilmin at a pressure of 135 mmHg at a 
speed of 4,800 rev/min. In vivo tests over 27 to 61 days have given 
satisfactory results at flow rates of 3 to 11 I/min. with no pump failures and no 
blood problems. An examination of one pump, after 59 days, showed a blood 
compatible biological lining similar to the HeartMate I pump. Figure 2.25 
shows the general assembly. 
Inlet 
Pump housing 
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Outlet 
Stator 
winding 
Schab R.. Loree H. (Date accessed 2005). 
Figure 2.25, The general arrangement of the 
HeartMate III pump. 
The magnetic suspension will give an infinite life assuming no collisions 
with the walls of the pumping chamber. Care will have to be taken with the 
control system as it will be more complicated than other systems. Two sub-
systems run together so that in case of a fault, one is capable of running the 
pump without interruption. Suitable reporting systems have been built in to 
signify any faults. 
The magnetic levitation system appears to be an answer to the 
problem of running a blood pumping device. One problem has not been 
answered however. Blood contains haemoglobin which contains iron. The 
effects of strong magnetic fields, (up to 2 Tesla), on haematology have been 
studied and no consistent results have been found. It is assumed that the 
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amount of magnetism involved with a magnetically driven and controlled blood 
pump will be small and the effects will be negligible, (Moulder J., 2001, and 
Moulder J., 2004). 
2.3.10 Description of axial flow pumps. 
In axial flow pump, fluid is drawn in at one end and exits at the other 
end along the line of the central rotating shaft and consists of a circular 
section barrel with a screw or propeller device mounted on bearings inside the 
barrel. The pumping action is created when the screw rotates and fluid moves 
axially through the barrel. 
Reul and Adkis, (2000), show that the rotation speeds can range from 
6,000 to 160,000 rev/min. Bearing types include blood lubricated ceramic 
bearings, diamond coatings, ball bearings and magnetically levitated 
bearings. 
2.3.11 Intra ventricular axial flow pump. 
This pump type described by Yamane, Ikkeda, et aI., (1996), is an axial 
flow pump designed to draw blood from the inside the ventricle and pump it 
directly into the ascending aorta. Power is supplied to the motor attached to 
and external to the ventricle. Figure 2.26 shows an installation of a pump of 
this type where it is sewn to the outside of the left ventricle. The pump is 
powered using an electrical cable passing through the skin. 
Care must be taken to ensure that no part of the ventricle is drawn into 
the pump inlet. Apart from damage to the heart, the blood flow will be 
interrupted and may stop even though the motor is still running. 
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Yamane, T. Ikkeda, T et ai, (1996). 
Figure 2.26. Installation of intraventricular axial flow pump. 
2.3.12 Hemopump. 
Lann, U., (1997), shows that the Hemopump is inserted into the aorta 
in the groin and passed up to the heart. The pump is positioned in the left 
ventricle and pumps blood from the interior of the left ventricle into the aorta. 
Figure 2.27 shows this arrangement. It is noted that the pump drive passes 
through the aortic valve and that the valve is held open while the pump is in 
position. There is no mention of damage to the valve. 
The best methods of driving these pumps so far include rotating 
magnetic field arrangements. 
Axial flow pumps have the advantages of being fully implantable, they 
are small and quiet, there are no valves required, and by varying the speed 
they can be pulsatile or non - pulsatile and are less complex than pulsatile 
pumps. They do not need a compliance chamber or atmospheric vent system. 
This reduces infection due to pipes passing through the skin. (Frazier, 2003). 
With non pulsatile support, the blood ejection pulse by the patient's heart on 
the arterial pressure trace can be seen. This can be used as an indicator of 
the performance of the patient's heart. This trace is difficult to see with 
pulsatile support. (Dabritz and Messmer, 1997) 
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Figure 2.27. The installation of the Hemopump. 
A disadvantage with any pump is if the internal 'hydraulic' conditions 
are not suitable for pumping blood safely and cavitation , high instantaneous 
pressures and high shear forces are present, blood damage could occur 
causing problems to the patient. 
The exact safe levels of blood shear are difficult to determine. Some 
investigators report platelet activation and adherence to blood vessel walls 
can increase with high shear rates, (Markou, Hanson, et aI., 1993). Others 
suggest that the blood vessel walls respond to the changes in wall shear rate 
rather than the level of shear, (Frangos, Eskin, 1985). Some evidence exists 
that atherosclerotic thickening and intimal hyperplasia occur at regions where 
the average wall shear stress is low and is oscillatory, (He and Ku , 1996 and 
Ku D. 1997 and Wotton D.W. and Ku D.N., 1999). This is an advantage for a 
non-pulsatile pump. The arteries appear to adapt to a 'normal ' wall shear 
stress average of 1.5 to 1.0 N/m 2, where a consistently high shear stress 
causes dilation, (enlargement), and a consistently low shear stress causes 
them to reduce in size. (Glagov and Zarins , et al. 1988). 
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2.3.13 Jarvik 2000 
One of the later, more successful artificial blood pumps, the Jarvik 
2000, shown in Figure 2.28, is a non-pulsa.ting, continuous flow, axial pump. 
The fully implanted pump measures 0.025 m in diameter, has a mass of about 
90 grams and has a displacement volume of 25 ml. Animal experiments 
indicated that the pump was free from thrombus problems. (Fuchs, Netz, 
2002). 
The pump has a mean power consumption of 6 - 7 watts and the 12V 
batteries last about eight hours. The pump speed , (between 8,000 and 12,000 
rev/min), is varied by an external controller on a belt and the pump delivers 3 
- 8 Llmin. There are no valves and the blood washes the pump bearings. 
Blood damage is said to be 'minimal' with some patients taking warfarin while 
others show no clot formation with only aspirin. Due to the small size of this 
pump, patients with a small body surface area can be treated, which implies 
that children may be future patients. (Kukuy, Oz, et ai , 2001). 
This pump is connected in parallel with the natural heart, which is still 
beating. This means the heart is not carrying the full blood circulation load and 
this assists in recovery. 
Cordes K, (2002 ). Project report , 2001-2002, p33. 
Figure 2.28. Jarvik 2000 pump showing design features 
and the relative size of parts. 
Figure 2.29 shows the parts and assembly of the pump. The main 
bearing of the pump is basically a length of stellite wire , diameter 0.9398 mm, 
running through the length of the pump and fastened at each end by crimp 
connectors in the inlet and outlet stators. A set of Bellville washers keeps the 
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wire under a tension load of 22.68 kg. with pyrolytic carbon sleeves providing 
both thrust and bearing surfaces. The major parts of the pump are titanium. 
The clearance between the tip of the rotor and casing is 0.1 016 mm and wear 
on the bearings will be critical as the rotor may touch the inside of the casing . 
For this reason the bearings were changed to silicon carbide and a 5 months 
endurance test was conducted with the pump running at a speed of 10,000 
rev/min. At the end of the test no measurable changes were seen for the 
shaft, the thrust bearing and at the inflow bearing at a measuring accuracy of 
0.00254 mm. The outflow bearing showed wear of 0.00254 mm. It was 
estimated that the wear on the bearings will provide satisfactory duration for 
up to ten years. (Jarvik R, 1995). 
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Hetzer, R. , Hennig, E. , Loebe, M. (editors), (1997). 
Figure 2.29, Assembly of the Jarvik 2000 blood pump. 
The rotor has inbuilt magnets and is driven by a rotating magnetic field 
in the motor armature, set up by an external control system. 
Three methods of supplying power to this pump have been developed. 
The first uses the usual method of an electrical power cable that exits 
through the patient's abdomen. 
The second method is a fully implanted pump and control system and 
uses the TETS system of energy transfer through the patient's skin to supply 
the pump with the necessary power. 
78 
The third method uses a plug and socket arrangement fitted to the 
patient's skull just behind one ear. From the fitting on the patients head , the 
power supply wires run under the bone of the skull , and then under the skin of 
the neck and body to the pump. This method reduces the infection risk 
relative to cables exiting through the abdomen. The external wires plug into 
the fitting on the skull and run down to a manual control and batteries on a 
belt or harness. Figure 2.30 outlines the installation . 
A UK patient has lived for approx. 2 years with this pump implanted. 
The natural heart has improved, reinforcing that if it is 'rested ' that there is a 
chance of recovery. There is nothing to suggest that the mainly non-pUlsating 
flow has caused damage to the patient who appears have an almost normal 
life in terms of walking and exercising outside the hospital environment. 
(Westaby S. and Banning A., et aI., 2000). 
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Figure 2.30. Installation of a Jarvik 2000 pump with the heart in situ . 
2.3.14 MicroMed-DeBakey pump. 
An intraventricular pump similar to the Jarvik 2000 has been designed 
by the Baylor College of Medicine collaborating with the NASA Johnson 
Space Centre. Known as the MicroMed - OeBakey pump, it is approx. 31 mm 
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in diameter, 76mm long, (volume 57ml), has a mass of 0.095 kg and has a 
maximum output of 10 IImin. The pump takes blood from the base of the left 
ventricle and delivers into the aorta. In use, average pump flow is 3.9 to 5.4 
I/min with warfarin anticoagulation treatment. With all intra-ventricular pumps, 
there must not be too much intake suction that will cause ventricular collapse 
or part of the ventricle to be drawn into the intake port. 
As the pump delivers non pulsatile blood, it is possible to see a pulse 
on the pressure trace from the natural heart and the size of the pressure pulse 
is an indication of the condition of the natural heart. Some patients have 
shown an improved exercise tolerance and go home while awaiting 
transplantation. (Kukuy and Oz et ai, 2001). 
The improved condition is beneficial as recovery from transplant is 
quicker and with less complications if the patient is in 'good' condition before 
the operation. A sectioned pump is shown in Figure 2.31. 
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Figure 2.31. Section through the MicroMed DeBakey pump. 
It is noted from Figure 2.31 that the blood flow pattern changes as it 
passes through the pump. The first section of the impeller looks similar to an 
Archimedean screw where the flow will be axial. Passing into the centre 
section of the pump, the induce'r I impel lor appears to generate a rotary flow, 
imparting kinetic energy to the blood as the rotor spins. The diffuser appears 
to have blades to convert the rotary flow into axial flow before the blood 
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leaves the pump. This is probably generates pressure at the outlet of the 
pump. It is assumed that excessive stresses are not set up in the blood wi th 
the changes in flow direction through this pump. 
2.3.15 HeartMate II pump. 
This axial flow pump uses blood immersed ceramic and jewel pivot 
bearings for the rotor. There should be no reactions with blood from the 
bearings as they are biocompatible but the reaction of blood as a lubricant is 
not fully understood. (Chapter 2.3.4, the Vienna pump, discusses some 
aspects of blood lubricated bearings.) A cross section of the pump, Figure 
2.32, shows a power cable leading out of the pump but a future version is 
planned using a fully implanted control system with TETS power transfer. 
There is no volume compensation with this pump which is fitted in the usual 
position between the left ventricle and the aorta . As this type of pump is 
'small'compared to pulsating type pumps, it can be placed closer to the heart 
with shorter inlet and outlet tubing. 
The pump is undergoing clinical trials and is expected to be suitable for 
adolescent, paediatric and adult patients. Schab and Loree (Date accessed 
2005). 
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Figure 2.32, Cross section of HeartMate II pump showing general 
arrangement and blood flow direction . 
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2.3.16 Incor Berlin pump. 
Huber C.H., Tozzi P., et aI. , (2004) , describe an axial flow implantable 
blood pump with magnetic suspension to position the rotor ins ide the pump 
and a magnetic drive to pump the blood . The rotor does not have bea ri ngs to 
wear, and assuming no collisions of rotor and pump casing , the pump life is 
considered to be 'infinite' . This pump is considered to be a 'fourth ' generation 
pump because it is 'contact free' in terms of bearings. The titanium pump, 
mass 0.2 kg, is 0.114 m long with an installed volume of 80 .6 ml. 
Figure 2.33 shows a section of the pump and it should be noted that 
the rotor is free to move axially inside the pump. From the position and speed 
of the rotor the differential pressure across the rotor can be calculated. 
Changes to the pressure difference cause the rotor to move axially inside the 
pump and if position sensors determine that the rotor is not located correctly 
inside the pump 'a counteracting force is generated in the magnetic 
suspension system' to return the rotor to its correct position This statement is 
not fully understood but it is assumed that the rotor speed is changed in order 
to keep the rotor in the optimum position inside the pump housing. The 
amount of energy used to keep the rotor in position is used to calculate the 
flow through the pump. 
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Figure 2.33 General arrangement of the InCor Berlin axial flow pump. 
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At a speed of 5,000 to 10,000 rev/min ., the pump del ivers up to 5 I/min 
at a back pressure of 100 mm Hg. at a power consumption of 2 - 4 W. 
The pump is implanted in the usual position between the left ventricle 
and the aorta. The power supply and control cables exit the body through the 
abdomen and a controller and batteries are carried on a belt or harness. 
Figure 2.34 shows the installation relative to the patient. 
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Figure 2.34 showing the installation of the Incor Berlin blood pump. 
Animal experiments over 6 hours gave an average flow of 2.5 IImin at a 
pressure of 58.8 mm Hg at 6590 rev/min . This is about half the quantity 
delivered by the human heart. At the end of the tests all pumps were free of 
thrombi. 
A trial of 24 patients showed 'good' results in that 5 died, 2 recovered 
sufficiently to leave hospital and three received heart transplants . The 
remainder stayed on pump assistance. It was suspected that thrombi had 
formed with two patients as pump flow decreased but motor current 
increased. Treatment appeared to resolve the problem without removing the 
pump or surgical intervention. 
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Goldstein D., (2003), reports that the blood contacting surfaces of the 
pump were bonded with heparin but the thrombus problem sti ll occurred. This 
indicates problems either in materials or in blood flow characteristics . 
2.3.17 Magnevad pump 
Goldowsky M. , (2004), describes another 'fourth ' generation , axial flow, 
implantable pump that uses magnetic suspension to locate the rotor and a 
magnetic drive to pump the blood. 
The pump is intended to deliver pulsatile flow by constantly varying the 
rotor speed . 
The rotor passive magnetic suspension system does not have any 
bearings, and with no collisions, the life of the pump is considered to be 
'infinite' . It has a mass of 0.082 kg, is 30 mm long and an installed volume of 
25 ml. Figure 2.35 shows a section through the pump. 
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Figure 2.35. Section through the Magnevad pump. 
The pump is made of three parts, an inlet stator, a magnetica lly 
suspended impeller and an outlet stator with a double cone arrangement. The 
cone(s) are intended to smooth the blood flow to minimise blood tu rbulence 
and the generation of blood clots . The cone feature is unique to this pump. 
The rotor is positioned by magnets at either end of the rotor and an 
ultrasonic sensor is used to determine the axial position of the rotor. If the 
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rotor is not in the correct position an automatic control system changes the 
rotor speed to keep the rotor in the correct axial position. 
The small hole in the centre of the rotor is intended to allow a small 
amount of blood to wash the gaps between the ends of the rotor and the inlet 
and outlet stators. 
The same basic design of pump, suitable scaled, is intended to be suitable for 
adults as well as children. 
The maximum speed of the pump is 15,000 rev/min but will deliver 5.2 
I/min at 13,000 rev/min at a pressure of 120 mm Hg. A speed of 11,000 
rev/min generates a pressure of 80 mm Hg and cycling the pump between 
these two speeds is intended to represent the typical blood pressure variation 
for an adult. 
For the pump to be running safely it will always have to be delivering 
some blood flow and this flow will have to be enough to prevent reverse flow 
through the pump and back into the heart. If the pump is running too fast on 
the pumping beat of the heart, it may generate a pressure behind the aortic 
valve that will not allow the valve to open. If the pump is running too slow 
when the heart pumps, the heart may generate enough pressure to open the 
aortic valve and attempt to push blood back through the pump. More 
information is needed to explain the operation of this and similar systems. 
2.3.18 Summary of non-pulsatile flow pumps. 
Pumps delivering non-pulsatile blood flow are the second generation of 
blood pumps but there does not appear to be full agreement amongst the 
medical profession that these pump types are fully satisfactory for the purpose 
intended because they do not give a pulsatile blood flow. Experience so far 
seems to show that the body adapts to this type of blood delivery method. 
Other researchers claim that pulsatile flow is necessary to maintain the blood 
flow through the brain and kidneys. More studies and data are required to 
answer this question. 
There is evidence of less drug support required to keep the blood from 
clotting with non-pulsatile pumps. Kukuy et al. (2001) report that some 
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patients only require aspirin instead of warfarin as anticoagulation treatment, 
compared to pulsatile pump users. 
There are no shaft seals to fail and no need for seal flushing systems 
with magnetically suspended systems. If this method of suspension can be 
guaranteed to be satisfactory, it would seem to be an ideal method. There 
could be problems with this method however concerning any interruption of 
power supply causing the rotor to contact the inside of the casing. 
A listing of some of the artificial heart types and applications is shown 
on Appendix 4. 
Control systems for rotary pumps appear to be simpler than with 
pulsating pumps, as patients can be sent home with portable, manual controls 
in use. 
As with all other pumps, battery life is an important restriction to patient 
mobility. A battery with a life of 8 hours barely covers the overnight sleeping 
period and must restrict the day time activities if the patient needs to leave 
home. 
The next part of the chapter will describe the power sources provided 
for blood pumps. It will show that power sources are provided in two main 
versions and that many power supply methods have not been successful. 
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2.4, Power sources. 
This part of the chapter will describe the power sources that are under 
hospital control. 
Brief descriptions of power sources that have been tried but have not 
been successful will also be discussed. 
2.4.1 General description. 
Those patients recovering following heart surgery may need a heart 
assisting device to recover satisfactorily. These devices are normally powered 
from the mains electricity supply through a control console and examples of 
would be the peristaltic roller pump, the intra aortic balloon pump, the Berlin 
pump and the BVS 5000 pumps described previously. 
For patients who have received a blood pump, they can be supplied with 
mains or battery power depending on whether they are in or out of hospital. 
With an 'in hospital' system, support is dependant on patient recovery 
and there is no restriction on the length of time power is supplied. With an 'out 
of hospital' system, batteries will need constant attention. 
It is advantageous for a patient to be as fit as possible before the 
transplant and they are encouraged to exercise. For this they may use a 
battery powered pump so that they can be mobile which implies the system 
has to be light and easy to use. 
The length of time the batteries last before recharging can be quite 
short, 6 to 8 hours is typical and several sets of batteries may be needed to 
ensure that one set is always ready. 
The HeartMate, (Figure 2.5), and the Berlin heart, (Figure 2.8), are 
systems that can be portable. 
With the Berlin heart 'Excor' system, the patient can leave the hospital 
if required but is tethered to a power system that is either carried around as a 
backpack or is pulled around in something approaching the size of a shopping 
trolley. While not the ideal way to live, the patient can exercise, keep 
reasonably fit and have some measure of independence while recovering or 
waiting for further treatment. 
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The system is designed for biventricular operation and uses two 
independent drive units. They are coupled so that if one unit fails the other 
continues to operate and supplies power to both blood pumps. The 12 volt 
batteries will give a service time of 6 hours and emergency batteries give 30 
minutes of power. Indicators give information on battery charge condition and 
warnings of any problems with the equipment. (Drews et ai, 2000). 
The length of time some patients using artificial heart support can be 
short, for example hours to days. Other patients have to wait considerably 
longer. Loebe et aI., (1995), report that The German Heart Institute, Berlin has 
one patient that has used artificial support for 500 days. Some patients at that 
hospital have been known to leave the hospital on shopping trips and other 
excursions. 
For those patients that have been fitted with a non pulsatile pump, the 
size of the batteries and control system can be reduced as the system takes 
less power and it is easier to control this type of pump. With this system the 
batteries and control system can be carried on a belt or lightweight harness 
and it does not need a backpack or trolley. 
The pump controls do not need to be automatic, the Jarvik 2000, uses 
a manual control for pump speed. The batteries last around 6 to 8 hours 
before recharge is needed. The power consumption is around 6 - 7 watts at a 
blood delivery of 5 - 6 I/min. (Westaby S., 2000). 
The power consumption for an artificial heart depends on the type of 
device. Some of the pulsating artificial hearts, required 15 to 20 Wand 
concern was expressed in terms of heat generation affecting the blood. The 
later, rotary, pumps require power ranging from 70 W for the Hemopump, (an 
intraventricular pump), to 6 W for the DeBakey pump, (an axial flow pump), 
with any heat generation being removed by the blood. A temperature rise of 
approximately one degree through the pump does not appear to affect the 
blood. This is not surprising as a fever temperature of 40° C, (104° F), is 
possible with full recovery. 
Radial flow pumps have a similar power range from 4W to 25W. (Reul 
and Akdis, 2000). Specialised batteries have been developed for blood pump 
applications. Lead-acid batteries are unsuitable for implantation, reasons 
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include 'gassing off' during charge and discharge and the time taken to 
recharge. 
The power supplied by a battery compared to the weight is important 
for a portable device. The power-to-weight ratio varies between various 
battery types and Table 2.9 is a comparison considering lead-acid gel 
batteries having a power-to-weight ratio of 1. This indicates that lithium 
batteries hold promise for implantable batteries at present. 
T~Qe of battery Power to weight ratio 
Lead- acid gel 1 
Nickel Cadmium 1.165 
Nickel- Metal Hydride 1.487 
Lithium 2.539 
Zinc- Air 4.261 
Starner T.. (1996). 
Table 2.9 Comparison of battery types and power to weight ratios 
Rowles, et aI., (1992), quote a combination of implanted nickel-
cadmium rechargeable batteries that supply power for 20 minutes and 
external silver-zinc batteries which are enough to drive a blood pump for 5 
hours. 
Lithium batteries have been developed for consumer electronics, 
(mobile telephones, electric vehicles) and have been considered for 
implantable medical devices. For these applications the batteries are strongly 
built, corrosion resistant and with low magnetic characteristics. These are the 
ideal physical attributes for an implanted battery. Bruce, (1997), provides a 
technical explanation of the chemistry involved in the operation of these 
batteries. The paper indicates that each cell has the advantage of storing 
more than twice the energy of 'normal' rechargeable batteries of the same 
size and mass. 
Batteries are made for implanted devices by the Saft Lithium Battery 
Division, Saft lithium battery, (2002). For example, the cells for the Berlin 
heart are flat, to giving a better fit to the body, and measure 17*48*65 mm. 
Each cell weighs 0.121 kg, has a nominal voltage of 3.6V and capacity rating 
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of 4.6 Ah. Stacking cells together gives the required voltage for the heart 
assist device. These cells can operate the pump for up to 10 hours without 
recharge and using specialised technology can recharge in 60 minutes. It is 
claimed that these batteries will recharge to greater than 85% of the 'new' 
capacity after 500 charging cycles. These figures would indicate a working life 
of about 7 months assuming the 85% recharge capacity. 
A method to determine the useful life for the battery must be found to 
ensure safety for the user as there is no point in expecting 8 hours of use if 
the battery fails at 5 hours. A practice of replacing batteries after a given 
number of years may have to be implemented even though they still seem to 
be satisfactory. There was no information of the cost of the batteries. 
2.4.2 Implanted power systems. 
A power system that has potential is the TETS system, (Transmission 
of Energy Through the Skin). This has been developed to enable implanted 
pumps to be powered from an internal battery and control system. The 
internal batteries, which last about half an hour, are recharged through the 
skin, which eliminates the prospect of infections. 
The first system used two pancake coils to transmit and receive the 
energy. One coil was placed outside the body, the other was implanted. The 
system was stated to have transmitted 38 watts with an efficiency of 95% 
using a frequency of 465 kHz. Figure 2.36 shows the circuit diagram of this 
system. 
Power ~-i 
line 
RF 
generator 
Transmitting 
coils 
1000 watts 
Skin 
Receiving 
coil _ 38 watts 
rooo' .. 
Myers and Parsonnet, (1969). 
Figure 2.36 Electrical circuit diagram of a TETS system. 
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It was important that the two coils were in close proximity in order to 
transmit the required energy and the system has been tested for this using an 
animal. The results indicated enough energy was transmitted as long as the 
receiving coil was within 1 m3 of the transmitting coil. (Schuder and 
Stephenson (1963) and Schuder, Stephenson and Townsend, (1969). Other 
systems have been developed that run from battery power. 
A similar system by Myers and Reed, (1968), used coils strapped 
externally to the body. The electrical coupling of the coils was set up so that 
any slight misalignment of the coils would not seriously affect the amount of 
power transmitted. The power and efficiency stayed reasonably constant for 
an air gap spacing of up to 17mm and an 'out of alignment' of the coils of up 
to 10 mm. The system used a lower frequency of 13 kHz and achieved an 
efficiency of 91 0/0. The system was stated to be capable of charging the 
internal batteries without noticeable skin damage. The patient can be trained 
to recharge the internal battery using a harness to position the external coil. 
The package is self-contained and does not need any external controls. 
Figures 2.37 and 2.38 show the system proposed. 
A harness carries the external batteries and control monitor. The 
external coil placed adjacent to the internal coil transmits the power through 
the skin required to run the internally implanted blood pump and control 
system. 
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Figure 2.37. Schematic layout of a TETS system, 
Transmission of Energy Through the Skin. 
u.s. patent no. 5,109,843. 
From Engineering in the Heart and Blood Vessels, 
Myers and Parsonnet, 1969. 
Another TETS system is proposed by Goto, et aI., (2001). This system 
uses near-infrared light passing through the skin to charge an implanted 
battery. It is claimed that 17 m of charge time can send enough energy to run 
an implanted pacemaker for 24h. The rise in skin temperature was stated as 
1.4°C during charging. Assuming a 'nominal' temperature of 37°C this would 
give a skin temperature of 38.4 °C. This temperature indicates that the patient 
would feel some sensation while the system was charging. This system is not 
suitable for a blood pump as a pacemaker uses a much smaller amount of 
power than an implanted blood pump, (mW compared to W), and with this 
particular system the increased length of charging time necessary might not 
be enough to power a blood pump. 
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Figure 2.38. Arrangement of TETS system relative to patient. 
Starner and Maguire, (1999), claim that a temperature of 43 °C for 
extended periods can cause the skin to burn although temporary contact at 
higher temperatures, (48°C for 10 minutes), can be maintained without 
damage. 
A 'safe' skin temperature of 41.5 °C was selected by Lele, (1987), 
following a review of medical literature. The effect of using the same area of 
skin repeatedly over an extended period of time is unknown and it may be 
necessary to move the TETS charging point to reduce damage. This 
movement will not be possible with the implanted coil although enough power 
may be transmitted at a lower efficiency if the two coils are offset relative to 
each other and using a different area of skin each time. 
Another development to transmit power through the skin is offered by 
Matsuki et aI., (1998). They propose a flexible implantable transformer, 1 mm 
thick, made from amorphous magnetic fibres and with a low heat profile. A 
transformer area of 2,100 mm2 was stated to be able to supply 6 W with a 
negligible temperature rise. (This implies an implanted device around 46 mm 
square). If the external part of the transformer was the same size, or larger to 
allow for misalignment, this could be included as part of cloth ing worn next to 
the skin. 
93 
Ozeki et aI., (2003), proposed a method of supplying TETS power 
through a specially built floor combined with special shoes. They indicated 
that it was possible to meet the power requirements with a DC to DC power 
efficiency greater than 60% as the patient moved around on the floor. This 
would be ideal for a patient living in one room in the home but not elsewhere. 
There was no mention of effects on electrical equipment in a house and no 
cost estimate. 
2.4.3 Alternative power supplies. 
Myers and Parsonnet, (1969), suggested generating electricity by 
placing two electrodes of differing metals into the body. This is technically 
possible but the corrosion products from the electrodes are likely to be toxic 
and the amount of electricity produced may not be enough to run a 
pacemaker, which requires 10 to 20 mW. 
Myers and Parsonnet, (1969), also suggested using thermocouples. 
The problem with this method is the lack of a cold junction because the 
human body regulates temperature to a very narrow band. The solution 
proposed creating an artificial hot junction with the body acting as the cold 
junction. This used a radioisotope powered device with Plutonium 238 as a 
power source. This would have a half life of about 90 years and a running 
temperature of 300 of. This would give a temperature difference of about 200 
of but the power generated was not considered enough to run an artificial 
heart device. 
Talaat, (1967), proposed implanting two identical, non-corrodible 
electrodes into the heart to make a cell and generate around 1 OOIJW. This is 
enough to run a pacemaker but not enough for a blood pump. 
Natural movements of the body have also been suggested as a power 
source. Starner, (1996), suggested a small turbine generator implanted in the 
blood stream and piezoelectric generators operated by the movement of the 
heart. 
Epstein, (2006), is attempting to build a 10 watt gas turbine engine on a 
microchip. This amount of power will run some of the smaller blood pumps. 
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Another alternative power supply that has been tried to assist the 
failing heart is skeletal muscle augmentation. 
Pepper, (2000) and Salmons and Jarvis, (1990), proposed partially 
removing the selected muscle from the patient and grafting it to the failing 
heart. A pacemaker device then stimUlates the muscle to contract at the 
correct speed and time effectively squeezing the heart to maintain blood flow. 
Pepper, (2000), also proposed wrapping a conditioned muscle, around 
the aorta to provide additional pulsation effects. 
The results of these types of procedures are not particularly good and 
much work remains to be done before this procedure becomes a realistic 
option for patients with heart problems. 
These methods have identical problems to the biological -mechanical 
pump system, described previously in this thesis, of muscle conditioning. 
They have not achieved acceptance. 
2.4.4 Pump control systems. 
The only method of controlling the output of a pump appears to be by 
changing either the speed of rotation for a rotary pump or the 'beat' rate for a 
pulsating pump. 
Catanese, et aI., (1996), indicate that the "HeartMate electric pump is 
usually operated in the 'automatic' mode, so that the pump ejects when it is 
90% filled. In this way the flow increases when patient activity increases and 
decreases when the patient activity decreases". From this it is understood that 
the pump fills passively and a proximity sensor is used to determine when the 
pump is filled to a predetermined amount. When that condition is reached, 
power is applied to empty the pump. 
Youngson, (1993) suggest automatic control could be based on the 
pulse rate of the existing biological heart. This requires the heart to be in 
place and functioning. 
Power adjustments according to flow are proposed with the Incor Berlin 
pump described previously in Chapter 2.3.16. This uses a position sensor to 
adjust the pump speed and flow. 
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Karl, (1997) suggests using a flow measurement device to monitor the 
blood flow rate and adjust the pump speed accordingly. This method will have 
problems in terms of calibration and stability. 
Rosenburg, (1995), indicated that it was preferable to use few or no 
sensors in the control system as they can suffer from signal 'drift' over time 
which makes them extremely difficult to deal with in vivo. 
The pumping rate can be changed manually by the user using an 
external control. This is the method used with the Jarvik 2000 pump but how 
the patient knows which setting to use is not stated. 
2.4.5 Summary. 
Methods of powering blood pumps have been described. For the 
patient in a hospital bed, power is no problem. For a patient outside the 
hospital, they must always be conscious that life depends on batteries and in 
this sense 'life' is only 6 - 8 hours long. 
Improvements to blood pumps have reduced the power consumption 
from around 70 W to as little as 4 W. Improvements to control systems, by 
making them smaller and lighter, have allowed patients to be mobile. Both 
these together have allowed some patients to go home and live a relatively 
normal life except for the problem of power supply. 
Improvements to batteries have improved the electrical storage 
capacity, the power to weight ratio and the amount of time required to 
recharge, but further improvements are necessary. 
All batteries have a 'useful' life and there comes a point where they will 
not last the expected length of time and it can be considered to be 'worn out'. 
There is no mention of methods to determine how much life the battery has 
left. The obvious method would be to replace the battery at 'timed' intervals. 
This could be months or years or the number of times the battery has been 
charged and discharged. This may be expensive but would be simple to do. 
For an external battery this will be no problem but for an internally implanted 
battery this will mean the patient undergoing another operation, to replace it, 
with all the attendant risks. 
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The development of the TETS system shows promise as it removes 
the problem of infection caused through pipes or cables passing through the 
skin. Heating of the skin while charging the internal battery has been noted. 
This does not appear to be a serious problem as long as the temperature rise 
is less than 5°C. 
There does not seem to be alternative methods to supply power to run 
an implanted blood pump of the present generations without the use of 
batteries. Attempts have been made to use the body itself but these have only 
produced enough power to drive pacemakers. 
Control systems need to be as simple as possible. Manual control is 
possible as used on the Jarvik 2000. Proximity sensors can be used as a 
signal generating device to control the pulse rate of a pulsating pump or the 
speed of a rotary pump. There are likely to be problems with calibration and 
'drift' with implanted sensors. These cannot be corrected without a surgical 
procedure and the attendant risks to the patient. 
The next part of this chapter will describe the performances obtained 
from various pump types compared to the human heart. It will outline the 
delivery and pressures obtained and the pump applications. Comparisons will 
be made of the relative sizes of each pump and the outputs delivered. 
2.5 Comparison of performance. 
It is generally accepted that the human heart pumps blood at a rate of 
about 5.5 I/min at rest under normal circumstances, Peterzen B., et aI., (1996) 
and Dawson T.H., (1991). Any manufactured device to replace the function of 
the heart should therefore be capable of pumping a similar amount. 
It is noted that there does not seem to be a recognised specification for 
the performance of a pump to replace or assist the human heart. This implies 
that manufacturers could be working to different specifications and therefore 
makes it extremely difficult for surgeons and others to compare what is 
offered. This omission could be of great importance to the condition of the 
patient. 
Table 2.10 shows the quoted delivery, the installed volume and the 
mass of the pumps listed, together with power consumption from the available 
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literature. These quantities are expressed as a ratio compared to the human 
heart as far as possible. 
The estimated figures for the human heart are taken as:-
Volume pumped 5.5 Ilmin, installed volume 622 ml, mass 0.283 kg. Grays 
Anatomy, (1995). (The installed volume is probably over estimated as it is 
calculated as a rectangular solid and takes no account of the shape of the 
heart). The Physics Factbook quotes the power consumption of the heart as 
1.868 W. 
Pump types are denoted as, P = pulsating flow, R = rotary flow, A = axial flow. 
Bearings = rotor is mounted on blood lubricated plain bearings. 
Mag. lev = rotor is magnetically levitated. 
Some of the pumps listed are capable of pumping more than the 
accepted delivery of the heart of 5.5 I/min. The pumps that deliver less than 
5.5 Ilmin may be useful for children as they are not suitable for adults needing 
full support. 
Not many references quote the installed volume of each pump. The 
human body cannot have spare room inside it and if a pump is installed 
organs may have to be moved aside or compressed to accommodate the 
pump. What damage or discomfort is this likely to cause? 
There is a trend in the mass of each pump type. The pulsating pumps 
can be heavier than the human heart, (2 to 3 times), while the rotary pumps 
can be lighter than the human heart by up to 0.85 the mass. The mass of the 
axial flow pumps can be less at around 0.34 although the HeartMate II 
appears to be heavier than the human heart. 
The mass of the pump is important is the sense of support inside the 
body. This topic is covered in greater detail in Recommended Features, Size 
and Installation, Chapter 2.6.3 
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PumQ tYQe / name Volume QumQed Installed volume Mass PumQ tYQe Power consumQtion 
Human heart 1 1 1 P 1 
Abiomed 5000 1.09 NA NA P 133.8 
HeartMate 1 1.96 0.63 2.4 P NA 
Berlin <1 Various but < 1 <1 P NA 
AbioCor (TAH) 1.8 NA 3.21 P NA 
Baylor (TAH) 1 0.82 2.19 P NA 
Novacor 1.55 NA NA P NA 
Spiral vortex 0.55 NA NA P NA 
Radioisotope pump 10.73 1.96 5.3 P NA 
Pendulum NA NA NA P NA 
Aachen NA NA NA P NA 
Vibrating flow pump I 0.36 NA 0.18 P NA 
Vibrating flow pump II 0.01 NA NA P NA 
Baylor rotary 1.55 NA NA R + bearings NA 
Vienna, ball bearings 1.8 NA 0.85 R + bearings NA 
Vienna, single pivot 1.27 NA NA R + bearings NA 
AB 180 0.55 NA NA R + bearings NA 
Venrta Assist 1.8 0.2 1.05 R + mag. lev NA 
HeartMate III 1.27 0.18 0.12 R + mag. lev 4.34 
Intraventricular NA NA NA A + bearings NA 
Hemopump NA NA NA A + bearings 37.47 
Jarvik 2000 1 0.04 0.32 A + bearings 1.61 - 3.75 
MicroMed OeBakey 1.8 0.09 0.34 A + bearings 3.21 
HeartMate II 1.82 0.2 1.2 A + bearings NA 
InCor Berlin 0.91 0.13 0.71 A + mag. lev 1.07-2.14 
Magnevad 1.8 0.04 0.29 A + mag. lev NA 
~- '-- ~ -
Table 2.10. Comparison of the various types of blood pumps. 
2.5.1 Summary. 
Of the pump types listed, not all have full information on volume 
pumped, installed volume and mass. The comparison shows that most pumps 
can equate or exceed the pumped volume of the heart and therefore are 
intended for adult use and not children. An adult size pump is taken as a 
pump that will deliver at least 5.5 I/min. 
The rotary and axial flow types have a reduced installed volume and 
lower installed mass than the pulsating type pumps. 
Only 2 of the pumps are listed as Total Artificial Hearts, (TAH). Use of 
this type of pump seems to have declined and effort has been put into the 
development of heart assisting pumps rather than heart replacement pumps. 
This reflects patient recovery by heart assistance rather than heart 
replacement by an artificial pump. 
The next part of the chapter covers the recommended features of any 
blood pump. It will cover the quantity to be pumped and the blood damage 
potential which is an important part of the performance of any pump. 
2.6 Recommended features of a blood pump. 
2.6.1 Quantity. 
Any implanted pump must be capable of supplying enough blood to 
satisfy the needs of the patient. For an adult, requiring the maximum 
assistance, the amount of blood will have to be around 5.5 I/min. For a child 
this amount will need to be less in proportion to the size of the child. Some 
pumps have been built to satisfy child applications. 
The pump will have to supply against the back pressure of the blood 
already circulating in the patient, (the diastolic pressure). For an adult this 
appears to be approximately 100 mm Hg but will vary depending on the 
condition of the patient. Hegyi T., Carbone M.T. et aI., (1994), indicate that for 
premature babies, the diastolic blood pressure can be as low as 20 to 25 mm 
Hg, but the actual value will again depend on the medical condition of the 
baby. 
The pump must be able to respond to any changes in performance with 
little or no time delay. For a pulsating pump this will mean rapidly changing 
the 'beat' rate and a rotating pump will need to have the ability to change 
speed quickly. This indicates a pump with low inertia in the moving parts. A 
pulsating pump will be 'power hungry' as the mass of the moving part will 
have to be accelerated and decelerated on every 'beat' but with a rotary 
pump, once the rotating mass has been accelerated to the new speed, very 
little extra power may be required to keep it running. This will be an advantage 
in terms of battery life. 
2.6.2 Power supplies and control. 
There is a need for a satisfactory method of supplying power to the 
pump. Early methods using flexible mechanical drives have proved to be 
unsuitable. 
There are two methods of operating blood pumps, pneumatic and 
electrical. An electrical power system to supply power to the pump is the 
TETS system where energy is transmitted through the skin to charge an 
internal battery. This prevents infection as there are no pipes/cables passing 
through the abdomen. 
Changing the output of a blood pump is achieved by changing the beat 
rate or rotation speed depending on the pump type. Manual control can be 
used. Automatic control is possible with inbuilt sensors providing the control 
signals. 
The batteries powering the pump must last a reasonable length of time. 
At present up to 8 hours is possible. A longer time would be preferred 
together with a shorter recharge time. 
The pump must not cause any inconvenience as far as possible. This 
means little or no noise, vibration, heat or other discomfort. 
2.6.3 Size and installation. 
The physical size of the pump is important as there is not likely to be a 
large amount of spare room inside the body. Patients may be advised to eat 
many small meals often rather than one large meal as some pumps, typically 
the pulsating types, appear to be positioned close to the stomach. There does 
not appear to be any physical support for the pump and in such close 
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proximity, movement of the heart may touch the pump. Any pump movement 
may cause problems with strain on the pipes and anything the pipes are 
attached to. It is assumed that the pumps are supported in order to prevent 
any problems of this nature but there is nothing in the literature describing this 
part of the pump installation. 
The equipment associated with the pump must not be too heavy to 
carry. The method mentioned in Chapter 2.4.1 using a backpack or trolley 
mounted system although acceptable to maintain life would not be acceptable 
socially and improvements must be found. The pump control system must be 
self contained and not require frequent adjustment or calibration. There must 
be alarms or indicators to show if the system is running properly or has a fault 
and which fault. The system must be 'fail safe' at all times. 
2.6.4 Effect on the patient. 
Although work has been done on the clinical aspects there seems to be 
little emphasis on the quality of life for the patient after implantation. This 
needs to cover characteristics from the pure medical condition to the mental 
outlook of the patient. 
It is important the patient has the ability to continue to contribute to 
society and to experience their own social well being. 
Quality of life conditions comprise: -
1) The realisation that life now depends on a man made device and 
that this device may have to last for the rest of life if a transplant is not 
possible. 
What effect does this have on the patient? Satisfactory explanations of the 
'after operation' conditions must ensure that the patient is aware of the 
implications. 
2) Are there physical complications likely with this device such as 
bleeding, difficulty in handling the operation of the device, changing batteries? 
Is the patient competent to handle these crises, either with help or by 
themselves? 
Is the patient competent to handle the drug regime necessary after 
implantation? 
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This will depend on the patients themselves although an amount of training 
and support will be necessary for success. 
3) Are there any emotional problems, perhap's distress and anxiety, a 
feeling of being "not normal"? 
2.6.5 Summary. 
This chapter has described some of the features that are necessary for 
a satisfactory blood pump. The pump must be able to deliver the correct 
quantity of blood which is normally taken as 5 I/min for an adult. Lower 
deliveries will be necessary for children, the amount depending on the age 
and size of the child. 
The pump must be able to supply this quantity of blood for an almost 
indefinite time period without causing any damage to the blood and without 
any medical problems to the patient. It is assumed that a small amount of 
blood damage accumulating for an extended length of time can be just as 
damaging to the patient as a large amount of damage over a short time. From 
the results of Leverett and Hellums, a maximum blood stress level of 100 
N/m2 may be possible for an indefinite time period but this is not proven here. 
The critical amount of damage is difficult to determine but from the previous 
results it is likely to be at a stress less than 25 N/m2 . 
Stresses below this limit appear to be satisfactory, but additional 
evidence is necessary to prove the case for an indefinite time period. In this 
concept an indefinite time period is taken to be at least 10 years. Limiting 
blood stress levels are difficult to determine as they appear to be a 
combination of many factors. These include surface interactions, surface 
finishes, hydraulic forces, heating and exposure time. From these results it 
does not seem possible to determine with great accuracy the critical amount 
of blood damage before problems are likely to occur. A range of stress and 
time limits may be more appropriate, the limits of which, when applied to the 
individual patient may in some part depend on the genetic make up of the 
patient, the general health at the time and on age. 
During this time period and with the pump running in vivo, some blood 
damage below critical levels may occur that are due to the pump. A healthy 
patient may have the capacity to withstand and recover from an amount of 
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blood damage, but the same amount of damage caused by the blood pump to 
a sick patient may be significant. 
Of the three types of pump available, (axial flow, radial flow and 
pulsating types), the axial flow pumps have a shorter residence time than the 
pulsating pump but have appreciably higher stresses. The centrifugal pump 
has lower stresses than the axial pump but has longer residence times 
leading to the possibility of increased surface effects. 
The development of rotary and axial flow pumps with magnetically 
suspended rotors has promise for a pump with a longer life than those at 
present. 
The physical size of the pump needs to be taken into account as a 
pump that is 'large' compared to the available room inside the patient will not 
be suitable for use. Internal movements of the body organs must not be 
allowed to move the pump excessively and cause strain on anything that the 
pump is attached to. The connections to the heart and aorta must not be 
compromised in this respect. 
Power supplies and the means of getting the power to the pump need 
consideration. The maximum 'life' for a battery before recharge is required is 
around 8 hours and improved battery technology is required to extend this 
time. Methods are being developed that enable power transfer without 
breaking the skin. This will reduce the possibility of infections entering the 
patient but care is necessary with skin temperatures while the energy transfer 
is taking place. 
Some work has been done on the mental effects of installing a blood 
pump to the patient. The realisation that life is dependant on a man made 
machine for life has caused mental problems with some patients. Little work 
appears to have been done to investigate or understand these problems. 
The next chapter will describe the materials used to build blood 
contacting devices with the advantages and disadvantages of each type in 
terms of manufacturing and properties. 
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Chapter 3. Materials. 
3.1 Biomaterials. General description. 
For the purpose of relieving or solving an adverse medical condition, 
man made devices can be placed inside the human body. These are known 
generally known as implants. These are not new devices and the Table 3.1 
shows a brief history and some milestone developments. 
Any material used to make an implant is known as a biomaterial and a 
definition is given is given by Boretos and Eden, (Eds), (1984) where:-
'A biomaterial is any substance, (other than a drug), or any combination of 
substances, either synthetic or natural in origin, which can be used for any 
period of time, as whole or part of a system which treats, augments, or 
replaces any tissue, organ, or function of the body'. 
This definition implies that the biomaterial interfaces with living tissue 
for a significant length of time. Bone plates and artificial heart valves are 
examples of implants in contact with blood or tissue. 
Any biomaterial is always a 'foreign' material and must not have an 
uncontrollable adverse reaction when implanted in the host tissue, Parks J, 
Lakes, R, (1992). Any implant can start a reaction and care has to be taken to 
ensure the biocompatibility of materials and the construction and operation of 
the implant. 
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Year I nvestiqators Development 
Late 18th I 19th C Various metal devices to fix bone fractures; wires and pins from Fe, Au, Ag and Pt 
1860 - 1870 J. Lister Aseptic surgical techniques. 
1886 H.Hansmann Ni plated steel bone fracture plate 
1893 -1912 W. A. Lane Steel screws and plates, (Lane fracture plate) 
1912 W. D. Sherman Vanadium steel plates, first developed for medical use; less stress concentration 
and better corrosion resistance. (Sherman Plate). 
1924 A. A. Zierold Introduced Stellites, (CoCrMo alloy) 
1926 M. Z. Lange Introduced 18-8sMo stainless steel, an improvement on 18-8 stainless steel 
1926 E. W. Hey-Goves Used carpenter's screw for femoral neck fracture 
1931 M. N. Sith-Peterson First femoral neck fracture fixation device made of stainless steel 
1936 C. Venable, W. Stuck Itntroduced Vitallium, (19-9 stainless steel), later changed to CoCr alloys 
1938 P. Wiles First total hip replacement prothesis 
1939 J. Burch, H. Carney Introduced Tantalum (Ta) 
1946 J. Judet, R. Judet First biomechanically designed femoral head replacement prothesis, 
first plastics, (PMMA), used in jOint replacements 
1940's Dorzee, Francechetti First used acrylics, (PMMA), for corneal replacement. 
1947 J. Cotton Introduced Ti and its alloys 
1952 Voorhees, Jaretzta First successful blood vessel replacement made of cloth for tissue ingrowth 
and Blackmore 
1958 Furman, Robinson First successful direct heart stimulation 
1958 J. Charnley First use of acrylic bone cement in total hip replacement on the advice of Dr. D. Smith 
1960 Starr, Edwards First commercial heart valves 
1970's W.J. Kolff Total heart replacement 
-~~--
-----------
Table 3.1. A brief history of implants 
Park. (1984) 
There are three reactions to an implant and these are described as 
tissue integrated reactions, rejection and thrombosis. 
Tissue integration reactions can include the implant becoming 'walled 
off', when tissue grows around the implant. If the implant has to be removed 
this can cause difficulties for the surgeon. The integration reaction can be 
used advantage by allowing tissue to grow 'into' the surface of the implant to 
provide a blood compatible surface or a secure fixing for bone replacement. 
Rejection of the implant makes it useless for the intended purpose and 
endangers the patient. An example of this is the transplantation of biological 
material from one person to another. The implant has to be carefully matched 
to the reCipient for success. It is possible to suppress the rejection process 
with drugs but this reduces the ability of the patient to fight any infections and 
implies the patient may have to remain on anti rejection drugs for the rest of 
his or her life. 
I mplants in contact with blood can cause the formation of blood clots, 
(thrombi). Under these conditions the implant may not operate properly and 
the blood clots formed will be a danger to the patient. 
Other problems include the possibility that the implant is a carcinogen 
which is a substance that produces cancer by means of direct contact with 
tissue, or by ingestion, or by inhalation. The contact with interior tissue is of 
particular concern as the cancer may not be easy to see and may have made 
considerable progress before it is discovered. Once discovered it may be 
extremely difficult or impossible to remove without severe problems to the 
patient. The implant must be free from infections. The implantation of a 
'foreign' body can create large infection problems as the implant provides a 
region that the body's fighting cells cannot always reach. 
Great care has to be taken with the choice of materials as there are 
very few that do not have some reaction at contact with blood. The incorrect 
choice of materials has caused problems. Zdrahala and Zdrahala, (1999) 
report life threatening events such as strokes have occurred. These events 
are not always fully understood but Fasol and Zilla, et aI., (1987), indicate that 
material 'failure' may not always be due to the material itself but the failure of 
blood cells to successfully attach to the surface of a material. Their tests 
indicated that it would take up to 6 - 8 weeks to establish a satisfactory blood 
compatible surface assuming that the cells were shear stress resistant. 
Following these results they concluded that "the endothelialization of artificial 
hearts is not possible when such hearts are used for urgent 'bridging' before 
cardiac transplantation". 
It has been suggested by Basmadjin, Sefton et ai, (1997), that a truly 
inert biomaterial is not possible and that even trace amounts of factor XII 
, 
(one of the factors responsible for blood clotting), will lead to an initiation of 
the coagulation process 
3.1.1 Reactions to implants. 
The basic design of an implant is important. A pump with a large 
internal volume pumping a small amount of blood may not give a good 
internal 'washout' and stagnant blood has more opportunity to cause more 
problems than flowing blood. With a low blood flow rate, the longer the time 
the blood is inside the implant, the greater the risk of clot formation with 
reactions with blood contacting surfaces. 
The suitability of a biomaterial is measured not only in the material 
characteristics but in coatings and surface finishes that provide resistance to 
the conditions inside the body. The body contains a degree of self-repair 
following the natural process of cell replacement but any artificial part does 
not have this characteristic and at best can only stay in the condition at 
implantation. 
Coatings can be applied to components to prevent blood clotting, but 
these can wear away and lose effectiveness. 
The surface finish of the implant is important and two approaches used 
are a smooth surface and a textured surface. 
A smooth surface can be formed on metallic parts by electropolishing, 
a process related to electrochemical machining and is described in DeGarmo, 
Black et al. (1990.) 
Dip moulding techniques can be used to manufacture smooth surface 
parts made from polymers. Cordes, (2002), describes this process. This 
process starts with a master form of the required product which is immersed 
into a liquid preparation of the material and then allowed to dry. With repeated 
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immersions an amount of the liquid adheres to the product until the coating 
over the master form has reached the thickness to make the requ ired product. 
Textured surfaces and pre washing of the surfaces with blood have 
enabled successful transplants to take place. 
A textured surface allows a layer of clotted blood to form so that the 
rest of the blood flows over the clotted layer and does not contact the materi al 
underneath. The initial blood flow is allowed to infiltrate into the pores of the 
textured surface and clot 'inside' the surface. This layer of clotted blood allows 
the rest of the blood to flow over the surface without any surface reactions. 
Figure 3.1 shows the result of one technique. As long as the clotted layer 
remains intact, the surface is safe to use. 
Gagnon et a!., (2000), indicate that with these techniques the 
HeartMate blood pump has shown a low incidence of thromboembolic 
complications, (3 - 5.20/0), while the only patient anticoagulation treatment has 
been with aspirin and dipyridamole. 
Blood flow region. 
~ ___________ Surface 
tissue . 
Tissue 
ingrowth. 
Sintered 
titanium balls. 
Pump 
titanium 
casing . 
Gagnon et ai , (2000). Perfusion 2000; 15: pp345-354. 
Figure 3.1. Sintered titanium inner surface on HeartMate pump. 
This surface promotes tissue ingrowth and prevents blood clots form ing. 
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Powder metallurgy techniques are used to generate textured surfaces on 
metal parts by sintering 'microspheres' on to the internal blood contacting 
surfaces, similar to the HeartMate pump, and a textured surface technique 
can be used for silicone rubber parts. The sintering process is described by 
DeGarmo, Black et aI., (1990). 
Biocompatibility is not necessarily a property of the material itself. The 
Biomedical Engineering Handbook, (1995), indicates that the form and finish 
of the material is important and the geometry of the device is also important 
for biocompatibility in addition to the material used. 
Some materials used for biomedical applications are porous. The size 
of the pore will determine the reaction between the device and the host tissue 
and are shown in Table 3.2. 
Pore size Allows transmission of 
Less than 2 nm Small molecules - gases 
2 to 50 nm Small proteins 
Greater than 50 nm Large proteins 
Greater than 104 nm Cells 
The Biomedical Engineering Handbook, (1995). 
Table 3.2. Relationship of pore size to materials transmitted. 
Materials with the 'wrong' size pores can cause problems; an example 
is tissue ingrowth into artificial heart valves. Materials with the 'right' size 
pores are used where tissue ingrowth is encouraged; bone ingrowth into 
orthopaedic implants is an example. This topic is detailed in The Biomedical 
Engineering Handbook, (1995). 
Many materials do not have a consistent pore size and if the material 
degrades, the pore size can change. This may affect the biocompatibility and 
the mechanical strength of the material. Brown University, (2002), indicates 
that the evaluation of biocompatibility involves the study of the damage and 
duration of effects on the host of any implant. 
Biomaterials can be classified into basic types; these are metals, 
ceramics, polymers, composites and natural. Care is necessary to prevent the 
transmission of infections from the donor to the recipient when using natural 
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or biological materials. Much work has been done assessing these types for 
suitability. Table 3.3 shows some of the materials and applications 
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Materials Advantages Disadvantages ExamQles 
Metals Strong, tough, May corrode, Joint 
Ti and its alloys, Co - ductile. dense, difficult replacements, 
Cr alloys, Stainless to make. bone plates and 
steels, Au, Ag, Pt etc. Cannot sew screws, dental 
through. root implants, 
pacer and suture 
wires. 
Ceramics Very Brittle, not Dental joint 
Aluminium oxide, biocompatible, resilient. replacements, 
Calcium phosphates inert, strong in Cannot sew coating of dental 
including compression. through. and orthopaedic 
hydroxyapatite, implants. 
carbon. 
Polymers Resilient, easy Not strong, Sutures, blood 
Nylon, silicone rubber, to fabricate deforms with vessels, hip 
polyester, time, may socket bearings, 
polytetrafluroethylene degrade. ear, nose other 
etc soft tissues. 
ComQosites Strong, tailor Difficult to Joint implants, 
Carbon - carbon, wire made make heart valves. 
or fibre reinforced 
bone cement. 
Natural Can be formed May transmit Heart valves, 
Collagen taken from into almost any infections, cosmetic 
animals or other shape viruses to the reconstructions. 
donors patient 
'The Biomedical Engineering Handbook'. (1995). 
Table 3.3 Materials for use in the body. 
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3.1.2 Mechanical characteristics. 
The mechanical suitability of a material is governed by three main 
factors, the elastic modulus, the yield stress and the ultimate stress and these 
are described as follows. 
a) The elastic modulus is the proportional deformation of the material 
within the limit of recoverable deformation as a result of stress applied to the 
material. Within the elastic limit the material can be loaded such that shape 
deformation occurs but when the material is unloaded, the material returns to 
the original shape. 
b) The yield stress is the upper stress limit for a material without 
permanently deforming the material. Exceeding this stress will result in the 
material undergoing permanent deformation from its original shape and 
subsequently it may not posses the required strength to work satisfactorily. 
Depending on the characteristics of the material, failure may occur soon 
afterwards. 
c) The ultimate stress defines the maximum strength of the material. At 
the ultimate stress the material has not failed but is permanently deformed. 
Any further loading of the material beyond this point produces a decrease in 
stress with increasing strain. 
d) The fracture point is where the material fails completely and breaks. 
Metals have a clearly defined elastic characteristic followed by a 
deformable region before the material fractures. 
Ceramics have a very small 'elastic' zone. This is followed by the 
material cracking and then almost instant failure. It is difficult to determine the 
initial point where the material starts to crack. 
Polymers have a very short elastic range followed by a very long, 
deformable, plastic range before failure. The material will not reform back to 
the original shape once the plastic range has been reached. 
Examples of these characteristics are given in Okunade S, (2000) 
and DeGarmo and Black, et ai, (1990). 
Composites can be made with a combination of characteristics 
depending on the application. 
126 
3.1.3 Fatigue. 
An important characteristic for all materials is fatigue failure. If a 
material is repeatedly stressed, eventually it will fail. The time to failure, or the 
number of times it is stressed before failure will depend on the material and 
the stress level. The stress level does not have to be close to the ultimate 
level for failure to occur. 
3.1.4 Suitability of a biomaterial. 
Materials that are super-hydrophobic, or highly water repellent, are 
being investigated to produce better water repellent coatings for clothing or 
windscreens. Sample, I. (2002), reports that developments have produced a 
material that does not contain any oxygen atoms, water is not attracted to it 
and the surface is covered in very fine ridges effectively reducing the area 
available for the water droplets to land on. BBC News (March 2003), report 
the development of a material treatment where water does not adhere to the 
surface. If this technology could be further developed, it may be possible to 
produce materials with a surface that would not attract or adhere to blood, as 
water is a major component of blood. 
A better approach may be to produce materials that are actively 
'antithrombogenic'. These will either encourage surface blood clotting to occur 
or to have active anticoagulant characteristics. 
3.1.5 Physical and chemical problems. 
Surface corrosion of a metal joint can increase the surface roughness 
and lead to increased wear. Particles wearing off the surface of the implant 
may cause it to become weak and fail. 
If a protective surface is worn off or two dissimilar metals are in close 
proximity to each other then corrosion problems can occur. Corrosion is 
explained elsewhere in his thesis. 
Surface fatigue fracture can lead to 'spalling' with relatively large 
particles of the material breaking off. 
These are problems that must be carefully considered for every 
application of an implant. 
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3.1.6 Wear. 
Wear is a problem with implants. For example, an artificial hip joint 
does not self-repair and with time, it may fail. But as the joint wears what 
happens to all the particles that wear away from the joint surfaces? The 
reaction by the body to these particles can cause problems and inflammation 
may occur local to the implant or at a site distant from the implant. 
An implant does not have the capability to self repair during its working 
life and materials have to be chosen that are biologically and mechanically 
compatible to ensure the minimum wear possible between contacting 
surfaces. Examples of wear rates of different materials are shown in Table 3.4 
and indicate about 2 magnitudes between the minimum and maximum rates 
of wear depending on the combination of materials. 
Material combination. Material worn. Rate (mm/~rl 
Metal/metal Metal. 0.0003. 
Metal/polymer Polymer. 0.01 - 0.19. 
Metal/composite. Composite. 0.03 - 0.09 (estimated). 
Ceramic / polymer. Polymer. 0.008. 
Ceramic / ceramic. Ceramic. 0.003. 
Medical Devices - materials for human contact. A design guide. (1996). 
Table 3.4. Approximate wear rates of different material combinations. 
Implants cannot be 'serviced' and combinations of materials that are 
'self lubricating' are necessary. The metal/polymer combination for hip 
replacements have proved to be successful while blood lubricated bearings 
for the Jarvik 2000 axial flow blood pump appear to work satisfactorily. 
3.2 Materials, metals. 
Metals for implants are developed from structural and biological 
aspects. Early implants used to repair broken bones failed due to poor 
mechanical design and were made from materials that corroded. 
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There are at least six ways to prevent corrosion difficulties, some of 
which are not applicable to medical conditions. These are discussed below. 
At least four distinct types of corrosion exist, these are described by 
Okunade, S. K., (2000). 
A material suited to the conditions is important with medical implants. 
Although metals have sufficient strength and can be biocompatible, they have 
disadvantages that they are relatively heavy and a surgeon cannot attach 
them using the normal sewing techniques. 
Metals can be heat treated to promote different metallurgical phases to 
give an improved corrosion resistance. Care is necessary not to promote 
worse conditions, such as grain growth, as larger interstitial spaces between 
the grains can be a source of a corrosion cell. 
Heat treatment methods can be used but care is required in terms of 
quality control. 
If a 'base' material is coated with a 'noble' material then the base is 
completely isolated from any electrolytic action. If the 'noble' coating is 
damaged, so that the base material is exposed, corrosion will start as the 
'noble' material now acts as the cathode in a corrosion cell. (A 'noble' material 
is a material that is less electrically active than 'base' material in contact with 
it. ). 
With sacrificial methods, the anode corrodes in preference to the 
cathode and to ensure continuous protection, the anode is replaced at regular 
intervals. 
While industrially this is a useful method, it would not be useful in 
medical applications for the following reasons 
a) Where would the sacrificed material go and will there be any effects on the 
patient from this material? 
b) How often would the anodes need changing to keep the system operating 
satisfactorily? 
c) How would the anode be changed if internally implanted? 
Applying a voltage to base material will make it into a cathode. This 
may be possible in medical applications but difficult to maintain. The effects 
on the patient are unknown. 
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An example of an inhibitor is the antifreeze in a car engine. Chemical 
inhibitors in the antifreeze slow down the rusting process inside the engine. 
This process is not applicable to medical applications. Ruoff, A, (1973) 
describes this type of process. 
Many of the above methods cannot be used in medical practice and 
the only defence against corrosion is to select the proper alloys and surface 
treatments for implants. For most alloys the corrosion rate is mainly 
dependent on the protective properties of the thin passive films that exist on 
the surfaces of these alloys. The quality of protection given by these films is 
related to their ability to resist chemical breakdown and their ability to reform 
rapidly once broken down, i.e., to repassivate. A report by Womato, LH, 
(1999), covers this topic. 
Ordinary steels are not suitable for medical implants. The development 
of stainless steels, with nickel and chromium, and cobalt chromium alloys has 
allowed a greater chance of success for this implant technique. The 
development of stainless steel type 316L, with a superior corrosion resistance 
to steel, is a good example of this. Appendix 5 lists the composition of 316L 
and the mechanical properties of surgical stainless steels. These materials 
are described in Parks et aI., (1992), and De Garmo and Black, et aI., (1990). 
Hanson S., (1995) describes the uses and applications of titanium for 
metallic implants. Titanium has a high strength to weight ratio, good stiffness, 
a high heat transfer rate and is corrosion resistant. The properties of titanium 
are between those of aluminium and steel, with a yield strength of about 450 
MPa, but this can be raised to about 1300 MPa by alloying and heat 
treatment. The cost of titanium is high in relation to steel due to fabrication 
difficulties and the high energy content required for manufacture. 
Even with biocompatible materials, corrosion can still be problem. If 
two materials of slightly different compositions, or even have areas of slightly 
different compositions, are in intimate contact with an electrolyte between 
them, it is possible that a small electrical potential will be set up. This can set 
up a small corrosion cell where one metal, the anode, will corrode away in 
preference to the other, the cathode. 
This process can happen inside the human body with the body fluids 
acting as the electrolyte. It is important to use appropriate materials and avoid 
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implanting different materials in the same region even though they are both 
'approved' materials. The manufacturer of medical implants has the 
responsibility to supply matched parts to ensure compatibility as far as 
possible and this responsibility can extend to the required grain structure of 
the material as, if the grain boundaries are large enough they can be 
considered to be small cracks that electrolyte can penetrate and initiate a 
corrosion cell. De Garmo and Black, et aI., (1990) cover this in detail. 
The failure of an implant is not always due to the materials used. As an 
example, if an artificial hip joint is poorly fitted or is overstressed by the user, 
the joint can fail through no fault of the implant itself. 
When a new hip has been fitted, in order to give the implant a 
maximum possible life, patients are advised to follow some simple rules in 
order not to overstress the implant. 
3.3 Materials, Plastics or Polymeric Materials. 
Polymeric or plastic-like materials have some advantages in terms of 
the manufacturing properties as they can be moulded, cast, extruded and 
used as thin films or coatings. They can give a range of useful properties such 
as low density and good corrosion resistance, low tooling costs, and design 
versatility. They can also be manufactured to provide a controlled porosity. 
This can enable a device to be 'absorbed' into the body by means of tissue 
ingrowth or even act as a filter depending on the pore size. This is described 
in the Biomedical Engineering Handbook, (1995). 
Correctly used these properties can lead to a product that is 'fit' for its 
purpose. 
3.3.1 Structure. 
The basic molecular structure of plastic is based on hydrogen and 
carbon in the relationship Cn H2n+2. The hydrocarbons are linked to form very 
large molecules known as 'mers'. When many 'mers' are joined together a 
'polymer' is created. 
The same kind and number of atoms can combine in different structural 
arrangements and form different compounds with different properties. These 
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arrangements are known as 'isomers' and are similar to allotropism, (the 
property of eXisting in more than one form), or polymorphism, (anyone of 
several forms in which the same thing may occur), in crystalline materials. 
This is described in De Garmo and Black, et aI., (1990). 
3.3.2 Biocompatibility problems. 
Many types of plastics are used in the medical device industries for 
many applications but each has to be carefully selected. Some plastics can 
show poor biocompatibility, for example nylon absorbs water and can become 
soft and change shape. 
Depending on the plastic, 'leaching' can be a problem where unwanted 
and potentially dangerous components of the plastic material itself appear in 
the blood or tissue of the patient. 
This can have two effects, 
a) The patient can experience discomfort as the unwanted material is 
absorbed. 
b) The implant itself can degrade and lose strength or shape as 
described by Chandy and Sharma, (1991), and Costa and Maquis, (1998). 
The reverse of leaching, that is absorption, can be a problem with 
some implants. Plastics are particularly prone to this effect. This happens 
when a component( s) of the body fluids pass into the material of the implant. 
The effects on the implant can be seen as swelling, distortion and it can lower 
the elastic modulus of the material and may lead to failure under physical 
loading. 
Unwanted components of the material leaching out into the body 
cannot be accepted. Conversely the leaching characteristic can be used to 
advantage when planned leaching can be used as a drug delivery system to 
enable optimal doses of a drug to be delivered over an extended time interval 
as explained by Yamac T., (1996) 
Applications for plastics include containers and piping as shown in 
Appendix 6. 
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3.4 Rubbers. 
Silicone rubbers are used for the diaphragms of blood pumps and 
other products and have the advantages of low moisture absorption and are 
chemically inert but have to be carefully selected in terms of life and to avoid 
cracking. It is advantageous to build a diaphragm from multiple thin layers of 
material. This gives flexibility of the total diaphragm and added reliability as if 
one diaphragm layer fails the others will continue to operate. 
3.5 Materials, Ceramics. 
Ceramics could be used for the casings of artificial hearts, as they are 
hard, durable and show good biocompatibility. Unfortunately the broad 
application of ceramics is limited because they are brittle and are prone to 
sudden failure. They are therefore are not used for parts of blood pumps that 
are heavily loaded as described by Doremus, (1992). 
However with suitable designs this material has been used as part of 
the bearings of rotating parts of a blood pump, as the intrinsic hardness of 
ceramics gives good wear resistance and a long life. 
There are additional problems with fixings using ceramic parts as 
obviously surgeons cannot sew through such a material and it tends to be 
heavy. 
3.6 Materials, natural. 
Artificial heart valves have been made using materials from animals 
where collagen from pigs has been used to make the flap part of the valve. 
However care must be taken to ensure the collagen is biologically 'dead' 
when used as it is possible to transfer pig cells to the human patient. 
If cell transfer happens, it is possible to transfer viruses and other 
infections from one species to another. The effects of such a transfer are not 
known and may not be controllable once released. This topic was reported in 
Government press release (1998) and BSC News (July 1998) and Carlton TV, 
(2000) 
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Due to the possibility of rejection any natural or biological 
have to be very carefully selected and matched to the recipient 
transplants from members of the same family can be rejected. 
Various types of tissue transplants are described below. 
Types of biomaterials. 
Tissue transplants 
implants 
as even 
A tissue transplant is where tissue is taken from a donor and 
transferred to a recipient. The donor and recipient may, or may not be, 
biologically related or even be the same species. The following transplant 
definitions are taken from the Online Medical Dictionary, 
http://www.online medical dictionary.org. 
An autograft. Tissue is transplanted from one location to another within 
the same patient. A skin graft or the harvesting of arteries for coronary artery 
bypass are examples. There will be no rejection problems. 
An isograft. Tissue is transplanted between genetically identical 
patients, (identical twins). There is a low possibility of rejection problems. 
A homograft, or allograft. Tissue transplanted between members of the 
same species, for example a kidney transplant between two unrelated 
humans. There will be rejection problems and treatment will be necessary as 
the two patients will not be genetically identical. 
A heterograft, or xenograft. A transplant between members of different 
species, for example a heart taken from a pig, and transplanted into a human. 
There will be rejection problems. This procedure is not used now as it was 
found possible that PERV, Porcine Endogenous Retro Virus, could be carried 
with the transplanted organ. The effect of this transfer across the species 
barrier was unknown and could not be estimated. This tissue transplant 
procedure is used for heart valves but the material of the valve has to be 
biologically 'dead' before transplantation into the patient and there is still the 
risk of rejection without treatment. 
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Non tissue materials. 
These are man made materials used for repair or replacement 
purposes and have been covered elsewhere in this chapter. 
3.7 Summary 
This chapter has outlined the advantages and disadvantages of the 
materials used in blood contacting devices and has shown that care must be 
taken to avoid adverse reactions. 
Some reactions can be used to advantage in tissue and bone repair 
and methods have been shown that can reduce adverse reactions. 
Manufacturing techniques are just as important as the choice of materials to 
promote biocompatibility. Surface texturing treatments can promote blood 
clotting to provide a blood compatible surface. Texturing can be applied to 
both metal and polymer surfaces. 
There is not one material that is suitable for all applications. Each 
material must be chosen with the characteristics that are nearest to the 'ideal' 
for the application. For stressed parts, metals can be chosen as they have a 
predictable characteristics under this condition. Ceramics must not be used 
for stressed parts as instantaneous failure can result if over stressed or 
damaged. A combination of metals and polymers seems to give the best 
combination for bearing materials at present although ceramics, replacing the 
polymer, can be used on lightly loaded parts. 
Materials that have the potential to cause cancer, or other problems, 
by material components leaching out into the body must not be used. Drug 
delivery systems using controlled leaching can be used but care must be 
taken to ensure the correct dose over the correct period of time. 
Natural or donated tissue transplants would be ideal as they have the 
correct size and shape and perform the correct function. There are great 
difficulties with this process regarding rejection and the possibility of 
transferring infections and viruses from person to person or from animal to 
person. Some drugs exist to combat this effect but they are not completely 
effective. 
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The next chapter covers the design of the 'new' pump. Where possible 
existing theory has been used but if reliable theory has not existed a 'best 
judgement' approach has been used. 
Problems with conventional pumps have been outlined and solutions 
offered. The design of the chosen pump type and the construction of the test 
rig are described together with instrumentation and calibration. 
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Chapter 4, Design of the prototype pump. 
4.1 Review of previous work. 
From the discussions in Chapter 1, blood is easily damaged and it is 
important to select the 'best' pump for the application. A 'best' pump is 
considered to be a pump that delivers blood at the required quantity and 
pressure with little or no blood damage however it is caused. Some of the 
features necessary for a satisfactory blood pump are tabulated below. 
Advantages Disadvantages 
Low blood shear stress Large internal surface area. 
Short blood dwell time I ncorrect materials and surface finish 
Low anticoagulation treatment. 
No valves Power transmission through the skin. 
Acceptable blood temperature rise Unsatisfactory blood flow conditions 
through pump include poor washing of surfaces, 
blood stagnation, blood cavitation, 
thrombus growth. 
Simple control system I nstallation problems with large pump 
Table 4.1, Some of the advantages and disadvantages of a blood pump. 
Some problems with blood pumps are discussed as follows. 
Low pressure conditions can be set up in the blood by the blade of a 
rotary pump. If the pressure is low enough, cavitation can be set up, which 
can damage blood cells. Reul and Akdis, (2000), state that 'cavitation is most 
critical in axial flow pumps' and that it is 'important to either monitor the inlet 
pressure or lower the rotation speed in case suction occurs'. Any cavitation 
bubbles generated at the inlet are likely to pass through the pump and cause 
damage to the blood by the generation of emboli and possible damage to the 
pump and beyond. Reul and Akdis, (2000), also indicate that for rotary 
pumps, (a maximum circumferential tip velocity of 10 m/s for any pump rotor 
is necessary to limit cavitation and blood shear rates. This implies that the 
smaller diameter axial flow pumps can run faster than radial flow pumps. 
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Whether this causes any additional problems in terms of bearing wear is not 
stated. At this limiting tip velocity, calculations show that a 5 mm diameter 
rotor can run at 38,200 rev/min while the speed for a 60 mm diameter rotor is 
3,190 rev/min. The results of the calculations are shown on Figure 4.1. 
Rotor speed for 10 m/sec tip velocity 
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Figure 4.1. Rotor speeds for tip velocity of 10m/sec. 
Massey, (1995), comments 'that increasing the number of blades in a 
pump improves the flow conditions but decreases the pump efficiency due to 
blade friction with the fluid. Compromises have to be made in the number of 
blades to achieve the required results'. 
From this statement by Massey, the flow pattern in a pump with an 
infinite number of blades would be ideal but the efficiency would be low. 
Applying these comments to a blood pump, a solution to the problems 
of pressure variations and shear around pump blades may be to use a rotary 
pump with no blades, just smooth disc(s). Morgan and Codispoti, et aI., 
(1998), imply that cavitation would not be problem with this type of pump. 
Hasinger et aI., (1963), indicate that this type of pump 'while having a 
low efficiency exhibits a favourable cavitation characteristic'. These are ideal 
flow characteristics for a blood pump if the low efficiency can be tolerated. 
Pumps of this type have been built before and are known as disc or shear 
force pumps 
The above solution would be ideal for pumping blood although with 
large internal areas, the materials used to build the pump and surface finishes 
could be a problem in terms of blood compatibility. 
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Advantages of a disc pump. 
Hasinger and Kehrt, (1963), put forward the following points regarding 
a disc or shear force pump 
a) Shear forces are dependant on the difference in velocity between 
the fluid and the shear surface. There is no danger of fluid separation and a 
very stable pump operation should result. 
b) The flow between the discs of this pump type is considered, 
generally, to be laminar. Only in larger rotors, with a disc diameter of 
approximately 300 mm and using water as a fluid is there a possibility of 
turbulent flow. 
c) In comparison to the conventional pump the shear force pump 
appears favourable in terms of cavitation. 
Disadvantages of a disc pump. 
a) Due to the close spacing of the discs, the pumped fluid must be free 
from suspensions large enough to bridge the gap in between the discs. 
b) At low flow conditions there is a tendency to trap gas bubbles in 
between the discs. If the ratio of the disc inner and outer diameters is kept 
small, say 2: 1, this problem is reduced but conversely a disc with a small 
diameters ratio will reduce efficiency. 
Following these examples, compromises will have to be made on each 
design and will be dependant on the application. 
Tests were conducted by Rice, (1963), to determine the feasibility of 
multiple disc pumps and compressors using air and water as test fluids. The 
conclusions were as follows 
a) 'Multiple disc pumps and compressors were feasible, they had 
advantages in special applications and were worthy of further investigation'. 
b) Disc turbo machinery efficiency was 'expected to remain constant as 
the machines were made smaller. This indicates that the disc pump may be 
superior to the conventional machine for very small volume pumping 
applications. 
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c) 'The disc pump may have an advantage when pumping 'exotic' 
fluids'. These are fluids considered to have a density and viscosity greatly 
different from water. 
d) 'The cost of disc machinery was considered to be low compared to 
ordinary pumps and that it could be manufactured in a modest machine shop '. 
e) 'The disc pump could be selected if, for a particular application, 
there is no advantage in performance between a conventional pump and a 
disc pump'. 
Calculated design data by Crawford and Rice, (1974), indicated that 
the 'multiple disc pump could be designed with high efficiency for fluid with 
any viscosity and density'. 
They also commented that 'it remained to be established by practice 
and investigation whether the pump has sufficient advantages compared to 
conventional machinery at the extremes of performance'. 
Part of the data presented by Crawford and Rice, (1974), was also 
suitable for gas blowers. One of the conclusions commented that 'if the 
pressure ratio was small enough, the speeds and stresses imposed on the 
discs are low enough that chemically inert materials, such as ceramic, could 
be used as disc materials'. This would obviously be useful when pumping 
corrosive gases but would also be ideal for pumping blood as ceramics are 
biocompatible. 
This paper assumed that the flow between the discs was laminar. It 
was stated that 'laminar flow exists for high values of the Reynolds number 
and low values of the volume flow rate parameter and for high values of 
volume flow rate parameter and low values of the Reynolds number. 
Turbulent flow exists for high values of both parameters'. It is assumed from 
this statement that laminar flow results from low values of both the volume 
flow rate parameter and Reynolds number. 
Laminar flow is preferred for a blood pump although small amounts of 
turbulent flow may be accommodated as there is evidence that a small 
amount of turbulent flow may exist in the aorta just after the blood leaves the 
heart. 
143 
From the above, it would seem likely that a disc pump would make a 
safe blood pump but with a relatively low efficiency compared to 'normal' 
rotary pumps. 
4.1.1 Disc Pumps. 
The history of a disc type pump goes back to 1850 when a water 
pump, invented by Sargent in the USA, was made from 29 circular discs 
mounted on a shaft with each disc spaced a few thousands of an inch apart. 
This was the first known example of pump relying on the viscous drag / 
boundary layer principle. At this time it was considered to be unsuccessful 
and nothing was done with the idea. (Advanced Fluid Technologies, 2000) 
A Serbian - American inventor, Nikola Tesla, took up this type of 
pump. Tesla, N, (1909), argued that a pump consisting of an assembly of 
circular discs rotating about a central spindle would pump fluid by virtue of 
{two basic principles of physics, adhesion and viscosity' and {the disc pump, or 
shear force pump, uses the natural characteristics of adhesion and cohesion 
to move fluid". He argued that the device would accomplish this by 
{harnessing the internal forces opposing molecular separation' and (the shock 
of the fluid against the asperities of the solid substance'. 
It is assumed that Tesla was indicating the fluid adhered, or was 
sticking, to the surface of the discs. The work of Poiseuille with flow through 
tubes indicates this characteristic where he described that the 'layer' of fluid 
closest to the wall of the tube remained stationary while the body of the fluid 
was moving relative to the tube. If the walls of the tube are 'replaced' by the 
surfaces of discs which then rotate, the fluid will tend to rotate with the discs. 
This implies that the fluid was 'sticking' to the surface and deformities 
of the discs, even though the discs were as smooth as possible and the 
'deformities' may not be intentional. 
Massey, (1995), describes the effect of fluid 'sticking' to a surface as 
the 'boundary layer' which is the layer of fluid closest to, say, the wing of an 
aircraft. An amount of fluid will be drawn along with the wing. This can create 
a 'wake' of disturbed fluid that can last for a considerable distance after the 
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wing has passed. The length and energy in the wake will depend on the 
shape and speed of the wing. 
Applying this 'wake' concept to disc pumps, either the discs will have to 
be made of material that is 'thin' relative to the diameter or the outer edges of 
the discs will have to be tapered, (using an ogival shape), to reduce the wake 
formation and turbulent flow problems. Figure 4.2 illustrates the problem and 
possible solution. 
Large turbulent flow region 
in 'wake' after discs. 
Thick discs, blunt edges. 
Smooth flow, 
little turbulence. 
Thin discs 
Smooth flow, 
little or no turbulence. 
Thick discs, 
tapered edges. 
Figure 4.2. Effect of blunt edges, thin discs and tapered edges 
on fluid flow through the disc pack. 
With cohesion the molecules of a fluid are attracted to each other at the 
molecular level, Van der Waals forces are an example of this. 
Van der Waals forces and cohesion are part of the physical forces of 
attraction and repulsion existing between molecules and are responsible for 
the cohesion of molecular crystals and liquids. On a practical level, once part 
of the fluid has started to move, for example the fluid immediately adjacent to 
the discs, the rest of the fluid will tend to follow. 
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In 1909, Tesla applied for patents for a turbine and a pump based on 
this principle. Figure 4.3 shows part of the patent appl ication for the pump. 
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Figure 4.3. Tesla Turbine Pump. 
Part of the drawings submitted for US Patent no. 1,061,142 
by Nikola Tesla in Oct. 1909. 
Source : - The Animated Software Company, Internet Glossary of Pumps. http://www.animatedsoftware.com 
There appears to have been little or no commercial exploitation in this 
design of pump until the 1970's when a Californian inventor, Mr. M. Gurth, 
took it up. He found that when increasing the disc spacing to as much as SOO 
mm, the boundary layer I viscous drag principal still applied and the pump 
worked well especially with liquids of a high viscosity, (2S0 cP or 0.2SNs/m2 
and above). Gurth took out US patents in the late 1970's and founded the 
Discflo Corporation in 1982. Further developments of this pump have since 
been patented . 
This type of pump is used to move viscous, abrasive fluids , fluids with 
high solids content, gas I air entrained fluids and delicate and shear sensitive 
products. The Discflo Corporation claim to pump living cells , plankton , 
bacteria , live fish, creams, liquid sugar, grapes, whole chickens. This type of 
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pump is claimed to be more reliable with lower life cycle costs than other 
pumps for this type of application. They appear to be the only company in the 
world making this type of pump. (Discflo Corporation) 
The Discflo pump is the same basic design as the Tesla pump built 
with a series of flat discs, separated so that there is a clearance space 
between them. The first disc is mounted to a driving shaft and the other discs 
are connected to the first disc. The disc pack is contained within a housing, 
which has the inlet at the centre of rotation and the outlet tangential to the disc 
rotation. 
Damage and wear with this type of pump is said to be minimal 
compared to a normal type of pump with blades on the disc surface. 
(Advanced Fluid Technologies, 2000). 
Evidence to promote this type of pump comes from Rice, (1963) and 
Hasinger and Kehrt, (1963), who considered this type of pump as an 
'excellent pump for exotic fluids due to the inherently stable flow regimes'. It 
has been successfully used to pump liquid fuels for the NASA space 
programme. 
Some work has been done by Miller et ai, (1989), and Miller et ai, 
(1990), as a pulsed output pump. The pump used polycarbonate discs 
mounted on a shaft. Each disc had an outer diameter of 76.2 mm, (3 inches) 
and an inner diameter of 38.1 mm, (1.5 inches). The discs were 1.6 mm, 
(0.063 inches), thick and they were spaced 0.406 mm, (0.016 inches), apart. 
The fluid entered the pump through the rotor pack at the opposite end to the 
driving shaft and as the fluid entered the spaces between the discs, it was 
sent into a spiral motion with the radial and frictional forces generated by disc 
contact. As the fluid spun off the surface of the discs, it was collected by the 
spiral volute chamber, acting as a housing and diffuser. The fluid then left the 
pump tangentially through the outlet port built into the housing. 
There was no evidence of any output performance results. 
Yamane et ai, (1996), and Jarvik, (1995), have indicated that a 
centrifugal type rotary pump was more suitable than an axial flow pump for 
artificial heart applications since a rotary type pump operates at larger 
clearances between the rotor and the housing than an axial flow pump giving 
less chance of shear and thrombus problems. 
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The suitability of a disc type rotary pump can be further argued by 
considering the flow of blood through a pipe when the red cells in the blood 
move towards the centre of the pipe leaving a layer of plasma at the pipe 
walls. The mode of operation of this pump is very similar if it is considered that 
this time it is the 'pipe', (the discs), that are moving and the blood is being 
drawn along with them. This implies that this pump type 'pulls' the product 
smoothly and without pulses through the system compared to other pump 
types that 'push'. If the red cells are kept away from the surface of the discs, 
this implies a reduced chance of mechanical damage to the cells through 
collisions with the walls and therefore a reduced chance of haemolysis and 
the formation of blood clots. Figure 4.4 outlines the expected velocity profile. 
Expected fluid 
velocity profile~ ;;-
Rotating 
disc 
Fluid 
'High' rotational velocity fluid 
at edge of the disc 
'Low' rotational fluid 
velocity at the centre of 
the gap between the discs 
Rotating 
disc 
~ Axis of 
rotation 
Figure 4.4 Expected fluid velocity profile between 
the discs of a Tesla type pump. 
An approximation of the fluid velocity profile in between the discs can 
be given if the fluid is considered as a series of layers. Using the previous 
explanations involving fluid flow in tubes, as the fluid enters the pump at the 
centre of the discs, the 'peripheral' velocity at this point will be low depending 
on the radius of the hole. 
As the fluid is accelerated circumferentially by the rotation of the disc, 
the fluid will move outwards radially across the face of the disc. The fluid layer 
closest to the discs will be moving the fastest of all the layers as it has been 
subjected to the greatest shear force. This layer will continue accelerating 
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circumferentially until it reaches the same peripheral velocity as the disc or 
leaves the disc surface at its outer radius. The adjacent layers will move at a 
slower speed depending on the viscosity of the fluid and the distance away 
from the disc surface. It is assumed that the velocity profile between two 
adjacent discs will tend to be a parabolic shape, with the slowest flow rate in 
the middle of the two discs, similar to the pipe flow profile. 
As there are no blades moving the fluid, there is no chance of large 
pressure changes and therefore little chance of cavitation. 
There is no information in terms of actual, measured, internal flow 
patterns and pressures for this type of pump. This is probably due to the 
practical difficulties of fitting probes inside the rotating mass of fluid without 
affecting the characteristics of the fluid flow. 
Papers by Leaman, (1950), Armstrong, (1952), Young, (1957), Smith, 
(1960) and Gordon, (1962), suggest increased interest in this type of pump 
at those times. All these papers were referenced from Crawford and Rice, 
(1974) 
4.2 Design choices. 
Attempting to build one of these pumps presented problems. For 
pumps with blades there was information on blade angles, velocity diagrams 
etc. in many textbooks, but there was no information about disc pumps. 
Enquiries from various manufacturers did not provide useful answers. The 
company that manufactures disc pumps, the Discflo Corporation, were only 
willing to supply sales and performance information. 
Figure 4.3 indicates the discs were made from thin section material, 
which is material that is thin relative to the disc diameter. Measurements 
taken from the drawing indicate a disc diameter-to-thickness ratio of around 
55 : 1. If this ratio is strictly followed, the manufacture of a 'small' pump will be 
difficult as it may not be possible to obtain biocompatible materials with 
enough physical strength that are thin enough and flat enough to maintain 
position and prevent collapse when the pump is stationary. A 'small' pump 
using thin discs will need to run at high speeds for the required output. 
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Stresses on the discs will have to be carefully assessed to ensure that the 
discs will not 'grow' due to creep and the disc will not break up during use. 
It was therefore considered that the pump produced would not be ideal 
due to the lack of reliable design information. 
In order to make the pump simple, an overhanging rotor design was 
used. With type of design, the rotor is located outside the bearings and is 
typical of many commercial designs. Figure 4.5 shows the general 
arrangement. This requires a shaft seal to prevent fluid leaking out of the 
pump. For a blood pump this is not a good feature as blood becoming trapped 
between the shaft and the seal will be damaged and the friction of the seal 
rubbing on the shaft will cause heat to be generated that has to be dispersed 
in the blood. From previous work, the maximum temperature that can be 
withstood by the skin is around 40 / 41 0 C. and blood is expected to have a 
similar value before being damaged. As. blood would not be used for these 
tests this feature was considered satisfactory. 
Bearings. Seal 
Rotor. 
Shaft. 
Figure 4.5. Outline of pump design. 
The pump body would be built in three sections and clamped together with 
through bolts. Section 1 would hold the shaft, bearings and seals, section 2 
would be the volute containing the rotor and section 3 would be a fluid inlet 
section. Although there might be problems sealing the pump sections, this 
design would make it easy to change the rotor. 
Figure 4.6 outlines the basic construction of the pump. 
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Shaft 
Section 1 with 
bearings, shaft 
and seal. 
Bearings 
Shaft 
Section 2 
with volute 
containing 
the rotor. 
Rotor 
Section 3 
fluid entry 
section. 
Figure 4.6 Layout of the sections of the pump. 
4.2.1 Material. 
Fluid 
entry 
A transparent material was required for the discs and pump so that 
internal flow patterns could be observed. Perspex was chosen as it is 
commercially available, it can be machined easily and can be polished to 
obtain a 'see through' surface. 
The thickness of each disc was to be as small as possible in order to 
pack as many discs as possible into a rotor assembly. The thinnest material 
commercially available was found to be 3mm thick, anything thinner than this 
would be a 'special' order and the thickness and flatness were not 
guaranteed. 
4.2.2 Discs and rotor assembly. 
It was not known if there was a 'best' ratio of the outer diameter and 
the diameter of the hole through the disc. It was considered necessary that 
the hole in the centre of the discs was a similar diameter to that of the human 
aorta. From Grays Anatomy, (1995), the diameter of the aorta as it emerged 
from the heart is given as around 1.25 inches, (31.75 mm), and to be 
approximately circular in section. These figures are not exact as people vary 
slightly. The measurements from Figure 4.3, the Tesla turbine pump, gave a 
disc diameters ratio of around 1.8 : 1. 
The hole through the discs was chosen as 30 mm diameter and the 
outer diameter as 60 mm, giving a disc diameters ratio of 2 : 1. This will keep 
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the pump to a reasonable overall physical size considering the possibility of 
development into a marketable product. The disc diameter ratio may not be 
the best for pump efficiency but the performance could be used for 
comparison purposes. 
The two end discs were to be thicker in section that the rest of the 
discs. This would give a location for the through bolts that were going to be 
used to hold the disc pack together. 
The rotor design was in three parts and the assembly of the discs was 
to be as follows. 
The first disc, the mounting disc, was to be fixed to the shaft through a 
square hole in the disc fitting over a square section spigot on the mounting 
boss fitted to the shaft. The hole in the centre of the spigot was threaded and 
a bolt was used to clamp the mounting disc into place on the spigot. The 
driving discs were to be assembled on the mounting disc, using through bolts 
and spacers, until the required number of discs had been fitted for the 
assembly. The last disc of the rotor, the end disc, was to be assembled in the 
same way as the driving discs using the through bolts. 
The total width of the disc pack, or rotor, was to be set so that a 
clearance of 1.5 mm was maintained between the end discs and the internal 
walls of the volute for all the rotor builds. The clearance was determined by 
knowing the thickness of each disc, multiplying by the number of discs, adding 
the total of the gaps between each disc and subtracting this from the width of 
the volute. Dividing this figure by 2 gave the calculated clearance. 
The material for the discs was thicker than ideal and it was considered 
that the flow patterns near the edges of the discs would not be ideal. Tapering 
the edges of the discs was considered but the time involved was considered 
to be excessive in terms of the machining and polishing involved. 
Photograph 4.1 shows the three rotors built for the tests. The rotor on 
the left was built with three pumping discs and was named rotor three. The 
middle rotor was originally built with four pumping discs but was later modified 
so that all the pumping discs were removed leaving just the end discs. This 
rotor was named as rotor zero. It is shown in Photograph 4.2. It was intended 
to determine if a pumping action was possible with this arrangement. 
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The rotor on the right in Photograph 4.1 had seven pumping discs and 
was named rotor seven. 
The surface area, mass and moment of inertia were calculated for each 
rotor and are listed in Figure 4.7. The mass and moment of inertia for the 
electric motor armature were estimated assuming the armature to be made of 
steel, (density 7,850 Kg/m3), and to be 50 mm diameter and 100 mm long. 
Surface area m2 Mass Kg Moment of Inertia Kg .M2 
Rotor 0 0.0383 0.037 0.00001326 
Rotor 3 0.089 0.059 0.00002520 
Rotor 7 0.157 0.084 0.00004083 
Motor armature ----- 1.541 (est.) 0.0004816 (est.) 
Figure 4.7. Calculated attributes for the pump rotors and 
the motor armature. 
Rotor 3, Rotor 4~ 0, Rotor 7. 
Photograph 4.1.The three rotors as originally built. 
The gap between each disc is as follows , rotor 0, 24 mm , rotor 3, 3mm and 
rotor 7, 1 mm. 
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Photograph 4.2. Rotor 0 - two end discs only. 
Photograph 4.3 shows the arrangement of shaft , bearings , seal and 
adaptor. This shows the adaptor fitted to the shaft and how the shaft was 
carried on two ball bearings. The seal was arranged to prevent fluid leakage 
out of the pump. The rotor fitted on to the adaptor as shown in Photograph 
4.4. 
Shaft Bearings Seal Adaptor. 
Photograph 4.3. Shaft with two bearings and seal on adaptor. 
154 
Shaft collar Bearings Seal Adaptor Rotor. 
Photograph 4.4, Shaft with a rotor in position on adaptor. 
The shaft collar was to be used to prevent shaft end movement when the 
pump was running. 
The end of the shaft was left plain and was connected to the motor by a 
flexible coupling to compensate for any 'out of alignment' with the motor and 
shaft when assembled into the test rig. 
Photograph 4.5 shows the pump without the rotor fitted . The shaft and 
adaptor are in place and the square drive on the end of the adaptor can be 
seen in the centre of the volute. 
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Photograph 4.5. Shaft fitted into pump. 
Photographs 4.6 and 4.7 show the rotor fitted on to the adaptor and where the 
rotor runs inside the volute. 
Photograph 4.6. Rotor zero fitted to adaptor and located inside the volute . 
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Photograph 4.7 Second view of rotor zero assembled to the pump. 
4.2.3 The pump volute. 
The internal shape of a pump volute is ideally a logarithmic spiral. From 
the equipment available at the University it was not possible to produce this 
shape . It implied many small segments joined end to end to form the 
logarithmic curve which would have taken considerable time and be open to 
mistakes. An alternative method used two half circles on different centres. 
This gives a shape close to a logarithmic spiral but using the standard 
routines built into the machine is easier to make and be less liable to 
mistakes. 
The dimensions for the volute are related to the thickness of the 
material used and the outlet area of the volute. These were taken into 
consideration in the volute design . 
In order to allow a clearance between the edges of the rotor discs and 
the cutwater point in the volute , the distance from the rotor centre-line to the 
cutwater point was set at plus 10% of the rotor outer radius , (33 mm) , as 
detailed in Turton, (1993), Figure 4.8 shows this arrangement. 
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10% r. l 
Disc 
radius, (r) 
Figure 4.8 Detail of cutwater point. 
The pump outlet was to have the same area as the aorta as it leaves 
the heart. Grays Anatomy, (1995), gives this as equivalent to 791.73 mm2 . 
Material, 50 mm thick, was chosen for the pump volute in order to a) fit 
the rotor in position but b) to provide enough additional material to provide a 
structural restraint for the volute and prevent it 'springing' open after 
machining. Suitable material was purchased from a supplier. Given the 
required outlet area and material thickness, a volute design was made based 
on these figures. 
The calculations for the volute dimensions are shown on Table 4.2. 
The drawings for the pump parts are shown on Appendix 10. 
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Table 4.2, Volute calculations. 
Diameter of human aorta at heart exit 
Width of passage 
Degrees Percentage 
around volute around volute 
0 0.00 
30 8.33 
60 16.67 
90 25.00 
120 33.33 
150 41.67 
180 50.00 
210 58.33 
240 66.67 
270 75.00 
300 83.33 
330 91.67 
360 100 
31.75 mm 
40mm 
Volute area 
mm~ 
0 
65.98 
131.96 
197.93 
263.91 
329.89 
395.87 
461.84 
527.82 
593.80 
659.78 
725.75 
791.73 
Area of human aorta 
Cutwater radius 
Volute de(2th Volute radius 
mm de(2th 
0 33.00 
1.65 34.65 
3.30 36.30 
4.95 37.95 
6.60 39.60 
8.25 41.25 
9.90 42.90 
11.55 44.55 
13.20 46.20 
14.84 47.84 
16.49 49.49 
18.14 51.14 
19.79 52.79 
-
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791.73 mm2 
33mm 
Volute tube Volute tube 
area. mm~ dia. 
0 
197.93 15.875 
395.87 22.451 
593.80 27.496 
791.73 31.750 
------
Tube'rad' 
+33 mm 
40.938 
44.225 
46.748 
48.875 
4.2.4 Summary. 
The disc pump appears to have favourable characteristics when 
applied to pumping blood. These include low shear stresses and the ability to 
handle fluids with viscosities that are greater than water. The ability to safely 
handle fluids with inclusions is also favourable. 
The pump is simple to build and if the disc stresses are low enough, 
ceramic materials can be used to fabricate the discs. This point is important 
as ceramics are biocompatible and do not react with blood. 
If the pump is built with 'thin' section discs, there should be little or no 
problem with disturbed fluid flow patterns as the fluid leaves the rotor. 
A disadvantage with this pump is the efficiency which may not be as 
high as a convential pump. If the disc pump is designed for a particular 
application, the difference may be small compared to a convential pump, and 
may be acceptable if an alternative pump is not available and the advantages 
outweigh the disadvantages. 
Another disadvantage with this pump design is the large internal area 
available for blood contact with the multiple discs. Careful selection of a 
biocompatible material and design will reduce this effect. 
The next chapter covers the building of the test rig and the testing of 
the pump. 
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Chapter 5, Pump testing. 
5.1 Test Rig, Introduction. 
A rig was constructed to test the pump. The pipe work was 
commercially available 25 mm, (1 inch), bore plastic pipe with gate valves 
fitted at the pump inlet and outlet to control the flow and pressure of the 
pumped fluid. 
Instrumentation was used to measure the pump speed, fluid flow, 
I-Istrain and differential pressure across the pump inlet and outlet, together 
with the power required to drive the pump. A brief description of the 
equipment and operation together with photographs of the rig and pump as 
installed are shown later. 
Electronic strain gauge differential pressure transducers, Radio Spares 
part no 286-686, were used to measure the pressure generated by the pump. 
The transducers, maximum pressure difference of 34.5 kN/m2, (5 Ibf/in2), were 
calibrated using a mercury manometer to determine the relationship between 
pressure and strain. 
Figure 5.1 shows the pressure calibration equipment used. 
Hand 
operated 
pressuring 
device 
Transducer 
Wheatstone bridge 
strain measuring 
equipment. 
Atmospheric 
pressure 
Atmospheric 
pressure 
Pressure 
difference 
(mm Hg) 
0-600 mm 
mercury 
manometer 
Fig. 5.1. Pressure calibration equipment. 
The results are shown on Appendices 7.1 and 7.2 The characteristic 
between pressure and strain was a straight line relationship. The slope of the 
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line was calculated as 0.02883 and the formula below was used to calculate 
pressure from the measured strain. 
Pr essure (mmHg) = 0.02883 x IJstrain 
Pressure tappings at the inlet and outlet of the pump were connected 
to the pressure transducers. The pressure was calculated using the formula 
above. 
Before every test, the output from each transducer was zeroed to 
ensure that the pressures measured were accurate relative to atmospheric 
pressure. 
In order to drive the pump, an electric motor and associated control 
equipment were purchased from suppliers. Details are shown in Appendix 8. 
Tests were conducted to determine the tacho generator output voltage 
relative to the tacho generator speed. By plotting this characteristic, an 
equation was obtained which was a close match to the plotted results as 
shown in Appendix 9. Using this equation the pump speed was calculated 
from the tachogenerator voltage. 
It was considered fitting thermocouples to the pump inlet and outlet to 
measure temperature differences. A digital thermocouple was used to 
measure the temperatures. The inlet and outlet of the pump were considered 
to be suitable temperature measuring points and a small quantity of Vaseline 
petroleum jelly was placed at these positions. The temperature probe could 
then be inserted into the Vaseline during the test and it was assumed that the 
Vaseline was at the same temperature as the point to be measured. 
A test was taken to determine temperature rise using water as the fluid. 
The pump was set to deliver 1 I/min at a differential pressure of 200 mm Hg. 
This resulted in an average pump speed of 4013 rev/min. The temperature 
was taken every 15 minutes for 5% hours. Each reading was at an accuracy 
of +/- 0.1 °C 
A temperature rise of 16 degrees C over this time period was noted. 
The room ambient temperature was about 20 - 21 degrees for the duration of 
this test. 
A plot of the results is shown on Appendix 11 
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A Rotometer with a flow range of 0 - 10 litres/min was used to 
measure fluid flow. (Elliott Process Instrumentation, SM 18 8-1). This is a 
commercial device and operates on the principle of drag on a submerged 
body. 
5.2 Pump rotors. 
Three rotors had been built and are described in Chapter 4.2.2 and are 
shown in Photographs 4.1 and 4.2 
The rotors were to be tested in the following order. 
a) The rotor with two end discs only 
b) The rotor with seven discs plus two end discs 
c) The rotor with three discs plus two end discs. 
This order was assumed to be the most suitable in terms of 
performance and it would hopefully leave the pump built with the optimum 
rotor at the end of the tests. 
Tests were conducted and the details are shown in Chapter 5.6.6 onwards. 
After the tests with the first rotor, the water was drained out of the test 
rig and the rig was run through a full speed range from 'fast' to 'slow' and back 
to 'fast' again in order to determine any hysteresis. Results were plotted 
showing tachogenerator volts and motor power consumption, (watts) as 
shown on Table 5.1. 
The characteristic equation for this relationship was determined and 
is shown below. 
Where P = power (Watts) 
N = speed (Rev Imin) 
ao = 2.53 
a1 = 7.866 x 10-3 
a2 = 5.411 x10-7 
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From this it was possible to calculate the no load power consumption at any 
speed. Subtracting this power from the power recorded during the tests would 
give the actual power required to pump the water. 
Tacho. output Speed, Average no load power, 
volts. rev/min. Watts 
20 3928.3 36.46 
18 3440.5 31.08 
16 2974.9 26.09 
14 2531.6 20.95 
12 2110.5 16.24 
10 1711.7 12.19 
8 1335.1 8.77 
6 980.9 6.05 
Table 5.1, Results of speed and 'no load' power consumption test. 
5.3 Physical similarity, introduction. 
It is important to predict product performance in order to prevent an 
unsatisfactory product reaching the market place. It is not always possible to 
test a full size prototype and model tests are used to predict the performance 
of the prototype. The model results are then 'scaled up' to obtain the results 
for the prototype. 
For the results to be valid the model must be 'physically similar' to the 
prototype. This term covers several kinds of similarity and these are described 
in Massey, (1995). In all these descriptions it should be understood that two 
systems are physically similar 'when the ratio of the corresponding 
magnitudes of these quantities between the two systems is everywhere the 
same t. 
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5.3.1 Non dimensional performance of pump. 
Non-dimensional coefficients can be used to predict the performance of 
machine B from the results of machine A as long as they are both 
geometrically similar machines. In order to provide a comparison with other 
pumps from published papers, these have been applied to the results 
obtained from the Tesla pump tests. 
Formulae for the non dimensional coefficients have been taken from 
Crawford and Rice, (1974), and are listed below together with the symbols 
used. 
Q-
Efficiency 11 = :t 
pOh2 
Re ynolds number NRE = 
IJ 
Q 
Volume flow rate parameter U = 2TT ~20h 
p 
Dimensionless torque T1 = Nph03 ~4 
P 
Dimensionless pressure change Pt = ,,2 2 pu rj 
(2) 
(3) 
(5) 
(6) 
An explanation of the symbols is shown in Table 5.2. The figures for 
rotor 3G refer to the density and viscosity of the water / 45% glycerine mixture 
and are a straight line interpolation from Kaye and Laby, (1995) and are 
shown as *. The figures taken from Lann, (1997) are shown as **. 
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The range of values for the non-dimensional coefficients quoted by Crawford 
and Rice, (1974), are as follows. 
Efficiency '1 
Reynolds number NRE 
Volume flow rate parameter Uo 
Dimensionless torque TI 
Dimensionless pressure change Pt 
o to 99 
o to 10 
o to 2 
o to 1250 
3.5 to -437 
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Symbol DescriQtion. Rotor 0 Rotor 7 Rotor 3 Rotor 3G 
Q Flow through entire pump. m::!/sec m::!/sec m::!/sec m::!/sec 
, 
pUt Pressure change through pump Pa or N/m2 Pa or N/m2 Pa or N/m2 Pa or N/mL 
P Power supplied to pump shaft. Watts Watts Watts Watts 
p Density of water (kg/m::! ) 1000 1000 1000 
P Density of test fluid 1100 * 
1055 ** 
0 Rotational speed. Red/sec Red/sec Red/sec Red/sec 
h Spacing between discs (m) 0.024 0.0005 0.003 0.003 
IJ Viscosity of water (kg/m.s @ 20 deg C) 0.001002 0.001002 0.001002 
IJ ' Viscosity of test fluid. 0.005275 * 
0.0035 ** 
Q1 Volume flow between adjacent discs. m3/sec m3/sec m;j/sec m::!/sec 
TT Relationship of circle diameter to radius 3.14159 3.14159 3.14159 3.14159 
r -1 Inner radius of discs at fluid entry to rotor (m) 0.015 0.015 0.015 0.015 
9 Acceleration due to gravity m/s£ 9.81 9.81 9.81 9.81 
N Number of spaces between discs 1 8 4 4 
-- - -- ---- - --
Table 5.2 Explanation of symbols used in the calculations. 
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A worked example of one of the tests, (test 81), shown below, lists typical 
results. 
Eft· . QPt . IClency '1 = P = 6.829 0/0. 
pOh2 
Re ynolds number NRE = I.J = 624. 
Q 
Volume rate parameter Uo = 1 2 = 0.0295. 2nOh~ 
D· . I P Imenslon ess torque T1 = 3 _ 4 = 2.6 
NphO r i 
Dimensionless pressure change Pt = ~t -2 = 0.9766 
pO r1 
These results have similar values to Crawford and Rice, (1974), shown 
in the list of symbols, except for the Reynolds Number which range from 1 to 
10 in the paper. This is low compared to Reynolds numbers in industrial 
applications which can range from hundreds to several thousands. 
Calculations were made to determine the gap between the discs using 
the Reynolds numbers of 1 to 10 quoted by Crawford and Rice, (1974), and 
using a speed range of 1000 to 4000 rev/min. The calculated gap ranged from 
0.049 to 0.309 mm. How these could be achieved in practice is not 
understood. Professor Rice had published these results from work at Arizona 
State University in the 1960's and 1970's. Enquiries of the University indicated 
that he and his work were unknown and explanation of these figures was not 
available. 
A list of the symbols used with the non dimensional and actual 
dimensional forms is shown in Table 5.3. 
In non dimensional analysis only three symbols are used. 
These are:-
Length. This is shown as L. In 'real' units this will be metres, (m) 
Mass. This is shown as M. In 'real' units this will be kilograms, (kg). 
Time. This is shown as T. In 'real' units this will be seconds, (s). 
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Symbol Name Non Actual 
dimensional dimensional 
form form. 
Q Volume flow rate Lj IT m3 Is 
N Rotational speed 1 IT 1 Is 
0 Rotor diameter L m 
g Acceleration due to gravity L I T£ m I s£ 
P Pressure I head M I L£ Kg I m£ 
p Fluid density M I L3 kg I m3 
l.J Viscosity of fluid. M I L.T kg I m.s 
P Power transfer. M.L IT Kg.m / s 
Massey, B.S., Mechanics of Fluids, (1995). 
Table 5.3, Symbols used for the non-dimensional analysis. 
5.4 Description of fluid characteristics. 
Fluid behaviour can be divided into Newtonian and non-Newtonian 
where the difference is in the way the fluid behaves while undergoing a shear 
force. 
A Newtonian fluid is defined as a fluid that has a simple relationship 
between shear stress and shear rate and the relationship is linear. Water is an 
example of Newtonian fluid. 
Non-Newtonian fluids. The descriptions of Non-Newtonian fluids that 
follow were taken from Massey, (1995), and Hughes et aI., (1967). 
Non-Newtonian fluids do not follow a linear stress - strain 
characteristic. They are in three general classifications. 
a) Time independent fluid. 
The time independent fluids can be represented by three separate 
types of fluids and are described as follows. 
i) Bingham plastic fluids. 
These show a yield stress at zero shear rate which when exceeded 
follows a straight line relationship between shear stress and shear rate. These 
fluids tend to be slurries, emulsions and suspensions of solids in liquid. 
ii) Pseudoplastic fluids. 
This does not show a yield stress but has a progressively decreasing 
slope of shear stress against shear rate. The slope of this characteristic at any 
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point is defined as the apparent viscosity at that point. This type of fluid 
approximates to blood, i.e., red blood cells that are suspended in plasma. 
iii) Dilatant fluids. 
This type of fluid is similar to a psueudoplastic fluid in that is does not 
have a yield stress but that the apparent viscosity increases with increasing 
shear rate. As before, the slope of this characteristic at any point is defined as 
the apparent viscosity at that point. 
Examples of these characteristics are shown in Figure 5.2. This shows 
that for a Newtonian fluid, the viscosity is a constant value irrespective of the 
rate of shear as the characteristic between shear stress and shear rate is a 
straight line. 
For a non-Newtonian fluid the viscosity is not a constant value in 
relation to shear rate, as the characteristic changes slope as the shear rate 
changes. Figure 5.2 shows two examples, a pseudoplastic fluid and a dilatent 
fluid. 
Shear 
stress. 
Bingham plastic non-Newtonian fluid. 
Af-----
Pseudo plastic non-Newtonian fluid. 
,.------ (Blood = Plasma + Cells) 
/+ ____ Newtonian fluid. (Water and blood 
plasma but no cells. ) 
Dilatent fluid, non-Newtonian fluid 
Rate of shear. 
Figure 5.2, Relationships of shear stress and shear rate for fluids. 
http://www.bendigo.latrobe.edu.au/biOISclphys/appscilbio30obe/lecture/lecture11.htm 
Massey B.S., (1995) 
b) Time dependent fluid. 
With this fluid the shear rate is not a single value function of the shear 
stress but depends on the shear time or the previous shear stress history of 
the fluid. 
There are two basic types of time dependent fluids 
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i) Thixotropic fluids. 
The apparent viscosity decreases depending on the length of time of 
shearing and the shear rate. As the fluid is sheared the molecular structure 
breaks down but will reform if the fluid is allowed to rest regaining the original 
viscosity. An example of a thixotropic fluid would be a printer's ink. 
ii) Rheopectic fluids 
With this fluid the viscosity increases with shear and the length of time 
and is the reverse of a thixotropic fluid. The thickening of egg white by beating 
is an example of this characteristic. 
c) Viscoelastic fluids. 
The shear strain and shear rate are related to the shear stress and the 
fluid shows both elastic and viscous characteristics. In a viscoelastic fluid 
some of the energy of deformation may be recoverable similar to the recovery 
after deformation of a solid. In a purely viscous fluid all the energy of 
deformation is lost. 
5.5 Test rig construction. 
A test rig was built and the layout is shown on figure 5.3. 
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Supply 
tank 
Fill valve 
Rotameter 
Air vent / bleed 
Inlet valve 
t 
Drain valve/ 1 
Delivery 
pressure 
transducer 
Outlet valve 
Drain 
Figure 5.3, Layout of test rig. 
Differential 
pressure 
transducer 
Pump 
and 
motor 
Air 
vent / 
bleed. 
The pump was mounted on a 'Dexion' structure that was bolted to a 
heavy table. The pipe work was made from 25mm, (one inch), bore plastic 
pipe as used in domestic water systems. Pipe bends were curves rather than 
90° corners and the entry length into the pump was a minimum of 10 pipe 
diameters in order to give a smooth a fluid flow as possible into the pump. 
Transducers were used to measure the pressures generated at the 
fluid inlet and outlet. The readings from the transducers were converted to 
millimetres of mercury using the formula shown elsewhere in this thesis. 
The pump was built from commercially available materials and 
additional parts such as bearings and seals were purchased as required. The 
construction of the pump and other details above are covered elsewhere in 
this thesis. 
Power for the motor was supplied from the domestic 240V 50 Hz mains 
supply, transformed and rectified to 24V DC using a power supply unit. The 
speed of the 24V DC motor was varied by using a manual control unit. The 
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motor, power supply unit and control unit, were all purchased from trade 
suppliers. 
cc=========~ 
Fluid inlet into the pump. 
Figure 5.4. The body of the pump. 
Figure 5.4 shows the pump casing ready for assembly to the table . The 
three sections of the pump have been bolted together and the position of the 
volute and cutwater can be seen above the inlet pipe. The outlet is at the right 
hand end of the pump. There are no pump internal parts shown in this 
photograph. 
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Fluid reservoir. 
Rotometer for 
flow measurement. Pump. 
Motor controls . 
Strain gauge bridges for 
Motor. pressure measurement 
Figure 5.5, General arrangement of test rig . 
Figure 5.5 shows the rig from the side. The motor is seen from the 
tachogenerator end with the pump shaft in line with the motor. The flow 
measurement device, the Rotometer, is at the extreme left hand end of the rig 
in this photograph. The pressure measurement and control equipment can 
also be seen. 
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24 V DC motor. Flexible coupling. Tesla pump. 
Figure 5.6, General arrangement of motor and pump. 
Figure 5.6 shows the pump mounted to the rig. The flexible drive 
connection from the motor to the pump can be seen . The pump is bolted to a 
'Dexion' structure, which was bolted to the table . The two sets of wires coming 
out of the motor are the motor power supply and the tachogenerator wires . 
It was possible to reach pump speeds of over 4000 rev/min. and at th is 
speed pump, deliveries of over 10 I/min were possible at differential pressures 
of over 250 mm Hg. 
The fluid pressures at the pump were calculated uSing the formula 
obtained from previous tests measuring strain against pressure . 
The rig was fitted with three digital multimeters. Two measured the 
voltage and current taken by the motor and the third was used to measure the 
voltage generated by the motor tachogenerator. 
The tests measured pump speed (tachogenerator voltage), del ivery 
quantity (I/min) , fluid pressures at the pump (strain ), motor voltage (volts) and 
motor current (amperes) . 
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A test programme was written to explore the performances of the three 
rotors, to decide which was the 'best' rotor and then to concentrate on that 
rotor to test for the full performance tests. Initial tests were to be conducted 
using water as the test fluid. Once these tests were completed the test fluid 
would be changed to a fluid representative of blood in terms of viscosity and 
any other characteristics that could be obtained. 
Each test was run from a 'set point' as long as the pressures did not 
exceed the rating of the pressure transducers. Two maximum 'set points' 
were chosen, based on the performance of the human heart. These were 
a) 10 litres I minute at a pressure of 200 mm Hg. 
b) 5 litres I minute at a pressure of 200 mm Hg. 
If the pump could achieve this performance, lower pressures and deliveries 
would be no problem. 
The figure for the 'set point' pressure was selected for two reasons, 
a) The maximum blood pressure difference measured in the vascular 
system can reach 200 mm Hg. This pressure occurs at the outlet from the 
heart. 
b) The 'set point' pressure at 200 mm Hg is less than the maximum 
pressure rating of the transducers of 5 Ibf/in2 ., equivalent to 259 mm Hg. 
Two sets of tests were taken. The first set explored the characteristics 
of the pump performance from the 'set point', irrespective of the speed 
reached. The pump and the valves in the test rig were adjusted to achieve the 
'set point', and then changing the pump speed only, recording the 
performance over the speed range. 
The second set of tests was at constant speed. The pump speed and 
test rig valves were adjusted to achieve the 'set point'. The test rig valve(s) 
would then be adjusted to change the output of the pump to give a series of 
output deliveries, ensuring that the pump speed was as constant as possible 
at each setting. Most tests were to be taken by closing the pump outlet valve 
with the inlet valve wide open. This would give the test fluid an unrestricted 
entry to the pump but a restricted outlet. 
A small number of tests were to be taken with the outlet valve fully 
open and the inlet valve adjusted to give the target 'set point'. This would give 
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an unrestricted outlet from the pump but with a restricted inlet. This was 
intended to determine if cavitation was possible. 
5.6, Results. 
5.6.1 Test conditions 
The 'set points' chosen for the first set of tests are shown in Table 5.4. 
Deliverv I/min Pressure difference mm Hg 
10 200 
10 150 
10 100 
5 200 
5 150 
5 100 
Table 5.4. The performance 'set points' for the initial tests. 
The differential pressure is the pressure difference between the pump 
inlet and outlet. With this connection, the pressure transducer senses the inlet 
and outlet pressures and records the difference between them but not the 
pressures relative to atmosphere or absolute. This method gives a measure of 
the pump pressure performance without reference to external pressures. 
Another set of performance 'set points' was chosen for the constant 
speed tests and these are shown in Appendix 12. 
Initial tests were conducted to ensure that the pump operated properly 
and to fix any leaks and other problems. These tests were not part of the test 
sequence and were not recorded. 
5.6.2 Test fluids, introduction. 
In order to achieve satisfactory results it was considered necessary to 
conduct tests to find a fluid that was representative of blood. Enquiries from 
Wickramasinghe R. of Colorado State University, bye-mail dated July 2003, 
indicated that there was not an 'industry standard' fluid used by all 
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researchers. This statement was surprising considering the importance of the 
work and the number of papers published on the subject of blood pumps and 
blood contacting devices. Many researchers appear to use a mixture of water-
glycerine or water-xanthan gum. Checks indicated that there were no health 
and safety problems with these mixtures. 
The pump tests were to be conducted using three different test fluids. 
These are described below. 
The first fluid used was tap water. This was allowed to settle in order to 
ensure that there were no air bubbles. Before each test the pump was run to 
ensure that there was no air entrained in the system. The water was not 
treated or mixed with any other fluid. 
The second fluid was water - glycerine. 
A third set of tests used a mixture of water - xanthan gum. Preparation 
of these fluids is described later. 
Thurston, (1996), discusses analog fluids for human blood and 
indicates that a safe, stable, reliable alternative has not been found but that 
some fluids can be used to imitate blood in selected ways. A mixture of 45% 
glycerol in water gives a viscosity that is close to that of blood at 25°C. It is 
low cost and transparent but does not give the viscoelastic flow properties of 
blood. 
Wickramasinghe, (2002), showed results using a mixture of 45% 
glycerine to 55% water by weight. This gives a fluid that is similar to blood in 
terms of viscosity but does not have the shear - viscosity relationship of blood. 
Brookshier and Tarbell, (1993), indicate that mixtures of water / 
xanthan gum / glycerine can do a 'reasonably good job of modelling the flow 
of blood in large arteries'. They do not recommend a preferred specification 
for a test fluid but instead state that the xanthan gum / glycerine solutions 
'should be useful blood analog fluids for in vitro hemodynamic studies'. 
These mixtures seemed to be the best available at the time and 
accordingly several small samples of different mixture strengths by weight 
were prepared. 
Although this was used as a test fluid, a water - glycerine mixture it is 
not equivalent to blood in all respects. Figure 5.7 shows the results of tests by 
Wickramasinghe, (2002), to determine the shear and viscosity relationship of 
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water and glycerol mixtures and comparing them to blood at hematocrits of 
25% and 65%. (Normal blood hematocrit is around 45%). These tests show 
that the viscosity for each mixture did not change relative to shear rate. This is 
the characteristic of a Newtonian fluid in which the flow and shear rate are 
always proportional to the applied stress and where the viscosity depends on 
temperature. It is obvious that Newtonian fluids do not accurately model blood 
over a useful range of shear rates 
Assuming that the normal blood hematocrit is 45%, none of the water / 
glycerine mixtures were suitable to simulate blood at any of the shear rates 
shown. Other mixtures of water - glycerine could have been made and tested 
but it is assumed that the water - glycerine characteristic would meet the 
slope of the blood characteristic at only one value of shear rate where the two 
lines would cross. 
Taking tests with many water - glycerine mixtures, it would be possible 
to obtain a result that conformed exactly to the shear / viscosity relationship of 
blood at anyone hematocrit but it would be of little practical use over a range 
of shear rates. 
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Fluid Water 0/0 Glycerol 0/0 Symbol 
A 100 0 
• B 95 5 <> 
C 90 10 
• D 80 20 D 
E 70 30 
• F 60 40 D 
G 50 50 
• 
From Wickramasinghe R., (2002) 
Figure 5.7, Viscosity and Shear rate of water / glycerine 
mixtures compared to blood. 
Other results published by Wickramasinghe, (2002), Figure 5.8, use 
test fluids made from mixtures of water / glycerine / xanthan gum. The results 
indicate that these are shear thinning fluids where the viscosity is lower when 
a greater shear rate is applied. 
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This is the characteristic of a non-Newtonian fluid, where the flow and 
shear rate are not in proportion to the applied stress and the viscosity 
changes with the shear rate. This characteristic is similar to blood. 
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From Wickramasinghe R., (2002) 
Figure 5.8 Variation of viscosity with shear rate for 
various non Newtonian fluids. 
Using the lines for 65% hematocrit blood and 25% hematocrit blood as 
guides, the approximate position of 45% hematocrit blood is superimposed on 
the figure. 
Assuming that the position of the blood hematocrit line of 45% is 
correct, the results indicate that the water - xanthan gum mixture, fluid J, has 
the closest relationship to 45% hematocrit blood than any of the other 
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mixtures as it has almost the same slope and crosses the 45% hematocrit 
line. 
Test fluid preparation. 
Preparation of water - glycerine mixture. 
Tests were conducted to determine the specific gravity and the 
percentage of glycerine in samples of water - glycerine mixtures. The specific 
gravity of water was measured as 1.000 and the specific gravity of 100% 
glycerine was measured as 1.250. The figure for the specific gravity for 
laboratory grade glycerine taken from the catalogue of 'Fisher Scientific' 
products is 1.257 - 1.261. 
From these two values of specific gravity for water and 1 00 % glycerine 
and assuming that the relationship between the specific gravity and the 
glycerine content was a straight line, the calculated result for 45% glycerine 
should have been a specific gravity of 1.1125. However tests conducted at 
various mixtures did not lie on the straight line connecting these two results. 
The results were plotted and using a 'best' fit curve, gave a curve with 
a quadratic equation of Y = 0.000006x2 + 0.001945x + 1.000117 as shown 
on Appendix 13.1. Based on this plot the specific gravity for a mixture of 45% 
glycerine in water was 1.099792. 
Re-plotting the same results using a 'best' straight-line plot gave a line 
with an equation of y = 0.0025x +0.9899 as shown on Appendix 13.2. Based 
on this plot the specific gravity for 45% glycerine was 1.1024. 
Tests on a sample gave a specific gravity of 1.100 for 45.7 % glycerine. 
The Handbook of Chemistry and Physics, (1946), quotes a specific gravity of 
1.1138 for a 45% aqueous glycerol solution with a viscosity of 4.509 @ 20° C. 
Although not stated it is assumed that the viscosity is quoted in centipoises. 
For the same water / glycerine mixture, L6nn and Wulff, et aI., (1997), 
quoted the density as 1,113 kg/m3 at 21 deg C and the dynamic viscosity as 
3.4*10-3 kg/m.s. The dynamic viscosity of blood, with a red blood cell volume 
of 40%, was quoted as 3.5*10-3 kg/m.s. Kaye and Laby, (1995), quoted the 
density of blood as 1,055 Kg/m3 . 
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Considering the above results, the average figure for the specific 
gravity of a 45% glycerine / water mixture is 1.1069 and the chosen figure for 
specific gravity of 1.100 for the water - glycerine mixture was considered 
accurate enough for test purposes. It could be read easily from a standard 
hydrometer and was repeatable. Any difference in the results due to variations 
in specific gravity of the fluid around this figure that could not be read using a 
standard hydrometer were considered to be insignificant 
Preparation of water - xanthan gum mixture. 
Following Wickramasinghe, (2002), samples of a water- xanthan gum 
mixture were made. The mixture selected was 99.99% water, 0.01 % xanthan 
gum. This was the simplest mixture shown and from the results on Figure 5.8, 
appeared to give a reasonably good relationship with 45% hematocrit blood 
when viscosity was plotted against shear. 
The addition of the gum was intended to give a non linear relationship 
between shear rate and viscosity and to simulate the performance of blood 
under shear forces where blood is considered to be a shear thinning Non-
Newtonian fluid. 
Four bottles of the water - xanthan gum mixture were made by filling 
each bottle with 5 litres of water and then adding 0.5 gram of xanthan gum 
powder. 
Some difficulty was found when mixing the water and gum. 
For bottle no. 1, it was noted that if the quantity of gum, 0.5 gram, was 
dropped directly into 5 litres of cold water, the gum tended to form small and 
large clumps of something like a glue. If a clump were broken up, dry powder 
could be seen in the centre of the clump. Shaking the bottle did not improve 
the mixing and clumps could be seen floating around in the bottle. 
For bottle no. 2, 0.5 gram of powder was added to 100 ml of cold 
water. This was then placed on to a laboratory mixer and heater table where 
the water was heated and stirred until it almost boiled. This produced a 
mixture that appeared to be homogenous throughout and was a better result 
than before. This was then added to cold water where some clumps could be 
seen but were less in number than before. 
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For bottle no. 3, O.S gram of powder was added to 100 ml of water 
which was then placed into an ultra sonic cleaner. The action of the cleaner 
was not effective in breaking up the clumps of powder and was discontinued 
after 10 minutes. This sample was heated and stirred as before. This gave a 
result similar to bottle no. 2. 
For bottle no. 4, 1S0 ml of water was heated but without boiling. O.S 
gram of powder was sprinkled on to the surface of the hot water as slowly as 
possible while the water was stirred. The powder was not allowed to 'clump' 
on the surface of the water. As stirring progressed the powder appeared to 
mix better than before. This gave the best result of the tests conducted, with 
no noticeable clumps floating around in the mixture. As this powder is used as 
a cooking additive it may be possible that heat is necessary to make it react 
and mix properly. 
A hydrometer was used to measure the specific gravity of water and 
one of the water / gum mixtures. The specific gravity of water had a value of 
1.00 as expected. The specific gravity of the xanthan gum / water mixture no. 
1 was measured at 0.998 which was less than the figure for water. The test 
was repeated with the same result. 
5.6.3 Viscosity tests. 
Tests were taken to determine the viscosity of the fluids. A small test 
rig was constructed comprising upper and lower reservoirs, a length of 
capillary tubing, a pressure transducer and pipe work such that the pressure 
difference across the length of the capillary tube could be measured while the 
fluid was flowing. The tube length was measured as S02 mm and the bore 
was calculated as 0.S83 mm. The pressure transducer had been previously 
calibrated. Chapter S.1, Pressure Measurement, details the procedure. 
The transducer calibration constant was 
0.02883 Strain = 1 mm Hg 
A measuring cylinder was used to collect the fluid that passed through 
the tubing and the quantity collected was timed. The height of the fluid 
reservoir compared to the centre of the capillary tube could be varied by either 
moving the tube or the reservoir. The change of fluid level in the reservoir 
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during each test was considered to be negligible. The general arrangement is 
shown in Figure 5.9. 
A minimum of 4 tests was taken at each height setting and the results 
were averaged to give a point for plotting. 
Fluid 
head, mm 
Fluid reservoir 
Capil1my tubing, 502;:::>' 
mm long x 0.583 mm 
Differential pressure 
transd ucer, 
o -34.5 Kn/m2, (0 - 5 Ibf/in2) 
bore 500 ml 
measuring 
cylinder 
Timer 
Figure 5.9 Schematic arrangement of viscosity test rig. 
5.6.4 Results of viscosity-shear tests. 
Tests were taken to confirm, 
a) the viscosity of water in order to prove the accuracy of the method 
used. 
b) the viscosity - shear rate relationship of a water - glycerine mixture 
c) the viscosity - shear rate relationship of a water - xanthan gum 
mixture. 
Water only test. 
The results of the water only test are shown in Figure 5.10. The 
average of the readings gave a viscosity for water of 0.00096731. The 
viscosity from the plot was 0.0009356011. These figures were close to the 
quoted viscosity of 0.001002 @ 20 0 C from Rogers and Mayhew, (1983). 
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The slope of the result, 0.0000000485, indicated that the viscosity of 
water varied very little with shear and was considered to be not shear 
sensitive and therefore a Newtonian fluid. 
Log Shear Vs log viscosity, (water), 
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Figure 5.10 Result of the viscosity / shear relationship of water. 
It was not possible to compare this result with Figure 5.7, from 
Wickramsinghe, (2002). Although the viscosity result was almost identical at 
0.001, the maximum shear rate for Wickramsinghe, (2002) was below 10 
where the Middlesex University shear was between 100 and 1000. 
Water I glycerine test. 
These tests were conducted using the same test rig and method of 
calculation as the water only tests. 
The results are shown in Figure 5.11. Taking the average of the 
readings gave a viscosity of 0.0042262. Plotting the results and fitting a 'best' 
line indicated that the viscosity of the water / glycerine mixture is around 
0.0037406 The 'flatness' of the slope at 0.00000258 indicates that this mixture 
is not shear sensitive and is a Newtonian fluid. 
It was not possible to compare this result with Figure 5.8 directly. 
Although the viscosity was between the results for 50% glycerine and 40% 
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glycerine, the maximum shear rate for Wickramsinghe, (2002), was below 10 
where the Middlesex University shear was between 100 and 1000. 
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Figure 5.11 Results showing the viscosity / shear relationship 
of the water glycerine mixture. 
The water - glycerine viscosity at 0.0042262 is close to the quoted 
viscosity of a 50% mixture quoted at 0.00420 @ 30° C by Kaye and Laby, 
(1995). Taking the results from Wickramsinghe, (2002), and estimating a 
viscosity for 55% water / 45% glycerol mixture gave a viscosity of 0.00494. 
Thurston, (1996), indicates a Newtonian viscosity of 0.00397 @ 25° C for a 
45% mixture. 
Water I xanthan gum test. 
Tests were conducted using the same test rig and method of 
calculation as the previous tests using a water / xanthan mixture in the same 
proportions as quoted by Wickramasinghe, (2002). 
The results are shown in Figure 5.12 and indicate that the effective 
viscosity of the water / xanthan gum mixture is around 0.0011 but the slope at 
0.00000001 does not clearly indicate that this mixture is shear sensitive and it 
is difficult to determine if it is a Newtonian or non Newtonian fluid. 
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Figure 5.12 Results of the viscosity / shear relationship 
of the water xanthan gum mixture. 
The results were compared to normal haematocrit blood and the 
results by Wickramsinghe, (2002). They are not comparable with the 
Wickramsinghe results as it was not possible to compare the shear values 
quoted by Wickramsinghe. 
Klabunde, (2002), indicated that blood viscosity was 3 to 4 times that of 
water. The viscosity of water can be found and multiplying by 3.5 would give 
an easy answer for the viscosity at 0.003507 but would not take account of 
the change of viscosity of blood due to temperature and other conditions. 
It is not understood how shear values in the range 1 to 10 were 
obtained by Wickramasinghe, (2002). With the water - xanthan gum tests, the 
smallest fluid 'head' used was about 3 mm and still gave a shear value of 
above 100. 
Thurston, (1996), described the use of xanthan gum as a blood 
analogue but indicted that a solution in the ratio of 500 ppm of gum in distilled 
water, (0.050/0), gave a viscosity below that of blood. He considered that a 
mixture of xanthan gum and glycerine could be made that would be a better 
blood analogue than either of the two fluids when used separately. 
The amount of xanthan gum quoted by Thurston, (1996), is 5 times the 
amount quoted by Wickramasinghe, (2002) and reinforces the impression that 
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the mixture tested was effectively water and would explain the poor results of 
these tests. 
5.6.5 Pump tests. 
These tests are intended to show the performance of the pump and are 
in two parts. The first part was to determine what appeared to be the best 
rotor using water as a test fluid. The second part was to re-test the pump with 
the 'best' rotor fitted using the alternative test fluids. 
The rotor builds and test fluids are shown in Table 5.5 where each rotor 
and fluid combination are referred to by the rotor identification number. 
No. of discs Fluid Rotor identification 
0 Water 0 
3 Water 3 
3 Water plus glycerine 3G 
3 Water plus xanthan gum 3X 
3 Calculated result for blood. 38 
7 Water 7 
Table 5.5, Rotor identification. 
Once the initial tests had been completed, and the 'optimum' rotor had 
been selected, additional tests were taken with the optimum rotor fitted but 
with changes to the test fluid. 
In the second part of the tests, the first test fluid was a mixture of water 
and glycerine. The second test fluid was a mixture of water and xanthan gum. 
Chapter 5.6.3 describes how the viscosity - shear results for the test fluids 
were determined. An additional calculated result for blood was added. This 
used the viscosity of blood as 0.0035 N.s/m2 taken from Lbnn and Wulff, et 
aI., (1997). 
An additional set of calculations was made to determine the non 
dimensional performance of the pump. The formulae for these calculations 
were taken from Crawford and Rice, (1974). The results of these calculations 
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will provide values that can be used for comparison with other pumps. This 
procedure is detailed in Chapter 5.3.1, Non dimensional coefficients. 
It was not possible to complete the full series of tests. The pump 
developed a serious leak and it was not possible to repair the pump and finish 
the tests before a campus move took place. The results for comparison 7a 
with rotor 3X were therefore never taken. Additional tests for a test fluid 
comprising a water / glycerine / xanthan gum mixture were also not taken. 
5.6.6 Results. 
Introduction. 
The first section will describe the determination of the 'optimum' rotor 
build based on a simple comparison of rotor speed against delivery using 
water as a test fluid. The rotor giving the required delivery at the lowest speed 
was considered to be the 'optimum' rotor for each of the performance 'set 
points' as listed in Table 5.6. Tests would also be taken with no restrictions to 
flow by setting both inlet and outlet valves fully open. The resultant speeds 
were expected to be lower than the other tests. 
Other tests were to show if performance changes could be detected if 
the output was controlled by restricting the inlet with the outlet unrestricted. 
These tests were also used to examine the flow to observe if any bubbles 
could be seen as this would indicate cavitation. 
The second set of tests describes the pump performance with the 
optimum rotor fitted to the pump and using the various test fluids. 
The performance with each rotor configuration is shown in a series of 
constant speed tests. These use the 'set point' figures as a starting point for 
each test to provide a comparison with each rotor build. The pressures used 
at the 'set points' will be the pump differential pressure which is a better 
measure of pump performance than the delivery pressure. It provides a 
comparison with other pump performances taken from published papers. 
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Comparison number. Performance 'set point' 
1a 10 I/min @ 200 mm Hg. 
2a 10 I/min @ 150 mm Hg 
3a 10 I/min @ 100 mm Hg 
4a 5 I/min @ 200 mm Hg 
5a 5 I/min @ 150 mm Hg 
6a 51/min @ 100 mm Hg 
7a 10 I/min @ both valves open 
8a 10 I/min @ 200 mm Hg, 
inlet valve set / outlet valve wide open 
9a 5 I/min @ 100 mm Hg, 
inlet valve set / outlet valve wide open 
Table 5.6. Performance 'set points' for all the pump tests. 
Determination of the optimum rotor. 
The pump was tested with water only and with the three rotor builds 0, 
3, and 7 as listed in Table 5.6. 
From the results on Table 5.7, the results at the 'set point' only, all 
three rotors were able to deliver the required set point performance but that 
there are noticeable differences in speed between the three rotors. 
Considering an output of 10 I/min @ 200 mm Hg, rotor 3 gave the lowest 
speed at 3492 rev/min while rotor 0 gave the worst performance at 4003 
rev/min. The performance of rotor 7 was similar to rotor 3. These results 
indicated that the rotor build effected pump performance. 
The results from the first series of tests are shown in appendices 14.1 
to 14.9. These show that in practically every test, rotor 0 needed a higher 
speed to generate the required flow than either of the other two rotors. 
The results with rotors 3 and 7 were similar to each other and it was 
difficult at times to determine the 'better' of the two from the results. It 
eventually was decided to use rotor 3 for the following reasons. 
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a) The results between rotors 3 and 7 were very similar but rotor 3 
appeared to have the advantage in most tests. 
b) The gaps between the discs of rotor 3 are greater than with rotor 7. 
If used with blood, the reduced number of discs and smaller surface area of 
rotor 3 would give less chance of blood clots forming. The performance with 
this rotor would therefore be more representative of the 'real' application. 
The tests with the restricted inlet and open outlet valve settings, 
Appendices 14.8 and 14.9, did not show any signs of cavitation. Comparison 
of the speed Vs delivery performance at 10 I/min @ 200mm Hg with inlet 
valve open and inlet valve restricted did not show any appreciable difference 
between the two results as shown on Appendix 14.10. A similar result was 
obtained for 5 I/min @ 100 mm Hg. as shown on Appendix 14.11. 
Following the completion of the above tests, the optimum rotor, rotor 
three, was fitted to the pump. A set of constant speed tests were then taken 
to determine the constant speed characteristics of the pump. Each speed was 
set to the required figure using the motor controls and the delivery was set 
using the outlet valve with the inlet valve wide open. Results were taken at 
speeds of 1000 to 4000 rev/min in 500 rev/min steps and the pump output 
'set points' were the same as for the rotor optimisation tests. Frequent checks 
were made to ensure that the speed remained constant during the test. 
The results of the tests are shown in Appendix 14.12 to Appendix 
14.17 
Appendix 14.12 shows the flow Vs delivery pressure of the pump at the 
setting point of 5 I/min. The result shows that for each flow Vs delivery 
pressure curve, the pressure is relatively constant over the flow range for the 
speed selected. The pressures generated were approximately 270 mm Hg at 
4000 rev/min and 10 mm Hg at 1000 rev/min. 
Appendix 14.13 shows the flow Vs differential pressure of the pump. 
The results show the same characteristics as the previous result, Appendix 
14.12. The pressures at the setting point of 5 IImin were 270 mm Hg at 4000 
rev/min and 20 mm Hg at 1000 rev/min. 
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Comparison 
no. 
I 1a 
2a 
3a 
4a 
5a 
6a 
7a 
8a 
9a 
Performance 'set point' Rotor 0, Rotor 7, Rotor 3, 
rev/min rev/min rev/min 
10 I/min @ 200 mm Hg 4003 3635 3499 
10 I/min @ 150 mm Hg 3464 2986 2959 
10 I/min @ 100 mm Hg 2833 2538 2414 
5 I/min @ 200 mm Hg 4016 3500 3445 
5 I/min @ 150 mm Hg 3386 2989 3020 
51/min @ 100 mm Hg 2773 2478 2373 
10 I/min @ both valves open 1245 1078 1003 
10 I/min @ 200 mm Hg, inlet valve 3534 3565 3455 
set / outlet valve wide open 
5 I/min @ 100 mm Hg, inlet valve 2768 2390 2289 
set / outlet valve wide open 
-- -- ---
Table 5.7. Comparative results for Flow Vs Speed with the 
three rotors and three fluids at the quoted 'set point' 
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Rotor 3G, Rotor 3X, 
rev/min. rev/min 
3177 3443 
2708 2905 
2143 2330 
3149 3367 
2658 2884 
2148 2306 
950 0 
3152 3395 
2133 2308 
-- - --
The power used by the pump was also recorded. The results on 
Appendix 14.14, show that the power is relatively constant over the flow range 
for the speeds selected. The power taken at the 5 I/min setting point was 
120W at 4000 rev/min and 5W at 1000 rev/min. 
The above tests were repeated at a setting point of 10 I/min with very 
similar characteristic results as detailed above. 
Appendix 14.15 shows the flow Vs delivery pressure at the 10 I/min 
setting point. The results show a similar characteristic to the 5 IImin results. 
The pressures at the setting point of 10 I/min were 275 mm Hg at 4000 
rev/min and 10 mm Hg at 1000 rev/min. 
Appendix 14.16 shows the flow Vs differential pressure at the 10 I/min 
setting point. The results are similar to the 5 I/min results. The pressures at 
the setting point of 10 I/min were 275 mm Hg at 4000 rev/min and 20 mm Hg 
at 1000 rev/min. 
Appendix 14.17 shows the flow Vs power at the 10 I/min setting point. 
The results are similar to the 5 IImin results. The power taken at the 10 IImin 
setting point was 120W at 4000 rev/min and 5W at 1000 rev/min. 
The relative 'flatness' of the performance curves are not the usual 
constant speed performance characteristics of a pump. These points will be 
discussed later in this thesis. 
Results with the alternative test fluids. 
Discussion of results with the optimum rotor fitted. 
A second set of tests was conducted with the optimum rotor fitted but 
using the test fluids simulating blood from the hydraulic point of view. 
These fluids are the water - glycerine and the water - xanthan gum 
mixtures described previously in Chapter 5.6.2. 
Figure 5.13 indicates that there appears to be a 'best' rotor in terms of 
minimum speed for the target performance. Rotor 3G gives the lowest speed 
for any set performance compared to the other rotor builds at the same 
performance setting. There is also a 'grouping' of the performance from these 
results. Examination of the results on Table 5.7 and Figure 5.13 indicate that 
the set point pressure appears to be the 'link' between these results. 
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Figure 5.13. The relationship between all the rotor types and 
speed at the 'set points' for all the test fluids used. 
From Figure 5.13, at the same differential pressure of 200 mm Hg., the 
speeds obtained for the three results at 10 I/min., 5 I/min and 10 I/min with the 
inlet controlled, are almost identical for each rotor build and test fluid used. 
The max and min rotor speeds for this pressure were 3499 and 3445 rev/min 
respectively, (1.5% difference). 
The same relationship of speed and pressure is seen at a pressure of 
150 mm Hg, (0.980/0 difference), and at a pressure of 100 mm Hg, (5.46% 
difference). This result implies that the pressure is a function of rotor speed. 
This in turn indicates that any other pump of the same type, but of a different 
rotor diameter, should achieve the same pressure if the rotor is running at the 
same peripheral speed. 
A three dimensional plot of the full set of comparisons at the 10 I/min @ 
200 mm Hg 'set point' is shown on Figure 5.14. These results include all the 
fluids and all the rotor configurations. This shows that rotor 0 needed the 
highest speed to meet the target performance. Rotor 3G gave the lowest 
speed to meet the target performance of all the rotors and fluids tested. This 
fluid had the highest viscosity of all the fluids tested. 
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Flow Vs Speed and Rotor Type - 10 IImin @ 200 mm Hg 
Speed rev/min 
4500 
4000 
3500 
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Rotor type 
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.4000-4 500 
03500-4000 
.3000-3500 
2500-3000 
.2000-2500 
01500-2000 
01000-1500 
500-1 000 
0-500 
Figure 5.14. Three dimensional representation showing the relationship 
between speed, flow, rotor type and test fluid at the setting point of 
10 I/min @ 200 mm Hg. 
Discussion of Flow Vs Speed tests 
The results in Appendix 14.18 show the performance of the three rotors 
0, 3 and 7 using water and the alternative test fluids at a 'set point 
performance' of 10 I/min @ 200 mm Hg. The 'best' performance was 
considered to be the lowest speed for the target 'set point'. 
From Appendix 14.18, rotor 3G gave a better performance compared 
to rotor 3 as the result showed the lowest speed for the same delivery. This is 
the performance difference between water and water / glycerine. Taking the 
figures from Table 5.7, there is a speed difference of 315 rev/min . Rotor 3X 
resulted in a lower speed, 49 rev/min, than rotor 3 for the same del ivery , as 
shown in Table 5.7. This was the difference in speed between water and 
water / xanthan gum. From these results, it was considered that the rotor 
could be optimised relative to any given test fluid and the controlling 
characteristic of the fluid could be viscosity as there was a greater change in 
viscosity between the water and water / glycerine mixture compared to the 
water and water / xanthan gum mixture. The results from the full series of 
tests are shown in Appendices 14.18, 14.25, 14.32, 14.39, 14.46, 14.53, 
14.60, 14.67 and 14.74. These show that in every test except one , rotor 0 
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needed a higher speed to generate the required flow than either of the other 
rotors. 
The results also show rotor 3G gave the lowest speed for the set 
delivery. This fluid was nearest to blood in terms of the viscosity of the fluids 
tested. It was difficult to distinguish between the results of rotors, 3, 3X and 7, 
as they tended to be superimposed on top of each other. In general these 
results tended to lie between the results of the other two rotors. 
Appendices 14.67 and 14.74 were intended to determine if the pump 
would show cavitation as during these tests the fluid entry was restricted and 
the outlet unrestricted. There were no indications of cavitation during any of 
these tests and the speeds were close for the same deliveries and pressures 
as shown by a comparison of Appendices 14.18 and 14.67 for 10 IImin @ 200 
mm Hg and Appendices 14.53 and 14.74 for the 5 IImin @ 100 mm Hg. 
Appendices 14.19 to 14.24, with the outlet valve controlling the delivery of 10 
I/min @ 200 mm Hg, are repeated in Appendices 14.68 to 14.73 but with the 
inlet valve controlling the delivery. These tests are repeated at 5 I/min @ 100 
mm Hg comparing Appendices 14.54 to 14.59, (outlet valve control), and 
Appendices 14.75 to 14.80, (inlet valve control). There is little or no difference 
in each set of comparative results and there was no evidence of cavitation in 
any of the tests. This indicates that the pump performance can be controlled 
by outlet or inlet restriction with little or no effect on the performance. 
From the result for Appendix 14.60, 10 I/min. 'as found', the speeds are 
the lowest recorded for all the tests. This test was taken with both the inlet 
and outlet valves fully open and gave the lowest pump speed for the target 
delivery. All the results were replotted as a three dimensional surface plot and 
are shown in Figure 5.15. This shows the results at the setting points for all 
the rotors and test fluid combinations used. The result for 7a is slightly 
distorted as one result was not possible. This is shown on Table 5.7 as zero. 
Figure 5.15 shows that rotor 3G gives the lowest speed of any of the 
rotors for the same comparison number as shown by the shaded bands, 
indicating the speeds, running across the plot. The comparisons with the 
lowest outputs, 3a and 6a, (10 I/min and 5 I/min at 100 mm Hg), give lower 
speeds than those comparisons with the higher outputs, 1 a and 4a, (10 IImin 
and 5 I/min at 200 mm Hg), for any rotor build. The lowest speed of all the 
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tests was with comparison 7a , when both the inlet and outlet valves were fully 
open and the pump was not producing any pressurised flow. Comparing the 
results for rotors 3, (water only) , 3X, (water / xanthan gum) and 3G , (water / 
glycerine) , rotor 3G gives the lowest speed . This indicates that fluid viscosity 
affects pump performance and that the higher the fluid viscosity the better the 
pump performance. 
Three dimensional surface plot of 
comparison number Vs rotor speed and rotor types . 
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Figure 5.15. Speed comparison of all rotors with all test fluids shown as a 
three dimensional surface plot. 
Blood shear stress calculation. 
Now that some pump speeds have been determined , an estimation of 
blood stresses can be made. Following the theory outlined in Chapter 1.3, 
Blood, and using the maximum speed found from the test results , a 
calculation was made of the maximum shear stress likely to be experienced 
by the blood with this pump. The position inside the pump that was likely to 
give the highest shear stress in the absence of CFD results was in the gap 
between the face of the first disc at the maximum diameter and the stationary 
wall of the volute as shown in Figure 5.16. 
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Figure 5.16 Relative positions of the first disc 
of the rotor and the volute wall. 
The stress calculations used the following figures from the pump build 
dimensions: -
Rotor diameter, 60 mm, the gap between the first disc of the rotor and 
the volute wall, 1.5 mm and pump speed, 4000 rev/min. The fluid was 
assumed to be blood with a viscosity of 0.0035 Kg/m.s. A calculation using 
these conditions gave a shear stress of 29 N/m2. 
This is less than the figures quoted for red cell damage of 
approximately 200 N/m2 following the results of Sutera and Mehrjardi, (1975) 
as shown in Chapter 1. This is above the figure of approximately 15 N/m2 
indicated for damage to the platelets quoted in Chapter 1 .3.6. Limiting the 
pump speed to give a blood shear stress of 15 N/m2 gives a pump speed of 
approximately 2050 rev/min under these build conditions. Figure 5.17 shows 
the result of the calculations. 
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Blood shear stress Vs speed. 
rJ) 40 
rJ) 
y = O.0073x 
CI) 30 !:iN ~ rJ) L.. 
co 
CI) 
.s::: 
(J) 
E 20 
-Z 
10 
~ 
----
-----r- --~-
0 I 
--------i 
o 1000 2000 3000 4000 
Speed rev/min 
Figure 5.17, Calculated blood shear stress against speed 
for the pump build tested. 
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Figure 5.18 shows the speeds and gaps for a pump built to produce a 
given shear stress at the periphery of a 60 mm diameter disc. This result 
shows that at a speed of 4000 rev/min for a stress of 10 N/m2 , the gap will be 
about 4.5 mm, but at the same speed for a stress of 40 N/m2, the gap reduces 
to about 1 mm. 
Following these calculations, the build tolerances of blood pumps will 
need careful consideration if shear stress problems are to be avoided. 
Additional calculations concerning the gap and stress values will be made 
later in this thesis. 
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Figure 5.18 The calculated gap against speed for given blood shear stresses. 
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Discussion of Flow Vs Pressure tests 
The three dimensional representations of delivery pressure and 
differential pressure at a set point of 10 I/min @ 200 mm Hg are shown on 
Figures 5.19 and 5.20. They indicate that the pressures generated are not 
effected by the rotor type and fluid combination , as for a given flow rate the 
pressure appears to be the same across the rotor type axis as indicated by 
the shading bands running across the plot. These plots do not indicate pump 
speed. 
Flow Vs Delivery Pressure and Rotor Type - 10 IImin @ 200 mm Hg 
Delivery 
Pressure 
mmHg 
Flow I/min 10 
Rotor 
Type 
Figure 5.19. Three dimensional representation of 
delivery pressure Vs flow and rotor type. 
Flow Vs Differential Pressure and Rotor Type -10 I/min @ 200 mm Hg 
Differential Pressure mm 
Hg 
Flow Ilmin 3 Rotor Type 
10 
Figure 5.20. Three dimensional representation of 
differential pressure Vs flow and rotor type 
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Appendices 14.81 to 14.86 show the pump performance at constant 
speed for delivery pressure and differential pressure at each of the setting 
points. The motor was set to give the required speed and the valves were set 
to give the required flow. The motor speed was checked at every reading to 
ensure accuracy. 
The results show that the pressure is essentially constant over the 
delivery range tested. This reinforces the impression that speed is the 
controlling factor determining the pressure generated by this pump type. 
Assuming identical rotor peripheral speeds, a 'small' pump running 'fast' may 
generate the same pressures as a 'large' pump running 'slow' but a 'large' 
pump would have a greater delivery at that pressure. 
A comparison of the delivery pressures can be seen on Appendices 
14.15, 14.81 and 14.85. These are the constant speed results at 10 I/min for 
all three fluids used. The results for 3500 rev/min show the delivery pressures 
are higher with the water / glycerine fluid at approximately 240 - 250 mm Hg 
than either of the other two fluids at 190 - 210 mm Hg. 
The differential pressure results, shown on Appendices 14.16, 14.82 
and 14.86, show the same characteristic at 3500 rev/min with a pressure of 
approximately 250 mm Hg for the water / glycerine fluid and 215 to 200 mm 
Hg for the other two fluids. 
Lower speeds show the same pattern but with lower values as 
expected. 
Discussion of Flow Vs Power tests. 
Appendices 14.87 and 14.88 show the performance of the pump at 
constant speed for power at each of the 10 I/min setting points previously 
listed usin9 the water / glycerine and water / xanthan gum fluids. In each test, 
the motor was set to give the required speed while the valves controlling the 
flow rate were set to give the required flow. The power shown is the value 
required to pump the fluid and is not the power required to run the pump itself. 
The motor speed was checked at every reading to ensure accuracy. 
The results show that the power characteristics are essentially constant 
with little change over the delivery range tested. 
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With some of the results it is noted that there is a difference in power 
consumption at the same speed depending on the fluid used. 
The results are plotted on two graphs to make the results clearer. 
From Appendix 14.87, (1000 to 2500 rev/min), at each speed, the 
water / glycerine fluid takes the most power while the water / xanthan gum 
fluid takes the least power. The lowest power consumption of 10 Watts, or 
less, occurs at speeds of 1500 rev/min or below. A similar result is shown in 
Appendix 14.88 (2500 to 4000 rev/min), where the results at 3500 rev/min 
show that the power requirement is greater with the water / glycerine fluid, at 
approximately 90 - 95 W, than with the other two fluids at 62 - 80 W. 
Appendix 14.89 shows the power requirement at 5 I/min for water and 
for water / glycerine. At 3500 rev/min the water requires 70 W while the water 
/ glycerine fluid requires approximately 100 W. 
Lower speeds show the same pattern as before but with lower values 
as expected. 
The data for water / xanthan gum fluid at 5 I/min was not taken due to 
problems with the pump. The tests with the water / glycerine mixture at 4000 
rev/min were not undertaken as the pressures exceeded the maximum rated 
pressure quoted by the manufacturer of the pressure transducers. 
Discussion of Flow Vs Efficiency results. 
From the results on Table 5.8, the 'set point' only, rotor 3G shows the 
highest efficiency and rotor 0 shows the lowest efficiency. The overall values 
of the efficiencies are low, the highest is less than 11 %. The results for rotor 
38 are not test results and should be ignored 
From Figure 5.21, the efficiency increases as the pressure and delivery 
combination reduces. This indicates that the efficiency increases as the pump 
load reduces. Pump load is understood to be a combination of delivery and 
pressure. 
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Comparison 
no. 
1a 
2a 
3a 
4a 
5a 
6a 
7a 
8a 
9a 
Performance 'set point'. Rotor 0, Rotor 7, Rotor3, Rotor 3G, Rotor 38, 
0/0. 0/0 % 0/0 0/0 
10 I/min @ 200 mm Hg 4.113 4.996 5.965 6.829 6.829 
10 I/min @ 150 mm Hg 4.798 7.595 7.076 8.102 8.102 
10 I/min @ 100 mm Hg 5.854 7.268 8.623 10.532 10.532 
5 I/min @ 200 mm Hg 2.047 3.251 2.861 3.263 3.263 
51/min @ 150 mm Hg 2.828 4.025 3.327 3.974 3.974 
51/min @ 100 mm Hg 3.299 4.239 4.289 5.464 5.464 
10 I/min @ both valves open. 6.398 8.190 9.331 10.743 10.743 
10 I/min @ 200 mm Hg, inlet 4.003 6.092 5.825 6.193 6.193 
valve set I outlet valve wide 
open. 
5 I/min @ 100 mm Hg, inlet 3.245 4.358 4.849 4.379 4.379 
valve set I outlet valve wide 
open. 
--
Table 5.8, The comparative results for Flow Vs Efficiency with the three rotors 
and three fluids at the quoted 'set points'. 
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Rotor 3X, 
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Figure 5.21. Relationship between all the rotor types and 
efficiency at the 'set points' for all the test fluids used . 
The comparisons of results at 10 I/min @ 200 mm Hg and 5 I/min @ 
100 mm Hg show that the performances are almost identical. It would appear 
that there is little or no change in efficiency if the pump output is controlled by 
throttling the inlet or the outlet. 
Three dimensional surface plot of 
Comparison no. Vs Efficiency and Rotor types 
Efficiency % 
Comparison No. Sa o 9a 
Rotor type 
Figure 5.22. Three dimensional representation of 
Efficiency Vs Flow and rotor type at the 'set points'. 
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Figure 5.22 is a three dimensional representation of efficiency Vs flow 
and rotor type at the 'set points'. It shows that the efficiency varies with rotor 
build and pump performance. The maximum efficiency is around 10% which is 
low when compared to other pumps where maximum efficiencies of 80% + 
ca n be expected. 
The reasons for the low efficiency are unknown but it could be that the 
pump is not an ideal design and construction. The disc diameter ratios at 2 to 
1 may be one reason. It is known that small pumps are not as efficient as 
large pumps as friction and other factors are in larger in proportion. For 
example, it is not possible to make clearances and surface finishes 
proportionally comparable between a large pump and a small pump and seals 
and bearings take proportionally more power to drive with a small pump. 
Lazarkiewicz and Troskolanski, (1965), indicate that one of the disadvantages 
of impeller pumps is low efficiency at small discharges and high pressures. 
This type of pump could have similar characteristics. 
Design conditions 
~ 
..... ~_ Shaft power, P 
Head, H 
Discharge, Q 
Figure 5.23, Typical performance curves for a centrifugal pump. 
B.S. Massey, Mechanics of Fluids, 6th edition. (1989). p549 
It should be noted that the shapes of the plotted curves from the Tesla 
test results do not meet the typical shapes shown in Figure 5.23, where this 
shows the typical performance of a centrifugal pump with backward sloping 
blades. This figure is taken from Massey B.S., (1989). 
Two examples of the low efficiency results are shown in Figures 5.24 
and 5.25 as three dimensional representations of efficiency at setting points of 
10 I/min @ 200 mm hg and 5 I/min @ 200 mm Hg respectively. These results 
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indicate that the efficiency is low at low flu id flow cond itions but it increases as 
the flow rate increases. The efficiency reaches a maximum of around 7% to 
8% at 3-4 I/min for the 10 I/min setting point and 4% to 5% at 2-3 I/min for the 
5 I/min setting point. 
The effect of rotor type and test fluid can also be seen . In the resu lts, 
the increase in efficiency between rotor 0 and rotor 3 confirms the ori ginal 
decision to use rotor 3 as the optimum rotor and shows that pump efficiency 
improves as the fluid viscosity increases. 
Efficiency Vs Flow and Rotor Type - 10 I/min @ 200 mm Hg 
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Figure 5.24 . Three dimensional representation of efficiency Vs flow rate and 
rotor type at the setting point of 10 I/min @ 200 mm Hg. 
Efficiency Vs Flow and Rotor Type - 5 IImin @ 200 mm Hg 
5 
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Flow IImin Rotor type 
5 
Figure 5.25. Three dimensional representation of efficiency Vs flow rate and 
rotor type at the setting point of 5 I/min @ 200 mm Hg . 
Results of Flow Vs Volume Flow Rate Parameter, Uo 
The results shown in Table 5.9 are shown for the 'set point' on ly. 
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Comparison 
no. 
1a 
2a 
3a 
4a 
5a 
6a 
7a 
8a 
9a 
Performance 'set point'. Rotor Rotor Rotor Rotor Rotor 
0 7 3 3G 38 
10 I/min @ 200 mm Hg 0.012 0.0774 0.0271 0.0295 0.0295 
10 I/min @ 150 mm Hg 0.014 0.0942 0.0317 0.0346 0.0346 
10 I/min @ 100 mm Hg 0.0166 0.1109 0.0389 0.0438 0.0438 
5 I/min @ 200 mm Hg 0.0059 0.0402 0.0136 0.0135 0.0141 
5 I/min @ 150 mm Hg 0.0069 0.0471 0.0155 0.0176 0.0176 
51/min @ 100 mm Hg 0.0085 0.0568 0.0198 0.0218 0.0218 
10 I/min @ both valves open. 0.0377 0.2611 0.0935 0.0987 0.0987 
10 I/min @ 200 mm Hg, inlet 0.0133 0.0789 0.0272 0.0298 0.0298 
valve set I outlet valve wide 
open. 
5 I/min @ 100 mm Hg, inlet 0.0085 0.0589 0.0205 0.0220 0.0220 
valve set I outlet valve wide 
open. 
Table 5.9, The comparative results for Flow Vs Flow Rate Parameter Uo with the 
three rotors at the quoted 'set points'. 
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Figure 5.26 Showing the relationship between rotor type and the 
flow parameter at the 'set points' for all the fluids used. 
Discussion of results, Flow parameter. 
The flow parameter is assumed to be a dimensionless measure of the 
flow through the pump and that the higher the parameter the better the pump 
is running for a given performance. 
From Figure 5.26, the rotor 7 had the highest flow parameter and that 
rotor 0 had the lowest flow parameter of the three rotors. This was taken as 
evidence that rotor build effects pump performance. 
It was difficult to determine any differences between rotor 3, 3G, 3X 
and 38 indicating that viscosity has only a small effect on the flow parameter. 
Examination of the results at 10 I/min @ 200 mm Hg, 10 I/min @ 150 
mm Hg and 10 I/min @ 100 mm Hg indicate a slightly higher flow parameter 
with a reduction in pressure setting. This is confirmed by the result at 10 I/min 
with both valves open, where a high flow parameter is found irrespective of 
the rotor build compared to the other tests. This indicates that the lower the 
pump work rate, the higher the flow parameter. 
It is difficult to determine any differences between both results at 10 
IImin @ 200 mm Hg and both results at 5 I/min @ 100 mm Hg. It is assumed 
that the flow parameter is not affected if the pump delivery is controlled by 
throttling either the inlet or the output. 
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Three dimensional surface plot of Comparison 
number Vs Flow rate parameter and rotor types. 
Flow rate 
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Figure 5.27. Three dimensional representation of 
Flow rate parameter Vs Flow and rotor type at the 'set points' 
The values of the results at 0.02 to 0.05 agree with the calculated 
figures published in Crawford and Rice, (1974), although they are close to the 
low end of the range of 0.02 to 1.00 shown in the paper. 
Figure 5.27 is a three dimensional representation of flow parameter Vs 
flow and rotor type at the 'set points' and indicates that the flow parameter 
varies only slightly with rotor build and performance setting. As the pressure 
setting reduces and the viscosity of the fluid increases, the flow rate 
parameter appears to increase. The peaks shown in Figure 5.27 are not 
understood 
Results of Flow Vs Dimensionless Pressure Parameter Pt-
The results shown in Table 5.10 are for the 'set point' only. 
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Comparison 
no. 
1a 
2a 
3a 
4a 
5a 
6a 
7a 
8a 
9a 
Performance 'set point'. Rotor 0, Rotor 7, Rotor 3, Rotor 3G, 
Pressure Pressure Pressure Pressure 
parameter parameter parameter parameter 
10 I/min @ 200 mm Hg 0.6820 0.8299 0.9019 0.9766 
10 I/min @ 150 mm Hg 0.6780 0.9084 0.9265 1.0059 
10 I/min @ 100 mm Hg 0.6795 0.8421 0.9269 1.0688 
5 I/min @ 200 mm Hg 0.6785 0.8839 0.9131 0.9910 
51/min @ 150 mm Hg 0.7026 0.9081 0.8865 1.0429 
51/min @ 100 mm Hg 0.7044 0.8780 0.9577 1.0657 
10 I/min @ both valves open 0.5935 0.8717 0.8653 0.9917 
10 I/min @ 200 mm Hg, inlet 0.6119 0.8548 0.9056 0.9925 
valve set I outlet valve wide 
open 
5 I/min @ 100 mm Hg, inlet 0.7040 0.9414 1.0322 1.0882 
valve set I outlet valve wide 
open. 
- --
Table 5.10, Comparative results for Flow Vs Stagnation Pressure 
parameter Pt with the three rotors and three fluids 
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Rotor 38, Rotor 3X, 
Pressure Pressure 
parameter parameter 
1.0183 0.912 
1.0488 0.961 
1.1144 0.993 
1.033 0.995 
1.0429 0.977 
2.791 1.015 
5.971 -
3.126 0.941 
3.580 1.011 
Comparison of pressure parameters 
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Figure 5.28. Showing the relationship between rotor type and 
pressure parameter at the set points for all the test fluids used. 
Discussion of results, pressure parameter. 
It is assumed that a pressure parameter is a dimensionless 
measurement of the pressure through the pump. From the results shown in 
Figure 5.28 above, it can be seen that the rotor 3 tended to have the highest 
pressure coefficient of rotors 0, 3 and 7 using water only. This confirms the 
concept of an 'optimum' rotor build for a particular fluid. The comparison of 
rotors 3 and 3G showed rotor 3G had the highest pressure coefficient 
indicating viscosity has an effect. The results for rotors 3 and 3X are similar 
which is not surprising considering the fluids tested had similar viscosity 
values. 
Examination of the figures shows as the pressure setting for each test 
is lowered, i.e. the pump work rate reduces, the pressure parameter 
increases. The effect is small compared to the effect of rotor build and fluid 
viscosity. 
It is difficult to determine the differences between both results at 10 
I/min @ 200 mm Hg and both results at 5 I/min @ 100 mm Hg. 
The values of the pressure parameter obtained from the tests, 3.58 to 
0.912, are similar to the calculated figures quoted in Crawford and Rice, 
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(1974), which range from plus 3.5 to negative values. It is not understood how 
a pump can have a negative pressure parameter. 
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Figure 5.29 is a three dimensional representation of the pressure 
parameter Vs flow and rotor type at the 'set points' . It shows that the pressure 
parameter varies only slightly with rotor build and performance setting, rotor 0 
having the worst result of all the rotor and fluid combinations tested . 
Results of Flow Vs Reynolds number. 
The figures shown here are a representation of the Reynolds number 
and are used for comparative purposes only. The calculation is taken from the 
paper by Crawford and Rice, (1974), and is understood to represent the 
Reynolds number of the fluid passing between a pair of adjacent discs and 
not through the pump itself. The 'best' performance was considered to be 
lowest Reynolds number achieved. 
The results shown in Table 5.11 are for the 'set points' only. For the purposes 
of plotting, the values for rotor 0 are reduced by a factor of 102, otherwise it 
would not be possible to see the results for the other values on the same 
graph. 
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Comparison 
no. 
1a 
2a 
3a 
4a 
5a 
6a 
7a 
8a 
9a 
Performance 'set point' Rotor 0, Rotor 7, Rotor 3, Rotor 3G, 
Reynolds Reynolds Reynolds Reynolds 
no. no. no. no. 
10 I/min @ 200 mm Hg 240997 95 3256 624 
10 I/min @ 150 mm hg 208546 78 2783 532 
10 I/min @ 100 mm Hg 170532 66 2270 421 
5 I/min @ 200 mm Hg 240997 91 3241 619 
51/min @ 150 mm Hg 203819 78 2841 522 
51/min @ 100 mm Hg 166908 65 2232 422 
10 I/min @ both valves open. 74916 28 944 187 
10 I/min @ 200 mm Hg, inlet valve 212731 93 3250 619 
set I outlet valve wide open 
5 I/min @ 100 mm Hg, inlet valve 166641 62 2153 419 
set I outlet valve wide open 
-
Table 5.11, The comparative results for Flow Vs Reynolds Number with 
the three rotors and three fluids. 
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Rotor 38, Rotor 3X, 
Reynolds Reynolds 
no. no. 
903 3238 
769 2732 
609 2194 
895 3167 
755 2413 
610 2169 
270 -
895 3194 
606 2171 
- -
Comparison of Reynolds numbers 
Figure 5.30. Showing the relationship between rotor type and Reynolds 
number at the 'set points' for all the test fluids used. 
(Note: - Rotor 0 values are reduced by a factor of 102 ) 
Discussion of results, Reynolds number. 
The value of the Reynolds number can be a critical factor in 
determining the success or failure of any fluid flow application. Massey, 
(1989), Chapter 5, 'Two Kinds of Flow', indicates there is a 'limiting' Reynolds 
number that determines whether fluid flow is laminar or turbulent. 
For water flow through pipes under ordinary conditions, the limiting 
Reynolds number between laminar and turbulent flow is usually taken as 
2000. This number is not precise in the sense that flow at a Reynolds number 
of 1999 is laminar and changes abruptly to turbulent flow at a Reynolds 
number of 2001 but the value of 2000 should be used as a guide to the flow 
conditions of a fluid only for flow in a pipe. 
For the purposes of a blood pump, it is considered that the lower the 
Reynolds number, the more the fluid is moving towards laminar flow, where 
laminar flow is assumed to have the least fluid stresses and less potential for 
blood damage. For the purposes of these tests the' best' performance is 
considered to be the result with the lowest Reynolds number irrespective of 
the value of that number. 
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If all the figures from Table 5.11 above were plotted on the same scale 
on Figure 5.30, the results for rotors 3 to 7 could not be differentiated from 
one another due to the high values for rotor O. Accordingly the figures for rotor 
o are plotted on a scale reduced by a factor of 102 compared to the other 
results and are included for completeness only. 
From Figure 5.30, rotor 7 had the lowest Reynolds number of the three 
rotors using water or any of the other test fluids. This result indicates that rotor 
build is important with this pump type and may be connected with the width of 
the gaps between the discs. It indicates that there could be an optimum rotor 
build for a particular application. 
From Figure 5.30 the comparison of rotors 3 and 3G show that rotor 
3G had the lowest Reynolds number of the two. This result shows that the 
Tesla pump is sensitive to fluid viscosity and that the more viscous the fluid, 
the better the pump operates in terms of Reynolds numbers 
Rotors 38 and 3G have similar values. Rotor 38 is a calculated result 
using a figure for the viscosity for blood which is close to the viscosity for the 
water / glycerine mixture. 
Rotor 3 and rotor 3X have similar values of Reynolds numbers, as 
expected, as the viscosities of the two fluids are similar. 
Assuming that the Reynolds number indicating the change from 
laminar flow to turbulent flow is 2000, rotors 3G, 38 and 7 would appear to be 
in laminar flow as they are below 2000. Rotors 0, 3 and 3X would appear to 
be turbulent flow as they are above 2000. 
Examination of Table 5.11 indicates that the results tend to form a 
pattern. Results for comparisons 1 a, 4a and 8a have values of the Reynolds 
number that are very similar. The values of the Reynolds numbers for 
comparisons 2a and 5a are close together as are the values for comparisons 
3a, 6a and 9a. The results for comparisons1 a and 8a and for comparisons 6a 
and 9a appear to be almost identical with each other. The relationship in each 
case appears to be the pressure setting at the 'set point'. 
These figures cannot be compared with the Reynolds numbers obtained from 
the paper by Crawford and Rice, (1974), as the maximum figure quoted in the 
paper is 10. 
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Three dimensional surface plot of comparison 
number Vs Reynolds no. and Rotor types. 
Reynolds no. 
4000 
3000 
1a
2a 
3a 
Comparison no. 
4a 
Sa 
6a 
9a 
Rotor type 
0 3000-4000 
0 2000-3000 
1000-2000 
0 0-1000 
Figure 5.31. Three dimensional representation of 
Reynolds number Vs Flow and rotor type at the 'set points'. 
Figure 5.31 is a three dimensional representation of the Reynolds 
numbers Vs flow and rotor type at the 'set points'. It shows that the Reynolds 
number varies with rotor build and performance setting . The result for rotor 0 
should be ignored as it is not comparable on the scale shown. Figure 5.31 
confirms that rotor 7 has a low Reynolds number irrespective of the 
comparison number. Comparing the results of rotor 3 in all its applications, the 
fluid with the highest viscosity, rotor 3G, shows the lowest Reynolds number 
while, rotors 3 and 3X, have the highest Reynolds number and are very 
similar to each other. The viscosity difference between the 3 and 3X was 
small and this result is not unexpected. The effect of workload on the pump is 
reflected in the difference in Reynolds numbers between the vanous 
comparison numbers where the 'peaks' of the plot indicate the highest 
pressure settings and the 'troughs' indicate the lowest pressure settings. 
Results of Flow Vs Dimensionless Torque Parameter T1. 
The results shown in Table 5.12 are shown for the 'set point' only . 
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Comparison 
no. 
1a 
2a 
3a 
4a 
5a 
6a 
7a 
8a 
9a 
Performance 'set point'. Rotor 0, Rotor 7, Rotor 3, Rotor 3G, 
Torque Torque Torque Torque 
parameter parameter parameter parameter 
10 I/min @ 200 mm Hg 1.220 8.081 2.574 2.654 
10 I/min @ 150 mm Hg 1.201 7.083 2.608 2.702 
10 I/min @ 100 mm Hg 1.208 8.073 2.625 2.793 
5 I/min @ 200 mm Hg 1.220 6.868 2.730 2.842 
51/min @ 150 mm Hg 1.082 6.675 2.609 2.911 
51/min @ 100 mm Hg 1.135 7.392 2.773 2.677 
10 I/min @ both valves open 2.197 17.462 5.449 5.727 
10 II min @ 200mm Hg, inlet 1.900 6.9598 2.653 2.998 
valve set I outlet valve wide open 
5 I/min @ 100 mm Hg, inlet valve 1.155 7.991 2.741 3.434 
set I outlet valve open. 
Table 5.12, The comparative results for Flow Vs Torque Parameter T1 with 
the three rotors at the quoted 'set points'. 
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Rotor 38, Rotor 3X, 
Torque Torque 
Parameter parameter 
2.767 2.307 
2.817 2.33 
2.913 2.389 
2.963 2.153 
3.035 2.185 
2.791 2.171 
5.971 -
3.126 2.199 I 
3.58 2.275 
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Figure 5.32. Showing the relationship between rotor type and 
the torque parameter at the 'set points' for all the test fluids used. 
Discussion of results, torque parameter. 
It is assumed that the torque parameter is a dimensionless measure of 
the power required to operate the pump and that the higher the torque 
parameter the better the pump is operating for a given performance. 
Figure 5.32 compares rotors 0, 3 and 7, and shows that rotor 7 had the 
highest torque parameter and rotor 0 had the lowest parameter of the three 
rotors using water only. This result indicates that the rotor build affects the 
torque parameter. A comparison of rotor 3 with rotor 3G showed that rotor 3G 
had a torque parameter that is marginally greater than rotor 3 indicating that 
viscosity has only a small effect. The results for rotors 3G and 38 and rotors 
3 and 3X are almost identical to each other as expected, as the viscosities in 
each case are almost identical. 
The results of comparisons of 10 I/min @ 200 mm Hg and 10 I/min @ 
200 mm Hg (inlet controlled) and 5 I/min @ 100 mm Hg and 5 I/min @ 100 
mm Hg (inlet controlled), show that they appear to be almost identical. This 
indicates that there is little or no change in the torque parameter if the pump 
output is controlled by throttling the inlet or outlet. 
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The values of the torque parameter obtained from the tests, 17.46 to 
1.08, are within the range of 0 to > 1000 in the paper published by Crawford 
and Rice, (1974). 
Three dimensional surface plot of Comparison 
number Vs Torque parameter and Rotor types. 
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Figure 5.33 Three dimensional representation of 
Torque parameter Vs Flow and rotor type at the 'set points' 
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Figure 5.33 is a three dimensional representation of the calculated 
torque parameter Vs flow and rotor type at the 'set points'. It indicates that the 
torque parameter varies noticeably with rotor build, as seen by the difference 
in parameter with rotors 0 and 7, but changes very little with performance 
setting. There does not appear to be much effect on torque parameter with 
the change in fluid viscosity. 
5.7, Flow visualisation. 
5.7.1 Introduction. 
A video was made to show the fluid flow pattern inside the pump from 
various angles and at various flow rates. How the fluid passes through the 
pump is important in terms of identifying points where high shear stresses 
could be generated and if any blood recirculation or stagnant flow areas are 
found inside the pump, stress and surface reactions may set up thrombi which 
could then pass through the pump causing problems to the patient. 
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A separate part of the video showed general views of the rig and how it 
operated. 
Two fluids are shown in the video. The first fluid was plain water and 
the second was the water / glycerine mixture described previously. 
All the sequences were taken with the pump fitted with rotor 3. 
Observations were made from three directions in order to determine 
the flow patterns. These directions were: -
a) Along the axis of rotation from the fluid inlet side of the pump, 
b) From above, looking down on the discs and 
c) Along the outlet passage in the direction of flow with the fluid moving 
away from the camera. 
Figure 5.34 shows this arrangement. 
In order to see the flow patterns, air was injected into the pump inlet 
and a light source was used to illuminate the pump such that the air bubbles 
would show up against a black background placed behind the pump. 
Still photographs, (35mm), were taken as necessary during these tests 
and are shown in Figure 5.40 onwards. 
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Fluid in 
Collimated 
light source 
Fluid out ¢:::=::::J II--,:::==:.:r-J .... ___ _ 
Direction c) 
Rotor discs 
Direction a) 
Figure 5.34 Layout of directions used to view the fluid flow. 
Direction a) is looking along the axis of rotation, 
Direction b) is looking down on the discs (as shown above). 
Direction c) is looking along the outlet passage. 
5.7.2 Video with water only. 
The pump was set up to deliver 10 I/min at a suitable delivery pressure. 
It was ensured that no air bubbles were seen in the water flow inside the 
pump and the light source was adjusted to illuminate the water inside the 
pump volute. 
Observations from direction a). 
With the pump running at the set condition and with no air present in 
the fluid, air was deliberately injected into the fluid inlet in order to view the 
characteristics of the fluid flow. The air initially appeared as a white 'fog' inside 
the pump but as the pump ran the 'fog' began to clear when it was noticed 
that a vortex, comprising air bubbles, had been generated in the water flow. 
The vortex was near the cutwater and covered the vertical distance from the 
225 
periphery of the discs to the upper wall of the pump outlet. As time went on, 
the vortex moved back and forth across the discs and eventually decayed as 
the amount of air bubbles reduced. 
The reason for the vortex is not known but it was assumed that it was 
an effect of the water being picked up and rotating with the disc(s) against the 
stationary wall of the volute at the entry position. 
It may be possible to reduce this effect by improving the fluid entry 
conditions and suggestions are shown later in this report. 
It was noted, following the movements of the air bubbles, that part of 
the flow in the volute tended to 'dive' under the cutwater and part to be swept 
along the flow passage where it dispersed. This was very pronounced at 
times and the flow after the cutwater along the outlet passage tended to have 
a recirculating flow pattern. This was more noticeable at low flow rates and 
pressures. Lazarkiewicz and Troskolanski, (1965), indicate that these effects 
are not unknown and are connected with a non uniform pressure distribution 
around the inner wall of the volute casing which in turn causes eddying and 
back flow around the area of the cutwater. This effect is most pronounced 
when the pump delivery approaches zero. Figure 5.35 below illustrates the 
effect from Lazarkiewicz and Troskolanski, (1965), and Figure 5.36 is a 
representation of the actual effect seen during the pump performance. 
Fluid 
outlet 
Rotor. 
Lazarkiewicz Sand Troskolar'lski, A, (1965) 
Figure 5.35, The flow pattern at the cutwater 
at low delivery. 
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Disc rotation 
Figure 5.36. Flow 'diving' under the cutwater, 
viewed from direction a), axis of rotation. 
Observations from directions b and c). 
The vortex tended to form at the cutwater and was mainly up against 
the volute wall closest to the inlet but occasionally jumped across the rotor to 
the gap between the first two discs, a distance of about 7 mm. The height of 
the vortex at this point was about 18 mm, the distance from the edge of the 
discs to the top wall of the outlet volute. Figures 5.37, 5.38 and 5.39 are a 
representation of what was happening. 
Cutwater 
Vortex and 
rotation 
Volute ~ 
Fluid flow 
direction 
Disc rotation +1---+---
Figure 5.37. Vortex position from direction a), axis of rotation. 
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Figure 5.38, Vortex position from direction b) . 
Vortex and rotation 
1111----
<.----' 
_. - • • 
Fluid flow 
direction 
Figure 5.39. Vortex position from direction c). 
Fluid flow 
direction 
Two photographs of the vortex were taken , Figures 5.40 and 5.41 . 
These show the column of bubbles indicating the position of the vortex that 
appeared close to the cutwater and to the inlet side of the pump. 
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Column of air bubbles. Cutwater. Rotor. 
Figure 5.40. Column of air bubbles showing the vortex at the cutwater. 
Column of air bubbles 
Rotor discs Fluid inlet side of pump 
Figure 5.41 Column of bubbles 
showing the vortex relative to the discs. 
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Further work is needed to improve the hydraulic performance of the 
pump. The application of a Computational Fluid Dynamics, (CFD), analysis 
package should provide a solution. 
5.7.3 Video with the water and glycerine mixture. 
A second set of video images was taken with the water and glycerine 
mixture. The pump was set up to give a specific performance for each video 
sequence. 
A similar performance to the water only tests was noted regarding the 
generation of the vortex and its position in relation to the cutwater and flow 
passage of the pump. The vortex occurred in the same place at the cutwater 
and across the pump flow passage as for the water only tests. 
It was noted that the flow pattern immediately after the cutwater was 
not stable. The flow pattern rotated clockwise at one time and anti-clockwise 
at another. 
With the pump stationary it was noticeable that the air bubbles trapped 
in between the discs did not disperse as quickly with the water / glycerine 
mixture compared to water only. One sequence, taken after the tests at the 
prepared conditions had been run, showed this clearly with the bubbles rising 
slowly from between the discs to the top of the flow passage in the pump. This 
is not unexpected as the water - glycerine mixture has a higher viscosity than 
water. 
The rest of the video shows general views of the test rig and of the 
instrumentation and how they were operated. 
5.7.4 Summary 
The construction of the test rig has been outlined with details of the 
instrumentation and calibration. The construction of the pump, rotors and the 
assembly to the test rig has been described and a brief description of the test 
fluids used in the pump performance tests is included. The water - glycerine 
mixture reproduced a fluid that gave a viscosity equivalent to blood but at only 
one temperature. It was not possible to produce a test fluid that accurately 
modelled blood viscosity over a wide temperature range. The water - xanthan 
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gum fluid was not useful for simulating blood. Although mixed to the strengths 
quoted by Wickramsinghe, (2002), the performance of this fluid was not 
appreciably different to that of water. There does not appear to be a fluid that 
can accurately model blood characteristics and it is not understood why an 
industry involved in the production of blood contacting medical devices does 
not have a standard, clearly specified, analogue fluid that can accurately 
model blood for use with the development of its products. This implies that 
different manufacturers may not be working to the same standard and that 
results may not be comparable. 
The results of the tests showed that the Tesla pump was capable of 
pumping the target amounts of fluid at the target pressures. There was a 
difference between the performance of the rotors, where the rotor with the 
smallest number of discs, rotor 0, gave the worst performance. The results 
from all the rotors indicated that there may be an optimum rotor build 
dependant on fluid viscosity but this needs more investigation. The results of 
the constant speed tests showed that the Tesla pump maintained the 
pressure, as set, over the delivery range of 1 - 10 I/min. and that the pressure 
appeared to be dependant on rotor speed. If rotor speed is translated into 
peripheral velocity, a small Tesla pump, running at high speed, may be able to 
produce the same pressure as a large Tesla pump running at a lower speed. 
Further work is necessary to confirm this point. 
Estimates of blood stress in the gap between the periphery of the disc 
closest to the volute wall and the wall itself showed a maximum stress of 29 
N/m. Calculations indicated that this figure could be lower with design 
changes to the pump. 
Power consumption ranged from 120 to 4 Watts depending on the 
speed of the pump. This was the power required to pump the fluid and did not 
include the power to overcome friction. 
The pump efficiency was low, the maximum obtained was 10-12%. 
The reason for this is not understood but small pumps are known to be less 
efficient as friction and fluid losses are greater in proportion compared to large 
pumps. 
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The non-dimensional parameters were comparable to previous 
research by Crawford and Rice, (1974), although tended to be at the one end 
of the ranges quoted. 
As found from practical experience, the Tesla pump Reynolds numbers 
looked reasonable but were higher than the theoretical results quoted in the 
paper by Crawford and Rice, (1974). Using the formula in the paper and using 
the speeds used with the Tesla pump tests, the gap between the discs was 
calculated at 0.05 to 0.3 mm. This is smaller than the gaps used in these tests 
and may be the reason why the Reynolds number results are so different. 
A problem was found with the fluid flow pattern inside the pump where 
a vortex was found inside the fluid close to the cutwater. The problem may be 
caused by the closeness of the end disc to the wall of the volute at fluid entry 
and it may be possible to reduce or eliminate the problem by changes to the 
pump build. Increasing the gap between the end disc and the volute wall may 
change the output of the pump but would reduce the fluid stress levels at that 
point. 
Work is necessary to eliminate this problem. The application of a 
Computational Fluid Dynamics, (CFD), package should be able to provide a 
solution. 
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Chapter 6, Discussion. 
6.1 Tesla pump performance. 
As there does not appear to be a published specification for blood 
pumps to assist or replace the human heart, and published data rarely 
includes engineering specifications and performance curves, it is difficult to 
compare the output of the pumps produced to date with what is required. The 
best that can be done is to compare the results already published and 
assume the performances found are suitable for medical purposes. 
The physical characteristics of a sample of blood pumps are shown in 
Table 2.10. This compares the volume pumped, the installed volume and the 
mass of each pump together with the pump type as far as can be determined 
from the available literature. These are compared to the human heart which 
has been given a value of 1 for each of the characteristics. 
Table 2.10 indicates that blood pumps can be placed in three groups. 
The Total Artificial Hearts and pulsating pumps are the largest and heaviest 
and the axial flow pumps are the smallest and lightest. The rotary pumps fall 
in between these two groups in terms of size and weight. There also appears 
to be a difference in delivery between the pumps that are already in use, (the 
commercial pumps), and what appear to be experimental pumps. The 
commercially produced pumps deliver similar amounts of blood but the 
experimental pumps deliver amounts that appear to be either too small or too 
large for clinical use. It is assumed that these pumps have not, or will not, 
reach hospital use and are produced only as investigative models. 
From the published papers, it is difficult to determine the performance 
of the published pumps described in this thesis, as only single point flow Vs 
pressure figures are given, for example, 10 I/min at a pressure of 100 mm Hg. 
It is assumed that the pressure quoted is the delivery pressure. 
The performances from Table 2.10 have been recalculated and 
compared with the Tesla pump by plotting the single point flow Vs pressure 
figures for the published pumps against the setting points for the Tesla pump. 
Only the extremes of the performance of the Tesla pump as tested are plotted 
as any combination of flow, from 1 to 10 I/min and pressure, from 1 to 200 mm 
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Hg, can be covered by the Tesla pump as shown by the results in this thesis. 
For the purposes of this plot the human heart delivery is taken as 5.5 
Ilmin at a pressure of 110 mm Hg. which is midway between the quoted 
systolic and diastolic pressures of 140 I 80 mm Hg. These results shown in 
Figure 6.1, indicate that some pumps can give a performance superior to the 
human heart. This is seen for some of the pulsating and for some of the rotary 
radial pumps. The rotary axial pumps appear to be equivalent to or slightly 
less than the heart. The Tesla pump can give a performance equivalent to, or 
greater than, the maximum flow requirements of the published pumps at 5 to 
10 Ilmin at pressures of up to 200 mm Hg. 
Pressure I flow comparison of blood pumps 
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Figure 6.1. Comparison of published pump results with the Tesla pump. 
One result for the Tesla pump is shown where both inlet and outlet 
valves were set fully open. Two pressures are shown, the delivery pressure at 
1 mm Hg, the differential pressure at 18 mm Hg both at a delivery of 10 I/min. 
These results indicate that the Tesla pump has a wide performance 
envelope with deliveries up to 10 I/min. at pressures ranging from 1 to 200 
mm Hg. There is no information to show that any of the other pumps can do 
this and this would make the Tesla pump more versatile than some of the 
other types in terms of performance requirements. 
The Tesla pump may be capable of exceeding the performance shown. 
It did not appear to be running at the maximum possible output under the 
above conditions as an amount of adjustment was available at the valves 
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controlling the flow and the speed control system was not at the maximum 
setting. 
To provide a clearer comparison, the above result was replotted as the 
ratio's of the performance of the human heart and the blood pumps and is 
shown on Figure 6.2 
Performance comparison of blood pumps compared to human 
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Figure 6.2. Comparison of published volume and pressure results with the 
Tesla pump shown as a ratio compared to the human heart. 
This figure confirms that pulsating pumps are capable of flows 
approaching twice that of the human heart but do not appear to provide 
pressures much different to the heart. Rotary radial pumps can provide 
approaching 2~ times the pressure and over 1 ~ times the delivery of the 
heart. Rotary axial pumps can provide up to twice the delivery but can only 
equate the pressure of the heart. 
The Tesla results envelope indicates that the pump is capable of up to 
twice the delivery and up to twice the pressure of the heart which must be a 
clear advantage compared to the other pumps. 
An examination of the mass of each blood pump compared to the 
human heart is shown on Figure 6.3. This shows that the pulsating pumps can 
be up to three times heavier than the heart. Some of the rotary radial pumps 
are heavier that the heart, one of them up to three times, but the rotary axial 
pumps are equivalent to, or, lighter than the heart. 
The Tesla pump was weighed. It is approximately four times heavier 
than the heart. This is not considered to be important at this time, as the pump 
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has had no work conducted on it to make it suitable for medical applications. 
With a proper design and use of materials it should be able to reduce this to at 
least 50% of the present pump. This would bring the mass of the Tesla pump 
into the region of the pulsating and rotary radial pumps but it would be unlikely 
to make it comparable to the mass of the rotary axial pumps. 
Mass comparison of blood pumps 
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Figure 6.3. Comparison of mass and flow ratio results with the Tesla pump 
shown as a ratio compared to the human heart. 
The published pumps were also compared in terms of the installed 
volumes as shown on Figure 6.4. All the published pumps appear to have a 
smaller volume than the human heart. A similar pattern compared to the 
previous result was noticeable in that the pulsating pumps had the largest 
volumes followed by the rotary radial pumps with the rotary axial pumps 
appearing to be the smallest. 
An estimation of the installed volume of the Tesla pump made it slightly 
greater than the human heart. As before this figure for the volume of the Tesla 
pump is not considered to be very important as there has been no work 
conducted on it to make it suitable for clinical application. It is expected that 
the volume could be reduced to at least the level of the rotary radial pumps 
which would make it about 25% of the volume of the human heart. 
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Installed volume comparison of blood pumps 
compared to human heart 
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Figure 6.4. Comparison of published pump results with the Tesla pump shown 
as a ratio compared to the human heart 
6.1.1 Constant speed performance. 
A literature search was made to determine the constant speed 
performance comparisons between the Tesla pump and other pumps. Three 
sets of constant speed results were found, two were for centrifugal, rotary 
pumps, the Baylor and the Vienna pumps, (similar designs to the Tesla 
pump), and the third result was for an axial flow pump, the Nimbus pump. The 
Tesla pump was tested by setting at the required speed and the output was 
adjusted to give a delivery of 10 I/min. The results are compared on Figures 
6.5, 6.6 for the centrifugal pumps and Figure 6.7 for the axial flow pump. 
There were no comparative results found for a pulsating pump that covered a 
delivery change relative to a change in 'beat' rate. 
The pressures shown here for the Tesla pump are delivery pressures 
and it is assumed that the pressures for the Baylor pump, the Vienna pump 
and the Nimbus pump are the same. 
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These results show that the Tesla pump maintains a relatively constant 
pressure, over the flow range tested at constant speed, compared to the other 
pumps. Taking the Tesla pump result at 3500 rev/min, the pressure difference 
over the delivery range of 1 to 10 I/min is 4.5 mm Hg for the differential 
pressure and 15.4 mm Hg for the delivery pressure. With the other pumps, 
the pressure drop is greater than this as the flow increases. The estimated 
delivery pressure drops for a flow of 1 to 10 I/min are 100 mm Hg for the 
Baylor pump, 50 mm Hg for the Vienna pump and 125 mm Hg for the Nimbus 
pump. 
The reason why the Tesla pump characteristic is different is not fully 
understood but may be a function of the action of the discs on the fluid. 
Wiseman, (1994), indicated that the pressure generated by a Tesla pump 'is 
inherently a product of its rotational speed and its runner diameter'. This 
implies that the rotor peripheral velocity controls the pressure generated by 
the pump irrespective of the delivery. If this is correct, a larger diameter rotor 
running at a lower rotational speed but giving the same peripheral speed than 
the present pump should give the same pressure. This remains to be 
confirmed. 
The Tesla pump constant pressure characteristic is confirmed by 
comparing the differential and delivery pressures over a range of speeds. 
Figure 6.8 shows a comparison of Tesla pump constant speed results with the 
delivery set at 10 I/min. The differential and delivery pressures relative to each 
speed are almost constant. The difference between the differential and 
delivery pressures at a delivery of 10 I/min at each speed is shown on Figure 
6. 9 which shows that the pressure difference reaches a maximum of less 
than 17 mm Hg at 1500 rev/min and approximately 13 mm Hg at 3500 
rev/min. In pumping terms this difference is the negative pressure at the pump 
inlet. 
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6.1.2 Non dimensional results. 
The non dimensional results obtained from the Tesla pump have been 
compared with results from the paper by Crawford and Rice, (1974). This has 
proved difficult as the results from the paper are all calculated results with 
fixed parameters for the duration of the calculation. These results are 
therefore not strictly comparable as 'like for like'. 
Three of the calculated results from Crawford and Rice, (1974) are 
shown on Figures 6.10, 6.11 and 6.12. 
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A sample of the Tesla pump results have been plotted using the same 
parameters as shown in the paper. These are shown in Figure 6.13. Note:-
The values for Uo have been multiplied by 100 so that they can be seen on 
the same scales as the rest of the results. 
Figure 6.10 shows the relationship between the calculated Reynolds 
number and efficiency with constant values for the through flow Uo. This 
indicates that maximum efficiency is reached at a Reynolds number of 5. In 
practical terms this is a very low figure as applying the formula to the Tesla 
pump gave typical Reynolds numbers in the range of hundreds. Enquiries 
were made from Arizona State University to obtain an explanation but were 
unsuccessful. 
Using the formula quoted by Crawford and Rice, (1974), and assuming 
water as a fluid and a speed range of 1000 to 4000 rev/min., the gap between 
the discs was calculated for a range of Reynolds numbers from 1 to 10. The 
calculated gap was 0.3 to 0.05 mm. This is smaller than the gap(s) used in 
this thesis and is assumed to be the reason for the difference between the 
values of the Reynolds numbers. There is no information on gap sizes in the 
paper by Crawford and Rice, (1974). 
The results on Figure 6.10 show that as through flow, Uo, becomes 
smaller, the efficiency increases. The combination of the Reynolds number 
and Uo results in a maximum efficiency of greater than 90%. This is a high but 
it is a calculated figure, does not take account of any physical losses and may 
not occur in practice. 
The Tesla pump Reynolds no. Vs Efficiency result, shown on Figure 
6.13 has similar shape to the calculated plot shown on Figure 6.10. The 
efficiency is low with low values of Reynolds number and rises to a peak value 
as the Reynolds number increases but then stays relatively constant up to a 
Reynolds number of greater than 600. 
The values of the Tesla pump through flow parameter, Uo, at 0.01-
0.03, are similar to the calculated values but are lower than the values of 0.02 
to 0.5 quoted by Crawford and Rice, (1974). 
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Figure 6.10. Calculated Reynolds number and Efficiency with 
constant values for the through flow Uo. 
Figure 6.11 shows the calculated comparison of Reynolds number and 
pressure parameter with constant values of the through flow, Uo. These 
curves have a similar shape to the previous result shown in Figure 6.10 as 
there is a peak value of the pressure parameter at a Reynolds number of 5 
and that the value of the pressure parameter increases as Uo decreases. 
The Tesla pump results, Figure 6.13, show that the pressure parameter 
Pt , at a value of around 1 is relatively constant over the range of Reynolds 
numbers although it does not compare with the results from Crawford and 
Rice, (1974) at around 20 to 25 at the value of the through flow parameter Uo 
of 0.01-0.03. In terms of curve shape this result is a good comparison with the 
calculated results shown on Figure 6.11. 
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Figure 6.11 shows the calculated comparison of Reynolds number and 
pressure parameter Pt with constant values for the through flow Uo. 
Figure 6.12 shows the calculated result of Reynolds number and 
torque parameter T1 with constant values of through flow Uo. This shows that 
for a given value of Uo, T1 stays relatively constant over a wide range of 
Reynolds numbers and that T1 increases as the value of Uo increases. 
The Tesla pump Reynolds number Vs Torque parameter plot shown on 
Figure 6.13 is not the same shape as the calculated plot. The torque 
parameter has a high value at low values of Reynolds number and reduces as 
the Reynolds number increases but stays relatively constant from a Reynolds 
number of 300 upwards. 
245 
_ 8 
"-
r:. 7 
o 
o 
:;; 6 
:::> 
~ 5 
* E 4 ~ 
"-3 
-c 
c: 
.. 2 ~ 
c: 
~ 1 
~ 
W 0 
50 
40 
30 
1 
20 
10 
o 
~ 
. 
..... 
-
.25 
Uo = .10 
.05 
~ .02 
' ,-
r:' 0 2 4 N RE 6 8 10 
,.,19. 2 Depend . 
RE. and 0 II ence 01 dimensionless torque, T,. on Reynolds number 
n ow rate parameter. U o• with '0 = 5.0 and Vo = 0 
Figure 6.12 shows the calculated comparison of 
Reynolds and torque parameter. 
\\ 
\\ 
~ , 
b 
f 
Comparisons of non-dimensional parameters 
--V ---
V 
"'-
I. 
r-.r 
--- Efficiency % 
....... lhroughflow parameter Uo*1 00 
*-Torque parameter T1 
*- Pressure arameter Pt 
o 100 200 300 400 500 600 700 
Reynolds number 
Figure 6.13. Tesla pump non dimensional parameters, Efficiency, %, Through 
flow parameter, Uo, Torque parameter, T1, and 
Pressure parameter, Pt, compared to Reynolds numbers, Re. 
If the calculated results are to be believed, the Tesla pump tested here 
needs further work to improve the figures. Any possible improvements will not 
be discussed here. 
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6.1.3 Viscosity results. 
Blood is a complex fluid as the viscosity changes relative to the shear 
rate making it a non Newtonian fluid. Attempts have been made by 
researchers to develop an analogue fluid to mimic blood but there does not 
seem to be a satisfactory substitute. 
Figure 6.14 is a reproduction of one of the results from 
Wickramasinghe R. (2002). It shows the viscosity I shear relationship of water 
and various mixtures of water and glycerine and shows the viscosity is 
constant over a range of shear. These fluids are considered to be Newtonian. 
For the viscosity of water, a value of 0.001 Pa.s was assumed and it is so 
close to the other results it is not possible to show it clearly. (1 Pa.s is 
equivalent to 1 Ns/m2 and viscosities will be expressed in Ns/m2 in this 
thesis). 
Two of the results in Figure 6.14 used mixtures of 40% and 50% 
glycerine. From previous work in this thesis, a mixture of 45%, by weight, 
glycerine in water had a viscosity similar to blood but without the viscosity I 
shear relationship of blood. From Figure 6.14, a line was calculated to 
represent a 45% glycerine I water mixture and this was used as a comparison 
to the Middlesex 45% glycerine I water result. 
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Figure 6.15 is a reproduction of the second of the results from 
Wickramasinghe R. (2002). It shows the mixtures of water / glycerine / 
xanthan gum tested for the relationship of viscosity against shear and is 
compared with pig blood at haematocrits of 25% and 65%. Human blood has 
an hematocrit of around 45% and why these results are not compared directly 
to human blood is not explained by Wickramasinghe.The blood results are 
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shown as dotted lines, the other results are shown as solid lines. It is 
noticeable that the results, although showing a change of viscosity relative to 
shear, are not curves in the same way as for pig blood. Inspection of the 
results for the water / glycerol / xanthan gum mixtures shows they are all 
straight lines and with the viscosity changes depending on the shear rate, 
these are all non-Newtonian fluids. The slope of these lines would indicate 
that any mixture of water / glycerol / xanthan gum would not be representative 
of blood over a range of shear although may be exact at a single value of 
shear depending on the concentration of the components in the mixture. 
Two mixtures shown in Figure 6.15 appeared to be reasonably parallel 
to the blood viscosity / shear results over the shear rates shown. From 
Wickramasinghe one of these mixtures was shown to be 99.99% water, 
0.01 % xanthan gum. It was obvious that if the shear rate were to be greater 
than 10, that this mixture would not be representative of blood although it may 
be close to 45% hematocrit blood in the shear rate range of 0.1 to1 The other 
mixture of 59.9925% water, 40% glycerine and 0.075% xanthan gum also 
may not be representative of blood above a shear rate of 10. Of the two 
mixtures the one most likely to be representative of 45% hematocrit blood in 
the shear range shown is the water / xanthan gum mixture. 
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From Appendix 2, the physiological wall shear rates vary from 43 to 
about 2000. Although the paper by Wickramasinghe, (2002), was concerned 
with blood gas transport, why were the blood viscosity / shear rate results 
published at shear rates different to the physiological rates? 
Tests were conducted at Middlesex University using water and 
mixtures of water / glycerine and water / xanthan gum. It was not possible to 
test any other fluids due to a Campus move. Additional tests combining water, 
glycerine and xanthan gum may have provided a fluid that was close to blood 
in terms of viscosity at the particular shear rates considered. 
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The results of tests at Middlesex using water only are shown on Figure 
6.16. The viscosity of 0.00094 is very close to the quoted value of viscosity of 
water from Rogers and Mayhew, (1983) of 0.001002. From this result, the 
methods used to determine viscosity were considered to be accurate enough 
for test purposes. Comparing them with the results on Figure 6.19 which is a 
comparison of results for all the mixtures tested it was not possible to 
distinguish results for water between the Middlesex, Wickramasinghe and 
Rogers and Mayhew, (1983). 
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Figure 6.16. Middlesex result for water. 
The Middlesex result for water I glycerine is shown on Figure 6.17. This 
gave a viscosity that was similar to blood, approximately 0.0037 N.s/m2, but 
would only be comparable at one value of shear as the viscosity of blood 
changes as noted from Figure 6.19. The relationship of shear and viscosity of 
the water I glycerine mixture appeared to be a straight line with zero slope 
hence this mixture was assumed to be a Newtonian fluid and not 
representative of blood. The comparison of the Middlesex and 
Wickramasinghe results show little or no difference as shown on Figure 6.19. 
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The Middlesex result for water + xanthan gum, shown on Figure 6.18, 
shows that the characteristic had a slope that was effectively zero and it is not 
understood how the Wickramasinghe result was obtained as the Middlesex 
result is little different from water. 
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Figure 6.18. Middlesex result for water + xanthan gum. 
Figure 6.19 is an attempt to compare all the viscosity results from 
Middlesex University and Wickramasinghe, (2002). This plot is obtained by 
taking the results obtained by the tests conducted at Middlesex University and 
extrapolating them to cover the same shear range as used by 
Wickramasinghe. Figure 6.19 shows that the Middlesex results for water / 
xanthan gum do not compare favourably with the results for Wickramasinghe. 
The reason for this is not understood. The mixture ratio of the water and gum 
was checked and found correct according to the paper. From 
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Wickramasinghe, the Middlesex xanthan gum result should have shown a 
decreasing value for viscosity with increasing shear rate as shown on Figure 
6.15. 
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Figure 6.19 Comparison of results for all the mixtures tested. 
Brookshier and Tarbell, (1991) found pig blood provided 'a good match 
of the complex viscosity of human blood over a wide range of hematocrits, 
(20-79 %) and shear stress, (1-1000s -1). Brookshier and Tarbell, (1993), 
attempted to produce a transparent, stable, shear thinning fluid that was a 
close match to human blood. Their results, a mixture of 0.04% xanthan gum + 
40% glycerine + water, appeared to give a reasonable result compared to 
46% hematocrit pig blood over a shear range of 1 to 1000. This fluid may be a 
good starting point for any further tests 
They concluded that 'the elastic properties of the fluid did not playa 
significant role in the flow behaviour'. This implies that the performance of a 
blood pump would not effected by the elastic nature of blood. 
6.1.4 Cavitation. 
The Tesla pump does not appear to have a problem with cavitation. 
Tests have been run with a restricted inlet resulting in the same performance 
as an open inlet. 
Figure 6.20 shows the flow Vs speed comparison of two tests, one with 
an open inlet, the other with a restricted inlet, for 10 I/min @ 200 mm Hg. 
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There is little or no difference in performance between the two settings. A 
similar result is shown on Figure 6.21 for the flow Vs differential pressure at 
the same set point. 
The flow Vs speed and flow Vs pressure differential tests were 
repeated for 5 I/min @ 100 mm Hg at the same valve settings, as shown on 
Figures 6.22 and 6. 23 respectively. Again there was little or no difference in 
results. 
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Figure 6.20. Speed Vs flow results comparing the outlet valve Vs the inlet 
valve to control the delivery at 10 I/min @ 200 mm Hg. 
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Figure 6.23. Differential pressure Vs flow results comparing the 
outlet valve Vs the inlet valve to control the delivery at 5 I/min @ 100 mm Hg 
There were no physical signs of cavitation during any of these tests. 
The pump delivery was stable during the tests and there were no additional 
noises or bubbles noted in the output. It is not known if other blood pumps 
have been tested for this condition as no evidence has been found of any 
tests to induce cavitation. 
Barske, (1960) tested a Tesla type pump to promote cavitation. It was 
tested over 'long test runs at speeds of up to 18,000 rev/min and inlet 
pressures throttled down to 1 Ib/in2 abs., (52 mm Hg), but no cavitation marks 
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were produced on its surfaces'. A discussion contribution to the paper by R. 
Sadek offered a design of impeller that in his opinion 'was cavitation free' but 
no results or other information was offered. 
6.1.5 Implantation. 
The installed volume is not always listed but some of these pumps are 
at least equal in size to the human heart. There are no reports in the literature 
to show the installation of pulsating pumps in terms of creating the volume 
inside the body or how the pump is fixed in position to prevent movement or 
strain on the connections to the blood circuits. This must be of concern as 
pulsating pumps are likely to move as the pulsating action takes place. 
Radial and axial flow pumps tend to be smaller and lighter than the 
pulsating types. This will make installation more acceptable as less room will 
be needed with less chance of damage to the body. As these pumps do not 
pulsate, the chances of pump movement are reduced. 
The problem of heat generation appears to be negligible due to a 
combination of good pump designs that do not generate excessive heat and 
adequate blood flow to conduct the remaining heat away that is then 
dissipated throughout the rest of the body. 
The Tesla pump was tested for temperature rise, Figure 6.24. The 
pump was set to deliver 1 I/min at a pressure of 200 mm Hg and ran for 5~ 
hours. A temperature rise of 16° C was recorded from an ambient temperature 
of 20 -21°C. This gave an average temperature rise of 0.048°C I min over the 
test period. There was no cooling supplied for the pump and the output of the 
pump was fed straight back into the inlet. 
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Figure 6.24. Tesla pump fluid temperature rise test. 
Takami et aL, (1996), using a pivot bearing support pump to evaluate 
efficiency and heat generation, recorded blood temperature rises of up to 
16°C in 4 minutes. If these results are correct, the Tesla pump should be 
satisfactory as the rate of temperature rise is lower. 
Control systems have been developed that can be implanted together 
with the pump. These systems must not have excessive temperature rises. 
The temperature limit of 41°C, discussed previously, is important. During tests 
on an implanted pump by Okamoto et aL, (2006), the implanted electronic 
control unit was kept at a temperature under 45°C but examination after the 
tests showed burns on the tissue surrounding the unit. 
The effect of temperature on muscle performance has been 
investigated. As the temperature rises to around 40 ° C, skeletal muscle 
tends to exhaust sooner compared to muscle at normal temperatures, 
(-37°C), as shown by Walters et ai, (2000), Nybo et ai, (2001), Todd et aL, 
(2005) and Thomas et al, (2006). No information has been found on the effect 
of blood temperature on cardiac muscle. If a blood pump raises the blood 
temperature sufficiently and the same effect applies, a damaged heart may be 
weakened further. 
With the combination of the new power transfer systems and the newer 
pumps, it is now possible to completely implant a pump with the closure of the 
chest. There has been no attempt to make the Tesla type pump in this thesis 
suitable for implantation but only to investigate the potential of this pump type. 
Implantation may be possible for this pump after development. 
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6.1.6 Surface contact area. 
In general, the smaller the pump, the smaller the blood contact area. 
With a pulsating pump, it is not possible to make the pump smaller, reducing 
the internal area, and maintain the blood flow rate without increasing the 
pump 'beat' rate and blood stress levels. This is a disadvantage with a 
pulsating pump. 
Radial and axial flow pumps are generally smaller than a pulsating 
pump and the blood flow rate can be increased by increasing the pump speed 
as long as the blood stress levels are not exceeded. 
Reducing the internal surface contact area, the use of biocompatible 
materials and surface conditions will be important to prevent blood clots 
forming. The use of metals and plastics such as titanium, the polycarbonates 
and polyurethanes are well established as well as the techniques for making 
biocompatible surfaces as developed for the HeartMate pump. 
The Tesla pump type will have a large internal surface area due to the 
number of discs and this pump will be at a disadvantage considering blood 
reactions. Calculations indicate a rotor contact area of 0.089 m2 for rotor 3 
and 0.157 m2 for rotor 7. The surface area of the volute has not been 
considered as it is a constant irrespective which rotor build is used. The 
difference in rotor surface contact area of rotor 7 of approximately 2 times 
compared to rotor 3 does not account for the difference in performance and 
without accurate information on the dimensions for any of the other pumps 
discussed, no comparison of surface areas can be made. 
Tests by Pierrat and Nassoy, (2004), to detach red blood cells from 
selected surfaces gave forces ranging from 1.4-9 N to 0.45 -9 N depending on 
the surface used. The results of similar work by Bowers, et aI., (1989), 
indicate that forces ranging from 6.29-9 N to 3.06-8 N are necessary to remove 
red blood cells from selected surfaces. 
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The tangential forces generated with the Tesla pump gave figures from 
4.12 -25 N to 1.32 -23 N depending on radius and speed. It is therefore doubtful 
that the forces generated will remove clotted blood for the surface of the 
discs. 
6.1.7 Systemic anticoagulation. 
Systemic anticoagulation is where anticoagulants such as heparin are 
added to blood to prevent blood clots forming. Blood clotting can be provoked 
for two reasons, a) surface reactions and b) excessive blood stress levels. If 
the materials and surface finishes are suitable there should be little or no 
problems with surface reactions and this has been covered previously. 
The running of the pump could cause blood stress problems however. 
Reul and Akdis, (2000), indicate that there are two problems concerning 
stress levels with rotary pumps; 
a) The circumferential tip velocity of the rotor should be limited to a 
maximum of around 10 m/s otherwise problems with cavitation and maximum 
allowable blood shear rates can occur. 
Applying this to the Tesla pump design, limiting the peripheral speed to 
10 m/s at a rotor diameter of 60 mm, a maximum rotational speed of around 
3200 rev/min is indicated. With the present Tesla pump this will give a delivery 
of 4 to 10 I/min at this speed depending on the set point and pump 
construction. The output can be varied by changing the number of discs on 
the rotor. More discs are expected to give a higher delivery for the same 
pressure at the same rotational speed. 
b) In most commercial blood pumps Newtonian shear stress is in the 
range of 20-100 N/m2 and axial pumps can reach around 400 N/m2 . 
For the present Tesla pump, a shear stress of -30 N/m2 has been 
calculated at a speed of 4000 rev/min. This figure is still high when white 
blood cells appear to have a maximum stress of 15 N/m2 before damage to 
the cell. 
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Lowering the pump speed and / or changing the pump construction will 
reduce stress levels but also reduce pump delivery. With the present pump 
the speed for this stress is 2050 rev/min, as shown on Figure 5.17. This will 
give a delivery of 2.5 to 7.5 I/min depending on set point and pump 
construction. 
The first generation blood pumps imitated the biological heart. For 
these pumps, valves were necessary to control blood flow direction and have 
been a source of problems. Many valve types have been made and range 
from 'ball in cage' types to flap valves made from biocompatible materials, 
animal and human tissue. There does not seem to be one type that is ideal 
and trouble free. 
A pump without valves is likely to be a better pump as problems with 
valves are avoided. As rotary pumps and the Tesla pump do not use valves 
there will be no problems with this part of the application and it will not be 
considered further. However, a rotary pump will have to maintain a minimum 
speed to avoid regurgitation. 
One of the many indications for heart transplant is a low systolic blood 
pressure; Pepper, (2000), indicates 80-90 mm Hg. The work by the blood 
pump will stress the blood but as long as the stress level is equal to or less 
than the biological levels there should be no appreciable blood damage. The 
Tesla pump appears to produce low blood stresses of less than 30 N/m2 with 
the present construction. Changes to the disc design and assembly of the 
pump indicate that the stress levels can be reduced further although the 
effects on the pump performance are not known at this point. Following these 
results the Tesla pump would seem to be more suitable to pump blood than 
some of the other pumps described in this thesis. 
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6.1.8 Simple mechanical blood propulsion system. 
The second generation pumps were rotary pumps and used one 
moving part, the impeller. This pump type was radial flow or axial flow. The 
first axial flow pumps used shaft drives powered from outside the body and 
seals on the drive shafts to keep the blood inside the pump. This is not a 
successful method and problems were experienced with seal leakage and 
blood damage due to heat generation at the seal face. Efforts to solve these 
problems with flushing systems to cool the pump meant that this type of pump 
became complicated and has now been superseded. 
Developments with power transfer systems have produced a system 
that transfers enough power through the skin to operate an implanted blood 
pump without damage to the skin. This makes the pump completely implanted 
with no risk of infection through power cables or pipes passing through the 
skin. Some rotary pumps use blood immersed bearings. An example of this 
type is the Jarvik 2000, an axial flow pump. The bearings are small in 
diameter in order to keep the rubbing speeds down. Westaby, (2000), quotes 
that the Jarvik 2000 uses 'blood immersed bearings 1 mm in diameter'. These 
bearings are satisfactory for this application because they are lightly loaded 
and are made from biocompatible materials. Other pumps use jewelled or 
ceramic bearings for durability and biocompatibility. The amount of blood 
damage does not appear to be excessive and is assumed to be within the 
range that the body can handle without severe reaction. 
The third generation blood pumps use magnetic or fluid force bearings 
to position the rotor. In this design the rotor is completely suspended and 
officially does not touch the inside of the pump casing. The Incor Berlin axial 
flow pump and the HeartMate III rotary pump are both examples of this 
design. 
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The InCor Berlin and HeartMate III pumps are examples of pumps with 
no physical bearings with the rotors magnetically suspended and driven. The 
position of the rotor in the InCor Berlin pump is sensed and is used to 
calculate the blood flow rate. The rotor speed is adjusted to maintain the 
correct flow rate. A flow rate calculation system does not appear to be used 
on the HeartMate III or any other of the rotary pumps and they do not appear 
to be designed for this. 
With the HeartMate III, the pump can be separated into two parts, the 
blood pumping section and the drive and electronics section. With this 
construction the blood contacting part of the pump can be changed 
independently of the other. This makes the electronics section reusable and 
the blood contacting part single use and disposable. 
The present Tesla pump design uses a shaft drive with seals but there 
is no reason why a redesign could not produce a pump with the pumping 
element mounted on blood immersed bearings and magnetically driven from 
outside the pump casing. This would give a pump with only one moving part 
as proposed by Westaby, (2000). 
6.1.9 System reliability. 
The control system of the pump should be as simple as possible for the 
human operator, even to the extent of not needing any human intervention. It 
may be necessary to compute speed or blood flow and this should be 
possible with a microprocessor system using feedback control to keep the 
pump delivery within acceptable limits. Any external controls should be as a 
few as possible and any natural characteristics of the system should be 
utilised. The electronic controller for a magnetically levitated pump will be 
more complicated compared to a pump with mechanical bearings as it will 
have to maintain blood flow and control the position of the rotor. This may 
lead to more errors and a greater possibility of failure. 
In terms of systems reliability, any blood pumping system cannot be 
'fail safe' if the pump is using only one system, because if that system fails, 
the pump stops. If complete reliability is required, then multiple control 
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systems are needed. If the primary system fails, another takes over 
automatically without interruption and signals that a system failure has 
occurred. This will give security to the patient and time to repair or replace the 
faulty system. The system will have to be a minimum of two levels but a three 
level system would be preferred. Whether this can be done in terms of cost 
and complexity needs discussion. 
6.1.10 Delivery. 
The requirement for adult patients as indicated by researchers is about 
5 litres/min at a pressure of 100 mm Hg. Some of the pumps described in this 
thesis deliver more, others less than this figure. It is assumed that those 
pumps that deliver less than 5 litres/min are used for organ perfusion support 
and not full cardiac assistance. 
There does not appear to be a 'standard' specification for delivery that 
is accepted by the industry that all researchers work towards. This makes 
comparisons between various pump designs difficult. 
263 
6.2 Comparison with other pumps. 
6.2.1 Size and output 
The present Tesla pump is capable of delivering 10 I/min at a 
differential pressure of 200 mm Hg. at less than 4000 rev/min. This delivery is 
in excess of what is required in terms of biological support which is usually 
quoted as 5 I/min at an afterload pressure of 100 mm Hg. As an example, the 
HeartMate III pump is stated to deliver 7 I/min at 135 mmHg for a speed of 
4800 rev/min., Schab and Loree, (2005), (This is a rotary pump with a 
magnetically suspended bladed rotor). This comparison indicates that the 
Tesla pump is too large for the application and that a smaller pump would be 
more suitable. 
The physical sizes of the pumps are difficult to compare and the figures 
quoted on Table 2.10 are an approximation. 
6.2.2 Pump configuration. 
The present Tesla pump design as shown in this thesis is not suitable 
for a blood pumping application. It is shaft driven and a seal is used to prevent 
fluid leakage along the shaft. Seals have been mentioned previously as a 
source of wear and heat generation problems. The miniature ball bearings on 
the shaft would not be acceptable for a blood pump application due to the 
need for lubrication. 
This design was considered to be suitable only to determine if a Tesla 
type pump could be used to pump fluids with characteristics approximating to 
blood. 
The HeartMate III and other pumps indicate that the rotary pump 
concept works, although more information is required in terms of pump 
endurance and subsequent blood condition. A lack of long term performance 
results in vivo is a problem with all blood pumps, as most are removed as 
soon as the patient has recovered enough to do without the pump. The 
implantation time can be hours to days. 
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6.2.3 The general requirements of a blood pump. 
The pump will need to be as small as possible in order that 
implantation inside the patient is possible without undue discomfort to the 
patient and to reduce the internal blood contact area. Due to the small size, 
the pump will have to run at high speed to deliver the quantity of blood. 
Careful design of the pump flow passages is necessary to provide smooth 
blood flow without excessive fluid stresses. This may lead to less 
anticoagulation procedures and previous chapters have outlined the problems 
with blood stresses and fluid flow problems. 
The materials of the pump must be biocompatible. This implies titanium 
for the construction of the pump. 
Consideration will have to be given to the assembly of the pump in 
terms of the relative positions of the inlet and outlet ports and the anatomical 
requirements of the patient. The connections to the patient must be 
acceptable and, if they exist, standard connections must be used. 
More work is required with the Tesla pump hydraulic performance to 
optimise the rotor configuration in terms of disc spacing and the disc inner and 
outer diameter ratios in order to determine a 'best' rotor for this application. It 
could be that a 'best' rotor is not possible following the present design of an 
assembly of same sized discs rotating on one centre line. Discs of different 
diameters with the largest disc in the centre of the rotor may be possible with 
the smaller discs acting as 'feeders' to the larger discs. This may produce a 
less abrupt change of stress and direction for the blood as it enters the pump. 
6.3 Design suggestions. 
Consideration will have to be given to evaluate the useful life of the 
pump together with the installation and power supply. 
Assuming the pump does not have an indefinite life, or has a life 
shorter than a patient will need to use it, consideration to a safe means of 
changing the pump will be required. As far as possible, major surgery should 
be avoided when changing the pump. This may involve developing 'reusable' 
methods of mounting the pump 'to' the patient. 
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Such methods may involve the development of 'plug in' electrical 
connectors and 'plug in' blood connectors and pipe work. 
It is hoped that a pump can be developed to fulfil all the biological 
requirements and patient expectations in regard to comfort. 
6.4 Proposed new design of pump. 
Before development work is started, the application must be clearly 
stated, for instance, the pump will be for use outside the body. This implies 
that size may not be particularly important but that secure fixings will have to 
be provided. 
6.4.1 Disc construction. 
It is proposed that the disc(s) comprising the rotor will be built with steel 
or other magnetic material as a spine. The discs will have to be 
biocompatible and not have any surface imperfections that could cause blood 
clotting problems. Depending on the forces required to drive the pump, it may 
be possible to build the rotor assembly with the end discs as the only 
magnetically attractively part of the rotor. The rotor will carry a spindle that will 
act as bearing shaft. 
The aim of a redesigned rotor assembly is to optimise fluid flow 
between the discs and to take advantage of more efficient disc diameter ratios 
as it is suspected that the ratio used in the tests was not an optimum figure. 
The change to the diameter ratio can be achieved in two ways and these are 
outlined below. 
Figure 6.25 shows the centre holes in the disc pack to be a gradually 
increasing diameter the nearer the fluid entry. This will create the impression 
of a 'tapered' entry and is similar to the methods employed in multiple branch 
pipe systems. 
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Fluid entry 
Figure 6.25 Rotor with 'tapered' central hole. 
Figure 6.26 shows discs of various outer diameters, with the largest 
diameter disc in the centre of the pack and the smallest discs to be at the 
ends of the pack. The central hole to be tapered with the largest diameter at 
the fluid entry position. This may cause problems with the design of the volute 
passageway and cutwater. 
<----' Fluid entry 
Figure 6.26 Rotor with various 
diameter discs and tapered central hole. 
Both these configurations will give discs of differing diameter ratios with 
Figure 6.26 giving the greatest variation. If there is an optimum ratio of the 
disc outer diameter and the diameter of the hole through the disc, these 
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arrangements are more likely to find and operate at the most efficient point 
than discs with fixed sizes for the outer and inner diameters. 
An important consideration for the differing diameter disc rotor is the 
variation in shear for a given rotational speed across the rotor. As shear is a 
product of linear velocity and the gap between the moving and stationary 
parts of a system, a large diameter disc running further away from the wall of 
the volute will produce a lower shear than a large diameter disc running close 
to the volute wall. A smaller diameter disc running at the same rotational 
speed but closer to the wall can produce the same shear depending on the 
disc diameter and gap. It may therefore be possible to produce a disc pump 
with a low shear figure across the rotor but with an improved performance. 
The cross section of the discs should also be considered for flow 
improvements as the blunt end of the disc may lead to flow problems. Figure 
6.27 shows a half section outline of an improved disc assembly. Each disc 
has a half tapered inlet at the central hole and tapers up to the periphery of 
the disc. The taper should help to reduce the stress levels of the fluid passing 
between the discs and between the end discs and the volute walls. The 
tapered design should also reduce the mechanical stresses imposed on the 
disc(s) as it rotates. 
Volute wall Discs Volute wall 
Disc assembly rotation 
Figure 6.27 Half section through rotor showing proposed disc design. 
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Tapering the disc to give a 0.5 mm land at the outer edge of the first 
disc will leave a gap between the volute wall and the periphery of the first disc 
of 2.75 mm. Figure 6.28 details the disc design. Keeping the gap between the 
volute wall and the disc at the fluid entry point at 1.5 mm, at a speed of 4000 
rev/min, the stress at the outer edge or periphery of the disc is reduced to 16 
N/m2. The stress for the untapered disc is 29 N/m2. Changing the speed to 
2000 rev/min, the stress reduces to 8 N/m2 at the periphery of the tapered 
disc. This is very close to biological levels for maximum blood stress quoted 
on Appendix 2, as less than 6 N/m2. 
Figures 6.29 and 6.30 show the calculated results for stress Vs wall 
gap at the two speeds quoted. 
'Land' at edge of disc, 0.5 mm 2.75 mm gap 
I~ 
Volute wall 
Disc 
1.5mmga~ L 
Figure 6.28. Details of the disc edge and calculated gaps. 
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Shear stress with tapered and non tapered discs @ 2000 rev/min 
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Figure 6.29. Calculated shear stress on tapered and non tapered 
discs at 2000 rev/min. 
Shear stress with tapered and non tapered discs @ 4000 rev/min 
E 35 
E 
Q. 30 ~ --Variable gap mm '" Cl 
-g 25 ~ ~ Variable gap stress N/m"2 '" ~ 20 
E ~ --- Constant gap mm Z 15 
III 
--- Constant gap stress N/m A 2 III 
~ 10 
III 
-)<- Maximum physiological stress 
.... 
----- ----- -----
'" 5 N/m"2 Gl 
.c 
rn 
0 
10 15 20 25 30 35 
Radius mm 
Figure 6.30. Calculated shear stress on tapered and non tapered 
discs at 4000 rev/min. 
Assuming that a pump can be built that will give a constant shear 
stress across the gap between the first disc and the volute wall, calculations 
have been made to determine the size of the rotor / volute gap for a shear 
stress of 5 N/m2 . This figure is below the maximum figure quoted on Appendix 
2, Physiological Flow Parameters. 
The result is shown on Figure 6.31 for pump speeds of 2000 and 4000 
rev/min. The effect on pump performance with these gaps is unknown. 
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Figure 6.31. Calculated rotor I volute gaps for a 
constant shear stress of 5 N/m 2 . 
6.4.2 Outer casing. 
The outer casing of the proposed pump will carry two bearing points 
supported on struts across the double entry ports. 
The casing will be made in two halves fused together such that there is no 
leakage between them. The inside surface is to be smooth. 
The pump will have a double entry system with blood flowing past the 
bearings. This will avoid any 'dead' areas for blood to stagnate or pool. 
6.4.3 Bearings. 
Double bearings will be preferred to support the discs. This will prevent any 
'whirl' possible when using an overhung bearing system. The bearings will be 
blood lubricated which follows the method used with the Jarvik 2000 pump. It 
gives a long lasting bearing system requiring minimum lubrication. 
6.4.4 Power and electronics. 
It is proposed that the pump will have no electronics 'built in'. This will 
make the pump itself a 'throwaway' item. The pump will fit into an electronics 
'cradle' containing the electronics that will generate a rotating magnetic field. 
The steel disc(s) inside the rotor, attracted by the magnetic field, will rotate 
with it. The viscous attraction of the blood to the disc(s) will pump the blood 
following Tesla's principles. Figure 6.32 shows the intended layout. 
271 
The pump is intended to be the disposable part, not the electronics. It 
is assumed that the electronics will be the expensive part of the pumping 
system and the disc(s) and casing will be the cheap part. This should provide 
for a cheaper rotary pump than one with electronics 'built in'. 
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Top cradle 
Fluid outlet 
Pump casing 
One of two 
bearings 
Bottom cradle 
Electronics package 
Steel disc(s) 
~ Fluid inlet 
Biocompatible 
covering 
Electronics package. 
Figure 6.32. Proposed design of new blood pump. 
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6.5 Flow improvements. 
The Tesla pump tested had a vortex swirl pattern at, or close to, at the 
fluid entry into the pump. Suggestions to stop the vortex are presented as 
follows:-
a) Induce a entry pre-swirl in the inlet pipe by fitting angled blades in 
the inlet pipe before the blood enters the pump. 
b) Allow the blood enter the pump at an angle to the centreline. 
c) Reposition the blood inlet such that blood is already travelling in 
same linear direction as part of the rotating disc. 
Of these possibilities, the repositioning of the entry pipe is considered 
to be optimum as angled blades are a complication and may lead to blood 
reactions from any increased stresses. 
Figure 6.33 shows a possible configuration where the inlet enters at an 
angle and is positioned below the centre line of the rotating disc(s). 
Fluid exit 
Fluid entry 
Pump 
rotation 
Figure 6.33 Proposed new fluid entry configuration. 
The angle and positions of the fluid entry and exit may have to be 
modified in relation to patient requirements. 
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Chapter 7. Conclusions. 
This work has shown that a Tesla pump will pump fluids. 
The pump output can be varied depending on the rotor construction 
and the fluid used. Rotors of different constructions gave different results for 
the same target performances with the same fluid. The Tesla pump was 
capable of delivering 10 I/min at 200 mm Hg at 3500 rev/min using water as a 
test fluid. 
The Tesla pump can exceed the delivery and generate pressures 
greater than the human heart. 
With the same rotor construction the pump performance improves 
compared to water when using a fluid with a viscosity greater than water. 
Appendices 14.18, 14.19 and 14.22 are replotted below with added emphasis 
to show the performance differences with the change in fluid viscosity. 
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Replot of Appendix 14.19 showing effects of viscosity on pump efficiency 
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Reynolds number comparison showing 
effect of fluid viscosity 
3500 
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FlowVmin 
Replot of Appendix 14.22 showing effect of viscosity 
on the Reynolds numbers. 
The speed I flow plot shows that the speed is lower for the same 
delivery with the highest viscosity mixture, water - glycerine, compared to 
water and water - xanthan gum. 
The efficiency I flow plot shows that the efficiency tends to be higher 
with a higher viscosity fluid over most of the flow range tested compared to 
the other fluids. 
The Reynolds number with the water - glycerine mixture is less than 
one third of the water and water I xanthan gum results for the same delivery. 
From these figures and assuming a 'limiting' Reynolds number of 2000, the 
output of the pump can exceed 10 I/min while with the other two fluids the 
delivery is limited to about 6 I/min. 
Although it was not possible to show any results, it is assumed that the 
pump performance will be worse using a fluid with a viscosity less than water. 
The results indicate a better performance with a 'large' gap and 'high' 
viscosity fluid compared to a 'small' gap and 'low' viscosity fluid although there 
must be a limit on the size of the gap as shown from the results of rotor 0, 
when comparing the Reynolds numbers. 
The gap may need to be 'matched' to the viscosity to give an optimum 
result as shown by the results from rotor O. 
The overall efficiency of the Tesla pump is low. The calculated 
efficiency from Crawford and Rice, (1974) is up to 99% but the highest figure 
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obtained with the Tesla pump was approximately 10% • Low efficiency is a 
characteristic of this type of pump. 
Disc design affects efficiency. From the calculated results of Crawford 
and Rice, (1974), discs with an inner I outer diameter ratio of 5 gave a higher 
efficiency than discs with a diameters ratio of 2. Comparing the shape of the 
efficiency curve of the Tesla pump tested here to the efficiency curve of a 
typical rotary pump gave the impression that the Tesla pump was not working 
at the maximum possible potential. The shape of the efficiency curve relative 
to speed indicated a higher speed may have given a higher efficiency. The 
Tesla pump tested here may have been too large for the application and a 
smaller pump running faster might have been more suitable. 
Attempts to promote cavitation were not successful. There was no sign 
of cavitation during any of the tests although differential pressures of 200 mm 
Hg were achieved. 
Without CFD calculations, it is assumed that the gap between the end 
discs of the rotor and the wall of the volute will give the maximum fluid shear 
stress in the pump. With a rotor-to-wall gap of 1.5 mm and a pump speed of 
2000 rev/min a shear stress of 15 N/m2 was obtained. This is greater than the 
maximum physiological level of stress for blood of 6 N/m 2 . Increasing the gap 
. between the rotor and volute walls would produce a lower shear stress level. 
An alternative disc design is proposed that is expected to reduce the 
stresses to close to the maximum physiological levels for the same pump 
speed. The effects of this change on pump performance are not known. 
The Tesla pump maintained constant pressures at constant speeds up 
to the maximum flow rate of 10 I/min. This effect is not fully understood as it is 
different to other pumps where the pressure falls off at constant speed as the 
flow rate increases. If as suspected, the pump was too large for this 
application and the delivery had been allowed to increase beyond 10 
litres/min, the characteristic of falling pressure with increased delivery may 
have been obtained. 
The pressure produced appeared to be dependant on the speed of the 
pump. If the assertion by Wiseman, (1994), is correct, a smaller pump running 
at a higher rotational speed but with the same peripheral speed should give 
the same pressure. Following this assertion, it should be possible to build a 
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pump with any disc diameter and rotational speed combination to give the 
required pressure and by changing the number of discs, to match an output 
specification. This would make the pump capable of matching an output 
specification anywhere within its maximum range of pressures and speed. 
The Tesla pump produced non dimensional parameter figures that 
were different to the calculated figures published by Crawford and Rice, 
(1974). Examples are shown in the table below. It Is not understood how a 
pressure change parameter can be negative for a pump. 
Coefficient Crawford and Rice Tesla QumQ results 
Efficiency 0/0 o to 99 0.5 to 12 
Re number o to 10 100 to 3500 
Volume flow rate parameter Uo o to 2 0.02 to 0.25 
Torque parameter T1 o to 1250 2 to 35 
Pressure change parameter Pt -437 to 3.5 0.4 to 1.5 
Improvements to the pump design and construction are expected to 
give practical results that are closer to the calculated results. 
From the video and photographs, the fluid flow patterns were not 
optimum. The generation of a vortex above the fluid inlet and the disturbed 
flow pattern in the fluid outlet indicates that more work needs to be done on 
the hydraulic design of the pump. It should be noted that these patterns were 
only seen after the injection of air into the pump inlet and not during any of the 
flow tests. 
Considering the difficulties with the flow patterns, an angled fluid entry 
to the pump may be beneficial in order to give a 'pre-swirl' effect to the fluid. 
Some design outlines are given in chapter 6. 
Further practical work needs to be done to explore the potential of this 
design of pump. The calculated data by Crawford and Rice, (1974), should be 
a good starting point. 
For a pump to be used as a heart-assisting device that is implanted 
into the patient, the size must be reduced in order that the pump will fit inside 
the patient. If pressure is controlled by rotor peripheral speed, a smaller pump 
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will have to run faster in order to maintain a satisfactory performance and 
careful design will be necessary to ensure acceptable blood stresses. 
It is proposed that this type of pump will be a 'single use' pump. 
For a pump used outside the body, it is proposed that the pump is built 
with no motor and no electronics attached to it. If the rotating parts could be 
attracted by a rotating magnetic field, external to the pump, the pumping 
action could be achieved without the driving mechanism in contact with blood. 
In the literature search there were no details of an automatic control to 
regulate the blood flow from a heart assisting device. 
There does not appear to be a test specification for a blood pump. 
Work has started on the development of an International Standard but has not 
yet been completed. 
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Chapter 8. Future work. 
The fluid flow patterns at present can be improved and need to be 
investigated to prevent flow separation and vortex generation. The use of a 
Computational Fluid Dynamics, (CFD), package is recommended in order to 
investigate solutions and provide an estimate of the fluid stress levels. The 
last point is very important as unacceptable fluid stresses and flow patterns 
may damage the blood and cause severe problems to the patient. 
Parts of the pump to be investigated are:-
a) The cutwater. The reason for the flow 'diving' under the cutwater and 
the flow separation needs to be investigated and a more acceptable design 
proposed. 
b) The vortex generated in the output flow appears to be related to the 
cutwater or the volute wall. The cause of the vortex needs to be established 
and a solution provided to eliminate this problem. 
c) The efficiency of the pump needs to be improved. The work by 
Crawford and Rice, (1974), indicated that the calculated efficiency reached a 
maximum with a disc diameter ratio of about 5, (this is the ratio of the 
diameter of the inner hole to the outer diameter of the disc). Using this work 
as a starting point, the design of the discs should be investigated to confirm 
this finding and suggest improvements. 
d) The CFD work should be used to investigate the flow between the 
discs and around the cutwater and to calculate the fluid stresses. Other 
design changes need to be investigated as necessary. 
e) Investigations are needed to determine the potential of the pump to 
heat the fluid it is pumping. Excessive temperatures can damage blood and 
changes must be made to ensure that the pump does not increase the blood 
temperature above acceptable limits. 
f) Any design changes must provide acceptable fluid stress levels. 
Previous work indicates that stress levels of approximately 5 N/m 2 would be 
acceptable. 
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APPENDIX 1. THE ELEMENTS OF BLOOD. 
Characteristics Red cells White cells l total white cells l 5 - 9 thousand Qer mm3 Platelets 
Number (4.5 - 5) NeutroQhils. EosinoQhils. BasoQhils. LymQhocvtes. Monocvtes. 250 - 300 
million 65-75% of all 2-4% of all 1 % of all white 20-25% of all 2-6% of all thousand 
per mm3 white cells white cells cells white cells white cells per mm3 
Average size, 
(diameter in microns) 7-8 10 - 12 10 - 14 9 - 12 6 - 12 12 - 15 2-3 
Appearance of None Dark, up to 5 Pale, 2-3 lobes Pale, 2-3 Very dark, Light, None 
nucleus lobes lobes slightly indented indented 
Appearance of Red Clear, many Pale, moderate Pale, a few Blue, agranular, Blue-grey Very dark 
cytoplasm tiny purple number of red coarse dark scant agranular 
granules granules blue granules 
Source Bone Bone marrow Bone marrow Bone marrow Lymphiod tissue Lymphiod Bone marrow, 
marrow tissue (megakaryocyte) 
Motility None Marked Little Marked Marked Marked None 
Phagocytic ability None Marked Negligible Negligible Negligible Marked None 
General function O2 and Phagocytosis ??? allergy? ??? Protective, Phagocytosis Blood clotting 
CO2 anticoagulent immunties, I 
transport antibody carrier 
Miscellaneous Shape of Found in Found in Cell fragment 
properties biconcave connective connective 
disc tissue in great tissue in great 
quantities quantities 
After:- Essential Human Anatomy and Physiology, B.R. Landau, Scott, Foresman &Co., Glenview, Illinois, USA, 1976, ISBN 0-673-05989-8 
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APPENDIX 2. PHYSIOLOGICAL FLOWN PARAMETERS IN THE HUMAN CIRCULATION. 
Vessel Diameter Volume flow rate Mean linear velocity Reynolds Wall shear rate Wall shear stress 
m*10-3 m/s*10-3 m/s*10-3 number lIs N/m2 
min max mean min max mean mean min max mean min max mean 
Ascending aorta 23.0-43.5 - - 364 - - 245-876 3210-6075 - - 45-305 - - 0.16-1.07 
Femoral artery 5 -6.9 23.1 3.7 -350 1175 188 283 -560 1885 302 1.96 6.59 1.06 
Common carotid 5.9 2.7 10.6 5.1 99 388 187 332 134 526 253 0.47 1.84 0.89 
Carotid sinus 5.2 1.8 6.9 3.3 85 325 156 244 130 500 240 0.46 1.69 0.84 
External carotid 3.8 0.9 3.7 1.8 83 327 157 180 175 687 331 0.61 2.41 1.16 
Small arteries 0.3 - - 3.5*10-3 - - 50 2.3 - - 1335 - - 4.67 
Arterioles 0.025 - - 2.5*10-6 - - 5 3.8*10-L - - 1600 - - 5.6 
Capillaries 0.006 - - 7.5*10-9 - - 0.2-1.5 3.6*10-4 - - 265-2000 - - -
to to 
5.7*10-8 2.7*10-3 
Thoracic inferior 20 - - 34-50 - - 107-160 323-482 - - 43-64 - - 0.15-0.22 
vena cave 
--- '-- --- -- -- - -
Goldsmith H.L., Turitto V.T., (1986) 
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APPENDIX 3. INVENTORY OF BLOOD PUMPS. 
DisQlacement QumQs Rotary blood QumQs. Continuous flow devices Total artificial heart 
Pulsatile VAD 
Axial QumQs Radial QumQs 
*HeartMate Novacor Hemopump *Jarvik Biopump Capiox 
IPNE 2000 
Lion Heat Thoratec Sun DeBakey Delphin Isoflow 
(Pierce- Waseda (Lifestream) 
Donachy) IVAP 
Medos / HIA *Berlin *HeartMate Impella Rotodynamic Gyro Pump 
Heart II pump 
(Axipumpl 
*Abiomed Nippon- Valvo Streamliner RotaFlow HiFlow 
BVS 5000 Zeon Pump 
VAD 
Toybo VAD ALVAD Nikkiso AB 180 
(Model 7) Pump 
BCM Cora *Vienna Evaheart 
Pump centrifugal 
*Roller *Intra- Abiomed CF Kriton 
Pump Aortic Pump 
balloon 
pump 
OHeartSaver PUCA MSCP *HeartMate 
Pump III 
*Abiocor 
The pumps denoted by * are described in this report. 
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Diagonal QumQs Heart reQlacement 
*VentrAssist HeartQuest *Abiomed Akutsu III 
TAH TAH 
DeltaStream HIA Cardiowest, Liotta TAH 
Microdiagonal TAH 
(Jarvik 7) 
PennState Utah TAH 
TAH (EHTAH) 
Phildelphia Nimbus 
Heart TAH (E4T) 
Baylor TAH *Undulation 
Pump 
Blood pumps for circulatory support 
Perfusion 2000; 15: 295-311. 
APPENDIX 4. ARTIFICIAL HEART TYPES AND APPLICATIONS. Perfusion 2000. 
Th d d bv * are described· 
Name Manufacturer Type Flow Capacity Speed Duration Power Application Usage 
*Roller Watson-Marlow- Pulse Pulsatile Not stated Not 4 hours Electric motor Adult Hospital 
I lPeristaltic) Bredel applicable 
*lntraAortic Datascope Pulse Pulsatile Not Not Short Pneumatic Adult Hospital 
Medical applicable applicable term 
*Abiomed Abiomed BV, Pulse Pulsatile 100 ml vol. Not Short Pneumatic Adult Hospital 
BVS 5000 Europe applicable term 
*HeartMate Thermo Pulse Pulsatile 2-101/min Demand 90 days Pneumatic/elec. Adult Hospital/ 
Cardiosystems driven public 
*Berlin Mediport Pulse Pulsatile 10-50 ml. Not 1 year + Pneumatic Infant-Adult Hospital/ 
Kardiotechnik vol. applicable public 
*Abiocor Abiomed Pulse Pulsatile Not stated Not Short Batteries Adult Hospital/ 
applicable term public 
*Atom pump Never made Pulse Pulsatile Not stated Not 30+ years Plutonium 238 Adult Never 
ap~licable used 
* Jarvik 2000 Jarvik Heart Inc. Rotary Axial 5-61/min Up to 12,000 Long Batteries Adult Hospital/ 
rev/min term public 
*AB 180 Abiomed Rotary Centrifugal 61/min 2500-4500 14 days 12V motor Adult Hospital 
rev/min 
DeBakey Baylor Rotary Axial 51/min 10,000 Not Batteries Adult Hospital 
Colleije/NASA rev/min stated 
Terumo Terumo Rotary Radial 5-61/min 2,000 to 48-72 Batteries Adult Hospital 
3,000 rev/min hours 
Thoratec Thoratec Europe Pulse Pulsatile 65 ml vol. Demand 38-80 Pneumatic Adult Hospital 
driven days 
Novacor Novacor Baxter Pulse Pulsatile 8.51/min Demand 9 months Batteries Adult Hospital/ 
driven public 
Medos Medos Pulse Pulsatile 0.5-9.5 Fixed and 2 weeks Pneumatic/elec. Infant-Adult Hospital 
Medizintechnik I/min demand + 
- - -
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Appendix 5. 
Mechanical Properties of Stainless Steel Surgical Implants 
Composition of 316 and 316L steels. a (by weight, 0/0.) 
ELEMENT. GRADE 1. GRADE 2. 
Carbon 0.08 max 0.03 max 
Manganese 2.00 max 2.00 max 
Phosphorus b 0.03 max 0.03 max 
Sulphur 0.03 max 0.03 max 
Silicon 0.75 max 0.75 max 
Chromium 17.00 - 20.0 17.00 - 20.00 
Nickel 12.00 - 14.00 12.00 - 14.00 
Molybdenum 2.00 - 4.00 2.00 - 4.00 
a Ref :_ Annual book of ASTM Standards, Part 46, American Society for 
Testing and Materials, Philadelphia, 1980, p578. 
b Slight variations are given, (0.025 max.), for special quality steels, (F318 and 
F319 of ASTM). 
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Appendix 5. (continued) 
Mechanical Properties of Stainless Steel Surgical Implants. a 
ULTIMATE YIELD ELONGATION, 2 ROCKWELL 
TENSILE STRENGTH, INCH, (50.8 MM). HARDNESS. 
STRENGTH (0.2% OFFSET). 
(MIN.) lMIN). 
Condition PSI, (Mpa) PSI, (Mpa) Min. (%) Max. 
Grade 1 
(type 316} 
Annealed 75,000, (515). 30,000, (205) 40 95 HRB 
Cold finished 90,000, (620) 45,000, (310) 35 ----
Cold worked 125,000, (860) 100,000, (690) 12 300 - 350 
Grade 2 
(tvpe 316L) 
Annealed. 73,000, (505) 28,000, (195) 40 95 HRB 
Cold finished 88,000, (605) 43,000, (295) 35 ---
Cold worked 125,000, (860) 100,000, (690) 12 ---
a Ref: - Annual Book of ASTM Standards, Part 46, American Society for 
Testing and Materials, Philadelphia, 1980, p579 
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Appendix 6 
Plastics and Applications. 
Name of plastic. Application. 
Polyvinylchloride, (PVC) Blood and solution bags, surgical packaging, IV 
sets, dialysis devices, catheter bottles, 
connectors and cannulae. 
Polyethylene, (PE) Pharmaceutical bottle, non-woven fabric, 
catheter pouch, flexible container and 
orthopaedic implants. 
Polypropylene, (PP) Disposable syringes, blood oxygenator 
membrane, suture, non-woven fabric and 
artificial vascular grafts. 
Polymethyl metacrylate, Blood pump and reservoirs, membrane for 
(PMMA) blood dialyser, implantable ocular lens and 
bone cement. 
Polystyrene, (PS) Tissue culture flasks, roller bottles and filter 
wares. 
Polyethylenterephthalate, Implantable suture, mesh, artificial vascular 
(PET) grafts and heart valves. 
Polytetrafluoroethylene, Catheter and artificial vascular grafts. 
(PTFE) 
Polyurethane, (PU) Film tubing and components. 
Polyamide, (nylon) Packaging film, catheters, sutures and mould 
parts. 
Project report K. Cordes, 
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APPENDIX 7.1 CALIBRATION FIGURES FOR THE PRESSURE TRANSDUCERS 
Strain indicator, model P-530, ser. No. 005384. Gauge factor = 2.11. Balance = 4.91 1 mm Hg*0.491/25.4=0.0193307 Ibflin2• 
Vishay switch and balance unit. Model SB - 1, Ser. no. 025761 
Observed readings Strain Correction factor 0.019331 
Press cm Hg Calculated pressures 
Trans. 1 Trans. 2 Trans. 3 Trans. 1 Trans. 2 Trans. 3 T1 mmHQ T1 Ibf/inL T2 mmHg T2lbflinL T3 mmHg T31bf/inL 
49.4 26.9 50.0 26.4 52.2 24.2 7900 8200 9400 225 4.349 236 4.562 280 5.41 
48.9 28.2 48.4 28.6 51.4 25.5 7100 6800 8900 207 4.002 198 3.828 259 5.01 
47.6 29.6 47.8 29.3 50.8 26.4 6200 6400 8400 180 3.480 185 3.576 244 4.72 
46.8 30.5 46.4 30.8 50.2 27.0 5600 5400 8000 163 3.151 156 3.016 232 4.48 
46.0 31.5 46.2 31 2 49.8 27.6 5000 5200 7700 145 2.8D3 l5D 2.900 222 4.29 
45.7 31.8 45.5 31.1 49.3 28.2 4800 4600 7300 139 2.687 144 2.784 211 4.08 
45.0 32.7 45.2 32.4 48.9 28.7 4200 4400 7000 123 2.378 128 2.474 202 3.90 
44.7 33.1 44.4 33.4 48.6 28.4 4000 3800 6800 116 2.242 110 2.126 202 3.90 
43.8 34.0 44.1 33.7 48.2 29.5 3400 3600 6500 98 1.894 104 2.010 187 3.61 
43.6 34.3 43.3 34.7 47.9 29.8 3200 3000 6300 93 1.798 86 1.662 181 3.50 
42.8 35.3 43.1 35.0 47.5 30.3 2600 2800 6000 75 1.450 J3J 1.566 172 3.32 
42.6 35.6 42.3 35.9 47.3 30.6 2400 2200 5800 70 1.353 64 1.237 167 3.23 
41.8 36.5 42.0 36.2 47.0 30.9 1800 2000 5600 53 1.025 58 1.121 161 3.11 
41.5 36.8 41.3 37.2 46.6 31.4 1600 1400 5300 47 0.909 41 0.793 152 2.94 
40.8 37.8 41.0 37.5 46.3 31.7 1000 1200 5100 30 0.580 35 0.677 146 2.82 
40.5 38.1 40.3 38.4 46.0 32.0 800 600 4900 24 0.464 19 0.367 140 2.71 
45.8 32.3 201L 400 47J)0 ~ ~O 0 0.000 135 2.61 
45.5 32.7 100 0 4500 0 0.000 0 0.000 128 2.47 
40.2 38.5 40.2 38.5 45.3 33.0 530 550 4300 17 0.329 17 0.329 123 2.38 
45.0 33.4 4100 116 2.24 
44.8 33.6 3900 112 2.17 
44.6 33.9 3700 107 2.07 
44.3 34.2 3500 101 1.95 
44.0 34.5 3300 95 1.84 
I 
43.7 35.0 3000 87 1.68 
43.4 35.3 2800 81 1.57 
43.1 35.5 2600 75 1.45 
42.8 35.9 2400 69 1.33 
42.5 36.3 2200 62 1.20 
42.3 36.6 2000 57 1.10 
, 42.0 36.8 1800 52 1.01 
418 37.2 1600 46 0.89 
41 5 37.5 1400 40 0.77 
41) 37JL 1200 35 0.68 
.~ 1 1 38.1 1000 30 0.58 I 
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Appendix 7.2. Strain Vs pressure for three transducers. 
T1 Strain Vs Pressure 
250 
0) 
::I: 200 
y = 0.0287x + 1.1896 
E 
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Q) -+- Series1 
~ 100 ::J 
II> - Linear (Series1) 
II> Q) 50 ~ 
a.. 
0 
0 2000 4000 6000 8000 10000 
Strain 
Transducer 1. Strain Vs pressure. 
T2 Strain Vs Pressure 
250 
0) 
::I: 200 
y = 0.0289x + 0.9022 
E 
E 150 
-+-Series1 
Q) 
~ 100 ::J 
II> 
- Linear (Series 1) 
II> Q) 50 ~ 
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0 
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Strain 
Transducer 2. Strain Vs pressure. 
T3 Strain Vs Pressure 
300 
~ 250 y = 0.0292x - 1.5785 
E 200 
E -+- Series1 
Q) 150 
~ 
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II> Q) 50 ~ a.. 
0 
0 2000 4000 6000 8000 10000 
Strain 
Transducer 3. Strain Vs pressure. 
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Appendix 8. 
Electric motor and control equipment. 
Motor. 
Parvalux type no. PM 50, 24vDC, 255 W, 5000 rev/min. 
Continuous rating, built to International Organisation for Standardization, 
(ISO), specification number ISO 9002. 
Tacho generator fitted to non-drive end of motor. 
Power supply. 
Radio Spares - unregulated power supply, RS part no 597-582. 
Input 115/230 V - 50/60 Hz 
Output 24V DC, 288 W. 
Control unit. 
Parvalux 2020 PWM manual controller, 
Input 12/24 V DC, 0-12 Amps. 
Output 0-24 V DC, 12 Amps. maximum rating. 
Contact details. 
Electric motor purchased from Parvalux Electric Motors Ltd., Bournemouth, 
England. [http://www.parvalux.co.uk], 
Control equipment from RS Components, PO Box 99, Corby, Northants, 
NN17 9RS. (rswww.com) 
293 
Appendix 9. Calibration of tachogenerator. 
Tachogenerator output Vs speed 
8000 
7000 
6000 
t: 
E 5000 
-> f!! 4000 
"C 
CI) 
CI) 3000 
c. 
en 2000 
1000 
y= 2.782; 138.2x + 51.5 / 
/ 
/ 
/ 
/ 
/ v 
¥' 
-- Volts Vs Speed 
- Poly. (Volts Vs Speed) 
0 
o 10 20 30 40 
Tachogenerator volts 
Calibration of tachogenerator output Vs speed. 
The equation shown below was used in all the calculations of speed from the 
tacho generator voltage. 
Speed ( rev / min) = (2.782 (tachovolts)2) + (1.382 tachovolts) + 51.5 
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Appendix 10.1, Entry block 
9 HOLES 6.5 DIA. 
,/ 
:> 
" 
'0 
THE 33 DIA. HOLE SIZE IS APPROXIMATE. 
SAMPLE PIPE W'ILL BE SUPPLIED, 
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MATL 
DRG T 
DRG N 
DRA\JN 
DATE 
30 
---
---
I 
r---1-. 
ACRYLIC 
ENTRY BLOCK 
MF 
3 APR. '02. i 
Appendix 10.2, Volute 40. 
1 HOLE 2 DIA. TO BREAKTHROUGH 
2 HOLES, HELICDILED, 
M5l1ElO DEEP. 
-,_ .. 
'I i 4 HOLES 6.5 DIA. ! 
o 
N 
-< 
If) 
C1' 
v 
If) 
C1' 
~ 
'oY;/// 
Y;> 
I~ \\. 
5 HOLES 6.5 DIA.\\ 
,~
n CENTRELINE FOR 
.. __ "'~ ~... '0' RING GROOVE. 
". , 
o 
lu-
CUT'w' ATER RADIUS 
O.5MM , 
~F. 
~ 
o 
f'.. 
ALL MACHINED SURFACES TO BE POLISHED TO ALLO'w' THE PASSAGE OF LIGHT 
'0' RING GROOVE TO BE SUITABLE FOR 3MM NITRILE RUBER CORD. 
THE SHAPE OF THE VOLUTE IS MADE UP FROM T'w'O CIRCULAR ARCS. 
EACH ARC IS TAKEN FROM THE VERTICAL CENTRELINE OF THE BLOCK. 
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~ 
o 
(") 
- 1 ACRYLIC 
T1 VOLUTE 40 
jDATE :j 28 JUNE '02.1 
CD 
ru 
ru 
..... 
Appendix 10.3, Bearing block 
// 
; 
"->-, 
o 
"-- '",,--
'" 
\ 
9 HOLES 6.5 DIA. 
\ 
:tlll II 1 ----
~-----~-- .. ----
a 
/ 
/ 
Ln 
(J'> 
~ 
THIRD ANGLE PROJECTION. 
'0' RING GROOVE FOR RING 40 I.D. lIE 3 SECTION. 
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MATL ACRYLIC 
DRG T BEARING BLOCK. 
DRG N 
DRA'w'N MF 
DATE 3 APR. '02. 
Appendix 10.4, Shaft. 
TAP M4 TO DEPTH SHO~N 
.e 
70 
4 R3 (MAX) I SURFACE FINISH TO BE SUITABLE 
FOR CONTACT VITH SHAFT SEAL, 
<:) 
...-i - ----.=--£ 3----r- J 
1 
¢6 
90 
14 
10 
19)5 
DGR T SHAFT 
DRG N 
DRA \-IN MF 
DATE 6 DEC '06 
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Appendix 10.5, Mounting disc. 
4 HOLES) DRIll THRO' 
(5) C'SK 90° TO <69, 
BOTH SIDES, 
.~ 
~ 
f 
4 HOLES) DRIll THRO' 
<64MM CLEARANCE, 
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II ~ 
MATl. ACRYLIC. 
DRG T MOUNTING DISC 2. 
DRG N 
DRAW'N MF 
DATE '02, 
Appendix 10.6, Drive disc 
4 HOLES 
4MM CLEARANCE. 
300 
-H~' 
II 
~ ~ 
~ 
~ 
MATL. ACRYLIC' 
TITLE DRIVE DISC. 
f,Wv1BER 
DRA'w'N MF 
DATE 22 JUNE '02. 
Appendix 10.7, End-disc 
4 HOLES 
4MM CLEARANCE. 
MATl. ACRYLIC 
TITLE END DISC. 
NUMBER 
DRA'w'N MF 
DATE 6 NOV 102 
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Appendix 10.8, Assembly. 
AIR. BLEED HOLE 
0(2(' "0, 
./ ~:-
cf 0 
II 
II 
DRIVE DISCS 
END DISC 
ENTRY BLOCK VOLUTE 
302 
MOUNTING DISC 
// 
SEAL 
BEARINGS 
/-/ 
SHAFT 
BEARING BLOCK 
MA TL. I ACRYLIC 
DRG TI ASSEMBLY 3 
DRG N 
DRA'WN I MF 
DATE I 3 JULY '02. 
Appendix 11. Results of temperature test. 
,------------------~--~-
Appendix 12. 
40 
U 35 
g> 30 
"C 25 
2! 20 
:J 
'§ 15 
~ 10 
~ 5 
I- 0 
-5 
V 
7 
.- .. 
/' 
o 
Temperature Vs time. 
-I 
....--
I---"" 
1 
..... 
---
I---'-~ .. 
--
2 3 4 5 6 
Time, hours. 
1- Temp, deg C.' 
c:. ,,",""'" ,,, , d.g C
1 
I 
Test sheet 18 of rotor 0 
The performance 'set points' for the constant speed tests. 
Delivery I, min-1 Speed rev.min-1 
10 4000 
10 3500 
10 3000 
10 2500 
10 2000 
10 1500 
10 1000 
5 4000 
5 3500 
5 3000 
5 2500 
5 2000 
5 1500 
5 1000 
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Appendix 13.1. For a 45% glycerine in water mixture, the polyline result 
gives a specific gravity of 1.099792. 
1.4 
1.2 
~1 
'> ~ 0.8 
u i 0.6 
a. 
In 0.4 
0.2 
Specific gravity of water I glycerine mixture. 
20 
-
y= 0.000006X2 • 0.001945x + 1.000117 
4lJ 60 
Glycerine % 
80 100 120 
Appendix 13.2. For a 45% glycerine in water mixture the straight line result 
gives a specific gravity of 1 .1024 
o 
20 
Specific gravity of water I glycerine mixture. 
y = O. 025x + 0.9 99 
40 60 
Glycerine % 
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-
80 100 120 
Appendix 14.1. Test fluid, water only. 
Optimisation of rotor, 10 I/min @ 200 mm Hg. 
4500 
4000 
c: 3500 
E 3000 
~ 2500 
~ 2000 
~ 1500 
., 
1000 
500 
o 
Optimisation of rotor. 
10 llmin @ 200 mm Hg, water only. 
Flow Vs Speed. 
I I , 
I I ~ 
I I-"'~ 
-'-
..................... 
I ....--:::; i-"""'" 
...;:::;-r-
~ 
~ 
I 
4 10 
FlOW'Umln 
12 
-+-- Test 2 Rotor 0 
....... Test 22 Rotor 7 
........ Test 41 Rotor 3 
Appendix 14.3. Test fluid, water only 
Optimisation of rotor, 10 IImin @ 100 mm Hg. 
Optimisation of rotor. 
10m llmin@ 100 mm Hg, water only. 
Flow Vs Speed. 
3000 
2500 
i2000 
:; 
~ 1500 
! 
:'1000 
'" 500 
0 
0 10 12 
FlowUmln 
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Appendix 14.2. Test fluid, water only 
Optimisation of rotor, 10 I/min @ 150 mm Hg 
4000 
3500 
c: 3000 
~ 2500 
f 2000 
." 
: 1500 
"-
<II 1000 
500 
a::;;..o 
--
Optimisation of rotor. 
10 IImin @ 150 mm Hg, water only. 
Flow Vs Speed. 
I I I 
i~ 
/"r~ 
~~ 
~ 
~ 
'---~-'----~. 
10 12 
Flowllmin 
Appendix 14.4. Test fluid, water only 
Optimisation of rotor, 5 I/min @ 200 mm Hg. 
4500 
4000 
c: 3500 
E 3000 
12500 
-:;: 2000 
~ 1500 
'" 1000 
500 
1 
I 
l--
Optimisation of rotor. 
5 IImin @ 200 mm Hg, water only. 
Flow Vs Speed. 
i I I 1 
-1 I 
I . 
I~ 
I ' /' ........ 1 1 I/"'../ I 
I .-/~ I 1 
~ 
I I 
~-
I 
I I I 
I I i j 
FlowUmln 
Appendix 14.5. Test fluid, water only 
Optimisation of rotor, 5 I/min @ 150 mm Hg. 
4000 
3500 
.E 3000 
.E 2500 
> 
:! 2000 
." 
: 1500 
"-
en 1000 
500 
o 
Optimisition of rotor. 
51lmin @ 150 mm Hg, water only. 
Flow Vs Speed. 
! 
1 ~ 
I ~ ./"'" 
1 I~ 
~ 
~,... i 
--
. I 
2 4 
Flowl/min 
Appendix 14.7. Test fluid, water only. 
Optimisation of rotor, 10 I/min, 'as found'. 
1400 
1200 
.= 1000 
E 
~800 
~ 600 
.. 
:: 400 
200 
Optimisation of rotor. 
10 I/min 'as found', water only. 
Flow Vs Speed. 
I~ 
10 
FlowUmln 
12 
.... Tesl1 Rolor 0 
.. Test 21 Rotor 7 
.... Test 40 Rotor 3 
Appendix 14.6. Test fluid, water only. 
Optimisation of rotor, 5 I/min @ 100 mm Hg. 
3000 
2500 
c: 
E 2000 
;; 
~ 1500 
. 
~ 1000 
en 
soo 
o 
Optimisation of rotor. 
S Ilmin @ 100 mm Hg, water only. 
Flow Vs Speed. 
o 
Flowllmin 
.... Test 12 Rotor 0 
.. Test 32 Rotor 7 
.... Test 51 Rotor 3 
Appendix 14.8 .Test fluids, water only. 
Optimisation of rotor, 10 I/min @ 200 mm Hg. Pump inlet restricted 
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Optimisition of rotor. 
10 Ilmin @ 200 mm Hg, water only, inlet valve set. 
Flow Vs Speed 
4000 .~~ 3500 . .=~ . 
~25OO ...• Test 15 Rotor 0 ~ 2000 .. .. I .. Test 35 Rotor 7 
.. 1500 . ... ,. Test 54 Rotor 3 
~1(xx) ~ , -
500 -1-1-'--+---1---+---1 
10 
FlowUmin 
I 
.----j 
-j 
12 
Appendix 14.9 .Test fluids, water only. 
Optimisation of rotor, 5 I/min @ 100 mm Hg. 
Pump inlet restricted 
Optimisation of rotor. 
S 11m in @ 100 mm Hg, water only, inlet valve set. 
Flow Vs Speed 
~r-----'------------'------r-----'-----, 
2500 I ! 7''- j 
1::1 ~: 1 I,~~--~ 
500 +-1 --+---+--+----+--+-----1 
4 
Flow Urn!n 
Appendix 14.11. Test fluid water only. Comparison of 
speed Vs flow with inlet valve open and restricted. 
5 I/min @ 100 mm Hg 
Speed Comparison of Open and Restricted inlet 
valves, water only. 
51/min @ 100 mm Hg. 
3000 I 
1 
.= 2500 
~ 2000 I I ~ -8- Outlet valve set. 
. ./" test 51 ~ 1500 
~ 1000 I ...-=I 
--Inlet valve set. 
a> ..- ! ~ 500 I 
test 55 
0 
0 2 3 4 5 6 
Flow Ilmln 
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Appendix 14.10. Test fluid, water only. Comparison 
of speed Vs flow with inlet valve open and restricted. 
10 I/min @ 200 mm Hg. 
Speed comparison of open and restricted inlet 
valve, water only. 10 Umin @ 200 mm Hg 
4000 
3500 £: ~ 3000 
""> 2500 / -a- Outlet valve set, ~ lesl41 ~ 2000 
-g 1500 --Inlet valve set, les 
~ 1000 / 54 
..... 
500 
0 
0 5 10 15 
Flow I/min 
~- ---
Appendix 14.12. Test fluid - water only. Constant speed 
tests, 1000 - 4000 rev/min. Flow Vs delivery pressure 
with optimum rotor @ 5 I/min 
Rotor three, constant speed (rev/min), test fluid water. 
Flow Vs Delivery pressure. 
3IlOr'--------------------------------------------------
2~+1---------------------------------------
--..-1000 
"I ~ ~ .,~ E ~ : ; ~= ~~ ~ ...
50 • 1 
Flow Umln 
Appendix 14.13. Test fluid - water. Constant speed. 
tests, 1000 - 4000 rev/min. Flow Vs differential pressure 
with optimum rotor @ 5 I/min. 
Rotor three, constant speed, (rev/min), test fluid - water. 
Flow Vs Differential pressure. 
~TI------------------------------------------------------
2~ ~1000 
~ -~ E~ _= 
~1~ -2~0 
~ -~ :~ -~ ~ ~+-______ ~~~~~~~~~~~~~~~~~~~~ _______ ~~o 
Flow Umln 
Appendix 14.15. Test fluid - water. Constant speed 
tests, 1000 - 4000 rev/min., Flow Vs delivery pressure 
with optimum rotor @ 10 I/min 
Rotor three, constant speed (rev/min). Test fluid water. 
Flow Va Delivery pressure. 
~:f~-~-·-~~· =~~-' ---:<200 - - -
~ . ------.. 
; 150 - ---
I l ~ ... -----. .~.-~=-<O'------4-___ -1:1-~· >~:- :-___ .~ 
L: ~ ,. o 4 8 10 12 flow "mln 
___ 1000 
...... '500 
......... 2000 
..... 2500 
-M- 3000 
"<1-3500 
--+-4000 
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Appendix 14.14. Test fluid - water. Constant speed, 
tests 1000 - 4000 rev/min. Flow Vs power 
with optimum rotor @ 5 I/min. 
Rotor three, constant speed, (rev/min), test fluid - water, 
Flow Vs Power. 
140,--------------------------------------
120 ~1000 
. 100 ........ 1500 
S -2000 1M _~ 
~oo _~ 
~ t=~~E -3500 ~4O ~~ 20 
Flowllmln 
Appendix 14.16. Test fluid - water. Constant speed 
tests, 1000 - 4000 rev/min Flow Vs differential pressure 
with optimum rotor @ 10 IImin 
Rotor three, constant speed (rev/min). Test fluid water. 
Flow Vs Differential pressure. 
300,,--------------------------------------------
250~1------------------------------------
~200~1--~~==~~~~~==~~~~~­
E 
~ 150 
l 100 I ~~_+ __ 
501 .~ 
o I - - .-------- - -
o 10 
Flow IImin 
·-1000 
-- • 1500 ~-• 2000 • 2500 • 3000 -- • 3500 -+ 4000 
12 
Appendix 14.17. Test fluid - water. Constant speed 
tests, 1000 - 4000 rev/min. Flow Vs power 
with optimum rotor @ 10 I/min. 
140 
120 
100 
. 
~ 80 
; 80 
0 
.. 
40 
20 
Rotor three, constant speed (rev/min). Test fluid water. 
Flow Vs Power 
-+-1000 
-+-1500 
....-2000 
-+-2500 
-><- 3000 
)( )( lE)E)~)( --i( 1 ....... 3500 
-+- 4000 
.to .. .. .. .. .. .. .. .. .. 
2 4 10 12 
Flowllmln 
Appendix 14.19 - Flow Vs Efficiency 
8 
7 
ae6 
~5 
~4 
.~ 3 
~2 
1 
o 
o 
a 
~ y 
-
F.. 
// 
f£d. 
w 
10 I/min @ 200 mm Hg, 
Flow Vs Efficiency 
~ ~ ----' 
f::Y b?~ 
---~ 
2 4 6 
Flowl/min 
8 10 12 
-+- RT est 2 Rotor 0 
... RTest 22 Rotor 7 
..... RTest 41 Rotor 3 
..... RTest 81 Rotor 3G 
.... Test 140 Rotor 3X 
... RTest 81 Rotor 38 
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Appendix 14.18. Comparison of 
flow Vs speed with all test fluids. 
Comparison tests with three test fluids. 
10 I/min@ 200 mm Hg. 
Flow Vs Speed. 
5000 
I c: 
-+- Test 2 Rotor 0 
'E 4000 ~ -+- Test 22 Rotor 7 ~ 3000 
~ ~ ~ ..... Test 41 Rotor 3 ~ 2000 
I~ ~I *" Testa1 Rotor 3G ~ 1000 
en ~ ~ Test 140 Rotor 3X 
0 I 
0 2 4 6 a 10 12 
Flow I/min 
Appendix 14.20 - Flow Vs Flow Parameter. 
10 I/min @200 mm Hg, 
Flow Vs Volume Flow parameter, 
0.10 
0.08 .... RT est 2 Rotor 0 ~ . / o~ ... RT est 22 Rotor 7 _ '" 
--:;;0.06 f ... RTest 41 Rotor 3 I "'e 1 ; :!!0.04 
• 
..... RTest 81 Rotor 3GI 
-co 
00. +- Test 140 Rotor 3X 
> 0.02 ~Ij""j ... RT est 81 Rolor 38 
0.00 
0 5 10 15 
Flowl/min 
Appendix 14.21 - Flow Vs Reynolds Number 
10 IImin @ 200 mm Hg, 
Flow Vs Reynolds Number, 
Comparison of 3 rotor builds. 
~ 300000 1 ! 1 E 250000 
1 
I ! 1/ ~ 200000 
I I/"" -+- RT est 2 Rotor 0 
." 150000 ... RT est 22 Rotor 7 
"C ! '~ I 0100000 
-.- RTest 41 Rotor 3 
;.. 50000 ~ j 
Q) 1 1 a:: 0 
0 2 4 6 8 10 12 
Flowllmin 
Appendix 14.23 - Flow Vs Pressure Parameter. 
... 1.2 
Q) 
- 1 Q) 
E 
~ 0.8 
'" 0..0:: 0.6 
~ 0.4 ::::J 
.. 
10 I/min @ 200 mm Hg, 
Flow Vs Pressure Parameter. 
I ~ o.~ I 
\ c.. 0 ~ 5 10 15 
L----. Flow IImin 
-+- RT est 2 Rotor 0 
... RT est 22 Rotor 7 
-.- RTest 41 Rotor 3 
-M- RTest 81 Rotor 3G 
+- Test 140 Rotor 3X 
.... RTest 81 Rotor 3B 
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Appendix 14.22 - Flow Vs Reynolds Number 
10 I/min @ 200 mm Hg, 
Flow Vs Reynolds Number, 
2 rotors with different test fluids 
... 3500 
"A I ~ 3000 L I ... RT est 22 Rotor 7 ; 2500 
./ i -.- RTest 41 Rotor 3 
c: 2000 V .... RTest 81 Rotor 3G ." ~ 1500 
./ +- Test 140 Rotor 3X g 1000 ~ ~ .... RTest 81 Rotor 38 ~ 500 l a::: 0 0 5 10 15 Flow Vmin 
Appendix 14.24 - Flow Vs Torque Parameter. 
~ 25 
t-
; 20 
Q) 
E 15 
'" ~10 
Q) 
~ 5 
::. 0 
10 I/min @ 200 mm Hg, 
Flow Vs Torque parameter. 
I ~ j ! i ! ! ' i-, 
0 2 4 6 8 10 12 
Flow IImin 
-+- RT est 2 Rotor 0 
... RT est 22 Rotor 7 
+ RTest 41 Rotor 3 
~ RT est 81 Rotor 3G 
-<>- Test 140 Rotor 3X 
l -+- RT est 81 Rotor 3B 
-. ~--------
Appendix 14.25 - Flow Vs Speed 
Comparison tests with three test fluids. 
10 I/min@ 150 mm Hg. 
Flow Vs Speed. 
4000 -,-----,----,-------r-~,--_r__-
c: 
...§ 3000 I bC!~ 
> 
~ 2000 I =- ...... ~.cT 
"C 
CD 
~1000+--=~~~~--+----+----~~ 
en 
O+I----~--~---+----+_--~--~ 
o 2 4 6 
Flowl/min 
8 10 12 
-+- Test 4 Rotor 0 
+- Test 24 Rotor 7 
...- Test 43 Rotor 3 
"*"" Test 83 Rotor 3G 
..... Test 141 Rotor 3X 
Appendix 14.27 - Flow Vs Flow parameter. 
10 I/min @ 150 mm Hg, 
Flow Vs Volume Flow Parameter. 
CD 
-
0.1 I _ _ I ~I ----------, 
~ .0.08 ~ 
~~ ~ Q; 0.06 -t--fhf-' --~----~----j 
-e 
~ S 0.04 I i :;;:d I I I I ± 
;:, Q. • 
"0 0.02 
> o +------+--.----f-----~ 
o 5 10 15 
Flow 11m in 
.... RT est 4 Rotor 0 
+- RTest 24 Rotor 7 
...- RT est 43 Rotor 3 
"*"" RT est 83 Rotor 3G 
..... Test 141 Rotor 3X 
.... RT est 83 Rotor 38 
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Appendix 14.26 - Flow Vs Efficiency 
10 I/min @ 150 mm Hg, 
Flow Vs Efficiency 
10 
~ 8 -+- RT est 4 Rotor 0 0 
--- RTest 24 Rotor 7 >-
<..> 6 
... RT est 43 Rotor 3 c 
C1> 
.. RT est 83 Rotor 3G .~ 4 
- ..... RT est 141 Rotor 3X 
w 2 
--- RT est 83 Rotor 38 
0 
0 5 10 15 
Flow IImin 
Appendix 14.28 - Flow Vs Reynolds number 
250000 
"-
CD 
.0 200000 
E 
~ 150000 
rn 
~ 100000 
c 
~ 50000 
a:: 
0 
0 2 
10 I/min @ 150 mm Hg, 
Flow Vs Reynolds Number. 
' /! ,.... 
-+------l 
4 6 8 10 12 
Flow I/min 
-+- RT est 4 Rotor 0 
--- RT est 24 Rotor 7 
... RT est 43 Rotor 3 
Appendix 14.29 - Flow Vs Reynolds number. 
10 Ifmin @ 150 mm Hg, 
Flow Vs Reynolds Number 
3000 ~ A l 
~ 2500 ..ff ~ 2000 f~ 
c I 
~ 1500 
g 1000 f 
I 500 ~ ~ 
----
o :- ........ ---+--
o 5 10 15 
Flow IImin 
• RTest 24 Rotor 7 
-... RT est 43 Rotor 3 
-><- RTest 83 Rotor 3G 
.;,.. Test 141 Rotor 3X 
-IE- RTest 83 Rotor 38 
Appendix 14.31 - Flow Vs Torque parameter. 
i 
20 
~ 
Q) " a; 15 I 1: 
E 
10 IImin @ 150 mm Hg, 
Flow Vs Torque Parameter. 
~lOL~ : i ---j Q) j g. 5 
~ 
o 
..... 
o 
o 2 4 6 8 10 12 
Flowl/min 1 _________ . __________ ----
.... RT est 4 Rotor 0 
... RTest 24 Rotor 7 
~ RT est 43 Rotor 3 
-><- RT est 83 Rotor 3G 
...... Test 141 Rotor 3X 
.... RT est 83 Rotor 38 
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Appendix 14.30 - Flow Vs Pressure parameter 
10 IImin @ 150 mm Hg, 
Flow Vs Pressure Parameter 
..: 2 
~ i 
-+- RT est 4 Rotor 0 Q) I 
E 1.5 & i ... RTest 24 Rotor 7 '" i ~ 
--0- RT est 43 Rotor 3 
'" 1 c.. 
Q) +- ....- *- RTest 83 Rotor 3G 
... ~ ~ 0.5 -<>- Test 141 Rotor3X c 
IJ) 
Q) 
-4-- RTest 83 Rotor 38 
... 
c... 0 
0 5 10 15 
Flowl/min 
Appendix 14.32 - Flow Vs Speed. 
3000 
Comparison tests with three test fluids. 
10 IImin @ 100 mm Hg, 
Flow Vs Speed. 
~2500 I .. ~, -+-Test6RotorO ~~OO ; ~' =;.--- + Test 26 Rotor 7 
~ 1500. - - ----. --0- Test 45 Rotor 3 
~ 1000· i. -...- Test 85 Rotor 3G 
CI) I 
~ 500 I : .. Test 142 Rotor 3X 
o 
o 2 4 6 8 10 12 
Flow IImin 
Appendix 14.33 - Flow Vs Efficiency. 
14 
12 
~ 10 
>-
~ 8 
.!!! 6 
(.) 
::: 4 
w 
2 
0 
0 2 4 
10 I/min @ 100 mm Hg, 
Flow Vs Efficiency. 
6 
Flowl/min 
8 10 12 
..... RT est 6 Rotor 0 
... RTest 26 Rotor 7 
..... RT est 45 Rotor 3 
...... RTest 85 Rotor 3G 
..... Test 142 Rotor 3X 
+- RTest 85 Rotor 38 
Appendix 14.35 - Flow Vs Reynolds number 
10 IImin @ 100 mm Hg, 
Flow Vs Reynolds Number 
200000 
... 
II) 
.c 
E 150000 
::l 
..... RT est 6 Rotor 0 c 
~ 100000 ... RTest 26 Rotor 7 
0 I ..... RT est 45 Rotor 3 
;. 50000 
II) 
a:: 
0 
0 2 4 6 8 10 12 
Flow IImin 
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Appendix 14.34 - Flow Vs Flow parameter. 
10 I/min @ 100 mm Hg, 
Flow Vs Flow Parameter 
0.12 ! 
~ 0.1 ~ -+- RT est 6 Rotor 0 
..... £2:~ I ... RT est 26 Rotor 7 ~ 0.08 V I .... RT est 45 Rotor 3 '" :0 0.06 L I ...... RT est 85 Rotor 3G c.. ~ 0.04 
~ ~ Test 142 Rotor 3X 0 
"""" 
u::: 0.02 f:: .... RT est 85 Rotor 38 ~ 0 
0 2 4 6 8 10 12 
FlowUmin 
Appendix 14.36 - Flow Vs Reynolds number 
2500 
... 
'" ~ 2000 
~ 1500 
II> 
~ 1000 
0 
c: 
~ 500 
0:: 
0 
0 2 
10 I/min @ 100 mm Hg, 
Flow Vs Reynolds Number 
4 6 
Flow I/min 
8 10 12 
~ RTest 26 Rotor 7 
• RT est 45 Rotor 3 
• RTest 85 Rotor 3G 
+- Test 142 Rotor 3X 
• RTest 85 Rotor 38 
- -
I 
Appendix 14.37 - Flow Vs Pressure parameter 
10 IImin @ 100 mm Hg, 
Flow Vs Pressure Parameter 
... 
1.6 ~ ~ 1.4 
.. ..:::::,::t::, -+- RT est 6 Rotor 0 E 1.2 
.... RT est 26 Rotor 7 I co 1 ... 
.......... 
...... RT est 45 Rotor 3 ~0.8 
~ 0.6 .....- "*" RT est 85 Rotor 3G 
~ 0.4 L -<>- Test 142 Rotor 3Z 
CD a: 0.2 .... RT est 85 Rotor 38 
0 
0 2 4 6 8 10 12 
Flow I{min 
Appendix 14.39 - Flow Vs Speed. 
Comparison tests with three test fluids. 
5 IImin @ 200 mm Hg. 
Flow Vs Speed 
5000 ~--,-------,-----,----r-~ 
.= 4000 ~ 
..§ -='T 
~ 3000 7r~..., 
~2000 ~~ 
CD 
~1000 ~I 
OT---~--~--~--~--~~ 
o 2 3 
Flow I{min 
4 5 6 
-+- Test 8 Rotor 0 
.... Test 28 Rotor 7 
...... Test 47 Rotor 3 
"*" Test 87 Rotor 3G 
-<>- Test 143 Rotor 3X 
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Appendix 14.38- Flow Vs Torque parameter. 
30 
... 
CD 
-:;; 25 
~ 20 
:;. 15 
CD 
:::::I 10 
c-
::; 5 
I-
o 
o 2 
10 IImin @ 100 mm Hg, 
Flow Vs Torque Parameter. 
4 6 
Flow I{min 
8 10 12 
-+- RT est 6 Rotor 0 
+- RTest 26 Rotor 7 
..... RT est 45 Rotor 3 
"*" RT est 85 Rotor 3G 
-<>- Test 142 Rotor 3Z 
..... RTest 85 Rotor 38 
Appendix 14.40 - Flow Vs Efficiency. 
511min @ 200 mm Hg, 
Flow Vs Efficiency 
5 
-+- Test 8 Rotor 0 
c;E!4 
.. Test 28 Rotor 7 
;;3 
..... Test 47 Rotor 3 c: 
CD .~-- ... ~ Test 87 Rotor 3G 0;:; 2 
- ~ Test 143 Rotor 3X 
-w1 
.. Test 87 Rotor 38 
0 
0 2 3 4 5 6 
Flow I/min 
---- --~- -- -
Appendix 14.41 - Flow Vs Flow parameter. 
5 I/min @ 200 mm Hg, 
Flow Vs Flow Parameter 
0.05 
\ i I 
I 
... I 
..... Test 8 Rotor 0 ~ 0.04 !~ CI) +- Test 28 Rotor 7 I E 
nI 0.03 I 
! 
..... Test 47 Rotor 3 ... 
nI 
Q. 0.02 -><- Test 87 Rotor 3G 
~ 
...... Test 143 Rotor 3X ~ 0.01 
....... Test 87 Rotor 38 
0 
0 2 3 4 5 6 
Flow I/min 
Appendix 14.43- Flow Vs Reynolds number 
4000 
~ 3500 
E 3000 
~ 2500 
~ 2000 
"0 1500 
;. 1000 
::. 500 
o 
o 
5 I/min @ 200 mm Hg, 
Flow Vs Reynolds Number 
2 3 4 5 
Flow I/min 
6 
+- Test 28 Rotor 7 
..... Test 47 Rotor 3 
-><- Test 87 Rotor 3G 
...... Test 143 Rotor 3X 
....... Test 87 Rotor 38 
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Appendix 14.42 - Flow Vs Reynolds number 
5 I/min @ 200 mm Hg, 
Flow Vs Reynolds Number 
300000 , 
I ... I ! , ~ 250000 , 
; 200000 '~ 
..... Test 8 Rotor 0 c: /1 I ~ 150000 V ... Test 28 Rotor 7 ~ 100000 V ..... Test 47 Rotor 3 ~ 50000 
I 
0 
0 2 3 4 5 6 
Flowl/min 
-_ .. __ ._-
Appendix 14.44 - Flow Vs Pressure parameter 
5 I/min @ 200 mm Hg, 
Flow Vs Pressure Parameter 
1.2··-, --, ----, 
-----r 
... 1 .... Test 8 Rotor 0 Q) 
l..-...::::::: ~ 0.8 ~ :::l .. Test 28 Rotor 7 V-- , 1 
..... Test 47 Rotor 3 
'" ~ 0.6 
i 
I ..... Test 87 Rotor 3G a. I 
3: 0.4 I 1 .... Test 143 Rotor 3X 0 I u::: 0.2 
.--J- I I ... Test 87 Rotor 38 o - --
0 2 3 4 5 6 
Flow I/min 
Appendix 14.45 - Flow Vs Torque parameter. 
5 I/min @ 200 mm Hg, 
Flow Vs Torque Parameter 
... 
15 ~ CI) -+ Test 8 Rotor 0 -CI) ; 10 --- Test 28 Rotor 7 
... "--, ~ -+- Test 47 Rotor 3 co 
c.. 
"* Test 87 Rotor 3G ~ 5 ~ 
-11 
0- -<>- Test 143 Rotor 3X 
... 
0 
--- Test 87 Rotor 38 t-
O 
0 2 4 6 
Flowllmin 
-- ----
Appendix 14.47- Flow Vs Efficiency. 
511min @ 150 mm Hg, 
Flow Vs Efficiency 
6,-----,----,-----,----------,----, 
234 
Flowlimin 
5 6 
-+- Test 10 Rotor 0 
.. Test 30 Rotor 7 
-.- Test 49 Rotor 3 
-><- Test 89 Rotor 3G 
..... Test 144 Rotor 3X 
+- Test 89 Rotor 38 
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Appendix 14.46 - Flow Vs Speed. 
Comparison tests with three test fluids. 
5 IImin @ 150 mm Hg. 
Flow Vs Speed 
4000TI----~--~---,----.---~---. 
s:::: 
~ 3000 : :7 ....... ~ 
> 
CI) 
"'20001 ~ 
~ 
CI) 
~1oo0 I ~ 
en 
O+I----T----r----r----r--~--~ 
o 2 3 4 5 6 
Flowl/min 
r--------,/ 
-+- Test 10 Rotor 0 
.. Test 30 Rotor 7 
.... Test 49 Rotor 3 
"* Test 89 Rotor 3G 
..... Test 144 Rotor 3X 
Appendix 14.48 - Flow Vs Flow parameter 
0.05 
~ ... 0.04 
0", 
;;: a; 0.03 
"'E 
; ~ 0.02 
- ra 
00. 
> 0.01 
o 
0 
5 IImin @ 150 mm Hg, 
Flow Vs Volume Flow Parameter. 
~ -+- Test 1 0 Rotor 0 
~ .. Test 30 Rotor 7 
I • Test 49 Rotor 3 
• Test 89 Rotor 3G 
~ -<>- Test 144 Rotor 3X 
.. I 
• Test 89 Rotor 38 I 
2 4 6 
Flowllmin 
Appendix 14.49 - Flow Vs Reynolds number 
511min @ 150 mm Hg, 
Flow Vs Reynolds Number 
... 250000 
CD 
~ 200000 V j E' -+- Test 10 Rotor 0: c 150000 
III ~ V ~ Test 30 Rotor 7 ~ 100000 ~ .... Test 49 Rotor 3 c 
:; 50000 
a:: 
0 
0 2 3 4 5 6 
Flow I/min 
----
Appendix 14.51 - Flow Vs Pressure parameter 
5 IImin @ 150 mm Hg, 
Flow Vs Pressure Parameter. 
..: 1.2 I j 
~ 1 -+- Test 10 Rotor 0 ~ -~~~7 ~ 0.8 .1 .... Test 49 Rotor 3 ~ I 
:! 0.6 I ...... Test 89 Rotor 3G 
~ 0.4 I! ~ T"t1«Rot,,3X ~ 0.2- i -- Test 89 Rotor 38 
Il.. 0 ------,-- i I 
o 2 3 4 5 6 
Flowllmin 
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Appendix 14.50 - Flow Vs Reynolds number 
511min @ 150 mm Hg, 
Flow Vs Reynolds Number 
3500 
... 
1: 3000 
; 2500 ~ .. Test 30 Rotor 7 
~ 2000 ~ 
f;J!P 
.... Test 49 Rotor 3 
~ 1500 ~ 
I:? 
-><- Test 89 Rotor 3G 
0 
..eP ~ -<>- Test 144 Rotor 3X 
c 1000 
>-
~ 500 ell-- Test 89 Rotor 38 
0 
0 2 3 4 5 6 
Flow I/min 
Appendix 14.52 - Flow Vs Torque parameter. 
... 
CI> 
20 
~ 15 
E 
~ 
... 
~ 10 
CI> 
j 
~ 5 
o 
I-
o 
o 
5 IImin @ 150 mm Hg, 
Flow Vs Torque Parameter 
-
2 3 
Flowlimin 
4 5 6 
-+-- Test 10 Rotor 0 
+- Test 30 Rotor 7 
1-- Test 49 Rotor 3 
+- Test 89 Rotor 3G 
-<>- Test 144 Rotor 3X 
.... Test 89 Rotor 38 
Appendix 14.53 - Flow Vs Speed. 
Comparison tests with three fluids. 
51/min @ 100 mm Hg. 
Flow Vs Speed. 
3000 ~-~------'---'--'-------Y--I r-----~ 
.: 2500 -1---l---+--t--t~::;;;;4-------j 
-+- Test 12 Rotor 0 
... Test 32 Rotor 7 { 2000 t----+-------;----+--;;;7"~~;;..e:T_-­
~1500+--~-~~~~~r_-j_-, 
~1000+----k~~~--~--_t----t_---
Q) 
~ 500 
O~--~--~--+---+---+_~ 
o 2 3 
Flowl/min 
4 5 6 
-*"" Test 51 Rotor 3 
*" Test 91 Rotor 3G 
-<>- Test 145 Rotor 3X 
Appendix 14.55 - Flow Vs Flow parameter 
5 I/min @ 100 mm Hg, 
Flow Vs Flow Rate Parameter 
... 0.06 T 1..--------:--2! =:2t"" 
-+- Test 12 Rotor 0 
.... Test 32 Rotor 7 eO.05 ~ ~ 0.04 V 
c.. 0.03 
CD 
~ 0.02 
~ 0.01 ~ 
u.. 0 
o 2 3 
Flow IImin 
4 5 6 
.... Test 51 Rotor 3 
"*" Test 91 Rotor 3G 
..... Test 145 Rotor 3X 
.. Test 91 Rotor 38 
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Appendix 14.54 - Flow Vs Efficiency 
5 I/min @ 100 mm Hg, 
Flow Vs Efficiency 
7 
6 ...-.-' r-- -+- Test 12 Rotor 0 
~5 / '7 
.... Test 32 Rotor 7 
>- // ~ ~ ~ ~4 V L2 V--..----:::: ~ .... Test 51 Rotor 3 <I> 
*" Test 91 Rotor 3G .0 3 ffh ~ :::2 
..... Test 145 Rotor 3X w ~ 1 "*" Test 91 Rotor 3B 
0 
0 1 2 3 4 5 6 
Flowl/min 
--- - -
Appendix 14.56 - Flow Vs Reynolds number 
Sl/min @ 100 mm Hg, 
Flow Vs Reynolds Number 
200000 T' -----,----r----,.-------.----~--~ 
... 
CD 
.g 
e150000 1;;>/ 
:::> 
c: 
~ 100000 1 =-....-=: 
o 
;. 50000 tl -----'~-+__--+-----1--~-
CD 
a: 
O I • I I .---------, 
o 2 3 4 5 6 
Flowl/min 
,------
• + Test 12 Rotor 0 
i ... Test 32 Rotor 7 
i· Tes!§1Rotor 3 
Appendix 14.57 - Flow Vs Reynolds number 
Sl/min @ 100 mm Hg, 
Flow Vs Reynolds Number 
2500 " -------,---~--:__~ 
... I ~/' ~ 2000 ./; 
E ~ ~ 1500 I :v-
III 
::!:! 1000 I ~ 
o _ ~~I~ 
o 2 4 6 
Flowl/min 
... Test 32 Rotor 7 
...... Test 51 Rotor 3 
*" Test 91 Rotor 3G 
-<>-- Test 145 Rotor 3X 
.... Test 91 Rotor 38 
Appendix 14.59 - Flow Vs Torque parameter. 
... 
Q) 
25 
CD 20 
E 
~ 15 
'" a. 
Q) 10 
~ 
~ 5 
o 
~ 
o 
o 
Sl/min @ 100 mm Hg, 
Flow Vs Torque parameter. 
2 3 
Flowllmin 
4 5 6 
-+- Test 12 Rotor 0 
--- Test 32 Rotor 7 
- Test 51 Rotor 3 
...... Test 91 Rotor 3G 
-<>- Test 145 Rotor 3X 
• Test 91 Rotor 38 
--- ---------------------------' 
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Appendix 14.58 - Flow Vs Pressure parameter 
SlImin@ 100 mm Hg, 
Flow Vs Pressure Parameter 
... 1.2 
CI> 
.... 1 .... Test 12 Rotor 0 CI> 
E ~ ... Test 32 Rotor 7 ~ 0.8 
'" 
-+- Test 51 Rotor 3 0.0.6 
CI> 
...... Test 91 Rotor 3G ~ 0.4 
"*" Test 145 Rotor 3X III 
~ 0.2 
...... Test 91 Rotor 38 
Q. 0 
0 1 2 3 4 5 6 
Flow IImin 
---' 
Appendix 14.60 - Flow Vs Speed 
Comparison tests with three test fluids. 
10 I/min 'as found'. 
Flow Vs Speed. 
1400 -,----,-----r----,----
.: 1200 ! I l.,. 
..§ 1000 I --== ---~ ~ 800 I ~ 
"0 600 
: 400 --~ 
::; 200 -I------------~-__t 
o -I------i------+--~---r___--+----- ., 
o 2 4 6 
Flowllmin 
8 10 12 
• Test 1 Rotor 0 
• Test 21 Rotor 7 
. ~ Test 40 Rotor 3 
• Test 80 Rotor 3G 
Appendix 14.61 - Flow Vs Efficiency. 
12 
o 10 
~ 
~ 8 
.~ 6 
u 
:E 4 
w 
10 IImin 'as found', 
Flow Vs Efficiency 
~'i ?f:; I I I I 
o 2 4 6 
Flowl/min 
8 10 12 
.... Test 1 Rotor 0 
--- Test 21 Rotor 7 
-.- Test 40 Rotor 3 
-*- Test 80 Rotor 3G 
-..- Test 80 Rotor 3B 
Appendix 14.63 - Flow Vs Reynolds number 
... 80000 
Q) 
.c 
E 60000 
:::I 
c: 
~ 40000 
o 
;'20000 
CI> 
0:: 
o 
o 2 
10 I/min 'as found', 
Flow Vs Reynolds Number 
4 6 8 10 
Flow I/min 
12 
.... Test 1 Rotor 0 
--- Test 21 Rotor 7 
-.- Test 40 Rotor 3 
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Appendix 14.62 - Flow Vs Flow parameter 
0.3 
2 0.25 
Q) 
E 0.2 
'" ;;; 0.15 
(L 
== 0.1 
o 
u::: 0.05 
o 
o 
I 
10 I/min 'as found', 
Flow Vs Flow Parameter 
! 1 
! ~
1/ I , 
/ 
LV ~ 
.. -~ 
~ 
2 4 6 8 10 
Flowl/min 
J j 
J 
J 
J 
12 
.... Test 1 Rotor 0 
.... Test 21 Rotor 7 
..... Test 40 Rotor 3 
"*" Test 80 Rotor 3G 
... Test 80 Rotor 3B 
Appendix 14.64 - Flow Vs Reynolds number 
1000 
... 
... 
.c 800 
E 
~ 600 
CII 
~ 400 
0 
c: 
~ 200 
0:: 
0 
0 2 
10 I/min 'as found', 
Flow Vs Reynolds Number 
, • , • T ~ 
4 6 8 10 12 
Flow I/min 
~ Test 21 Roted 
..... Test 40 Rotor 3 
...- Test 80 Rotor 3GI
1 l - Test 80 Rotor 3B I: 
Appendix 14.65 - Flow Vs Pressure parameter 
10 I/min, 'as found', 
Flow Vs Pressure Parameter 
.. 1.4 
Q) Q;1.2 
;;;;::: -+- Test 1 Rotor 0 E 1 
-- Test 21 Rotor 7 ." .. a-[ 0.8 
..... Test 40 Rotor 3 ~ 0.6 
-- Test 80 Rotor 3G I ; 0.4 
.... Test 80 Rotor 3B (I) ~ 0.2 
c.. 0 
0 2 4 6 8 10 12 
Flow IImin 
Appendix 14.67- Flow Vs Speed. 
4000 
c: 
..§ 3000 
> 
~ 2000 
"0 
Q) 
~ 1000 
en 
0 
0 
Comparison tests with three test fluids. 
10 IImin @ 200 mm Hg, Inlet Valve Set. 
2 4 
Flow Vs Speed. 
6 
Flowllmin 
8 10 12 
..... Test 15 Rotor 0 
.... Test 35 Rotor 7 
..... Test 54 Rotor 3 
"*" Test 94 Rotor 3G 
"*" Test 146 Rotor 3X 
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Appendix 14.66 - Flow Vs Torque parameter 
10 I/min 'as found', 
Flow vs Torque Parameter 
40 
! ~ 35 
E 30 '---~~ I ... Test 1 Rotor 0  
... Test 21 Rotor 7 ~ 25 I ~ ~20 ~ ..... Test 40 Rotor 3 ~ 15 
- Test 80 Rotor 3G 
~10 
..... Test 80 Rotor 3B 
::. 5 I 0 
0 2 4 6 8 10 12 
Flow IImin 
Appendix 14.68 - Flow Vs Efficiency. 
8 
7 
~6 
~5 
;4 
.~ 3 
~2 
1 
o 
o 2 
10 IImin @200 mm Hg. 
Flow Vs Efficiency, Inlet Valve Set 
4 6 
Flow I/min 
8 10 12 
... Test15RotorO 
... Test 35 Rotor 7 
... Test 54 Rotor 3 
"*" Test 94 Rotor 3G 
..... T est146 Rotor 3X 
... Test 94 Rotor 38 
Appendix 14.69 - Flow Vs Flow parameter 
10 I/min @200 mm Hg, 
Flow Vs Flow Parameter, Inlet Valve Set. 
0.10 
1 I ... -+- Test 15 Rotor 0 
.e 0.08 
Q) lL:\ i .... Test 35 Rotor 7 E 
tel 0.06 g I I I ..... Test 54 Rotor 3 ... tel ! 
-*"" Test 94 Rotor 3G Cl. 0.04 
:JI: " i 
..... Test146 Rotor 3X ~ 0.02 ~. 
-'<- Test 94 Rotor 38 u.. I 
0.00 1 
0 2 4 6 8 10 12 
Flow Ifmin 
Appendix 14.71 - Flow Vs Reynolds number 
10 IImin @ 200 mm Hg, 
Flow Vs Reynolds Number, Inlet Valve Set. 
... 3500 r-~-'--~---,------r-----'~~~­
~ 3000 I---;---.L.---+--t-~,,+----J 
E 2500 .... Test 35 Rotor 7 
:::l 
c: 2000 ..... Test 54 Rotor 3 
III ~ 1500 -*"" Test 94 Rotor 3G 
o c: 1000 ..... T est146 Rotor 3X 
>-~ 500 I -«- Test 94 Rotor 38 
o 
o 2 4 6 8 10 12 
Flow IImin 
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Appendix 14.70 - Flow Vs Reynolds number 
10 "min @200 mm Hg, 
Flow Vs Reynolds Number, Inlet Valve Set. 
250000 ,I ---,---,---,----,------
... 
Q) .. ~ 200000 I 7£, I '-, -----,I 
~ 150000 I 7"" 
III 
~ 100000 I :0-/ I 
o 
c: 
~ 50000 =-¥' 
0::: 
o I • • •• •• 
... Test 15 Rotor 0 
.... Test 35 Rotor 7 
... Test 54 Rotor 3 
o 2 4 6 
Flowllmin 
8 10 12 
Appendix 14.72 - Flow Vs Pressure parameter 
... 1.6 
~ 1.4 
Q) 
, E 1.2 
~ 1.0 
'" 0.0.8 
~ 0.6 
;;: 0.4 
III 
~ 0.2 
a.. 0.0 
10 IImin @ 200 mm Hg, 
Flow Vs Pressure Parameter, Inlet Valve Set 
-J--t----.~"'--+I----t---I::::..--I _ i 
f": 
o 
:..:.. --I ~ -r---+ - -- 1 
I __ ,- I 
2 4 
--+----j-
---- ---t-
----
6 
Flowllmin 
8 10 12 
..... Test 15 Rotor 0 
... Test 35 Rotor 7 
... Test 54 Rotor 3 
.... Test 94 Rotor 3G i 
.... Test146 Rotor 3xl 
l:""" Test 94 Rotor 3B i 
Appendix 14.73 - Flow Vs Torque parameter. 
..: 20 
<II 
~ 15 
I'CI 
... 
~ 10 
<II 
:::l l: 5 
Q. 
I- o 
o 
10 I/min @200 mm Hg, 
Flow Vs Torque Parameter, Inlet Valve Set. 
2 4 6 
Flow IImin 
8 10 12 
-+- Test 15 Rotor 0 
--- Test 35 Rotor 7 
-6- Test 54 Rotor 3 
...- Test 94 Rotor 3G 
-<>- Test146 Rotor 3X 
+- Test 94 Rotor 38 
Appendix 14.75 - Flow Vs Efficiency. 
6 
5 
~ 
" 
»4 
<..) 
~3 
<..) 
::;2 
w 
1 
0 
0 
5l1min@ 100 mm Hg, 
Flow Vs Efficiency, Inlet valve Set 
2 3 4 5 6 
Flowllmin 
-+- Test 16 Rotor 0 
--- Test 36 Rotor 7 
..... Test 55 Rotor 3 
...- Test 95 Rotor 3G 
~ Test 147 Rotor 3X 
+- Test 95 Rotor 38 
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Appendix 14.74 - Flow Vs Speed. 
Comparison tests with three test fluids. 
5 I/min @ 100 mm Hg, Inlet Valve Set. 
Flow Vs Speed . 
3000~------------,---,----.---, 
.=2500+---~---------T----~~~--~ 
~2000+----+--------~~~~~~---­
~1500+----+----~~~~~T----[----
~ 
: 1000+---~~~~~--r_--_r----r_----
~ 500+---------~----~--_r----T_--_, 
O+---~---,~--~--_+----~~ 
o 2 3 
Flow I/min 
4 5 6 
.... Test 16 Rotor 0 
.... Test 36 Rotor 7 
..... Test 55 Rotor 3 
*" Test 95 Rotor 3G 
..... Test 147 Rotor 3X 
Appendix 14.76 - Flow Vs Flow parameter 
... 0.07 
CI) 
-:;;0.06 
~ 0.05 
... 
~0.04 
~0.03 
'" ... 0.02 
~ ~0.01 
LL 0 
o 
5 IImin @ 100 mm Hg, 
Flow Vs Flow Rate Parameter, Inlet Valve Set 
2 3 4 5 
Flowllmin 
... Test 16 Rotor 0 
... Test 36 Rotor 7 
- ..... Test 55 Rotor 3 1[' 
*" Test 95 Rotor 3G i 
I, 
~ Test 147 Rotor 3X 
-----j I ... Test 95 Rotor 38 
--1 
6 
Appendix 14.77 - Flow Vs Reynolds number 
51/min @ 100 mm Hg, 
Flow Vs Reynolds Number, Inlet Valve Set 
200000 
I ... j CI> ~ / E 150000 
1 ~I,~ ~ :::l I -+- Test 16 Rotor 0 c: 
II) 100000 .... Test 36 Rotor 7 
:2 ~ --- Test 55 Rotor 3 0 ;. 50000 
CI> 1 1 a::: 0 
0 2 3 4 5 6 
Flowl/min 
_._---
Appendix 14.79 - Flow Vs Pressure parameter 
5 I/min @ 100 mm Hg, 
Flow Vs Pressure Parameter, Inlet Valve Set 
... 1.4 ~ i ~ 1.2 -+- Test 16 Rotor 0 
~ 1.0 I ..... Test 36 Rotor 7 
~ 0.8 I I --- Test 55 Rotor 3 
~ 0.6 i -><- Test 95 Rotor 3G 
~ 0.4 1 ..... Test 147 Rotor 3X 
II) I ~ 0.2 -4-- Test 95 Rotor 3B 
~ 0.0 L1 234 Flowllmin 5 6 
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Appendix 14.78 - Flow Vs Reynolds number 
51/min @ 100 mm Hg, 
Flow Vs Reynolds Number, Inlet Valve Set 
2500 
... 
CI> A ~ 2000 .... Test 36 Rotor 7 ¢? 
:::l ~ 
--- Test 55 Rotor 3 c: 1500 ~ P" II) "*- Test 95 Rotor 3G ~ 1000 .--::1 ~ ..... Test 147 Rotor 3X c: 
~ 500 - ... Test 95 Rotor 3B ,.......-
a::: 
0 
0 1 2 3 4 5 6 
Flow I/min 
Appendix 14.80 - Flow Vs Torque parameter 
5 IImin @ 100 mm Hg, 
Flow Vs Torque Parameter, Inlet Valve Set 
25 I l ... I Q) -+- Test 16 Rotor 0 
-:;; 20 ~i I r--E I i ... Test 36 Rotor 7 ~ 15 
co ~, I I .... Test 55 Rotor 3 0- I 
"*- Test 95 Rotor 3G 
'" 10 
---
- .--~ 
:::l 
be ..... Test 147 Rotor 3X ~ 5 
0 , 
.. Test 95 Rotor 38 I-
0 
0 1 2 3 4 5 6 
Flow I/min 
- -
Appendix 14.81 Test fluid - water / glycerine. Constant 
speed tests, 1000 -3500 rev/min. Flow Vs Delivery Presure 
- optimum rotor - flow of 10 I/min. 
300 
250 
'" x e200 
e 
e 150 
" ~ 100 
11. 
50 
0 
0 
Rotor three, constant speed (rev/min), test fluid water I glycerine. 
Flow Vs Delivery Pressure 
6 
Flowl/mln 
8 10 12 
--1000 
~1500 
~2000 
--2500 
__ 3000 
--- 3500 
Appendix 14.83. Test fluid - water / glycerine. Constant 
speed tests 1000 - 3500 rev/min. Flow Vs Delivery Pressure -
optimum rotor - flow of 5 I/min 
Rotor three, constant speed (rev/min), test fluid water / glycerine. 
Flow Vs Delivery Pressure. 
~f 
'" 250 _ : ::: ~ 200 -
~ 150 j --
: 
! 100 __ ~ _ 
0. 
50 
o+-
o 
-. 
~-------.---
5 
Flow Umln 
~ 1000 
__ 1500 
~2000 
__ 2500 
-M-3000 
___ 3500 
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Appendix 14.82. Test fluid - water / glycerine. 
Constant speed tests, 1000 - 3500 rev/min. Flow Vs 
Differential Pressure - optimum rotor - flow of 10 IImin. 
Rotor three, constant speed (rev/min), test fluid water / glycerine. 
Flow Vs Differential Pressure. 
300T'---------------------------
250+1--~----~--------------~--*-~~---------
t '00 I I:: ~ ~ ~ ~ ~ ~ ~ : ~ ~ a.. • * .. .. • • • .. • 
50+1--~--~ __ --__ --._~~ ____ ~--~ __ -------
o 4 10 12 
Flowllmin 
------1000 
-+-1500 
~2000 
....... 2500 
"'*"3000 
.....3500 
Appendix 14.84. Test fluid - water I glycerine. 
Constant speed tests, 1000 - 3500 rev/min. Flow Vs 
Differential Pressure - optimum rotor - flow of 5 I/min. 
Rotor three. constant speed (rev/min), test fluid water I glycerine. 
Flow Vs Differential pressure. 
300 -- -------
I 
250 I ____ _ ~ 200 ~ ------.~~~ 
~ 150 t------ -----
~ .-----* -----. 
., 100 - --- ----I I -- ----- ------..-- ~- -. 
50 +- -
0+- ---
5 
Flow Urnln 
------- -~ 
• 1000 
...... 1500 
.·2000 
··2500 
3000 
• 3500 
Appendix 14.85. Test fluid - water / xanthan gum. 
Constant speed tests 1000 - 4000 rev/min. Flow Vs 
Delivery Pressure - optimum rotor - flow of 10 Ilmin 
300 
250 
'" J: 
E 200 
E 
?: 150 
G 
~ 100 
c 
50 
0 
0 
Rotor three, constant speed, test fluid water + xanthan gum. 
Flow Vs Delivery pressure. 
4 6 
Flow lIml" 
10 12 
.... 1000 
.... 1500 
___ 2000 
.... 2500 
..... 3000 
.... 3500 
~4000 
Appendix 14.87. All test fluids. Constant speed tests 
Tests 1000 - 2500 rev/min. Flow Vs Power -optimum 
rotor - flow of 10 I/min. 
Rotor thre., constant speed, 1000 to 2500 rev/min, .11 test fluids. 
Power consumption Vs Flow. 
40 i--:---a--B e e e e e E> 
351-~ ~ --
i :f--- -H~H :-: .--c:-. .c'. : i 2(): (j-'-'" 0 e Q . 0 <± 0 ~
· :1 ~jmiIjii~~§ 
10 12 
Fla.llmkl 
-+-1000w 
__ '00<l0 
-.·10CJ0x 
-.-1SOOw 
~1500g 
,,,·1500II: 
____ 2000w 
-<>-200<l0 
.• - 2000x 
-+-25OOw 
-+-2500g 
•• 2SOOJ: 
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Appendix 14.86. Test fluid - water / xanthan 
gum Constant speed tests 1000 - 4000 rev/min. Flow Vs 
Differential Pressure - optimum rotor - flow of 10 Ilmin 
300 
250 
'" ~ 200 
E 
! 150 
" ~ e 100 
0-
50 
0 
0 
Rotor three, constant speed, test fluid water and xanthan gum. 
Flow Vs Differential pressure. 
4 6 
FlowUmin 
8 10 12 
.... 1000 
.... 1500 
-*"2000 
-+- 2500 
-«-3000 
.... 3500 
-+-4000 
Appendix 14.88. All test fluids. Constant speed 
tests 2500 - 4000 rev/min. Flow Vs Power - optimum 
rotor -flow of 10 I/min. 
Rotor three, constant sp •• d, 2500 to 4000 revlmln, .11 t •• t fluid •. 
Power conaumptlon V. flow 
1.oCCl ~ 
12(1 -- • . ~~-----
100 • ~ OIl __ ~ : .... ~ ~ ~ '.;~'H H~H H~H''t 
~ • • * * a a ~-. j OIl ._______:i :i :;:;i"" .. i\;-c;Z. i ·K· :i H i 
• • • • -----+------ • • • .------. 
40 _-+"""''''-1";= .~. • ~ . ~ l"J ," ~ t-, 
20 ___ !-. I , 'H ',HH, .H ...... H. i 
o +---
, 
.0 F __ 11 
_. 
''''-25OOw 
~2500g 
• 250e,.; 
-+-.000w 
-+-3000" 
• 3000. 
--. ·35QOw 
........ 500g 
... 3MXb: 
• 4000w 
e· 4000 • 
Appendix 14.89. Two test fluids. Constant speed tests 
1000 - 4000 rev/min. Flow Vs Power - optimum 
rotor - flow of 5 I/min. 
140 
120 
l! 100 
.. 
~ 80 
:; 60 ~ 
0 
a. 40 
20 
0 
0 
Rotor three, constant speed, 1000 to 4000 rv/min, all test fluids. 
Power consumption Vs Flow 
_+_100Ow 
--e---10oog 
-+-150Ow 
• • • • • --6-1500g 
__ 2000w 
/!i' I'f I'f --/!i'- - 1\ __ 2000g 
--+--250Ow ~ .,. . .,.:~ . .., ::.,.~.,..-:-.--:.-:~:-~:-.-:-.-:-.~,.., ,,*--=-.-:-.--:.-:::.~ -+-2500g 
·.·3000w ~"""""·1I"""""·1"""·""'''''·''''''. .G.30oog 
iii i i =::~~~: 
2 3 
Flow l/min 
4 
.. ·400Ow 
6 
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